A Generation Ahead
2013 Form 10-K & Proxy
249494_Xilinx_CVR_R1.indd 1
6/13/13 4:49 PM
2013 Form 10-K & Proxy
Financial Highlights
(In Thousands, Except Per Share Amounts)
FY 2013
Net Revenues
Operating Income
Net Income
Diluted Earnings Per Share
Cash Dividends Paid Per Share
Net Revenues By End Markets
(Percent of Total Net Revenues)
Communications and Data Center
Industrial, Aerospace and Defense
Broadcast, Consumer and Automotive
Other
Net Revenues By Geography
(Percent of Total Net Revenues)
North America
Asia Pacific
Europe
Japan
$ 2,168,652
$ 580,732
$ 487,536
1.79
$
0.88
$
46%
34%
16%
4%
30%
35%
25%
10%
FY 2012
$ 2,240,736
$ 627,773
$ 530,079
1.95
$
0.76
$
45%
35%
15%
5%
31%
33%
26%
10%
249494_Xilinx_CVR_R1.indd 2
6/13/13 4:49 PM
2013
Form 10K
This page intentionally left blank.
United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 10-K
(Mark One)
(cid:59) Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended March 30, 2013
(cid:134) Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ___________ to ____________.
Commission File Number 000-18548
Xilinx, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
2100 Logic Drive, San Jose, CA
(Address of principal executive offices)
77-0188631
(I.R.S. Employer
Identification No.)
95124
(Zip Code)
(Registrant’s telephone number, including area code) (408) 559-7778
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common stock, $0.01 par value
Name of each exchange on which registered
The NASDAQ Global Select Market
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES (cid:59) NO (cid:134)
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. YES (cid:134) NO (cid:59)
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. YES (cid:59) NO (cid:134)
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files). YES (cid:59) NO (cid:134)
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405) is not contained herein, and will
not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III
of this Form 10-K or any amendment to this Form 10-K. (cid:59)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting
company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange
Act.
Large accelerated filer (cid:59)
Accelerated filer (cid:134)
Non-accelerated filer (cid:134)
Smaller reporting company (cid:134)
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES (cid:134) NO (cid:59)
The aggregate market value of the voting stock held by non-affiliates of the registrant based upon the closing price of the registrant’s common
stock on September 29, 2012 as reported on the NASDAQ Global Select Market was approximately $7,673,124,000. Shares of common stock
held by each executive officer and director and by each person who owns 5% or more of the outstanding common stock have been excluded
in that such persons may be deemed affiliates. This determination of affiliate status is not necessarily a conclusive determination for other
purposes.
As of May 10, 2013, the registrant had 263,863,503 shares of Common Stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Parts of the Proxy Statement for the Registrant’s Annual Meeting of Stockholders to be held on August 14, 2013 are incorporated by
reference into Part III of this Annual Report on Form 10-K.
Xilinx, Inc.
Form 10-K
For the Fiscal Year Ended March 30, 2013
TABLE OF CONTENTS
PART I
Item 1. Business
Item 1A. Risk Factors
Item 1B. Unresolved Staff Comments
Item 2. Properties
Item 3. Legal Proceedings
Item 4. Mine Safety Disclosures
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 6. Selected Financial Data
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 7A. Quantitative and Qualitative Disclosures about Market Risk
Item 8. Financial Statements and Supplementary Data
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9A. Controls and Procedures
Item 9B. Other Information
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Item 11. Executive Compensation
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13. Certain Relationships and Related Transactions, and Director Independence
Item 14. Principal Accounting Fees and Services
PART IV
Item 15. Exhibits and Financial Statement Schedules
Signatures
Page
3
3
14
22
22
23
24
25
25
27
28
40
42
80
80
81
82
82
82
82
83
83
83
84
86
-2-
PART I
FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements may be found throughout this Annual Report and particularly in Items 1.
"Business" and 3. "Legal Proceedings" which contain discussions concerning our development efforts, strategy, new product
introductions, backlog and litigation. Forward-looking statements involve numerous known and unknown risks and
uncertainties that could cause actual results to differ materially and adversely from those expressed or implied. Such risks
include, but are not limited to, those discussed throughout this document as well as in Item 1A. "Risk Factors." Often,
forward-looking statements can be identified by the use of forward-looking words, such as "may," "will," "could," "should,"
"expect," "believe," "anticipate," "estimate," "continue," "plan," "intend," "project" and other similar terminology, or the
negative of such terms. We disclaim any responsibility to update or revise any forward-looking statement provided in this
Annual Report or in any of our other communications for any reason.
ITEM 1.
BUSINESS
Xilinx, Inc. (Xilinx, the Company or we) designs and develops programmable devices and associated technologies, including:
•
•
•
•
•
integrated circuits (ICs) in the form of programmable logic devices (PLDs), including programmable System on Chips
(SoCs) and three dimensional ICs, or 3D ICs;
software design tools to program the PLDs;
targeted reference designs;
printed circuit boards; and
intellectual property (IP), which consists of Xilinx and various third-party verification and IP cores.
In addition to its programmable platforms, Xilinx provides design services, customer training, field engineering and technical
support.
Our PLDs include field programmable gate arrays (FPGAs), complex programmable logic devices (CPLDs) that our customers
program to perform desired logic functions, and programmable SoCs, which combine industry standard ARM® processor-based
systems with programmable logic in a single device. We also design and develop 3D ICs, which stack FPGA logic die or a
combination of FPGA and 28 Gigabits/second (28G) transceiver die in a single package to exceed the capacity and bandwidth
of monolithic devices, but with manufacturing and time-to-volume advantages of smaller die. Our products are designed to
provide high integration and quick time-to-market for electronic equipment manufacturers in end markets such as wired and
wireless communications, industrial, scientific and medical, aerospace and defense, audio, video and broadcast, consumer,
automotive and data processing.
We sell our products and services through independent domestic and foreign distributors and through direct sales to original
equipment manufacturers (OEMs) and electronic manufacturing service providers (EMS). Sales are generated either by these
independent distributors, independent sales representative or our direct sales organization.
Xilinx was founded and incorporated in California in February 1984. In April 1990, the Company was reincorporated in
Delaware. Our corporate facilities and executive offices are located at 2100 Logic Drive, San Jose, California 95124, and our
website address is www.xilinx.com.
Industry Overview
There are three principal types of ICs used in most digital electronic systems: processors, which generally are utilized for
control and computing tasks; memory devices, which are used for storing program instructions and data; and logic devices,
which generally are used to manage the interchange and manipulation of digital signals within a system. Xilinx designs and
develops PLDs, a type of logic device. Alternatives to PLDs may include application specific integrated circuits (ASICs) and
application specific standard products (ASSPs). PLDs, ASICs and ASSPs may be utilized in many of the same types of
electronic systems. However, differences in unit pricing, development cost, product performance, reliability, power
consumption, capacity, features and functionality, ease of use and time-to-market determine which devices are best-suited for
specific applications.
-3-
PLDs have key competitive advantages over ASICs and ASSPs, including:
•
•
Faster time-to-market and increased design flexibility. Both of these advantages are enabled by Xilinx desktop
software which allows users to implement and revise their designs quickly. In contrast, ASICs and ASSPs require
significant development time and offer limited, if any, flexibility to make design changes.
PLDs are standard components. This means that the same device can be sold to many different users for a myriad of
applications. In sharp contrast, ASICs and ASSPs are customized for an individual user or a specific application.
PLDs are generally disadvantaged in terms of relative device size when compared to chips that are designed to perform a fixed
function in a single or small set of applications. ASICs and ASSPs tend to be smaller than PLDs performing the same fixed
function, resulting in a lower unit cost. However, there is a high fixed cost associated with ASIC and ASSP development that
is not applicable to PLD customers. This fixed cost of ASIC and ASSP development is expected to significantly increase on
next generation technology nodes. From a total cost of development perspective, ASICs and ASSPs have generally been more
cost effective when used in high-volume production; and PLDs have generally been more cost effective when used in low- to
mid-volume production. However, we expect PLDs to be able to address higher volume applications and gain market share
from ASIC and ASSP suppliers as the fixed cost of ASIC and ASSP development increases on next generation technology
nodes.
An overview of typical PLD end market applications for our products is shown in the following table:
-4-
End Markets
Sub-Segments
Applications
Communications & Data Center
Wireless
Wireline
Industrial, Aerospace & Defense
Industrial, Scientific and Medical
Aerospace and Defense
Broadcast, Consumer &
Consumer
Automotive
Automotive
Audio, Video and Broadcast
Storage and Servers
Office Automation
Other
• 3G/4G Base Stations
• Wireless Backhaul
• Enterprise Routers and Switches
• Metro Optical Networks
• Data Centers
• Factory Automation
• Medical Imaging
• Test and Measurement Equipment
• Satellite Surveillance
• Radar and Sonar Systems
• Secure Communications
• Digital Televisions
• Digital SLR Cameras
• Set-Top Boxes
• Infotainment Systems
• Driver Information Systems
• Driver Assistance Systems
• Cable Head-End Systems
• Post Production Equipment
• Broadcast Cameras
• Security and Encryption
• Computer Peripherals
• Copiers
• Printers
Strategy and Competition
Our strategy for expansion is the displacement of ASICs and ASSPs in the development of next generation electronic systems.
The costs and risks associated with application-specific devices can only be justified for high-volume or highly-specialized
commodity products. Programmable platforms, alternatively, are becoming critical for our customers to meet increasingly
stringent product requirements - cost, power, performance and density - in a business environment characterized by increased
complexity, shrinking market windows, rapidly changing market demands, capped engineering budgets, escalating ASIC and
ASSP non-recurring engineering costs and increased economic and development risk.
With every new generation of FPGAs, our strategy is to increase the performance, density and system-level functionality and
integration, while driving down cost and power consumption at each manufacturing process node. This enables us to provide
simpler, smarter programmable platforms and design methodologies allowing our customers to focus on innovation and
differentiation of their products.
Our PLDs compete in the logic IC industry, an industry that is intensely competitive and characterized by rapid technological
change, increasing levels of integration, product obsolescence and continuous price erosion. We expect increased competition
from our primary PLD competitors, Altera Corporation (Altera), Lattice Semiconductor Corporation (Lattice) and Microsemi
Corporation (Microsemi) and from new companies that may enter the traditional programmable logic market segment. In
addition, we expect continued competition from the ASIC market, which has been ongoing since the inception of FPGAs, as
well as competition from the ASSP market. Other competitors include manufacturers of:
high-density programmable logic products characterized by FPGA-type architectures;
high-volume and low-cost FPGAs as programmable replacements for ASICs and ASSPs;
•
•
• ASICs and ASSPs with incremental amounts of embedded programmable logic;
-5-
•
•
•
•
•
high-speed, low-density CPLDs;
high-performance digital signal processing (DSP) devices;
products with embedded processors;
products with embedded multi-gigabit transceivers; and
other new or emerging programmable logic products.
We believe that important competitive factors in the logic IC industry include:
•
•
•
•
•
•
•
•
•
•
product pricing;
time-to-market;
product performance, reliability, quality, power consumption and density;
field upgradability;
adaptability of products to specific applications;
ease of use and functionality of software design tools;
availability and functionality of predefined IP;
inventory and supply chain management;
access to leading-edge process technology and assembly capacity; and
ability to provide timely customer service and support.
Silicon Product Overview
A brief overview of the silicon product offerings is listed in the table below. These products comprise the majority of our
revenues. Additionally, some of our more mature product families have been excluded from the table, although they continue to
generate revenues. We operate and track our results in one operating segment for financial reporting purposes.
-6-
Product Families
PLDs
Virtex®-7
Kintex®-7
Artix®-7
Zynq®-7000
Virtex-6
Spartan®-6
Virtex-5
Date
Introduced
June 2010
June 2010
June 2010
March 2011
February 2009
February 2009
May 2006
See information under the caption "Results of Operations - Net Revenues" in Item 7. "Management’s Discussion and Analysis
of Financial Condition and Results of Operations" for information about our revenues from our product families.
28-nanometer (nm) Product Families
The 7 series devices that comprise our 28-nm product families are fabricated on a high-K metal gate, high performance, low
power 28-nm process technology. These devices are based on a scalable and optimized architecture, which enables design, IP
portability and re-use across all families as well as provides designers the ability to achieve the appropriate combination of I/O
support, performance, feature quantities, packaging and power consumption to address a wide range of applications. The 7
series devices consist of the following three families:
• Virtex-7 FPGAs, including 3D ICs, are optimized for applications requiring the highest capacity, performance, DSP
and serial connectivity with transceivers operating up to 28G. Target applications include 400G and 100G line cards,
high-performance computing and test and measurement applications.
• Kintex-7 FPGAs represent Xilinx’s first mid-range FPGA family. These devices maximize price-performance and
performance per watt. Target applications include wireless LTE infrastructure, video display technology and medical
imaging.
• Artix-7 FPGAs offer the lowest power and system cost at higher performance than alternative high volume FPGAs.
These devices are targeted to high volume applications such as handheld portable ultrasound devices, multi-function
printers and software defined radio.
The Zynq-7000 family is the first family of Xilinx programmable SoCs. This new class of product combines an industry-
standard ARM dual-core Cortex™-A9 MPCore™ processing system with Xilinx 28-nm architecture. There are five devices in
the Zynq-7000 SoC family that allow designers to target cost sensitive as well as high-performance applications from a single
platform using industry-standard tools. These devices are designed to enable incremental market opportunities in applications
such as industrial motor control, driver assistance and smart surveillance systems, and smart heterogeneous wireless networks.
40-nm and 45-nm Product Families
The Virtex-6 FPGA family consists of 13 devices and is the sixth generation in the Virtex series of FPGAs. Virtex-6 FPGAs
are fabricated on a high-performance, 40-nm process technology. There are three Virtex-6 families, and each is optimized to
deliver different feature mixes to address a variety of markets as follows:
• Virtex-6 LXT FPGAs - optimized for applications that require high-performance logic, DSP and serial connectivity
with low-power 6.6G serial transceivers.
• Virtex-6 SXT FPGAs - optimized for applications that require ultra high-performance DSP and serial connectivity
with low-power 6.6G serial transceivers.
• Virtex-6 HXT FPGAs - optimized for communications applications that require the highest-speed serial connectivity
with up to 11.2G serial transceivers.
-7-
The latest generation in the Spartan FPGA series, the Spartan-6 FPGA family, is fabricated on a low-power 45-nm process
technology. The Spartan-6 family is the PLD industry’s first 45-nm high-volume FPGA family, consisting of 11 devices in two
product families:
•
•
Spartan-6 LX FPGAs - optimized for applications that require the lowest cost.
Spartan-6 LXT FPGAs - optimized for applications that require LX features plus 3.125G serial transceivers.
65-nm Product Families
The Virtex-5 FPGA family consists of 26 devices in five product families: Virtex-5 LX FPGAs for logic-intensive designs,
Virtex-5 LXT FPGAs for high-performance logic with serial connectivity, Virtex-5 SXT FPGAs for high-performance DSP
with serial connectivity, Virtex-5 FXT FPGAs for embedded processing with serial connectivity and Virtex-5 TXT FPGAs for
high-bandwidth serial connectivity.
Other Product Families
Prior generation Virtex families include Virtex-4, Virtex-II Pro, Virtex-II, Virtex-E and the original Virtex family. Spartan
family FPGAs include 90-nm Spartan-3 FPGAs, the Spartan-3E family and the Spartan-3A family. Prior generation Spartan
families include Spartan-IIE, Spartan-II, Spartan XL and the original Spartan family.
CPLDs operate on the lowest end of the programmable logic density spectrum. CPLDs are single-chip, nonvolatile solutions
characterized by instant-on and universal interconnect. CPLDs combine the advantages of ultra low power consumption with
the benefits of high performance and low cost. Prior generations of CPLDs include the CoolRunnerTM and XC9500 product
families.
EasyPath™ FPGAs
EasyPath FPGAs offer customers a fast, simple method of cost-reducing FPGA designs. EasyPath FPGAs use the same
production masks and fabrication process as standard FPGAs and are tested to a specific customer application to improve yield
and lower costs. As a result, EasyPath FPGAs provide customers with significant cost reduction when compared to the
standard FPGA devices without the conversion risk, engineering effort, or the additional time required to move to an ASIC.
The latest generation of EasyPath FPGAs and EasyPath-7 FPGAs provide lower total product cost of ownership for cost-
reducing high performance FPGAs.
Design Platforms and Services
Programmable Platforms
We offer three types of programmable platforms that support our customers’ designs and reduce their development efforts:
The Base Platform is the delivery vehicle for all of our new silicon offerings used to develop and run customer-specific
software applications and hardware designs. Released at launch, the Base Platform is comprised of: FPGA silicon; Vivado®
Design Suite design environment; integration support of optional third-party synthesis, simulation, and signal integrity tools;
reference designs; development boards and IP.
The Domain-Specific Platform targets one of the three primary Xilinx FPGA user profiles: the embedded processing developer;
the DSP developer; or the logic/connectivity developer. It accomplishes this by augmenting the Base Platform with a targeted
set of integrated technologies, including: higher-level design methodologies and tools; domain-specific IP including embedded,
mixed signal, video, DSP and connectivity; domain-specific development hardware and reference designs; and operating
systems and software.
The Market-Specific Platform enables software or hardware developers to quickly build and run their specific application or
solution. Built for specific markets such as automotive, consumer, aerospace and defense, communications, audio, video and
broadcast, industrial, or scientific and medical, the Market-Specific Platform integrates both the Base and Domain-Specific
Platforms with higher targeted applications elements such as IP, reference designs and boards optimized for a particular market.
-8-
Design Tools
To accommodate the various design methodologies and design flows employed by the wide range of our customers’ user
profiles such as system designers, algorithm designers, software coders and logic designers, we provide the appropriate design
environment tailored to each user profile for design creation, design implementation and design verification. During April
2012, Xilinx introduced the next-generation Vivado™ Design Suite designed to improve developer productivity resulting in
faster design integration and implementation. The Vivado suite hallmarks include an easy-to-use IP-centric design flow and
significant improvement in run times. The standards-based Vivado tools include high-level synthesis to provide a more direct
flow in retargeting DSPs and general purpose processor designs into our FPGAs, IP Integrator to rapidly stitch together cores at
higher levels of abstraction, and a new analytical place-and-route engine which significantly improves run times. The Vivado
suite supports both Xilinx 7 series FPGAs and Zynq-7000, our programmable SoCs.
The previous generation tool suite, the Integrated Software Environment (ISE®) Design Suite, supports Xilinx 7 series FPGAs,
programmable SoCs and all previous generation FPGAs, enabling customers to transition to the Vivado Design Suite when the
timing is right for their design needs. Both the Vivado Design Suite and ISE Design Suite operate with a wide range of third-
party Electronic Design Automation software point-tools offerings.
Intellectual Property
Xilinx and various third parties offer hundreds of no charge and fee-bearing IP core licenses covering Ethernet, memory
controllers, Interlaken and PCIe® interface, as well as an abundance of domain-specific IP in the areas of embedded, DSP and
connectivity, and market-specific IP cores. In addition, our products and technology leverage industry standards such as ARM
AMBA® AXI-4 interconnect technology, IP-XACT and IEEE P1735 encryption to facilitate plug-and-play FPGA design and
take advantage of the large ecosystem of ARM IP developers.
Development Boards, Kits and Configuration Products
In addition to the broad selection of legacy development boards presently offered, we have introduced a new unified board
strategy that enables the creation of a standardized and coordinated set of base boards available both from Xilinx and our
ecosystem vendors, all utilizing the industry-standard extensions that enable customization for market specific applications.
Adopting this standard for all of our base boards enables the creation of a scalable and extensible delivery mechanism for all
Xilinx programmable platforms.
We also offer comprehensive development kits including hardware, design tools, IP and reference designs that are designed to
streamline and accelerate the development of domain-specific and market-specific applications.
Finally, Xilinx offers a range of configuration products including one-time programmable and in-system programmable storage
devices to configure Xilinx FPGAs. These PROM (programmable read-only memory) products support all of our FPGA
devices.
Third-Party Alliances
Xilinx and certain third parties have developed and continue to offer a robust ecosystem of IP, boards, tools, services and
support through the Xilinx alliance program. Xilinx also works with these third parties to promote our programmable
platforms through third-party tools, IP, software, boards and design services.
Engineering Services
Xilinx engineering services provide customers with engineering resources to augment their design teams and to provide expert
design-specific advice. Xilinx tailors its engineering services to the needs of its customers, ranging from hands-on training to
full design creation and implementation.
Research and Development
Our research and development (R&D) activities are primarily directed toward the design of new ICs, the development of new
software design automation tools for hardware and embedded software, the design of logic IP, the adoption of advanced
semiconductor manufacturing processes for ongoing cost reductions, performance and signal integrity improvements and
lowering PLD power consumption. As a result of our R&D efforts, we have introduced a number of new products during the
past several years including the Virtex-7, Kintex-7, Artix-7 and Zynq-7000 families. We have made enhancements to our IP
core offerings and introduced Vivado tools, our next generation software design suite. We extended our collaboration with our
foundry suppliers in the development of 65-nm, 45-nm, 40-nm and 28-nm manufacturing technology, enabling us to be the first
-9-
company in the PLD industry to ship 45-nm high-volume as well as 28-nm FPGA devices. Additionally, our investment in
R&D has allowed us to ship the industry’s first 28-nm PLD with embedded ARM technology as well as the industry’s first 3D
IC devices.
Our R&D challenge is to continue to develop new products that create value-added solutions for customers. In fiscal 2013,
2012 and 2011, our R&D expenses were $475.5 million, $435.3 million and $392.5 million, respectively. We believe technical
leadership and innovation are essential to our future success and are committed to maintaining a significant level of R&D
investment.
Sales and Distribution
We sell our products to OEMs, EMSs and to electronic components distributors who resell these products to OEMs and EMSs.
We use a dedicated global sales and marketing organization as well as independent sales representatives to generate sales. In
general, we focus our direct demand creation efforts on a limited number of key accounts. Distributors and independent sales
representatives create demand within the balance of our customer base in defined territories. Distributors also provide
inventory, value-added services and logistics for a wide range of our OEM customers.
Whether Xilinx, the independent sales representative, or the distributor identifies the sales opportunity, a local distributor will
process and fulfill the majority of all customer orders. In such situations, distributors are the sellers of the products and as such
they bear all legal and financial risks generally related to the sale of commercial goods, including such risks as credit loss,
inventory shrinkage, theft and foreign currency fluctuations, but excluding indemnity and warranty liability.
In accordance with our distribution agreements and industry practice, we have granted our authorized distributors the
contractual right to return certain amounts of unsold product on a periodic basis and also receive price adjustments for unsold
product in the case of a change in list prices subsequent to the initial sale. Revenue recognition on shipments to distributors
worldwide is deferred until the products are sold to the distributors’ end customers.
Avnet, Inc. (Avnet) distributes the substantial majority of our products worldwide. As of March 30, 2013 and March 31, 2012,
Avnet accounted for 64% and 67%, respectively, of our total accounts receivable. Resale of product through Avnet accounted
for 46%, 48% and 51% of our worldwide net revenues in fiscal 2013, 2012 and 2011, respectively. We also use other regional
distributors throughout the world. We believe distributors provide a cost-effective means of reaching a broad range of
customers while providing efficient logistics services. Since PLDs are standard products, they do not carry many of the
inventory risks posed by ASICs, and they simplify the requirements for distributor technical support. From time to time, we
may add or terminate distributors in specific geographies, or move customers to a direct fulfillment model as we deem
appropriate given our strategies, the level of distributor business activity and distributor performance and financial condition.
See "Note 2. Summary of Significant Accounting Policies and Concentrations of Risk" to our consolidated financial statements,
included in Item 8. "Financial Statements and Supplementary Data," for information about concentrations of credit risk and
"Note 16. Segment Information" for information about our revenues from external customers and domestic and international
operations.
No end customer accounted for more than 10% of our net revenues in fiscal 2013, 2012 or 2011.
Backlog
As of March 30, 2013, our backlog from OEM customers and backlog from end customers reported by our distributors
scheduled for delivery within the next three months was $253.0 million, compared to $261.0 million as of March 31, 2012.
Orders from end customers to our distributors are subject to changes in delivery schedules or to cancellation without significant
penalty. As a result, backlogs from both OEM customers and end customers reported by our distributors as of any particular
period may not be a reliable indicator of revenue for any future period.
Wafer Fabrication
As a fabless semiconductor company, we do not manufacture wafers used for our IC products or PROMs. Rather, we purchase
our wafers from independent foundries including United Microelectronics Corporation (UMC), Taiwan Semiconductor
Manufacturing Company Limited (TSMC), and Samsung Electronics Co., Ltd. (Samsung). Currently, UMC manufactures the
substantial majority of our wafers and TSMC manufactures the wafers for our newest products.
Precise terms with respect to the volume and timing of wafer production and the pricing of wafers produced by the
semiconductor foundries are determined by periodic negotiations with each wafer foundry.
-10-
Our strategy is to focus our resources on market development and creating new ICs and software design tools rather than on
wafer fabrication. We continuously evaluate opportunities to enhance foundry relationships and/or obtain additional capacity
from our main suppliers as well as other suppliers of wafers manufactured with leading-edge process technologies, and we
adjust loadings at particular foundries to meet our business needs.
Sort, Assembly and Test
Wafers are sorted by the foundry or independent sort subcontractors. Sorted die are assembled by subcontractors. During the
assembly process, the wafers are separated into individual die, which are then assembled into various package types.
Following assembly, the packaged units are generally tested by Xilinx personnel at our Singapore facility or by independent
test subcontractors. We purchase most of our assembly and some of our test services from Siliconware Precision Industries
Ltd. in Taiwan and Amkor Technology, Inc. in Korea and the Philippines.
Quality Certification
Xilinx has achieved and currently maintains quality management systems certification to TL9000/ISO9001 for our facilities in
San Jose, California; Longmont, Colorado; Singapore and Hyderabad, India. In addition, Xilinx achieved and currently
maintains ISO 14001 and OHSAS 18001 environmental health and safety management system certifications in the San Jose
and Singapore locations.
Patents and Licenses
While our various proprietary intellectual property rights are important to our success, we believe our business as a whole is not
materially dependent on any particular patent or license, or any particular group of patents or licenses. As of March 30, 2013,
we held over 3,000 issued United States (U.S.) patents, which vary in duration, and over 400 pending U.S. patent applications
relating to our proprietary technology. We maintain an active program of filing for additional patents in the areas of, but not
limited to, circuits, software, IC architecture, IP cores, system design, testing methodologies and other technologies relating to
our products and business. We have licensed some parties to certain portions of our patent portfolio and obtained licenses to
certain third-party patents as well.
We have acquired various licenses from third parties to certain technologies that are implemented in IP cores or embedded in
our PLDs, such as processors. Those licenses support our continuing ability to make and sell these PLDs to our customers. We
also have acquired various licenses to certain third-party proprietary software, open-source software and related technologies,
such as compilers, for our design tools. Continued use of such software and technology is important to the operation of the
design tools upon which customers depend.
We maintain the Xilinx trade name and trademarks, including the following trademarks that are registered in the U.S. and other
countries: Xilinx, the Xilinx logo, Artix, ISE, Kintex, Spartan, Virtex, Vivado and Zynq-7000. Maintaining these trademarks,
and the goodwill associated with them, is important to our business. We have also obtained the rights to use certain trademarks
owned by consortiums and other trademark owners that are related to our products and business.
We intend to continue to protect our IP rights (including, for example, patents, copyrights and trademarks) vigorously. We
believe that failure to enforce our intellectual property rights or failure to protect our trade secrets effectively could have an
adverse effect on our financial condition and results of operations. We incurred, and in the future we may continue to incur,
litigation expenses to defend against claims of infringement and to enforce our intellectual property rights against third parties.
However, any such litigation may or may not be successful.
Corporate Responsibility
Xilinx places a high level of importance on corporate responsibility. Through senior-level sponsorship, regular environmental,
health and safety assessments and company-wide performance targets, we strive to achieve a culture that emphasizes
contribution to local and global communities through a number of key initiatives:
Company
We strive to meet or exceed industry and regulatory standards for ethical business practices, product responsibility, and
supplier management. All Xilinx’s directors, officers and employees are required to comply not only with the letter of the
laws, rules and regulations that govern the conduct of our business, but also with the spirit of those laws.
-11-
Environment
We monitor regulatory and resource trends and are committed to setting focused targets for key resources and emissions. These
targets address several parameters, including product design; chemical, energy, and water use; waste recycling; and emissions.
As a company, we focus on reducing natural resource use, the solid and chemical waste of our operations and minimizing our
overall environmental impact with regards to the communities around us and consistent with global climate change efforts.
Community
We are committed to growing strategic relationships with a wide range of local organizations and programs that are designed to
develop and strengthen communities located around the world. Xilinx develops local community relationships at key sites
through funding and involvement that encourages active participation, teamwork, and volunteerism. Xilinx supports
opportunities initiated by its employees and that involve participation and empowerment of its employees. We are committed to
charitable giving programs that work toward systemic change and measurable results.
Workplace
We provide a safe and healthy work environment where employee diversity is embraced and opportunities for training, growth,
and advancement are strongly encouraged. The Xilinx Code of Social Responsibility outlines standards to ensure that working
conditions at Xilinx are safe and that workers are treated with respect, fairness and dignity.
Employees
As of March 30, 2013, we had 3,329 employees compared to 3,265 as of the end of the prior fiscal year. None of our
employees are represented by a labor union. We have not experienced any work stoppages and believe we maintain good
employee relations.
Executive Officers of the Registrant
Certain information regarding the executive officers of Xilinx as of May 23, 2013 is set forth below:
Name
Moshe N. Gavrielov
Steven L. Glaser
Scott R. Hover-Smoot
Jon A. Olson
Victor Peng
Raja G. Petrakian
Krishna Rangasayee
Vincent L. Tong
Frank A. Tornaghi
Age
58
51
58
59
53
49
44
51
58
Position
President and Chief Executive Officer (CEO)
Senior Vice President, Corporate Strategy and
Marketing
Corporate Vice President, General Counsel and
Secretary
Senior Vice President, Finance and Chief Financial
Officer (CFO)
Senior Vice President, Programmable Platforms
Group
Senior Vice President, Worldwide Operations
Senior Vice President, and General Manager,
Communications Business Unit
Senior Vice President, Worldwide Quality and New
Product Introductions
Senior Vice President, Worldwide Sales
There are no family relationships among the executive officers of the Company or the Board of Directors.
Moshe N. Gavrielov joined the Company in January 2008 as President and CEO and was appointed to the Board of Directors
in February 2008. Prior to joining the Company, Mr. Gavrielov served at Cadence Design Systems, Inc., an electronic design
automation company, as Executive Vice President and General Manager of the Verification Division from April 2005 through
November 2007. Mr. Gavrielov served as CEO of Verisity Ltd., an electronic design automation company, from March 1998
to April 2005 before its acquisition by Cadence Design Systems, Inc. Prior to joining Verisity, Mr. Gavrielov spent nearly 10
years at LSI Corporation (formerly LSI Logic Corporation), a semiconductor manufacturer, in a variety of executive
management positions, including Executive Vice President of the Products Group, Senior Vice President and General Manager
of International Marketing and Sales and Senior Vice President and General Manager of LSI Logic Europe plc. Additionally,
Mr. Gavrielov held various engineering and engineering management positions at Digital Equipment Corporation and National
Semiconductor Corporation.
-12-
Steven L. Glaser joined the Company in January 2011 as Corporate Vice President, Strategic Planning. In April 2012, Mr.
Glaser was promoted to his current position of Senior Vice President, Corporate Strategy and Marketing. Prior to joining the
Company, Mr. Glaser held various senior positions in Cadence Design Systems between April 2005 and January 2011,
including Corporate Vice President of Strategic Development and Corporate Vice President of Marketing for the Verification
Division. From June 2003 to April 2005, he served as Senior Vice President of Marketing at Verisity Ltd. Prior to that, Mr.
Glaser held various senior business and technical positions at companies in the semiconductor and electronic design automation
industries.
Scott R. Hover-Smoot joined the Company in October 2007 as Vice President, General Counsel and Secretary. From
November 2001 to October 2007, Mr. Hover-Smoot served as Regional Counsel and Director of Legal Operations with TSMC,
an independent semiconductor foundry. He served as Vice President and General Counsel of California Micro Devices
Corporation, a provider of application-specific protection devices and display electronics devices from June 1994 to November
2001. Prior to joining California Micro Devices Corporation, Mr. Hover-Smoot spent over 20 years working in law firms
including Berliner-Cohen, Flehr, Hohbach, Test, Albritton & Herbert and Lyon & Lyon.
Jon A. Olson joined the Company in June 2005 as Vice President, Finance and CFO. Mr. Olson assumed his current position
of Senior Vice President, Finance and CFO in August 2006. Prior to joining the Company, Mr. Olson spent more than 25 years
at Intel Corporation, a semiconductor chip maker, serving in a variety of positions, including Vice President, Finance and
Enterprise Services, and Director of Finance.
Victor Peng joined the Company in April 2008 as Senior Vice President, Silicon Engineering Group and became Senior Vice
President, Programmable Platforms Development in November 2008. In April 2012, Mr. Peng assumed his current position of
Senior Vice President, Programmable Platforms Group. Prior to joining the Company, Mr. Peng served as Corporate Vice
President, Graphics Products Group at Advanced Micro Devices (AMD), a provider of processing solutions, from November
2005 to April 2008. Prior to joining AMD, Mr. Peng served in a variety of executive engineering positions at companies in the
semiconductor and processor industries.
Raja G. Petrakian joined the Company in October 1995 and has served in a number of key roles within Operations, including
Senior Director of Supply Chain Management and Vice President of Supply Chain Management. Dr. Petrakian assumed his
current position of Senior Vice President, Worldwide Operations in March 2009. Prior to joining Xilinx, Dr. Petrakian spent
more than three years at the IBM T.J. Research Center serving as a research staff member in the Manufacturing Research
Department.
Krishna Rangasayee joined the Company in July 1999 and has served in a number of key roles, including as Senior Director
of Vertical Markets and Partnerships from November 2005 through June 2008. He then served as the Vice President of
Strategic Planning from July 2008 through September 2010 and was promoted to the rank of Corporate Vice President for the
same function. Mr. Rangasayee assumed the position of Corporate Vice President and General Manager, Communications
Business Unit in October 2010. Mr. Rangasayee was promoted to his current position of Senior Vice President, and General
Manager, Communications Business Unit in April 2012. Prior to joining Xilinx, Mr. Rangasayee held various positions at
Altera, a provider of programmable logic solutions, and Cypress Semiconductor, a semiconductor company.
Vincent L. Tong joined the Company in May 1990 and has served in a number of key roles, including Vice President of
Product Technology and as Vice President, Worldwide Quality and Reliability. In April 2008, he assumed his current position
of Senior Vice President, Worldwide Quality and New Product Introductions and assumed the additional role of Executive
Leader, Asia Pacific in October 2011. Prior to joining the Company, Mr. Tong served in a variety of engineering positions at
Monolithic Memories, a producer of logic devices, and AMD. Mr. Tong serves on the board of the Global Semiconductor
Alliance, a non-profit semiconductor organization.
Frank A. Tornaghi joined the Company in February 2008 as Vice President, Worldwide Sales and assumed his current
position of Senior Vice President, Worldwide Sales in April 2008. Prior to joining the Company, Mr. Tornaghi spent 22 years
at LSI Corporation. Mr. Tornaghi acted as an independent consultant from April 2006 until he joined the Company. He served
as Executive Vice President, Worldwide Sales at LSI Corporation from July 2001 to April 2006 and as Vice President, North
America Sales, from May 1993 to July 2001. From 1984 until May 1993, Mr. Tornaghi held various management positions in
sales at LSI Corporation.
-13-
Additional Information
We make available, via a link through our investor relations website located at www.investor.xilinx.com, access to our Annual
Report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports filed
or furnished pursuant to Section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934, as amended (Exchange Act) as
soon as reasonably practicable after they are electronically filed with or furnished to the Securities and Exchange Commission
(SEC). All such filings on our investor relations website are available free of charge. Printed copies of these documents are
also available to stockholders without charge, upon written request directed to Xilinx, Inc., Attn: Investor Relations, 2100
Logic Drive, San Jose, CA 95124. Further, a copy of this Annual Report on Form 10-K is located at the SEC’s Public
Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information on the operation of the Public Reference Room
can be obtained by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and
information statements and other information regarding our filings at http://www.sec.gov. The content on any website referred
to in this filing is not incorporated by reference into this filing unless expressly noted otherwise.
Additional information required by this Item 1 is incorporated by reference to the section captioned "Net Revenues - Net
Revenues by Geography" in Item 7. "Management’s Discussion and Analysis of Financial Condition and Results of
Operations" and to "Note 16. Segment Information" to our consolidated financial statements, included in Item 8. "Financial
Statements and Supplementary Data."
This annual report includes trademarks and service marks of Xilinx and other companies that are unregistered and registered in
the U.S. and other countries.
ITEM 1A.
RISK FACTORS
The following risk factors and other information included in this Annual Report on Form 10-K should be carefully considered.
The risks and uncertainties described below are not the only risks to the Company. Additional risks and uncertainties not
presently known to the Company, or that the Company’s management currently deems immaterial, also may impair its business
operations. If any of the risks described below were to occur, our business, financial condition, operating results and cash flows
could be materially adversely affected.
Our success depends on our ability to develop and introduce new products and failure to do so would have a material
adverse impact on our financial condition and results of operations.
Our success depends in large part on our ability to develop and introduce new products that address customer requirements and
compete effectively on the basis of price, density, functionality, power consumption and performance. The success of new
product introductions is dependent upon several factors, including:
•
•
•
timely completion of new product designs;
ability to generate new design opportunities and design wins;
availability of specialized field application engineering resources supporting demand creation and customer adoption
of new products;
ability to utilize advanced manufacturing process technologies on circuit geometries of 28-nm and smaller;
achieving acceptable yields;
ability to obtain adequate production capacity from our wafer foundries and assembly and test subcontractors;
ability to obtain advanced packaging;
availability of supporting software design tools;
utilization of predefined IP logic;
customer acceptance of advanced features in our new products; and
•
•
•
•
•
•
•
• market acceptance of our customers’ products.
Our product development efforts may not be successful, our new products may not achieve industry acceptance and we may
not achieve the necessary volume of production that would lead to further per unit cost reductions. Revenues relating to our
mature products are expected to decline in the future, which is normal for our product life cycles. As a result, we may be
increasingly dependent on revenues derived from design wins for our newer products as well as anticipated cost reductions in
the manufacture of our current products. We rely primarily on obtaining yield improvements and corresponding cost reductions
in the manufacture of existing products, and on introducing new products that incorporate advanced features and other
price/performance factors that enable us to increase revenues while maintaining consistent margins. To the extent that such cost
reductions and new product introductions do not occur in a timely manner, or to the extent that our products do not achieve
market acceptance at prices with higher margins, our financial condition and results of operations could be materially adversely
affected.
-14-
We rely on independent foundries for the manufacture of all of our products and a manufacturing problem or
insufficient foundry capacity could adversely affect our operations.
Most of our wafers are manufactured in Taiwan by UMC. In addition, we also have wafers manufactured in South Korea by
Samsung and the wafers for our newest products are manufactured in Taiwan by TSMC. Terms with respect to the volume and
timing of wafer production and the pricing of wafers produced by the semiconductor foundries are determined by periodic
negotiations between Xilinx and these wafer foundries, which usually result in short-term agreements that do not provide for
long-term supply or allocation commitments. We are dependent on these foundries, especially UMC, which supplies the
substantial majority of our wafers. We rely on UMC, TSMC and our other foundries to produce wafers with competitive
performance attributes. Therefore, the foundries, particularly TSMC who manufactures our newest products, must be able to
transition to advanced manufacturing process technologies and increased wafer sizes, produce wafers at acceptable yields and
deliver them in a timely manner. Furthermore, we cannot guarantee that the foundries that supply our wafers will offer us
competitive pricing terms or other commercial terms important to our business.
We cannot guarantee that our foundries will not experience manufacturing problems, including delays in the realization of
advanced manufacturing process technologies or difficulties due to limitations of new and existing process technologies.
Furthermore, we cannot guarantee the foundries will be able to manufacture sufficient quantities of our products or that they
will continue to manufacture a product for the full life of the product. In addition, weak economic conditions may adversely
impact the financial health and viability of the foundries and result in their insolvency or their inability to meet their
commitments to us. For example, in the first quarter of fiscal 2010, we experienced supply shortages due to the difficulties
encountered by the foundries when they had to rapidly increase their production capacities from low utilization levels to high
utilization levels because of an unexpected increase in demand. In the fourth quarter of fiscal 2010 and first nine months of
fiscal 2011, we also experienced supply shortages due to very strong demand for our products and a surge in demand for
semiconductors in general, which led to tightening of foundry capacity across the industry. The insolvency of a foundry or any
significant manufacturing problem or insufficient foundry capacity would disrupt our operations and negatively impact our
financial condition and results of operations.
We have established other sources of wafer supply for many of our products in an effort to secure a continued supply of wafers.
However, establishing, maintaining and managing multiple foundry relationships require the investment of management
resources as well as additional costs. If we do not manage these relationships effectively, it could adversely affect our results of
operations.
General economic conditions and the related deterioration in the global business environment could have a material
adverse effect on our business, operating results and financial condition.
During the past three years, global consumer confidence eroded amidst concerns over declining asset values, inflation,
volatility in energy costs, geopolitical issues, the availability and cost of credit, rising unemployment, and the stability and
solvency of financial institutions, financial markets, businesses and sovereign nations, among other concerns. These concerns
slowed global economic growth and resulted in recessions in numerous countries, including many of those in North America,
Europe and Asia. Recent events have shown that the financial condition of sovereign nations, particularly in Europe, is of
continuing concern as the sovereign debt crisis remains unresolved. Recent events have also elevated concerns that
macroeconomic conditions will worsen and economic recovery will be delayed. These weak economic conditions resulted in
reduced customer demand and had a negative impact on our results of operations for the second and third quarter of fiscal 2012
and the third quarter of fiscal 2013. If weak economic conditions persist or worsen, a number of negative effects on our
business could continue, including customers or potential customers reducing or delaying orders, the insolvency of key
suppliers, potentially causing production delays, the inability of customers to obtain credit, and the insolvency of one or more
customers. Any of these effects could impact our ability to effectively manage inventory levels and collect receivables and
ultimately decrease our net revenues and profitability.
The semiconductor industry is characterized by cyclical market patterns and a significant industry downturn could
adversely affect our operating results.
The semiconductor industry is highly cyclical and our financial performance has been affected by downturns in the industry.
Down cycles are generally characterized by price erosion and weaker demand for our products. Weaker demand for our
products resulting from economic conditions in the end markets we serve and reduced capital spending by our customers can
result, and in the past has resulted, in excess and obsolete inventories and corresponding inventory write-downs. We attempt to
identify changes in market conditions as soon as possible; however, the dynamics of the market in which we operate make
prediction of and timely reaction to such events difficult. Due to these and other factors, our past results are not reliable
predictors of our future results.
The nature of our business makes our revenues difficult to predict which could have an adverse impact on our business.
In addition to the challenging market conditions we may face, we have limited visibility into the demand for our products,
particularly new products, because demand for our products depends upon our products being designed into our end customers’
products and those products achieving market acceptance. Due to the complexity of our customers’ designs, the design to
-15-
volume production process for our customers requires a substantial amount of time, frequently longer than a year. In addition,
we are dependent upon "turns," orders received and turned for shipment in the same quarter. These factors make it difficult for
us to forecast future sales and project quarterly revenues. The difficulty in forecasting future sales impairs our ability to project
our inventory requirements, which could result, and in the past has resulted, in inventory write-downs or failure to meet
customer product demands in a timely manner. In addition, difficulty in forecasting revenues compromises our ability to
provide forward-looking revenue and earnings guidance.
If we are not able to successfully compete in our industry, our financial results and future prospects will be adversely
affected.
Our PLDs compete in the logic IC industry, an industry that is intensely competitive and characterized by rapid technological
change, increasing levels of integration, product obsolescence and continuous price erosion. We expect increased competition
from our primary PLD competitors, Altera, Lattice and Microsemi, and from new market entrants. In addition, competition
from the ASIC market and from the ASSP market continues. We believe that important competitive factors in the logic IC
industry include:
•
•
•
•
•
•
•
•
•
•
product pricing;
time-to-market;
product performance, reliability, quality, power consumption and density;
field upgradeability;
adaptability of products to specific applications;
ease of use and functionality of software design tools;
availability and functionality of predefined IP logic;
inventory and supply chain management;
access to leading-edge process technology and assembly capacity; and
ability to provide timely customer service and support.
Our strategy for expansion in the logic market includes continued introduction of new product architectures that address high-
volume, low-cost and low-power applications as well as high-performance, high-density applications. However, we may not be
successful in executing this strategy. In addition, we anticipate continued pressure from our customers to reduce prices, which
may outpace our ability to lower the cost for established products.
Other competitors include manufacturers of:
high-density programmable logic products characterized by FPGA type architectures;
high-volume and low-cost FPGAs as programmable replacements for ASICs and ASSPs;
•
•
• ASICs and ASSPs with incremental amounts of embedded programmable logic;
•
•
•
•
•
high-speed, low-density complex programmable logic devices;
high-performance digital signal processing devices;
products with embedded processors;
products with embedded multi-gigabit transceivers; and
other new or emerging programmable logic products.
Several companies have introduced products that compete with ours or have announced their intention to sell PLD products. To
the extent that our efforts to compete are not successful, our financial condition and results of operations could be materially
adversely affected.
The benefits of programmable logic have attracted a number of competitors to this segment. We recognize that different
applications require different programmable technologies, and we are developing architectures, processes and products to meet
these varying customer needs. Recognizing the increasing importance of standard software solutions, we have developed
common software design tools that support the full range of our IC products. We believe that automation and ease of design are
significant competitive factors in this segment.
We could also face competition from our licensees. In the past we have granted limited rights to other companies with respect
to certain aspects of our older technology, and we may do so in the future. Granting such rights may enable these companies to
manufacture and market products that may be competitive with some of our older products.
Increased costs of wafers and materials, or shortages in wafers and materials, could adversely impact our gross margins
and lead to reduced revenues.
If greater demand for wafers is not offset by an increase in foundry capacity, market demand for wafers or production and
assembly materials increases, or if a supplier of our wafers ceases or suspends operations, our supply of wafers and other
materials could become limited. Such shortages raise the likelihood of potential wafer price increases, wafer shortages or
shortages in materials at production and test facilities, resulting in potential inability to address customer product demands in a
timely manner. For example, as a result of the March 2011 earthquake in Japan, certain suppliers were forced to temporarily
halt production, resulting in a tightening of supply for those materials. Such shortages of wafers and materials as well as
-16-
increases in wafer or materials prices could adversely affect our gross margins and would adversely affect our ability to meet
customer demands and lead to reduced revenue.
We depend on distributors, primarily Avnet, to generate a majority of our sales and complete order fulfillment.
Resale of product through Avnet accounted for 46% of our worldwide net revenues in fiscal 2013 and as of March 30, 2013,
Avnet accounted for 64% of our total net accounts receivable. Any adverse change to our relationship with Avnet or our
remaining distributors could have a material impact on our business. Furthermore, if a key distributor materially defaults on a
contract or otherwise fails to perform, our business and financial results would suffer. In addition, we are subject to
concentrations of credit risk in our trade accounts receivable, which includes accounts of our distributors. A significant
reduction of effort by a distributor to sell our products or a material change in our relationship with one or more distributors
may reduce our access to certain end customers and adversely affect our ability to sell our products.
In addition, the financial health of our distributors and our continuing relationships with them are important to our success.
Unpredictable economic conditions may adversely impact the financial health of some of these distributors, particularly our
smaller distributors. This could result in the insolvency of certain distributors, the inability of distributors to obtain credit to
finance the purchase of our products, or cause distributors to delay payment of their obligations to us and increase our credit
risk exposure. Our business could be harmed if the financial health of these distributors impairs their performance and we are
unable to secure alternate distributors.
We are dependent on independent subcontractors for most of our assembly and test services, and unavailability or
disruption of these services could negatively impact our financial condition and results of operations.
We are dependent on subcontractors to provide semiconductor assembly, substrate, test and shipment services. Any prolonged
inability to obtain wafers with competitive performance and cost attributes, adequate yields or timely delivery, any disruption
in assembly, test or shipment services, delays in stabilizing manufacturing processes and ramping up volume for new products,
transitions to new service providers or any other circumstance that would require us to seek alternative sources of supply, could
delay shipments and have a material adverse effect on our ability to meet customer demands. In addition, unpredictable
economic conditions may adversely impact the financial health and viability of these subcontractors and result in their
insolvency or their inability to meet their commitments to us. These factors would result in reduced net revenues and could
negatively impact our financial condition and results of operations.
A number of factors, including our inventory strategy, can impact our gross margins.
A number of factors, including yield, wafer pricing, product mix, market acceptance of our new products, competitive pricing
dynamics, geographic and/or market segment pricing strategies can cause our gross margins to fluctuate. In addition,
forecasting our gross margins is difficult because a significant portion of our business is based on turns within the same quarter.
Our current inventory levels are higher than historical norms due to our decision to build ahead of a previously planned closure
of a particular foundry process line at one of our foundry partners, weaker than anticipated sales and a planned increase in
safety stock across newer technologies in anticipation of future revenue growth. In the event demand does not materialize, we
may be subject to incremental obsolescence costs. In addition, future product cost reductions could have an increased impact on
our inventory valuation, which would then impact our operating results.
Reductions in the average selling prices of our products could have a negative impact on our gross margins.
The average selling prices of our products generally decline as the products mature. We seek to offset the decrease in selling
prices through yield improvement, manufacturing cost reductions and increased unit sales. We also continue to develop higher
value products or product features that increase, or slow the decline of, the average selling price of our products. However,
there is no guarantee that our ongoing efforts will be successful or that they will keep pace with the decline in selling prices of
our products, which could ultimately lead to a decline in revenues and have a negative effect on our gross margins.
Because of our international business and operations, we are vulnerable to the economic conditions of the countries in
which we operate and currency fluctuations could have a material adverse affect on our business and negatively impact
our financial condition and results of operations.
In addition to our U.S. operations, we also have significant international operations, including foreign sales offices to support
our international customers and distributors, our regional headquarters in Ireland and Singapore and an R&D site in India. Our
international operations have grown because we have relocated certain operations and administrative functions outside the U.S.
Sales and operations outside of the U.S. subject us to the risks associated with conducting business in foreign economic and
regulatory environments. Our financial condition and results of operations could be adversely affected by unfavorable
economic conditions in countries in which we do significant business or by changes in foreign currency exchange rates
affecting those countries. We derive over one-half of our revenues from international sales, primarily in the Asia Pacific region,
Europe and Japan. Past economic weaknesses in these markets adversely affected revenues. Sales to all direct OEMs and
distributors are denominated in U.S. dollars. While the recent movements of the Euro and Yen exchange rates against the U.S.
dollar had no material impact to our business, increased volatility could impact our European and Japanese customers.
Currency instability and volatility and disruptions in the credit and capital markets may increase credit risks for some of our
-17-
customers and may impair our customers’ ability to repay existing obligations. Increased currency volatility could also
positively or negatively impact our foreign-currency-denominated costs, assets and liabilities. In addition, any devaluation of
the U.S. dollar relative to other foreign currencies may increase the operating expenses of our foreign subsidiaries adversely
affecting our results of operations. Furthermore, because we are increasingly dependent on the global economy, instability in
worldwide economic environments occasioned, for example, by political instability, terrorist activity or U.S. or other military
actions could adversely impact economic activity and lead to a contraction of capital spending by our customers. Any or all of
these factors could adversely affect our financial condition and results of operations in the future.
We are subject to the risks associated with conducting business operations outside of the U.S. which could adversely
affect our business.
In addition to international sales and support operations and development activities, we purchase our wafers from foreign
foundries and have our commercial products assembled, packaged and tested by subcontractors located outside the U.S. All of
these activities are subject to the uncertainties associated with international business operations, including tax laws and
regulations, trade barriers, economic sanctions, import and export regulations, duties and tariffs and other trade restrictions,
changes in trade policies, anti-corruption laws, foreign governmental regulations, potential vulnerability of and reduced
protection for IP, longer receivable collection periods and disruptions or delays in production or shipments, any of which could
have a material adverse effect on our business, financial condition and/or operating results. Additional factors that could
adversely affect us due to our international operations include rising oil prices and increased costs of natural resources.
Moreover, our financial condition and results of operations could be affected in the event of political conflicts or economic
crises in countries where our main wafer providers, end customers and contract manufacturers who provide assembly and test
services worldwide, are located. Adverse change to the circumstances or conditions of our international business operations
could have a material adverse effect on our business.
We are exposed to fluctuations in interest rates and changes in credit rating and in the market values of our portfolio
investments which could have a material adverse impact on our financial condition and results of operations.
Our cash, short-term and long-term investments represent significant assets that may be subject to fluctuating or even negative
returns depending upon interest rate movements, changes in credit rating and financial market conditions. Since September
2007, the global credit markets have experienced adverse conditions that have negatively impacted the values of various types
of investment and non-investment grade securities. During this time, the global credit and capital markets have experienced
significant volatility and disruption due to instability in the global financial system, uncertainty related to global economic
conditions and concerns regarding sovereign financial stability.
Therefore, there is a risk that we may incur other-than-temporary impairment charges for certain types of investments should
credit market conditions deteriorate or the underlying assets fail to perform as anticipated. Our future investment income may
fall short of expectations due to changes in interest rates or if the decline in fair values of our debt securities is judged to be
other than temporary. Furthermore, we may suffer losses in principal if we are forced to sell securities that have declined in
market value due to changes in interest rates or financial market conditions.
Our failure to protect and defend our intellectual property could impair our ability to compete effectively.
We rely upon patent, copyright, trade secret, mask work and trademark laws to protect our intellectual property. We cannot
provide assurance that such intellectual property rights can be successfully asserted in the future or will not be invalidated,
violated, circumvented or challenged. From time to time, third parties, including our competitors, have asserted against us
patent, copyright and other intellectual property rights to technologies that are important to us. Third parties may attempt to
misappropriate our IP through electronic or other means or assert infringement claims against our indemnitees or us in the
future. Such assertions by third parties may result in costly litigation, indemnity claims or other legal actions, and we may not
prevail in such matters or be able to license any valid and infringed patents from third parties on commercially reasonable
terms. This could result in the loss of our ability to import and sell our products or require us to pay costly royalties to third
parties in connection with sales of our products. Any infringement claim, indemnification claim, or impairment or loss of use of
our intellectual property could materially adversely affect our financial condition and results of operations.
Our ability to design and introduce new products in a timely manner is dependent upon third-party intellectual
property.
In the design and development of new products and product enhancements, we rely on third-party intellectual property such as
software development tools and hardware testing tools. Furthermore, certain product features may rely on intellectual property
acquired from third parties. The design requirements necessary to meet future consumer demands for more features and greater
functionality from semiconductor products may exceed the capabilities of the third-party intellectual property or development
tools that are available to us. If the third-party intellectual property that we use becomes unavailable or fails to produce designs
that meet consumer demands, our business could be adversely affected.
-18-
We rely on information technology systems, and failure of these systems to function properly or unauthorized access to
our systems could result in business disruption.
We rely in part on various information technology (IT) systems to manage our operations, including financial reporting, and we
regularly evaluate these systems and make changes to improve them as necessary. Consequently, we periodically implement
new, or upgrade or enhance existing, operational and IT systems, procedures and controls. For example, in the third quarter of
fiscal 2012 we upgraded the IT systems we use to manage our operations and record and report financial information, and in
the past we simplified our supply chain and were required to make certain changes to our IT systems. Any delay in the
implementation of, or disruption in the transition to, new or enhanced systems, procedures or controls, could harm our ability to
record and report financial and management information on a timely and accurate basis. These systems are also subject to
power and telecommunication outages or other general system failures. Failure of our IT systems or difficulties in managing
them could result in business disruption. We also may be subject to unauthorized access to our IT systems through a security
breach or attack. In the past there have been attempts by third parties to penetrate and or infect our network and systems with
malicious software, in an effort to gain access to our network and systems. We seek to detect and investigate any security
incidents and prevent their recurrence, but in some cases, we might be unaware of an incident or its magnitude and effects. Our
business could be significantly harmed and we could be subject to third party claims in the event of such a security breach.
Earthquakes and other natural disasters could disrupt our operations and have a material adverse affect on our
financial condition and results of operations.
The independent foundries upon which we rely to manufacture our products, as well as our California and Singapore facilities,
are located in regions that are subject to earthquakes and other natural disasters. UMC’s and TSMC's foundries in Taiwan and
Seiko’s foundries in Japan and our assembly and test partners in Japan and other regions as well as many of our operations in
California are centered in areas that have been seismically active in the recent past and some areas have been affected by other
natural disasters such as typhoons. Any catastrophic event in these locations will disrupt our operations, including our
manufacturing activities and our insurance may not cover losses resulting from such disruptions of our operations. This type of
disruption could result in our inability to manufacture or ship products, thereby materially adversely affecting our financial
condition and results of operations. For example, as a result of the March 2011 earthquake in Japan, production at the Seiko
foundry at Sakata was halted temporarily, impacting production of some of our older devices. In addition, suppliers of wafers
and substrates were forced to halt production temporarily. Disruption of operations at these foundries for any reason, including
other natural disasters such as typhoons, tsunamis, volcano eruptions, fires or floods, as well as disruptions in access to
adequate supplies of electricity, natural gas or water could cause delays in shipments of our products, and could have a material
adverse effect on our results of operations. Furthermore, natural disasters can also indirectly impact us. For example, our
customers’ supply of other complimentary products may be disrupted by a natural disaster and may cause them to delay orders
of our products. Certain types of these natural disasters might be exacerbated by the effects of climate change, which would
increase the overall adverse effect of all the above. In addition, the access to water sources for our supply chain could also be
adversely affected with climate change, which would potentially negatively affect our manufacturing strategy.
If we are unable to maintain effective internal controls, our stock price could be adversely affected.
We are subject to the ongoing internal control provisions of Section 404 of the Sarbanes-Oxley Act of 2002 (the Act). Our
controls necessary for continued compliance with the Act may not operate effectively at all times and may result in a material
weakness disclosure. The identification of material weaknesses in internal control, if any, could indicate a lack of proper
controls to generate accurate financial statements and could cause investors to lose confidence and our stock price to drop.
We compete with others to attract and retain key personnel, and any loss of, or inability to attract, such personnel
would harm us.
We depend on the efforts and abilities of certain key members of management and other technical personnel. Our future
success depends, in part, upon our ability to retain such personnel and attract and retain other highly qualified personnel,
particularly product engineers. Competition for such personnel is intense and we may not be successful in hiring or retaining
new or existing qualified personnel. From time to time we have effected restructurings which eliminate a number of positions.
Even if such personnel are not directly affected by the restructuring effort, such terminations can have a negative impact on
morale and our ability to attract and hire new qualified personnel in the future. If we lose existing qualified personnel or are
unable to hire new qualified personnel, as needed, our business, financial condition and results of operations could be seriously
harmed.
Unfavorable results of legal proceedings could adversely affect our financial condition and operating results.
From time to time we are subject to various legal proceedings and claims that arise out of the ordinary conduct of our business.
Certain claims are not yet resolved, including those that are discussed under Item 3. "Legal Proceedings," included in Part I of
this Form 10-K, and additional claims may arise in the future. Results of legal proceedings cannot be predicted with certainty.
Regardless of its merit, litigation may be both time-consuming and disruptive to our operations and cause significant expense
and diversion of management attention and we may enter into material settlements to avoid these risks. Should we fail to
prevail in certain matters, or should several of these matters be resolved against us in the same reporting period, we may be
-19-
faced with significant monetary damages or injunctive relief against us that would materially and adversely affect a portion of
our business and might materially and adversely affect our financial condition and operating results.
Our products could have defects which could result in reduced revenues and claims against us.
We develop complex and evolving products that include both hardware and software. Despite our testing efforts and those of
our subcontractors, defects may be found in existing or new products. These defects may cause us to incur significant warranty,
support and repair or replacement costs, divert the attention of our engineering personnel from our product development efforts
and harm our relationships with customers. Subject to certain terms and conditions, we have agreed to compensate certain
customers for limited specified costs they actually incur in the event our hardware products experience epidemic failure. As a
result, epidemic failure and other performance problems could result in claims against us, the delay or loss of market
acceptance of our products and would likely harm our business. Our customers could also seek damages from us for their
losses.
In addition, we could be subject to product liability claims. A product liability claim brought against us, even if unsuccessful,
would likely be time-consuming and costly to defend. Product liability risks are particularly significant with respect to
aerospace, automotive and medical applications because of the risk of serious harm to users of these products. Any product
liability claim, whether or not determined in our favor, could result in significant expense, divert the efforts of our technical and
management personnel, and harm our business.
In preparing our financial statements, we make good faith estimates and judgments that may change or turn out to be
erroneous.
In preparing our financial statements in conformity with accounting principles generally accepted in the U.S., we must make
estimates and judgments in applying our most critical accounting policies. Those estimates and judgments have a significant
impact on the results we report in our consolidated financial statements. The most difficult estimates and subjective judgments
that we make concern valuation of marketable and non-marketable securities, revenue recognition, inventories, long-lived
assets including acquisition-related intangibles, goodwill, taxes and stock-based compensation. We base our estimates on
historical experience, input from outside experts and on various other assumptions that we believe to be reasonable under the
circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. We also have other key accounting policies that are not as subjective, and
therefore, their application would not require us to make estimates or judgments that are as difficult, but which nevertheless
could significantly affect our financial reporting. Actual results may differ materially from these estimates. If these estimates or
their related assumptions change, our operating results for the periods in which we revise our estimates or assumptions could be
adversely and perhaps materially affected.
The conditional conversion features of the outstanding debentures, if triggered, may adversely affect our financial
condition and operating results.
Our outstanding debentures have conditional conversion features. In the event the conditional conversion features of the
debentures are triggered, holders of such debentures will be entitled to convert the debentures at any time during specified
periods at their option. If one or more holders elect to convert their debentures, we would be required to settle any converted
principal through the payment of cash, which could adversely affect our liquidity. Even if holders do not elect to convert their
debentures, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of
the debentures as a current rather than long-term liability, which would result in a material reduction of our net working capital.
In addition, we could be required to increase the number of shares used in our per share calculations to reflect the potentially
dilutive impact of the conversion.
Our failure to comply with the requirements of the International Traffic and Arms Regulations could have a material
adverse effect on our financial condition and results of operations.
Certain Xilinx space-grade FPGAs and related technologies are subject to the International Traffic in Arms Regulations
(ITAR), which are administered by the U.S. Department of State. The ITAR governs the export and reexport of these FPGAs,
the transfer of related technical data and the provision of defense services, as well as offshore production, test and assembly.
We are required to maintain an internal compliance program and security infrastructure to meet ITAR requirements.
An inability to obtain the required export licenses, or to predict when they will be granted, increases the difficulties of
forecasting shipments. In addition, security or compliance program failures that could result in penalties or a loss of export
privileges, as well as stringent ITAR licensing restrictions that may make our products less attractive to overseas customers,
could have a material adverse effect on our business, financial condition and/or operating results.
Our inability to effectively control the sale of our products on the gray market could have a material adverse effect on
us.
We market and sell our products directly to OEMs and through authorized third-party distributors which helps to ensure that
products delivered to our customers are authentic and properly handled. From time to time, customers may purchase products
-20-
bearing our name from the unauthorized "gray market." These parts may be counterfeit, salvaged or re-marked parts, or parts
that have been altered, mishandled, or damaged. Gray market products result in shadow inventory that is not visible to us, thus
making it difficult to forecast supply or demand. Also, when gray market products enter the market, we and our authorized
distributors may compete with brokers of these discounted products, which can adversely affect demand for our products and
negatively impact our margins. In addition, our reputation with customers may be negatively impacted when gray market
products bearing our name fail or are found to be substandard.
The conflict minerals provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act could result in
additional costs and liabilities.
In accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act, the SEC established new disclosure and
reporting requirements for those companies who use "conflict" minerals mined from the Democratic Republic of Congo and
adjoining countries in their products, whether or not these products are manufactured by third parties. These new requirements
could affect the sourcing and availability of minerals used in the manufacture of our semiconductor products. There will also
be costs associated with complying with the disclosure requirements, including for due diligence in regard to the sources of any
conflict minerals used in our products, in addition to the cost of remediation and other changes to products, processes, or
sources of supply as a consequence of such verification activities. We may face reputational challenges if we are unable to
sufficiently verify the origins for all minerals used in our products through the due diligence process we implement. Moreover,
we may encounter challenges to satisfy those customers who require that all of the components of our products are certified as
conflict free.
Considerable amounts of our common shares are available for issuance under our equity incentive plans and
convertible debentures, and significant issuances in the future may adversely impact the market price of our common
shares.
As of March 30, 2013 we had 2.00 billion authorized common shares, of which 263.6 million shares were outstanding. In
addition, 43.6 million common shares were reserved for issuance pursuant to our equity incentive plans and Employee Stock
Purchase Plan, 43.4 million common shares were reserved for issuance upon conversion or repurchase of the convertible
debentures and 20.0 million common shares were reserved for issuance upon exercise of warrants. The availability of
substantial amounts of our common shares resulting from the exercise or settlement of equity awards outstanding under our
equity incentive plans or the conversion or repurchase of convertible debentures using common shares, which would be dilutive
to existing stockholders, could adversely affect the prevailing market price of our common shares and could impair our ability
to raise additional capital through the sale of equity securities.
We have indebtedness that could adversely affect our financial position and prevent us from fulfilling our debt
obligations.
The aggregate amount of our consolidated indebtedness as of March 30, 2013 was $1.29 billion (principal amount). We also
may incur additional indebtedness in the future. Our indebtedness may:
• make it difficult for us to satisfy our financial obligations, including making scheduled principal and interest
payments on the debentures and our other indebtedness;
limit our ability to borrow additional funds for working capital, capital expenditures, acquisitions or other general
corporate purposes;
limit our ability to use our cash flow or obtain additional financing for future working capital, capital expenditures,
acquisitions or other general business purposes;
require us to use a portion of our cash flow from operations to make debt service payments;
limit our flexibility to plan for, or react to, changes in our business and industry;
place us at a competitive disadvantage compared to our less leveraged competitors;
increase our vulnerability to the impact of adverse economic and industry conditions; and
require us to repatriate off-shore cash to the U.S. at unfavorable tax rates.
•
•
•
•
•
•
•
Our ability to meet our debt service obligations will depend on our future performance, which will be subject to financial,
business and other factors affecting our operations, many of which are beyond our control.
The call options and warrant transactions related to our 2.625% Senior Convertible Debentures due June 15, 2017
(2.625% Debentures) may affect the value of the debentures and our common stock.
To hedge against potential dilution upon conversion of the 2.625% Debentures, we purchased call options on our common
stock from the hedge counterparties. We also sold warrants to the hedge counterparties, which could separately have a dilutive
effect on our earnings per share to the extent that the market price per share of our common stock exceeds the applicable strike
price of the warrants of $42.46 per share.
As the hedge counterparties and their respective affiliates modify hedge positions, they may enter or unwind various
derivatives with respect to our common stock and/or purchase or sell our common stock in secondary market transactions. This
-21-
activity also could affect the market price of our common stock and/or debentures, which could affect the ability of the holders
of the debentures to convert and the number of shares and value of the consideration that will be received by the holders of the
debentures upon conversion.
Acquisitions and strategic investments present risks, and we may not realize the goals that were contemplated at the
time of a transaction.
We recently acquired technology companies whose products complement our products, and in the past we have made a number
of strategic investments in other technology companies. We may make similar acquisitions and strategic investments in the
future. Acquisitions and strategic investments present risks, including:
•
•
•
our ongoing business may be disrupted and our management’s attention may be diverted by investment,
acquisition, transition or integration activities;
an acquisition or strategic investment may not further our business strategy as we expected, and we may not
integrate an acquired company or technology as successfully as we expected;
our operating results or financial condition may be adversely impacted by claims or liabilities that we assume from
an acquired company or technology or that are otherwise related to an acquisition;
• we may have difficulty incorporating acquired technologies or products with our existing product lines;
• we may have higher than anticipated costs in continuing support and development of acquired products, and in
general and administrative functions that support such products;
our strategic investments may not perform as expected; and
•
• we may experience unexpected changes in how we are required to account for our acquisitions and strategic
investments pursuant to U.S. GAAP.
The occurrence of any of these risks could have a material adverse effect on our business, results of operations, financial
condition or cash flows, particularly in the case of a larger acquisition or several concurrent acquisitions or strategic
investments.
ITEM 1B.
UNRESOLVED STAFF COMMENTS
Not applicable.
ITEM 2.
PROPERTIES
Our corporate offices, which include the administrative, sales, customer support, marketing, R&D and manufacturing and
testing groups, are located in San Jose, California. This main site consists of adjacent buildings providing 588,000 square feet
of space, which we own. Excess space in this facility is leased to tenants under multi-year lease agreements. We also own two
parcels of land totaling approximately 121 acres in South San Jose near our corporate facility. At present, we do not have any
plans to develop the land.
We own a 228,000 square foot facility in the metropolitan area of Dublin, Ireland, which serves as our regional headquarters in
Europe. The Irish facility is primarily used for service and support for our customers in Europe, R&D, marketing and IT
support.
We own a 222,000 square foot facility in Singapore, which serves as our Asia Pacific regional headquarters. We own the
building but the land is subject to a 30-year lease expiring in November 2035. The Singapore facility is primarily used for
manufacturing support and testing of our products and services for our customers in Asia Pacific/Japan, coordination and
management of certain third parties in our supply chain and R&D. Excess space in the facility is leased to a tenant under long-
term lease agreement.
We own a 130,000 square foot facility in Longmont, Colorado. The Longmont facility serves as the primary location for our
software efforts in the areas of R&D, manufacturing and quality control. In addition, we own a 200,000 square foot facility and
40 acres of land adjacent to the Longmont facility for future expansion. The facility is partially leased to tenants under long-
term lease agreements and partially used by us.
We lease office facilities for our engineering design centers in Hyderabad, India; Portland, Oregon; Edinburgh, Scotland;
Toronto and Ottawa, Canada; Beijing, China; Belfast, Northern Ireland; Hazlet, New Jersey; Gothenberg, Sweden; Tallinn,
Estonia and Brisbane, Australia. We also lease sales offices in various locations throughout North America, which include the
metropolitan areas of Austin, Chicago, Dallas, Detroit, Los Angeles, Montreal, Nashua, Phoenix, Raleigh, San Diego, Seattle
and Toronto as well as international sales offices located in the metropolitan areas of Bangalore, Beijing, Chengdu, Brussels,
Helsinki, Hong Kong, London, Manila, Milan, Munich, Nanjing, Osaka, Paris, Seoul, Shanghai, Shenzhen, Stockholm,
Taichung, Taipei, Tel Aviv, Tokyo and Xi’an.
-22-
ITEM 3.
LEGAL PROCEEDINGS
Patent Litigation
On December 28, 2007, a patent infringement lawsuit was filed by PACT XPP Technologies, AG (PACT) against the
Company in the U.S. District Court for the Eastern District of Texas, Marshall Division (PACT XPP Technologies, AG. v.
Xilinx, Inc. and Avnet, Inc. Case No. 2:07-CV-563). The lawsuit pertained to eleven different patents and PACT sought
injunctive relief, damages including enhanced damages, interest and attorneys’ fees. Nine of the eleven patents were dismissed
from the case prior to trial. Trial commenced in the matter on May 14, 2012 and on May 18, 2012 the jury concluded its
deliberations. The jury found five claims of the two patents held by PACT were valid and were willfully infringed by the
Company. The jury awarded PACT the sum of $15.4 million as damages and royalties on past Xilinx sales. The presiding
judge will decide the component for willful infringement at a future date which has not yet been determined, and such
enhanced damages, including the willfulness component, could be as much as treble the $15.4 million jury verdict. In its post-
trial motions, the plaintiff has moved for attorneys’ fees, an ongoing royalty for future sales of infringing products, pre- and
post-judgment interest, and certain other relief. The Company intends to appeal the verdict and has filed motions for judgment
as a matter of law.
On February 14, 2011, the Company filed a complaint for declaratory judgment of patent non-infringement and invalidity
against Intellectual Ventures in the U.S. District Court for the Northern District of California. On September 30, 2011, the
Company amended its complaint in this case to eliminate certain defendants and patents from the action (Xilinx, Inc. v.
Intellectual Ventures I LLC and Intellectual Ventures II LLC, Case No CV11-0671). The lawsuit pertains to five patents and
seeks judgments of non-infringement by Xilinx and judgments that the patents are invalid and unenforceable, as well as costs
and attorneys’ fees. Claims related to four of the five patents have been dismissed.
On February 15, 2011, Intellectual Ventures added the Company as a defendant in its complaint for patent infringement
previously filed against Altera, Microsemi and Lattice in the U.S. District Court for the District of Delaware (Intellectual
Ventures I LLC and Intellectual Ventures II LLC v. Altera Corporation, Microsemi Corporation, Lattice Semiconductor
Corporation and Xilinx, Inc., Case No. 10-CV-1065). The lawsuit pertains to five patents, four of which Xilinx is alleged to be
infringing. Intellectual Ventures seeks unspecified damages, interest and attorneys’ fees and the proceedings are in their early
stages. The Company is unable to estimate its range of possible loss in this matter at this time.
On October 17, 2011, Xilinx filed a complaint for patent non-infringement and invalidity and violation of California Business
and Professions Code Section 17200 in the U.S. District Court for the Northern District of California against Intellectual
Ventures and related entities as well as additional defendants (Xilinx, Inc. v. Intellectual Ventures, LLC. Intellectual Ventures
Management, LLC, Detelle Relay KG, LLC, Roldan Block NY LLC, Latrosse Technologies LLC, TR Technologies
Foundation LLC, Taichi Holdings, LLC, Noregin Assets N.V., LLC and Intellectual Venture Funding LLC Case No CV-
04407). By order dated January 25, 2012, the Court granted with leave to amend defendants’ motion to dismiss Xilinx’s claim
for violation of California Business and Professions Code section 17200. The Company has amended its complaint to remove
the claim for violation of California Business and Professions Code section 17200. The remainder of the lawsuit pertains to
seven patents and seeks judgments of non-infringement by Xilinx and judgments that the patents are invalid and unenforceable,
as well as costs and attorneys’ fees. Claims related to five of the seven patents have been dismissed.
On March 23, 2012, a patent infringement lawsuit was filed by Advanced Processor Technologies LLC (APT) against the
Company in the U.S. District Court for the Eastern District of Texas, Marshall Division (Advanced Processor Technologies
LLC v. Xilinx, Inc., Case No. 2;12-CV-158). The lawsuit pertains to three patents and APT seeks royalties, injunctive relief
and unspecified damages and the proceedings are in their early stages. The Company is unable to estimate its range of possible
loss in this matter at this time.
On May 30, 2012, a patent infringement lawsuit was filed by Semcon Tech, LLC (Semcon) against the Company in the U.S.
District Court for the District of Delaware (Semcon Tech, LLC v. Xilinx, Inc., Case No. 1:12-CV-00691). The lawsuit pertains
to one patent and Semcon seeks unspecified damages, costs and expenses and the proceedings are in their early stages. The
Company is unable to estimate its range of possible loss in this matter at this time.
On November 5, 2012, a patent infringement lawsuit was filed by Mosaid Technologies Inc. (Mosaid) against the Company in
the U.S. District Court for the Eastern District of Texas (Mosaid Technologies Inc. v. Xilinx, Inc., Case No 6:12-CV-00847).
The lawsuit pertains to five patents and Mosaid seeks unspecified damages, costs, fees, royalties and injunctive relief and the
proceedings are in their early stages. The Company is unable to estimate its range of possible loss in this matter at this time.
We intend to continue to protect and defend our IP vigorously.
-23-
Other Matters
From time to time, we are involved in various disputes and litigation matters that arise in the ordinary course of our business.
These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax,
regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter
and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a
range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to
uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best
information available at the time. As additional information becomes available, we continue to reassess the potential liability
related to pending claims and litigation and may revise estimates.
ITEM 4.
MINE SAFETY DISCLOSURES
Not applicable.
-24-
PART II
ITEM 5.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS
AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock trades on the NASDAQ Global Select Market under the symbol XLNX. As of May 3, 2013, there were
approximately 600 stockholders of record. Since many holders’ shares are listed under their brokerage firms’ names, the actual
number of stockholders is estimated by us to be over 110,000.
The following table sets forth the high and low closing sale prices, for the periods indicated, for our common stock as reported
by the NASDAQ Global Select Market:
First Quarter
Second Quarter
Third Quarter
Fourth Quarter
Fiscal 2013
Fiscal 2012
High
Low
High
Low
$
$
36.72
35.31
36.30
39.14
$
31.00
30.63
32.17
35.61
$
37.06
37.11
33.46
37.45
30.55
27.44
27.06
32.10
Dividends Declared Per Common Share
The following table presents the quarterly dividends declared on our common stock for the periods indicated:
First Quarter
Second Quarter
Third Quarter
Fourth Quarter
$
$
Fiscal
2013
0.22
0.22
0.22
0.22
Fiscal
2012
0.19
0.19
0.19
0.19
On March 5, 2013, our Board of Directors declared a cash dividend of $0.25 per common share for the first quarter of fiscal
2014. The dividend is payable on June 5, 2013 to stockholders of record on May 15, 2013.
Securities Authorized for Issuance Under Equity Compensation Plans
See "Equity Compensation Plan Information," included in Item 12. "Security Ownership of Certain Beneficial Owners and
Management and Related Stockholder Matters" in Part III of this Form 10-K for information regarding our equity
compensation plans.
Issuer Purchases of Equity Securities
In June 2010, the Board authorized the repurchase of up to $500.0 million of common stock (2010 Repurchase Program). In
August 2012, the Board authorized the repurchase of an additional $750.0 million of the Company’s common stock and
debentures (2012 Repurchase Program). The shares authorized for purchase under the 2012 Repurchase Program are in
addition to the shares that were purchased under the 2010 Repurchase Program. The 2010 and the 2012 Repurchase Programs
have no stated expiration date. Through March 30, 2013, the Company had used all of the $500.0 million authorized under the
2010 Repurchase Program, and $10.6 million of the $750.0 million authorized under the 2012 Repurchase Program, leaving
$739.4 million available for future repurchases. The Company’s current policy is to retire all repurchased shares, and
consequently, no treasury shares were held as of March 30, 2013 and March 31, 2012.
We did not repurchase any of our common stock during the fourth quarter of fiscal 2013. See "Note 14. Stockholders’ Equity"
to our consolidated financial statements, included in Item 8. "Financial Statements and Supplementary Data" for information
regarding our stock repurchase plans.
Company Stock Price Performance
The following graph shows a comparison of cumulative total return for our common stock, the Standard & Poor’s 500 Stock
Index (S&P 500 Index), and the Standard & Poor’s 500 Semiconductors Index (S&P 500 Semiconductors Index). The graph
covers the period from March 28, 2008, the last trading day before our fiscal 2008, to March 28, 2013, the last trading day of
-25-
our fiscal 2013. The graph and table assume that $100 was invested on March 28, 2008 in our common stock, the S&P 500
Index and the S&P 500 Semiconductors Index and that all dividends were reinvested.
Company / Index
Xilinx, Inc.
S&P 500 Index
S&P 500
Semiconductors Index
03/28/08
03/27/09
04/01/10
04/01/11
03/30/12
03/28/13
100.00
100.00
100.00
86.75
63.66
74.00
117.53
93.92
112.85
150.52
108.35
122.64
174.74
117.02
144.39
187.62
133.36
130.51
Note: Stock price performance and indexed returns for our Common Stock are historical and are not indicators of future price
performance or future investment returns.
-26-
ITEM 6.
SELECTED FINANCIAL DATA
Consolidated Statement of Income Data
Five years ended March 30, 2013
(In thousands, except per share amounts)
Net revenues
Operating income
Income before income taxes
Provision for income taxes
Net income
Net income per common share:
Basic
Diluted
Shares used in per share calculations:
Basic
Diluted
Cash dividends per common share
March 30,
2013
March 31,
2012 (1)
April 2,
2011 (2)
$ 2,168,652
580,732
547,006
59,470
487,536
$ 2,240,736
627,773
597,051
66,972
530,079
$ 2,369,445
795,399
771,080
129,205
641,875
April 3,
2010 (3)
$ 1,833,554
432,149
421,765
64,281
357,484
March 28,
2009 (4)
$ 1,825,184
429,518
458,026
96,307
361,719
$
$
$
1.86
1.79
261,652
272,573
0.88
$
$
$
2.01
1.95
263,783
272,157
0.76
$
$
$
2.43
2.39
$
$
1.30
1.29
264,094
268,061
0.64
$
276,012
276,953
0.60
$
$
$
1.31
1.31
276,113
276,854
0.56
(1) Fiscal 2012 consolidated statement of income data included restructuring and litigation charges of $3,369 and $15,400, respectively.
(2) Fiscal 2011 consolidated statement of income data included restructuring charges of $10,346 and impairment loss on investments of $5,904.
(3) Fiscal 2010 consolidated statement of income data included restructuring charges of $30,064 and impairment loss on investments of $3,805.
(4) Fiscal 2009 consolidated statement of income data included restructuring charges of $22,023, a gain on early extinguishment of convertible debentures of
$75,035, impairment loss on investments of $54,129 and a charge of $3,086 related to an impairment of a leased facility that we did not occupy.
Consolidated Balance Sheet Data
Five years ended March 30, 2013
(In thousands)
Working capital
Total assets
Convertible debentures
Other long-term liabilities
Stockholders' equity
2013
$ 1,910,851
4,729,451
922,666
456,701
2,963,296
2012
2011
2010
2009
$ 2,107,533
4,464,122
906,569
507,092
2,707,685
$ 2,254,646
4,140,850
890,980
467,113
2,414,617
$ 1,549,905
3,184,318
354,798
351,889
2,120,470
$ 1,519,402
2,811,901
352,110
277,965
1,948,760
-27-
ITEM 7.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
This discussion and analysis of financial condition and results of operations should be read in conjunction with our
consolidated financial statements and accompanying notes included in Item 8. "Financial Statements and Supplementary Data."
Cautionary Statement
The statements in this Management’s Discussion and Analysis that are forward-looking, within the meaning of the Private
Securities Litigation Reform Act of 1995, involve numerous risks and uncertainties and are based on current expectations. The
reader should not place undue reliance on these forward-looking statements. Our actual results could differ materially from
those anticipated in these forward-looking statements for many reasons, including those risks discussed under "Risk Factors"
and elsewhere in this document. Often, forward-looking statements can be identified by the use of forward-looking words, such
as "may," "will," "could," "should," "expect," "believe," "anticipate," "estimate," "continue," "plan," "intend," "project" and
other similar terminology, or the negative of such terms. We disclaim any responsibility to update or revise any forward-
looking statement provided in this Management’s Discussion and Analysis for any reason.
Nature of Operations
We design, develop and market programmable devices and associated technologies, including advanced ICs in the form of
PLDs, software design tools and predefined system functions delivered as IP. In addition to our programmable platforms, we
provide design services, customer training, field engineering and technical support. Our PLDs include FPGAs, CPLDs and
programmable SoCs. These devices are standard products that our customers program to perform desired logic functions. Our
products are designed to provide high integration and quick time-to-market for electronic equipment manufacturers in end
markets such as wired and wireless communications, industrial, scientific and medical, aerospace and defense, consumer and
automotive, audio, video and broadcast, and data processing. We sell our products globally through independent domestic and
foreign distributors and through direct sales to OEMs by a network of independent sales representative firms and by a direct
sales management organization.
Critical Accounting Policies and Estimates
The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the
results we report in our consolidated financial statements. The SEC has defined critical accounting policies as those that are
most important to the portrayal of our financial condition and results of operations and require us to make our most difficult
and subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this
definition, our critical accounting policies include: valuation of marketable securities, which impacts losses on debt and equity
securities when we record impairments; revenue recognition, which impacts the recording of revenues; and valuation of
inventories, which impacts cost of revenues and gross margin. Our critical accounting policies also include: the assessment of
impairment of long-lived assets including acquisition-related intangibles, which impacts their valuation; the assessment of the
recoverability of goodwill, which impacts goodwill impairment; accounting for income taxes, which impacts the provision or
benefit recognized for income taxes, as well as, the valuation of deferred tax assets recorded on our consolidated balance sheet;
and valuation and recognition of stock-based compensation, which impacts gross margin, research and development (R&D)
expenses, and selling, general and administrative (SG&A) expenses. Below, we discuss these policies further, as well as the
estimates and judgments involved. We also have other key accounting policies that are not as subjective, and therefore, their
application would not require us to make estimates or judgments that are as difficult, but which nevertheless could significantly
affect our financial reporting.
Valuation of Marketable Securities
Our short-term and long-term investments include marketable debt securities. As of March 30, 2013, we had marketable debt
securities with a fair value of $3.18 billion.
We determine the fair values for marketable debt securities using industry standard pricing services, data providers and other
third-party sources and by internally performing valuation testing and analyses. See "Note 3. Fair Value Measurements" to our
consolidated financial statements, included in Item 8. "Financial Statements and Supplementary Data," for details of the
valuation methodologies. In determining if and when a decline in value below adjusted cost of marketable debt and equity
securities is other than temporary, we evaluate on an ongoing basis the market conditions, trends of earnings, financial
condition, credit ratings, any underlying collateral and other key measures for our investments. We did not record any other-
than-temporary impairment for marketable debt or equity securities in fiscal 2013, 2012 or 2011.
-28-
Revenue Recognition
Sales to distributors are made under agreements providing distributor price adjustments and rights of return under certain
circumstances. Revenue and costs relating to distributor sales are deferred until products are sold by the distributors to the
distributors’ end customers. For fiscal 2013, approximately 58% of our net revenues were from products sold to distributors for
subsequent resale to OEMs or their subcontract manufacturers. Revenue recognition depends on notification from the
distributor that product has been sold to the distributor’s end customer. Also reported by the distributor are product resale price,
quantity and end customer shipment information, as well as inventory on hand. Reported distributor inventory on hand is
reconciled to deferred revenue balances monthly. We maintain system controls to validate distributor data and to verify that the
reported information is accurate. Deferred income on shipments to distributors reflects the estimated effects of distributor price
adjustments and the estimated amount of gross margin expected to be realized when distributors sell through product purchased
from us. Accounts receivable from distributors are recognized and inventory is relieved when title to inventories transfers,
typically upon shipment from Xilinx at which point we have a legally enforceable right to collection under normal payment
terms.
As of March 30, 2013, we had $71.3 million of deferred revenue and $17.9 million of deferred cost of revenues recognized as a
net $53.4 million of deferred income on shipments to distributors. As of March 31, 2012, we had $90.0 million of deferred
revenue and $23.0 million of deferred cost of revenues recognized as a net $67.0 million of deferred income on shipments to
distributors. The deferred income on shipments to distributors that will ultimately be recognized in our consolidated statement
of income will be different than the amount shown on the consolidated balance sheet due to actual price adjustments issued to
the distributors when the product is sold to their end customers.
Revenue from sales to our direct customers is recognized upon shipment provided that persuasive evidence of a sales
arrangement exists, the price is fixed, title has transferred, collection of resulting receivables is reasonably assured, and there
are no customer acceptance requirements and no remaining significant obligations. For each of the periods presented, there
were no significant formal acceptance provisions with our direct customers.
Revenue from software licenses is deferred and recognized as revenue over the term of the licenses of one year. Revenue from
services is recognized when the service is performed. Revenue from Support Products, which includes software and services
sales, was less than 5% of net revenues for all of the periods presented.
Allowances for end customer sales returns are recorded based on historical experience and for known pending customer returns
or allowances.
Valuation of Inventories
Inventories are stated at the lower of actual cost (determined using the first-in, first-out method) or market (estimated net
realizable value). The valuation of inventory requires us to estimate excess or obsolete inventory as well as inventory that is not
of salable quality. We review and set standard costs quarterly to approximate current actual manufacturing costs. Our
manufacturing overhead standards for product costs are calculated assuming full absorption of actual spending over actual
volumes, adjusted for excess capacity. Given the cyclicality of the market, the obsolescence of technology and product
lifecycles, we write down inventory based on forecasted demand and technological obsolescence. These forecasts are
developed based on inputs from our customers, including bookings and extended but uncommitted demand forecasts, and
internal analyses such as customer historical purchasing trends and actual and anticipated design wins, as well as market and
economic conditions, technology changes, new product introductions and changes in strategic direction. These factors require
estimates that may include uncertain elements. The estimates of future demand that we use in the valuation of inventory are the
basis for our published revenue forecasts, which are also consistent with our short-term manufacturing plans. The differences
between our demand forecast and the actual demand in the recent past have not resulted in any material write down in our
inventory. If our demand forecast for specific products is greater than actual demand and we fail to reduce manufacturing
output accordingly, we could be required to write down additional inventory, which would have a negative impact on our gross
margin.
Impairment of Long-Lived Assets Including Acquisition-Related Intangibles
Long-lived assets and certain identifiable intangible assets to be held and used are reviewed for impairment if indicators of
potential impairment exist. Impairment indicators are reviewed on a quarterly basis. When indicators of impairment exist and
assets are held for use, we estimate future undiscounted cash flows attributable to the assets. In the event such cash flows are
not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair
values based on the expected discounted future cash flows attributable to the assets or based on appraisals. Factors affecting
impairment of assets held for use include the ability of the specific assets to generate separately identifiable positive cash flows.
-29-
When assets are removed from operations and held for sale, we estimate impairment losses as the excess of the carrying value
of the assets over their fair value. Market conditions are amongst the factors affecting impairment of assets held for sale.
Changes in any of these factors could necessitate impairment recognition in future periods for assets held for use or assets held
for sale.
Long-lived assets such as other intangible assets and property, plant and equipment are considered non-financial assets, and are
only measured at fair value when indicators of impairment exist.
Goodwill
Goodwill is not amortized but is subject to impairment tests on an annual basis, or more frequently if indicators of potential
impairment exist, and goodwill is written down when it is determined to be impaired. We perform an annual impairment review
in the fourth quarter of each fiscal year and compare the fair value of the reporting unit in which the goodwill resides to its
carrying value. If the carrying value exceeds the fair value, the goodwill of the reporting unit is potentially impaired. For
purposes of impairment testing, Xilinx operates as a single reporting unit. We use the quoted market price method to determine
the fair value of the reporting unit. Based on the impairment review performed during the fourth quarter of fiscal 2013, there
was no impairment of goodwill in fiscal 2013. Unless there are indicators of impairment, our next impairment review for
goodwill will be performed and completed in the fourth quarter of fiscal 2014. To date, no impairment indicators have been
identified.
Accounting for Income Taxes
Xilinx is a multinational corporation operating in multiple tax jurisdictions. We must determine the allocation of income to
each of these jurisdictions based on estimates and assumptions and apply the appropriate tax rates for these jurisdictions. We
undergo routine audits by taxing authorities regarding the timing and amount of deductions and the allocation of income among
various tax jurisdictions. Tax audits often require an extended period of time to resolve and may result in income tax
adjustments if changes to the allocation are required between jurisdictions with different tax rates.
In determining income for financial statement purposes, we must make certain estimates and judgments. These estimates and
judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred tax
assets, which arise from temporary differences between the tax and financial statement recognition of revenue and expense.
Additionally, we must estimate the amount and likelihood of potential losses arising from audits or deficiency notices issued by
taxing authorities. The taxing authorities’ positions and our assessment can change over time resulting in a material effect on
the provision for income taxes in periods when these changes occur.
We must also assess the likelihood that we will be able to recover our deferred tax assets. If recovery is not likely, we must
increase our provision for taxes by recording a reserve in the form of a valuation allowance for the deferred tax assets that we
estimate will not ultimately be recoverable.
We perform a two-step approach to recognize and measure uncertain tax positions relating to accounting for income taxes. The
first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is
more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes,
if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being ultimately
realized. See "Note 15. Income Taxes" to our consolidated financial statements included in Item 8. "Financial Statements and
Supplementary Data."
Stock-Based Compensation
Determining the appropriate fair-value model and calculating the fair value of stock-based awards at the date of grant requires
judgment. We use the Black-Scholes option-pricing model to estimate the fair value of employee stock options and rights to
purchase shares under our Employee Stock Purchase Plan. Option pricing models, including the Black-Scholes model, also
require the use of input assumptions, including expected stock price volatility, expected life, expected dividend rate, expected
forfeiture rate and expected risk-free rate of return. We use implied volatility based on traded options in the open market as we
believe implied volatility is more reflective of market conditions and a better indicator of expected volatility than historical
volatility. In determining the appropriateness of implied volatility, we considered: the volume of market activity of traded
options, and determined there was sufficient market activity; the ability to reasonably match the input variables of traded
options to those of options granted by us, such as date of grant and the exercise price, and determined the input assumptions
were comparable; and the length of term of traded options used to derive implied volatility, which is generally one to two years
and which was extrapolated to match the expected term of the employee options granted by us, and determined the length of
the option term was reasonable. The expected life of options granted is based on the historical exercise activity as well as the
expected disposition of all options outstanding. We will continue to review our input assumptions and make changes as deemed
-30-
appropriate depending on new information that becomes available. Higher volatility and expected lives result in a proportional
increase to stock-based compensation determined at the date of grant. The expected dividend rate and expected risk-free rate of
return do not have as significant an effect on the calculation of fair value.
In addition, we developed an estimate of the number of stock-based awards which will be forfeited due to employee turnover.
Quarterly changes in the estimated forfeiture rate have an effect on reported stock-based compensation, as the effect of
adjusting the rate for all expense amortization is recognized in the period the forfeiture estimate is changed. If the actual
forfeiture rate is higher than the estimated forfeiture rate, then an adjustment is made to increase the estimated forfeiture rate,
which will result in a decrease to the expense recognized in the financial statements. If the actual forfeiture rate is lower than
the estimated forfeiture rate, then an adjustment is made to decrease the estimated forfeiture rate, which will result in an
increase to the expense recognized in the financial statements. The impact of forfeiture true up in fiscal 2013, 2012 and 2011
reduced stock-based compensation expense by $2.6 million, $3.7 million, and $5.1 million, respectively. The expense we
recognize in future periods could also differ significantly from the current period and/or our forecasts due to adjustments in the
assumed forfeiture rates.
Results of Operations
The following table sets forth statement of income data as a percentage of net revenues for the fiscal years indicated:
Net revenues
Cost of revenues
Gross margin
Operating expenses:
Research and development
Selling, general and administrative
Amortization of acquisition-related intangibles
Restructuring charges
Litigation
Total operating expenses
Operating income
Interest and other expense, net
Income before income taxes
Provision for income taxes
Net income
Net Revenues
(In millions)
Net revenues
2013
2012
2011
100.0%
34.0
66.0
100.0%
35.1
64.9
100.0%
34.6
65.4
21.9
16.9
0.4
—
—
39.2
26.8
1.6
25.2
2.7
22.5%
19.4
16.3
0.3
0.2
0.7
36.9
28.0
1.4
26.6
2.9
23.7%
16.6
14.8
—
0.4
—
31.8
33.6
1.0
32.6
5.5
27.1%
2013
Change
2012
Change
2011
$
2,168.7
(3)% $
2,240.7
(5)% $
2,369.4
Net revenues in fiscal 2013 and 2012 decreased 3% and 5%, respectively. New Product revenues increased in fiscal 2013 and
2012 but were offset by declines from our Mainstream, Base and Support Products. The declines were primarily due to lower
sales in the Communications end market. See also "Net Revenues by Product" and "Net Revenues by End Markets" below for
more information on our product and end-market categories.
No end customer accounted for more than 10% of net revenues for any of the periods presented.
Net Revenues by Product
We sell our products to global manufacturers of electronic products in end markets such as wired and wireless communications,
aerospace and defense, industrial, scientific and medical and audio, video and broadcast. The vast majority of our net revenues
are generated by sales of our semiconductor products, but we also generate sales from support products. We classify our
product offerings into four categories: New, Mainstream, Base and Support Products. The composition of each product
category is as follows:
-31-
• New Products include our most recent product offerings and include the Virtex-7, Kintex-7, Artix-7, Zynq-7000,
Virtex-6 and Spartan®-6 product families.
• Mainstream Products include the Virtex-5, Spartan-3 and CoolRunner-II product families.
• Base Products consist of our older product families including the Virtex-4, Virtex-II, Virtex-E, Virtex, Spartan-II,
Spartan, CoolRunner and XC9500 products.
•
Support Products include configuration solutions, HardWire, software and support services.
These product categories, except for Support Products, are modified on a periodic basis to better reflect the maturity of the
products and advances in technology. The most recent modification was made on April 1, 2012, which was the beginning of
our fiscal 2013. The amounts for the prior periods presented have been reclassified to conform to the new categorization. New
Products include our most recent product offerings and are typically designed into our customers’ latest generation of electronic
systems. Mainstream Products are generally several years old and designed into customer programs that are currently shipping
in full production. Base Products are older than Mainstream Products with demand generated generally by the customers’
oldest systems still in production. Support Products are generally products or services sold in conjunction with our
semiconductor devices to aid customers in the design process.
Net revenues by product categories for the fiscal years indicated were as follows:
(In millions)
New Products
Mainstream Products
Base Products
Support Products
Total net revenues
2013
$
473.6
942.9
666.8
85.4
$ 2,168.7
% of
Total
22
43
31
4
100
%
Change
81
(9)
(21)
(8)
(3)
$
$
2012
261.3
1,039.7
847.2
92.5
2,240.7
% of
Total
12
46
38
4
100
%
Change
$
74
(1)
(20)
(14)
(5) $
2011
150.2
1,051.8
1,060.3
107.1
2,369.4
Net revenues from New Products increased significantly in fiscal 2013 as a result of sales growth of our Virtex-6 and Spartan-6
product families as well as 7 Series and Zynq-7000 products. Sales from our 7 Series and Zynq-7000 products surpassed $100
million during fiscal 2013. In fiscal 2012, net revenues from New Products increased primarily as a result of strong market
acceptance of these products, particularly our Virtex-6 and Spartan-6 product families. We expect sales of New Products to
continue to grow as more customer programs enter into volume production with our Virtex-6 and Spartan-6 product families
and as our 7 Series and Zynq-7000 products continue their sales ramp.
Net revenues from Mainstream Products decreased in both fiscal 2013 and fiscal 2012 from the comparable prior year periods.
The decreases in both periods were largely due to the decline in sales of our Virtex-5 and Spartan-3 product families, which
were impacted by the weaker economic environment.
Net revenues from Base Products decreased in fiscal 2013 and fiscal 2012 from the comparable prior year periods. The
decreases in both periods were as expected due to a decline in sales from our Virtex-2 and Virtex-4 product families. Base
Products are mature products and their sales are expected to decline over time.
Net revenues from Support Products decreased in fiscal 2013 and 2012 compared to the prior year period. The decreases in
both periods were due to a decline in sales from our PROM products.
Net Revenues by End Markets
Our end market revenue data is derived from our understanding of our end customers’ primary markets. On April 1, 2012, we
modified our end market categories in two ways. First, Data Center customers were moved from the Data Processing category
into the Communications category. Additionally, all end market categories were renamed to better reflect actual sales
composition. Amounts for the prior periods presented have been reclassified to conform to the new categorization. Net
revenues by end markets were reclassified into the following four categories: Communications and Data Center; Industrial,
Aerospace and Defense; Broadcast, Consumer and Automotive; and Other. The percentage change calculation in the table
below represents the year-to-year dollar change in each end market.
-32-
Net revenues by end markets for fiscal years indicated were as follows:
(% of total net revenues)
Communications and Data Center
Industrial, Aerospace and Defense
Broadcast, Consumer and Automotive
Other
Total net revenues
2013
% Change
in Dollars
2012
% Change
in Dollars
2011
46%
34
16
4
100%
(1)
(4)
2
(33)
(3)
45%
35
15
5
100%
(10)
1
(3)
(8)
(5)
48%
32
15
5
100%
Net revenues from Communications and Data Center, our largest end market, decreased slightly in fiscal 2013 in terms of
absolute dollars, compared to the prior year period. The decrease in fiscal 2013 was primarily due to weaker sales from wired
communications, which completely offset the increased sales from wireless communications. Net revenues from
Communications and Data Center declined in fiscal 2012 from the comparable prior year period. The decline was due to lower
sales from both wired and wireless communication applications with wireless communication applications driving most of the
decline.
Net revenues from the Industrial, Aerospace & Defense end market decreased in fiscal 2013 versus the comparable prior year
period. The decline in fiscal 2013 was primarily due to decreases in sales from defense and industrial, scientific, and medical
applications, which offset the increase in sales from test and measurement applications. Net revenues from the Industrial,
Aerospace & Defense end market increased in fiscal 2012 compared to the prior year period. The increase was due to increased
sales from defense and industrial, scientific and medical applications, which more than offset lower sales from test and
measurement applications.
Net revenues from the Broadcast, Consumer and Automotive end market increased in fiscal 2013 from the comparable prior
year period. The increase in fiscal 2013 was due to an increase in sales from audio, video and broadcast, and automotive
applications. Net revenues from the Broadcast, Consumer and Automotive end market decreased in fiscal 2012 due primarily
to a decline in sales from audio, video and broadcast, consumer, and automotive applications.
Net revenues from the Other end market decreased in fiscal 2013 and 2012 from the comparable prior year periods. The
decreases in both periods were due to weaker sales from computing and storage applications.
Net Revenues by Geography
Geographic revenue information reflects the geographic location of the distributors, OEMs or contract manufacturers who
purchased our products. This may differ from the geographic location of the end customers. Net revenues by geography for the
fiscal years indicated were as follows:
(In millions)
North America
Asia Pacific
Europe
Japan
Total net revenues
2013
655.6
753.8
548.4
210.9
2,168.7
$
$
% of
Total
%
Change
2012
30
35
25
10
100
(4)
1
(7)
(5)
(3)
$
$
684.4
744.5
589.8
222.0
2,240.7
% of
Total
31
33
26
10
100
%
Change
(4) $
(12)
(4)
11
(5) $
2011
710.4
843.9
615.3
199.8
2,369.4
Net revenues in North America decreased in fiscal 2013 from the comparable prior year period. The decrease was primarily
due to weaker sales across most end markets, including Communications & Data Center, Industrial and Aerospace & Defense,
and Other. Net revenues in North America decreased in fiscal 2012 from the comparable prior year period. The decrease was
primarily due to a decline in sales across most of our end markets with particular weakness coming from the Communications
end market due to a decline in sales from wired communications applications.
Net revenues in Asia Pacific increased slightly in fiscal 2013 from the comparable prior year period. The increase in fiscal 2013
was primarily due to an increase in sales from the Communications and Data Center end market, particularly wireless
communications applications, and industrial, scientific, and medical, and test and measurement applications. Net revenues in
Asia Pacific decreased in fiscal 2012 from the comparable prior year period. The decrease was primarily due to a decline in
sales from the Communications end market, with particular weakness coming from wireless communications applications.
-33-
Net revenues in Europe decreased in fiscal 2013 compared with the prior year period. The decrease in fiscal 2013 was primarily
due to decreased sales from the Communications and Data Center and Automotive end markets. Net revenues in Europe
decreased in fiscal 2012 from the comparable prior year period. The decrease was due to lower sales from the Communications
end market, with particular weakness coming from wireless communications applications.
Net revenues in Japan decreased in fiscal 2013 compared with the prior year period. The decrease in fiscal 2013 was primarily
due to decreased sales in industrial, scientific, and medical, and test and measurement applications. The fiscal 2012 increase in
net revenues in Japan, as compared to prior year period, was primarily driven by strength in the Industrial and Other end
market, with particular strength coming from test and measurement applications.
Gross Margin
(In millions)
Gross margin
Percentage of net revenues
2013
Change
2012
Change
2011
$
1,431.4
(2)% $
1,454.7
(6)% $
1,549.9
66.0%
64.9%
65.4%
Gross margin was 1.1 percentage points higher in fiscal 2013 from the comparable prior year period. The increase in gross
margin was driven primarily by the Company’s continued focus on margin expansion and costs reduction across our product
portfolio, and was offset, in part, by mix of products. The decrease in the gross margin percentage in fiscal 2012 from the
comparable prior year period was driven by lower revenues and costs related to the ramp of New Products, which was partially
offset by continuing improvement in product costs. New Products generally have lower gross margins than Mainstream and
Base Products as they are in the early stage of their product life cycle and have higher unit costs associated with relatively
lower volumes and early manufacturing maturity.
Gross margin may be affected in the future due to shifts in the mix of customers and products, competitive-pricing pressure,
manufacturing-yield issues and wafer pricing. We expect to mitigate any adverse impacts from these factors by continuing to
improve yields on our New Products, improve manufacturing efficiencies, and improve average selling price management.
Sales of inventory previously written off were not material during all periods presented.
In order to compete effectively, we pass manufacturing cost reductions to our customers in the form of reduced prices to the
extent that we can maintain acceptable margins. Price erosion is common in the semiconductor industry, as advances in both
product architecture and manufacturing process technology permit continual reductions in unit cost. We have historically been
able to offset much of this revenue decline in our mature products with increased revenues from newer products.
Research and Development
(In millions)
Research and development
Percentage of net revenues
2013
Change
2012
Change
2011
$
475.5
9% $
435.3
11% $
392.5
22%
19%
17%
R&D spending increased $40.2 million, or 9%, during fiscal 2013, and $42.8 million, or 11%, during fiscal 2012, compared to
the same periods last year. The increases for both periods were primarily attributable to higher employee-related expenses
(including stock-based compensation expense), and mask and wafer expenses related to our 28-nm development activities.
R&D for fiscal 2013 also included spending for next generation products.
We plan to continue to selectively invest in R&D efforts in areas such as new products and more advanced process
development, IP cores and the development of new design and layout software. We may also consider acquisitions to
complement our strategy for technology leadership and engineering resources in critical areas.
Selling, General and Administrative
(In millions)
2013
Change
2012
Change
2011
Selling, general and administrative
$
365.7
—% $
365.3
4% $
350.6
Percentage of net revenues
17%
16%
15%
SG&A expenses were relatively flat during fiscal 2013 compared to the same period last year. We incurred higher employee-
related expenses (including stock-based compensation expense) in fiscal 2013, but the increase was offset by lower sales
commission due to lower revenues. SG&A expenses increased $14.7 million or 4% during fiscal 2012 compared to the same
-34-
period last year. The increase was primarily due to higher legal expenses related to litigation during the period. See "Note 17.
Litigation Settlements and Contingencies" to our consolidated financial statements, included in Item 8. "Financial Statements
and Supplementary Data" for information.
Amortization of Acquisition-Related Intangibles
(In millions)
2013
Change
2012
Change
2011
Amortization of acquisition-related intangibles
$
Percentage of net revenues
9.5
—%
26% $
7.6
—%
632% $
1.0
—%
Amortization expense for fiscal 2013 increased compared to the same period last year. The increase was primarily due to the
impact of amortization of intangible assets obtained from acquisitions in the second quarter of fiscal 2013. Amortization
expense also increased in fiscal 2012 compared to the same period last year. The increase was related to the intangible assets
acquired in the fourth quarter of fiscal 2011 and in the first quarter of fiscal 2012. See "Note 18. Business Combinations" to our
consolidated financial statements, included in Item 8. "Financial Statements and Supplementary Data."
Restructuring Charges
During the second quarter of fiscal 2012, we implemented restructuring measures designed to consolidate our research and
development activities in the U.S. and to reduce our global workforce by 46 net positions, or less than 2%. We have completed
this restructuring plan and recorded total restructuring charges of $3.4 million in the second quarter of fiscal 2012, which was
predominantly related to severance costs and benefits expenses.
During fiscal 2011, we announced restructuring measures designed to realign resources and drive overall operating efficiencies
across the Company and recorded total restructuring charges of $10.3 million. These measures impacted 56 positions, or less
than 2% of our global workforce, in various geographies and functions worldwide. The reorganization plan was completed by
the end of the fourth quarter of fiscal 2011.
The restructuring charges described above have been shown separately as restructuring charges on the consolidated statements
of income. There was no remaining accrual as of March 30, 2013 related to these restructurings.
Litigation
On May 18, 2012, the jury in the trial of a patent infringement lawsuit filed by PACT against us concluded its deliberations.
The jury found two patents held by PACT were valid and were willfully infringed by us. The jury awarded PACT the sum of
$15.4 million as damages and royalties on our past sales. We accrued this award on our consolidated balance sheet during the
fourth quarter of fiscal 2012. The presiding judge will decide the component for willful infringement at a future date which has
not yet been determined, and such enhanced damages, including the willfulness component, could be as much as treble the
$15.4 million jury verdict. See Item 3. "Legal Proceedings," included in Part I and "Note 17. Litigation Settlements and
Contingencies" to our consolidated financial statements, included in Item 8. "Financial Statements and Supplementary Data."
Stock-Based Compensation
(In millions)
Stock-based compensation included in:
Cost of revenues
Research and development
Selling, general and administrative
2013
Change
2012
Change
2011
$
$
6.4
37.9
33.6
77.9
13% $
17%
14%
15% $
5.6
32.3
29.5
67.4
17% $
12%
11%
12% $
4.8
28.8
26.7
60.3
The $10.5 million and $7.1 million increases in stock-based compensation expense for fiscal 2013 and 2012, respectively, as
compared to the prior year periods were primarily related to higher expenses associated with restricted stock units, as we
granted more restricted stock units at a higher fair value in the recent years. The higher expense from restricted stock units was
partially offset by lower expenses related to stock option grants as we granted lower number of stock options in the current
fiscal year.
-35-
Interest and Other Expense, Net
(In millions)
Interest and other expense, net
Percentage of net revenues
2013
Change
2012
Change
2011
$
33.7
10% $
30.7
26% $
24.3
2%
1%
1%
Our net interest and other expense increased by $3.0 million for fiscal 2013 compared to the same period last year. The increase
was primarily due to an impairment of investments in non-marketable equity securities. The increase in net interest and other
expense in fiscal 2012 over the prior-year period was primarily due to the interest expense related to the 2.625% Debentures,
which were issued in June 2010 and therefore had a partial-year impact in fiscal 2011 and full-year impact in fiscal 2012.
Provision for Income Taxes
(In millions)
Provision for income taxes
Percentage of net revenues
Effective tax rate
2013
Change
2012
Change
2011
$
59.5
(11)% $
67.0
(48)% $
129.2
3%
11%
3%
11%
6%
17%
The difference between the U.S. federal statutory tax rate of 35% and the Company’s effective tax rate in all periods is
primarily due to income earned in lower tax rate jurisdictions, for which no U.S. income tax has been provided, as the
Company intends to permanently reinvest these earnings outside of the U.S.
The effective tax rate remained flat for fiscal 2013 as compared with fiscal 2012. While both periods included benefits related
to the U.S. federal research credit, the credit was larger in fiscal 2013 than fiscal 2012 primarily due to the retroactive
reinstatement of the research tax credit as part of the American Taxpayer Relief Act of 2012 enacted on January 2, 2013. The
income tax provision for fiscal 2013 included five quarters of research tax credit as compared to fiscal 2012 provision which
included three quarters. The net benefits relating to the federal research credit for fiscal 2013 and 2012 were $12.7 million and
$9.1 million, respectively. Both periods also included benefits relating to lapses of statutes of limitation; however, the fiscal
2013 benefit was less than the comparable release in fiscal 2012. The benefits relating to lapses of statutes of limitation for
fiscal 2013 and 2012 were $9.0 million and $15.9 million, respectively.
The decrease in the effective tax rate in fiscal 2012, when compared with fiscal 2011, was primarily due to a shift in the
geographic mix of earnings subject to U.S. tax. The fiscal 2012 decrease in effective tax rate also included benefits of $15.9
million relating to lapses of statutes of limitation, which resulted in the realization of certain previously unrecognized tax
positions.
Financial Condition, Liquidity and Capital Resources
We have historically used a combination of cash flows from operations and equity and debt financing to support ongoing
business activities, acquire or invest in critical or complementary technologies, purchase facilities and capital equipment,
repurchase our common stock and debentures under our repurchase program, pay dividends and finance working capital.
Additionally, our investments in debt securities are available for future sale.
Fiscal 2013 Compared to Fiscal 2012
Cash, Cash Equivalents and Short-term and Long-term Investments
The combination of cash, cash equivalents and short-term and long-term investments as of March 30, 2013 and March 31, 2012
totaled $3.37 billion and $3.13 billion, respectively. As of March 30, 2013, we had cash, cash equivalents and short-term
investments of $1.71 billion and working capital of $1.91 billion. As of March 31, 2012, cash, cash equivalents and short-term
investments were $1.92 billion and working capital was $2.11 billion.
During fiscal 2013, our operations generated net positive cash flow of $656.5 million, which was $170.2 million lower than the
$826.7 million generated during fiscal 2012. The positive cash flow from operations generated during fiscal 2013 was primarily
from net income as adjusted for non-cash related items and increase in income taxes payable. These items were partially offset
by increases in accounts receivable and other assets, as well as decreases in deferred income on shipments to distributors and
accounts payable.
Net cash used in investing activities was $511.5 million during fiscal 2013, as compared to $960.9 million in fiscal 2012. Net
cash used in investing activities during fiscal 2013 consisted of $396.2 million of net purchases of available-for-sale securities,
-36-
$85.1 million of other investing activities and $30.3 million for purchases of property, plant and equipment (see further
discussion below).
Net cash used in financing activities was $310.3 million in fiscal 2013, as compared to $299.4 million in fiscal 2012. Net cash
used in financing activities during fiscal 2013 consisted of $230.5 million dividend payments to stockholders and $197.7
million of repurchase of common stocks, which was partially offset by $107.7 million of proceeds from issuance of common
stock under employee stock plans and $10.2 million for the excess of the tax benefit from stock-based compensation.
Accounts Receivable
Accounts receivable increased by $14.2 million and days sales outstanding (DSO) increased to 38 days at March 30, 2013 from
35 days at March 31, 2012. The increase was primarily due to timing of shipments and collections.
Inventories
Inventories decreased to $201.3 million as of March 30, 2013 from $204.9 million as of March 31, 2012, but combined
inventory days at Xilinx and distribution increased slightly to 108 days at March 30, 2013 from 106 days at March 31, 2012.
While we were able to manage our inventory and reduce the balance in terms of absolute dollar at the end of fiscal 2013 from
prior year, during fiscal 2013 and 2012 our inventory levels were still relatively higher than historical trends due to our decision
to build ahead of a number of legacy parts in response to the previously planned closure of a particular foundry process line.
The vast majority of these parts are expected to be shipped over the next two years.
We attempt to maintain sufficient levels of inventory in various product, package and speed configurations in order to keep
lead times short and to meet forecasted customer demand and address potential supply constraints. Conversely, we also attempt
to minimize the handling costs associated with maintaining higher inventory levels and to fully realize the opportunities for
cost reductions associated with architecture and manufacturing process advancements. We continually strive to balance these
two objectives to provide excellent customer response at a competitive cost.
Property, Plant and Equipment
During fiscal 2013, we invested $30.3 million in property, plant and equipment compared to $70.1 million in fiscal 2012.
Primary investments in fiscal 2013 were for equipment and building improvements in order to support our new products
development and infrastructures.
Current Liabilities
Current liabilities increased to $386.8 million at the end of fiscal 2013 from $342.8 million at the end of fiscal 2012. The
change was primarily due to an increase in the U.S. federal income tax liability which will be paid in the first quarter of fiscal
2014, partially offset by the decrease in deferred income on shipments to distributors.
Stockholders’ Equity
Stockholders’ equity increased $255.6 million during fiscal 2013 from $2.71 billion in fiscal 2012 to $2.96 billion in fiscal
2013. The increase was primarily attributable to $487.5 million in net income for fiscal 2013, $77.9 million of stock-based
compensation, $107.7 million of issuance of common stock under employee stock plans and $1.4 million of other
comprehensive income. The increase was partially offset by $197.7 million of repurchase of common stocks and $230.5
million of payment of dividends to stockholders.
Fiscal 2012 Compared to Fiscal 2011
Cash, Cash Equivalents and Short-term and Long-term Investments
The combination of cash, cash equivalents and short-term and long-term investments as of March 31, 2012 and April 2, 2011
totaled $3.13 billion and $2.69 billion, respectively. As of March 31, 2012, we had cash, cash equivalents and short-term
investments of $1.92 billion and working capital of $2.11 billion. Cash provided by operations of $826.7 million for fiscal 2012
was $102.5 million higher than the $724.2 million generated during fiscal 2011. Cash provided by operations during fiscal
2012 resulted primarily from net income as adjusted for non-cash related items and decreases in accounts receivable and
inventories and increase in accrued liabilities, and were partially offset by decreases in deferred income on shipment to
distributors, accounts payable and income taxes payable.
Net cash used in investing activities was $960.9 million during fiscal 2012, as compared to $625.4 million in fiscal 2011. Net
cash used in investing activities during fiscal 2012 consisted of $852.0 million of net purchases of available-for-sale securities,
$70.1 million for purchases of property, plant and equipment (see further discussion below) and $38.8 million for acquisition of
businesses.
-37-
Net cash used in financing activities was $299.4 million in fiscal 2012, as compared to net cash provided by financing activities
of $92.2 million in fiscal 2011. Net cash used in financing activities during fiscal 2012 consisted of $219.6 million of
repurchase of common stocks and $200.4 million for dividend payments to stockholders, which was partially offset by $108.7
million of proceeds from issuance of common stock under employee stock plans and $12.0 million for the excess of the tax
benefit from stock-based compensation.
Accounts Receivable
Accounts receivable, net of allowances for doubtful accounts, customer returns and distributor pricing adjustments decreased
by 25% from $286.5 million at the end of fiscal 2011 to $215.0 million at the end of fiscal 2012. The decrease in accounts
receivable balance was primarily attributable to a decrease in net revenues in the fourth quarter of fiscal 2012 from the
comparable prior year period. Due to higher accounts receivable collections, DSO decreased to 35 days as of March 31, 2012
from 45 days as of April 2, 2011.
Inventories
Inventories decreased from $264.7 million as of April 2, 2011 to $204.9 million as of March 31, 2012. The combined inventory
days at Xilinx and the distribution channel decreased to 106 days as of March 31, 2012, compared to 135 days as of April 2,
2011. The inventory balances for both March 31, 2012 and April 2, 2011 were relatively higher than historical trends due to
build ahead of a number of legacy parts in response to the previously planned closure of a particular foundry line.
Property, Plant and Equipment
During fiscal 2012, we invested $70.1 million in property, plant and equipment compared to $65.0 million in fiscal 2011.
Primary investments in fiscal 2012 were for equipment, building improvements, testers, handlers, software in order to support
our new products development and infrastructures.
Current Liabilities
Current liabilities decreased from $368.1 million at the end of fiscal 2011 to $342.8 million at the end of fiscal 2012. The
decrease was primarily due to the decrease in deferred income on shipments to distributors and accounts payable due to timing
and lower revenues, partially offset by the increase in other accrued liabilities.
Stockholders’ Equity
Stockholders’ equity increased $293.1 million during fiscal 2012 from $2.41 billion in fiscal 2011 to $2.71 billion in fiscal
2012. The increase in stockholders’ equity was attributable to total comprehensive income of $526.8 million (which included
net income of $530.1 million) for fiscal 2012, issuance of common stock under employee stock plans of $108.7 million and
stock-based compensation related amounts totaling $77.6 million (including the related tax benefits associated with stock
option exercises). The increases were partially offset by the repurchase of common stock of $219.6 million and payment of
dividends to stockholders of $200.4 million.
Liquidity and Capital Resources
Cash generated from operations is used as our primary source of liquidity and capital resources. Our investment portfolio is
also available for future cash requirements as is our $250.0 million revolving credit facility entered into in December 2011
(expiring in December 2016). We are not aware of any lack of access to the revolving credit facility; however, we can provide
no assurance that access to the credit facility will not be impacted by adverse conditions in the financial markets. Our credit
facility is not reliant upon a single bank. There have been no borrowings to date under our existing revolving credit facility.
We repurchased 6.2 million shares of our common stock for $197.7 million during fiscal 2013. During fiscal 2012, we used
$219.6 million of cash to repurchase 7.0 million shares of common stock. During fiscal 2013, we paid $230.5 million in cash
dividends to stockholders, representing $0.88 per common share. During fiscal 2012, we paid $200.4 million in cash dividends
to stockholders, representing $0.76 per common share. On March 5, 2013, our Board of Directors declared a cash dividend of
$0.25 per common share for the first quarter of fiscal 2014. The dividend is payable on June 5, 2013 to stockholders of record
on May 15, 2013. Our common stock and debentures repurchase program and dividend policy could be impacted by, among
other items, our views on potential future capital requirements relating to R&D, investments and acquisitions, legal risks,
principal and interest payments on our debentures and other strategic investments.
The global credit crisis has caused exceptional levels of volatility and disruption in the capital markets, diminished liquidity
and credit availability, and increased counterparty risk. Nevertheless, we anticipate that existing sources of liquidity and cash
flows from operations will be sufficient to satisfy our cash needs for the foreseeable future. We will continue to evaluate
opportunities for investments to obtain additional wafer capacity, to procure additional capital equipment and facilities, to
-38-
develop new products, and to potentially acquire technologies or businesses that could complement our business. However, the
risk factors discussed in Item 1A and below could affect our cash positions adversely. In addition, certain types of investments
such as auction rate securities may present risks arising from liquidity and/or credit concerns. In the event that our investments
in auction rate securities become illiquid, we do not expect this will materially affect our liquidity and capital resources or
results of operations.
As of March 30, 2013, marketable securities measured at fair value using Level 3 inputs were comprised of $28.7 million of
student loan auction rate securities. The amount of assets and liabilities measured using significant unobservable inputs (Level
3) as a percentage of the total assets and liabilities measured at fair value was less than 1% as of March 30, 2013. See "Note 3.
Fair Value Measurements" to our consolidated financial statements, included in Item 8. "Financial Statements and
Supplementary Data," for additional information.
During fiscal 2013, we redeemed $700 thousand of student loan auction rate securities for cash at par value.
Contractual Obligations
The following table summarizes our significant contractual obligations as of March 30, 2013 and the effect such obligations are
expected to have on our liquidity and cash flows in future periods. This table excludes amounts already recorded on our
consolidated balance sheet as current liabilities as of March 30, 2013.
(In millions)
Operating lease obligations (1)
Inventory and other purchase obligations (2)
Electronic design automation software licenses (3)
Intellectual property license rights obligations (4)
2.625% senior convertible debentures-principal and
interest (5)
3.125% junior convertible debentures-principal and
interest (5)
Total
Payments Due by Period
Total
Less than 1
year
1-3 years
$
$
20.5
96.2
13.0
5.0
666.3
$
6.3
96.2
10.3
—
15.8
1,206.9
2,007.9
$
$
21.6
150.2
$
6.4
—
2.7
—
31.5
43.1
83.7
3-5 years
3.3
$
—
—
—
619.0
43.1
665.4
$
More than 5
years
$
4.5
—
—
5.0
—
1,099.1
1,108.6
$
(1) We lease some of our facilities, office buildings and land under non-cancelable operating leases that expire at various dates through November 2035.
Rent expense, net of rental income, under all operating leases was approximately $3.9 million for fiscal 2013. See "Note 9. Commitments" to our
consolidated financial statements, included in Item 8. "Financial Statements and Supplementary Data," for additional information about operating leases.
(2) Due to the nature of our business, we depend entirely upon subcontractors to manufacture our silicon wafers and provide assembly and some test services.
The lengthy subcontractor lead times require us to order the materials and services in advance, and we are obligated to pay for the materials and services
when completed. We expect to receive and pay for these materials and services in the next three to six months, as the products meet delivery and quality
specifications.
(3) As of March 30, 2013, we had $13.0 million of non-cancelable license obligations to providers of electronic design automation software and
hardware/software maintenance expiring at various dates through March 2015.
(4) We committed up to $5.0 million to acquire, in the future, rights to intellectual property until July 2023. License payments will be amortized over the
useful life of the intellectual property acquired.
(5) For purposes of this table we have assumed the principal of our debentures will be paid on maturity dates, which is June 15, 2017 for the 2.625%
Debentures and March 15, 2037 for the 3.125% junior convertible debentures. See "Note 13. Convertible Debentures and Revolving Credit Facility" to
our consolidated financial statements, included in Item 8. "Financial Statements and Supplementary Data," for additional information about our
debentures.
As of March 30, 2013, $37.6 million of liabilities for uncertain tax positions and related interest and penalties were classified as
long-term income taxes payable in the consolidated balance sheet. Due to the inherent uncertainty with respect to the timing of
future cash outflows associated with such liabilities, we are unable to reliably estimate the timing of cash settlement with the
respective taxing authorities. Therefore, liabilities for uncertain tax positions have been excluded from the contractual
obligations table above.
Off-Balance-Sheet Arrangements
As of March 30, 2013, we did not have any significant off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC
Regulation S-K.
-39-
Recent Accounting Pronouncements
See "Note 2. Summary of Significant Accounting Policies and Concentrations of Risk" to our consolidated financial statements,
included in Item 8. "Financial Statements and Supplementary Data," for information about recent accounting pronouncements,
including the expected dates of adoption and estimated effects, if any, on our consolidated financial statements.
ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Risk
Our exposure to interest rate risk relates primarily to our investment portfolio, which consists of fixed income securities with a
fair value of approximately $3.18 billion as of March 30, 2013. Our primary aim with our investment portfolio is to invest
available cash while preserving principal and meeting liquidity needs. Our investment portfolio includes municipal bonds,
mortgage-backed securities, bank certificates of deposit, commercial paper, corporate bonds, student loan auction rate
securities, U.S. and foreign government and agency securities and a debt mutual fund. In accordance with our investment
policy, we place investments with high credit quality issuers and limit the amount of credit exposure to any one issuer based
upon the issuer’s credit rating. These securities are subject to interest rate risk and will decrease in value if market interest rates
increase. A hypothetical 100 basis-point (one percentage point) increase or decrease in interest rates compared to rates at
March 30, 2013 and March 31, 2012 would have affected the fair value of our investment portfolio by approximately $51.0
million and $26.0 million, respectively.
Credit Market Risk
Since September 2007, the global credit markets have experienced adverse conditions that have negatively impacted the values
of various types of investment and non-investment grade securities. During this time the global credit and capital markets
experienced significant volatility and disruption due to instability in the global financial system, uncertainty related to global
economic conditions and concerns regarding sovereign financial stability. Therefore, there is a risk that we may incur other-
than-temporary impairment charges for certain types of investments should credit market conditions deteriorate. See "Note 4.
Financial Instruments" to our consolidated financial statements, included in Item 8. "Financial Statements and Supplementary
Data."
Foreign Currency Exchange Risk
Sales to all direct OEMs and distributors are denominated in U.S. dollars.
Gains and losses on foreign currency forward contracts that are designated as hedges of anticipated transactions, for which a
firm commitment has been attained and the hedged relationship has been effective, are deferred and included in income or
expenses in the same period that the underlying transaction is settled. Gains and losses on any instruments not meeting the
above criteria are recognized in income or expenses in the consolidated statements of income as they are incurred.
We enter into forward currency exchange contracts to hedge our overseas operating expenses and other liabilities when deemed
appropriate. As of March 30, 2013 and March 31, 2012, we had the following outstanding forward currency exchange contracts
(in notional amount):
(In thousands and U.S. dollars)
Singapore Dollar
Euro
Indian Rupee
British Pound
Japanese Yen
March 30, 2013
70,197
39,865
16,941
11,602
10,891
149,496
$
$
March 31, 2012
60,925
$
41,467
18,943
14,250
11,076
146,661
$
As part of our strategy to reduce volatility of operating expenses due to foreign exchange rate fluctuations, we employ a
hedging program with forward outlook of up to two years for major foreign-currency-denominated operating expenses. The
outstanding forward currency exchange contracts expire at various dates between April 2013 and February 2015. The net
unrealized losses, which approximate the fair market value of the forward currency exchange contracts, are expected to be
realized into net income within the next two years.
Our investments in several of our wholly-owned subsidiaries are recorded in currencies other than the U.S. dollar. As the
financial statements of these subsidiaries are translated at each quarter end during consolidation, fluctuations of exchange rates
-40-
between the foreign currency and the U.S. dollar increase or decrease the value of those investments. These fluctuations are
recorded within stockholders’ equity as a component of accumulated other comprehensive income (loss). Other monetary
foreign-denominated assets and liabilities are revalued on a monthly basis with gains and losses on revaluation reflected in net
income. A hypothetical 10% favorable or unfavorable change in foreign currency exchange rates at March 30, 2013 and
March 31, 2012 would have affected the annualized foreign-currency-denominated operating expenses of our foreign
subsidiaries by less than $10.0 million for each year. In addition, a hypothetical 10% favorable or unfavorable change in
foreign currency exchange rates compared to rates at March 30, 2013 and March 31, 2012 would have affected the value of
foreign-currency-denominated cash and investments by less than $5.0 million as of each date.
-41-
ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
XILINX, INC.
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
Net revenues
Cost of revenues
Gross margin
Operating expenses:
Research and development
Selling, general and administrative
Amortization of acquisition-related intangibles
Restructuring charges
Litigation
Total operating expenses
Operating income
Interest and other expense, net
Income before income taxes
Provision for income taxes
Net income
Net income per common share:
Basic
Diluted
Shares used in per share calculations:
Basic
Diluted
March 30,
2013
$ 2,168,652
737,206
1,431,446
Years Ended
March 31,
2012
$ 2,240,736
786,078
1,454,658
April 2,
2011
$ 2,369,445
819,558
1,549,887
475,522
365,684
9,508
—
—
850,714
580,732
33,726
547,006
59,470
487,536
$
435,276
365,272
7,568
3,369
15,400
826,885
627,773
30,722
597,051
66,972
530,079
1.86
1.79
$
$
2.01
1.95
392,482
350,626
1,034
10,346
—
754,488
795,399
24,319
771,080
129,205
641,875
2.43
2.39
$
$
$
261,652
272,573
263,783
272,157
264,094
268,061
$
$
$
See notes to consolidated financial statements.
-42-
XILINX, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
Net income
Other comprehensive income (loss), net of tax:
Change in net unrealized gains on available-for-sale securities
Reclassification adjustment for gains on available-for-sale securities
Net change in unrealized gains (losses) on hedging transactions
Cumulative translation adjustment
Other comprehensive income (loss)
Total comprehensive income
March 30,
2013
Years Ended
March 31,
2012
April 2,
2011
$
487,536
$
530,079
$
641,875
3,343
(1,740)
1,733
(1,940)
1,396
488,932
$
7,159
(1,062)
(8,324)
(1,026)
(3,253)
526,826
$
5,975
(2,438)
6,776
1,425
11,738
653,613
$
See notes to consolidated financial statements.
-43-
XILINX, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except par value amounts)
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net of allowances for doubtful accounts and customer returns of
$3,425 and $3,446 in 2013 and 2012, respectively
Inventories
Deferred tax assets
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, at cost:
Land
Buildings
Machinery and equipment
Furniture and fixtures
Accumulated depreciation and amortization
Net property, plant and equipment
Long-term investments
Goodwill
Acquisition-related intangibles, net
Other assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued payroll and related liabilities
Income taxes payable
Deferred income on shipments to distributors
Other accrued liabilities
Total current liabilities
Convertible debentures
Deferred tax liabilities
Long-term income taxes payable
Other long-term liabilities
Commitments and contingencies
Stockholders' equity:
Preferred stock, $.01 par value; 2,000 shares authorized; none issued and outstanding
Common stock, $.01 par value; 2,000,000 shares authorized; 263,649 and 263,612 shares
issued and outstanding in 2013 and 2012, respectively
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income
Total stockholders’ equity
Total Liabilities and Stockholders’ Equity
See notes to consolidated financial statements.
March 30,
2013
March 31,
2012
$
623,558
1,091,187
$
788,822
1,128,805
229,175
201,250
60,709
91,760
2,297,639
93,701
303,958
340,402
46,735
784,796
(419,109 )
365,687
1,651,033
158,990
36,054
220,048
$ 4,729,451
$
72,766
124,195
60,632
53,358
75,837
386,788
922,666
415,442
37,579
3,680
$
$
214,965
204,866
64,822
48,029
2,450,309
94,260
314,455
332,232
47,475
788,422
(393,440)
394,982
1,209,228
149,538
36,332
223,733
4,464,122
78,613
121,309
—
67,002
75,852
342,776
906,569
463,045
14,479
29,568
—
—
2,636
1,276,278
1,675,722
8,660
2,963,296
$ 4,729,451
2,636
1,195,458
1,502,327
7,264
2,707,685
4,464,122
$
-44-
XILINX, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating
activities:
Depreciation
Amortization
Stock-based compensation
Net gain on sale of available-for-sale securities
Amortization of debt discount on convertible debentures
Provision (benefit) for deferred income taxes
Tax benefit from stock-based compensation
Excess tax benefit from stock-based compensation
Others
Changes in assets and liabilities:
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued liabilities (including restructuring activities)
Income taxes payable
Deferred income on shipments to distributors
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of available-for-sale securities
Proceeds from sale and maturity of available-for-sale securities
Purchases of property, plant and equipment
Other investing activities
Net cash used in investing activities
Cash flows from financing activities:
Repurchases of common stock
Proceeds from issuance of common stock through various stock plans, net
Payment of dividends to stockholders
Proceeds from issuance of convertible debts, net of issuance costs
Purchase of call options
Proceeds from issuance of warrants
Proceeds from sale of interest rate swaps
Excess tax benefit from stock-based compensation
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Interest paid
Income taxes paid (refunded), net
March 30,
2013
Years Ended
March 31,
2012
April 2,
2011
$
487,536
$
530,079
$
641,875
56,327
17,233
77,862
(2,815)
15,880
(44,100)
8,984
(10,156)
2,779
(14,210)
3,889
5,000
(13,932)
(5,846)
(2,319)
88,069
(13,644)
656,537
55,658
16,690
67,418
(2,515)
15,545
79,326
9,917
(11,957)
44
71,499
60,121
(7,401)
1,427
(20,640)
14,198
(19,909)
(32,761)
826,739
50,361
8,531
60,258
(3,821)
13,921
109,561
4,861
(7,406)
5,791
(23,699)
(133,724)
(4,854)
(841)
2,833
(3,496)
(15,630)
19,631
724,152
(3,910,398)
3,514,224
(30,265)
(85,076)
(511,515)
(4,333,508)
3,481,501
(70,071)
(38,819)
(960,897)
(2,578,393)
2,052,016
(64,979)
(34,085)
(625,441)
(197,689)
107,716
(230,469)
—
—
—
—
10,156
(310,286)
(165,264)
788,822
623,558
$
(219,638)
108,663
(200,361)
—
—
—
—
11,957
(299,379)
(433,537)
1,222,359
788,822
(468,943)
170,353
(169,072)
587,644
(112,319)
46,908
30,214
7,406
92,191
190,902
1,031,457
$ 1,222,359
37,301
6,975
$
$
37,301
(2,447)
$
$
29,827
30,561
$
$
$
See notes to consolidated financial statements.
-45-
XILINX, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
Common Stock
Outstanding
Shares
273,487
Amount
2,735
$
Additional
Paid-in
Capital
$ 1,102,411
Retained
Earnings
$ 1,016,545
Accumulated
Other
Comprehensive
Income (Loss)
(1,221)
$
Total
Shareholders’
Equity
2,120,470
$
(In thousands, except per share amounts)
Balance as of April 3, 2010
Components of comprehensive income:
Net income
Other comprehensive income
Total comprehensive income
Issuance of common shares under employee stock plans
Repurchase and retirement of common stock
Stock-based compensation expense
Stock-based compensation capitalized in inventory
Equity component of 2.625% Debentures, net
Purchase of call options
Issuance of warrants
Cash dividends declared ($0.64 per common share)
Tax benefit from stock-based compensation
Balance as of April 2, 2011
Components of comprehensive income:
Net income
Other comprehensive income
Total comprehensive income
Issuance of common shares under employee stock plans
Repurchase and retirement of common stock
Stock-based compensation expense
Stock-based compensation capitalized in inventory
Cash dividends declared ($0.76 per common share)
Tax benefit from stock-based compensation
Balance as of March 31, 2012
Components of comprehensive income:
Net income
Other comprehensive income
Total comprehensive income
Issuance of common shares under employee stock plans
Repurchase and retirement of common stock
Stock-based compensation expense
Stock-based compensation capitalized in inventory
Cash dividends declared ($0.88 per common share)
Tax benefit from stock-based compensation
Balance as of March 30, 2013
—
—
8,870
(17,755)
—
—
—
—
—
—
—
264,602
—
—
6,040
(7,030)
—
—
—
—
263,612
—
—
6,191
(6,154)
—
—
—
—
263,649
—
—
641,875
—
—
11,738
—
—
89
(178)
—
—
—
—
—
—
170,264
(217,461)
60,258
394
108,094
(112,319)
46,908
—
—
(251,304)
—
—
—
—
—
(169,072)
—
1,238,044
—
2,646
4,861
1,163,410
—
—
61
(71)
—
—
—
—
2,636
—
—
61
(61)
—
—
—
—
2,636
$
—
—
530,079
—
108,602
(154,132)
67,418
242
—
9,918
1,195,458
—
(65,435)
—
—
(200,361)
—
1,502,327
—
—
487,536
—
107,655
(113,956)
77,862
275
—
8,984
$ 1,276,278
—
(83,672)
—
—
(230,469)
—
$ 1,675,722
$
641,875
11,738
653,613
170,353
(468,943)
60,258
394
108,094
(112,319)
46,908
(169,072)
4,861
2,414,617
530,079
(3,253)
526,826
108,663
(219,638)
67,418
242
(200,361)
9,918
2,707,685
487,536
1,396
488,932
107,716
(197,689)
77,862
275
(230,469)
8,984
2,963,296
—
—
—
—
—
—
—
—
—
10,517
—
(3,253)
—
—
—
—
—
—
7,264
—
1,396
—
—
—
—
—
—
8,660
$
See notes to consolidated financial statements.
-46-
XILINX, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Nature of Operations
Xilinx, Inc. (Xilinx or the Company) designs, develops and markets programmable devices and associated technologies,
including advanced ICs in the form of PLDs, software design tools and predefined system functions delivered as IP. In addition
to its programmable platforms, the Company provides design services, customer training, field engineering and technical
support. The wafers used to manufacture its products are obtained primarily from independent wafer manufacturers located in
Taiwan and Korea. The Company is dependent on these foundries to produce and deliver silicon wafers on a timely basis. The
Company is also dependent on subcontractors, primarily located in the Asia Pacific region, to provide semiconductor assembly,
test and shipment services. Xilinx is a global company with sales offices throughout the world. The Company derives over one-
half of its revenues from international sales, primarily in the Asia Pacific region, Europe and Japan.
Note 2. Summary of Significant Accounting Policies and Concentrations of Risk
Basis of Presentation
The accompanying consolidated financial statements include the accounts of Xilinx and its wholly-owned subsidiaries after
elimination of all intercompany transactions. The Company uses a 52- to 53-week fiscal year ending on the Saturday nearest
March 31. Fiscal 2013, 2012 and 2011 were 52-week years ended on March 30, 2013, March 31, 2012 and April 2, 2011,
respectively. Fiscal 2014 will be a 52-week year ending on March 29, 2014.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of
contingent liabilities at the date of the financial statements and the reported amounts of net revenues and expenses during the
reporting period. Such estimates relate to, among others, the useful lives of assets, assessment of recoverability of property,
plant and equipment, long-lived assets including acquisition-related intangible assets and goodwill, inventory write-downs,
allowances for doubtful accounts, customer returns, deferred tax assets, stock-based compensation, potential reserves relating
to litigation and tax matters, valuation of certain investments and derivative financial instruments as well as other accruals or
reserves. Actual results may differ from those estimates and such differences may be material to the financial statements.
Reclassification
Reclassifications were made to consolidate certain accounts on the prior year consolidated statements of income (within
"Interest and other expense, net") and cash flows (within "Adjustments to reconcile net income to net cash provided by
operating activities") to conform to the current year presentation. There was no impact to net income or net cash provided by
operating activities in those prior-year periods.
Cash Equivalents and Investments
Cash equivalents consist of highly liquid investments with original maturities from the date of purchase of three months or less.
These investments consist of commercial paper, U.S. and foreign government and agency securities, money market funds, and
bank certificates of deposit. Short-term investments consist of U.S. and foreign government and agency securities, commercial
paper, bank certificates of deposit, corporate bonds, municipal bonds and mortgage-backed securities with original maturities
greater than three months and remaining maturities less than one year from the balance sheet date. Long-term investments
consist of mortgage-backed securities, corporate bonds, U.S. government and agency securities, a debt mutual fund, and
municipal bonds with remaining maturities greater than one year, unless the investments are specifically identified to fund
current operations, in which case they are classified as short-term investments. As of March 30, 2013 and March 31, 2012,
long-term investments also included approximately $28.7 million and $28.9 million, respectively, of auction rate securities that
experienced failed auctions in the fourth quarter of fiscal 2008. These auction rate securities are secured primarily by pools of
student loans originated under Federal Family Education Loan Program (FFELP) that are substantially guaranteed by the U. S.
Department of Education. Equity investments are also classified as long-term investments since they are not intended to fund
current operations.
The Company maintains its cash balances with various banks with high quality ratings, and with investment banking and asset
management institutions. The Company manages its liquidity risk by investing in a variety of money market funds, high-grade
commercial paper, corporate bonds, municipal bonds, U.S. and foreign government and agency securities and a debt mutual
fund. This diversification of investments is consistent with its policy to maintain liquidity and ensure the ability to collect
principal. The Company maintains an offshore investment portfolio denominated in U.S. dollars. All investments are made
-47-
pursuant to corporate investment policy guidelines. Investments include Euro commercial paper, Euro dollar bonds, Euro dollar
floating rate notes, offshore time deposits, U.S. and foreign government and agency securities, and mortgage-backed securities
issued by U.S. government-sponsored enterprises and agencies.
Management classifies investments as available-for-sale or held-to-maturity at the time of purchase and re-evaluates such
designation at each balance sheet date, although classification is not generally changed. Securities are classified as held-to-
maturity when the Company has the positive intent and the ability to hold the securities until maturity. Held-to-maturity
securities are carried at cost adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization,
as well as any interest on the securities, is included in interest income. No investments were classified as held-to-maturity as of
March 30, 2013 or March 31, 2012. Available-for-sale securities are carried at fair value with the unrealized gains or losses, net
of tax, included as a component of accumulated other comprehensive income in stockholders’ equity. See "Note 3. Fair Value
Measurements" for information relating to the determination of fair value. Realized gains and losses on available-for-sale
securities are included in interest and other expense, net, and declines in value judged to be other than temporary are included
in impairment loss on investments. The cost of securities matured or sold is based on the specific identification method.
In determining whether a decline in value of non-marketable equity investments in private companies is other than temporary,
the assessment is made by considering available evidence including the general market conditions in the investee’s industry,
the investee’s product development status, the investee’s ability to meet business milestones and the financial condition and
near-term prospects of the individual investee, including the rate at which the investee is using its cash, the investee’s need for
possible additional funding at a lower valuation and bona fide offers to purchase the investee from a prospective acquirer.
When a decline in value is deemed to be other than temporary, the Company recognizes an impairment loss in the current
period’s operating results to the extent of the decline.
Accounts Receivable
The allowance for doubtful accounts reflects the Company’s best estimate of probable losses inherent in the accounts
receivable balance. The Company determines the allowance based on the aging of Xilinx’s accounts receivable, historical
experience, known troubled accounts, management judgment and other currently available evidence. Xilinx writes off accounts
receivable against the allowance when Xilinx determines a balance is uncollectible and no longer actively pursues collection of
the receivable. The amounts of accounts receivable written off were insignificant for all periods presented.
Inventories
Inventories are stated at the lower of actual cost (determined using the first-in, first-out method), or market (estimated net
realizable value) and are comprised of the following:
(In thousands)
Raw materials
Work-in-process
Finished goods
March 30, 2013
$
$
12,484
165,034
23,732
201,250
March 31, 2012
11,707
$
164,438
28,721
204,866
$
The Company reviews and sets standard costs quarterly to approximate current actual manufacturing costs. The Company’s
manufacturing overhead standards for product costs are calculated assuming full absorption of actual spending over actual
volumes, adjusted for excess capacity. Given the cyclicality of the market, the obsolescence of technology and product
lifecycles, the Company writes down inventory based on forecasted demand and technological obsolescence. These forecasts
are developed based on inputs from the Company’s customers, including bookings and extended but uncommitted demand
forecasts, and internal analyses such as customer historical purchasing trends and actual and anticipated design wins, as well as
market and economic conditions, technology changes, new product introductions and changes in strategic direction. These
factors require estimates that may include uncertain elements. The estimates of future demand that the Company uses in the
valuation of inventory are the basis for its published revenue forecasts, which are also consistent with our short-term
manufacturing plans. The differences between the Company’s demand forecast and the actual demand in the recent past have
not resulted in any material write down in the Company’s inventory. If the Company’s demand forecast for specific products is
greater than actual demand and the Company fails to reduce manufacturing output accordingly, the Company could be required
to write down additional inventory, which would have a negative impact on the Company’s gross margin.
-48-
Property, Plant and Equipment
Property, plant and equipment are recorded at cost, net of accumulated depreciation. Depreciation for financial reporting
purposes is computed using the straight-line method over the estimated useful lives of the assets of three to five years for
machinery, equipment, furniture and fixtures and 15 to 30 years for buildings. Depreciation expense totaled $56.3 million,
$55.7 million and $50.4 million for fiscal 2013, 2012 and 2011, respectively.
Impairment of Long-Lived Assets Including Acquisition-Related Intangibles
The Company evaluates the carrying value of long-lived assets and certain identifiable intangible assets to be held and used for
impairment if indicators of potential impairment exist. Impairment indicators are reviewed on a quarterly basis. When
indicators of impairment exist and assets are held for use, the Company estimates future undiscounted cash flows attributable to
the assets. In the event such cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets
are written down to their estimated fair values based on the expected discounted future cash flows attributable to the assets or
based on appraisals. When assets are removed from operations and held for sale, Xilinx estimates impairment losses as the
excess of the carrying value of the assets over their fair value.
Goodwill
Goodwill is not amortized but is subject to impairment tests on an annual basis, or more frequently if indicators of potential
impairment exist, using a fair-value-based approach. Based on the impairment review performed during the fourth quarter of
fiscal 2013, there was no impairment of goodwill in fiscal 2013. Unless there are indicators of impairment, the Company’s next
impairment review for goodwill will be performed and completed in the fourth quarter of fiscal 2014. To date, no impairment
indicators have been identified.
Revenue Recognition
Sales to distributors are made under agreements providing distributor price adjustments and rights of return under certain
circumstances. Revenue and costs relating to distributor sales are deferred until products are sold by the distributors to the
distributors’ end customers. For fiscal 2013, approximately 58% of the Company’s net revenues were from products sold to
distributors for subsequent resale to OEMs or their subcontract manufacturers. Revenue recognition depends on notification
from the distributor that product has been sold to the distributor’s end customer. Also reported by the distributor are product
resale price, quantity and end customer shipment information, as well as inventory on hand. Reported distributor inventory on
hand is reconciled to deferred revenue balances monthly. The Company maintains system controls to validate distributor data
and to verify that the reported information is accurate. Deferred income on shipments to distributors reflects the effects of
distributor price adjustments and the amount of gross margin expected to be realized when distributors sell through product
purchased from the Company. Accounts receivable from distributors are recognized and inventory is relieved when title to
inventories transfers, typically upon shipment from Xilinx at which point the Company has a legally enforceable right to
collection under normal payment terms.
As of March 30, 2013, the Company had $71.3 million of deferred revenue and $17.9 million of deferred cost of revenues
recognized as a net $53.4 million of deferred income on shipments to distributors. As of March 31, 2012, the Company had
$90.0 million of deferred revenue and $23.0 million of deferred cost of revenues recognized as a net $67.0 million of deferred
income on shipments to distributors. The deferred income on shipments to distributors that will ultimately be recognized in the
Company’s consolidated statement of income will be different than the amount shown on the consolidated balance sheet due to
actual price adjustments issued to the distributors when the product is sold to their end customers.
Revenue from sales to the Company’s direct customers is recognized upon shipment provided that persuasive evidence of a
sales arrangement exists, the price is fixed, title has transferred, collection of resulting receivables is reasonably assured, and
there are no customer acceptance requirements and no remaining significant obligations. For each of the periods presented,
there were no significant formal acceptance provisions with the Company’s direct customers.
Revenue from software licenses is deferred and recognized as revenue over the term of the licenses of one year. Revenue from
support services is recognized when the service is performed. Revenue from Support Products, which includes software and
services sales, was less than 5% of net revenues for all of the periods presented.
Allowances for end customer sales returns are recorded based on historical experience and for known pending customer returns
or allowances.
-49-
Foreign Currency Translation
The U.S. dollar is the functional currency for the Company’s Ireland and Singapore subsidiaries. Monetary assets and
liabilities that are not denominated in the functional currency are remeasured into U.S. dollars, and the resulting gains or losses
are included in the consolidated statements of income under interest and other expense, net. The remeasurement gains or losses
were immaterial for all fiscal periods presented.
The local currency is the functional currency for each of the Company’s other wholly-owned foreign subsidiaries. Assets and
liabilities are translated from foreign currencies into U.S. dollars at month-end exchange rates and statements of income are
translated at the average monthly exchange rates. Exchange gains or losses arising from translation of foreign currency
denominated assets and liabilities (i.e., cumulative translation adjustment) are included as a component of accumulated other
comprehensive income in stockholders’ equity.
Derivative Financial Instruments
To reduce financial risk, the Company periodically enters into financial arrangements as part of the Company’s ongoing asset
and liability management activities. Xilinx uses derivative financial instruments to hedge fair values of underlying assets and
liabilities or future cash flows which are exposed to foreign currency or commodity price fluctuations. The Company does not
enter into derivative financial instruments for trading or speculative purposes. See "Note 5. Derivative Financial Instruments"
for detailed information about the Company’s derivative financial instruments.
Research and Development Expenses
Research and development costs are current period expenses and charged to expense as incurred.
Stock-Based Compensation
The Company has equity incentive plans that are more fully discussed in "Note 6. Stock-Based Compensation Plans." The
authoritative guidance of accounting for share-based payment requires the Company to measure the cost of all employee equity
awards that are expected to be exercised based on the grant-date fair value of those awards and to record that cost as
compensation expense over the period during which the employee is required to perform service in exchange for the award
(over the vesting period of the award). In addition, the Company is required to record compensation expense (as previous
awards continue to vest) for the unvested portion of previously granted awards that remain outstanding at the date of adoption.
The authoritative guidance of accounting for share-based payment requires cash flows resulting from excess tax benefits to be
classified as a part of cash flows from financing activities. Excess tax benefits are realized tax benefits from tax deductions for
exercised options in excess of the deferred tax asset attributable to stock compensation costs for such options. The exercise
price of employee stock options is equal to the market price of Xilinx common stock (defined as the closing trading price
reported by The NASDAQ Global Select Market) on the date of grant. Additionally, Xilinx’s employee stock purchase plan is
deemed a compensatory plan under the authoritative guidance of accounting for share-based payment. Accordingly, the
employee stock purchase plan is included in the computation of stock-based compensation expense.
The Company uses the straight-line attribution method to recognize stock-based compensation costs over the requisite service
period of the award. Upon exercise, cancellation or expiration of stock options, deferred tax assets for options with multiple
vesting dates are eliminated for each vesting period on a first-in, first-out basis as if each award had a separate vesting period.
To calculate the excess tax benefits available for use in offsetting future tax shortfalls as of the date of implementation, the
Company followed the alternative transition method.
Income Taxes
All income tax amounts reflect the use of the liability method under the accounting for income taxes, as interpreted by
Financial Accounting Standards Board (FASB) authoritative guidance for measuring uncertain tax positions. Under this
method, deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary
differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.
Product Warranty and Indemnification
The Company generally sells products with a limited warranty for product quality. The Company provides an accrual for
known product issues if a loss is probable and can be reasonably estimated. As of the end of both fiscal 2013 and 2012, the
accrual balance of the product warranty liability was immaterial.
-50-
The Company offers, subject to certain terms and conditions, to indemnify customers and distributors for costs and damages
awarded against these parties in the event the Company’s hardware products are found to infringe third-party intellectual
property rights, including patents, copyrights or trademarks, and to compensate certain customers for limited specified costs
they actually incur in the event our hardware products experience epidemic failure. To a lesser extent, the Company may from
time-to-time offer limited indemnification with respect to its software products. The terms and conditions of these indemnity
obligations are limited by contract, which obligations are typically perpetual from the effective date of the agreement. The
Company has historically received only a limited number of requests for indemnification under these provisions and has not
made any significant payments pursuant to these provisions. The Company cannot estimate the maximum amount of potential
future payments, if any, that the Company may be required to make as a result of these obligations due to the limited history of
indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim and
indemnification provision. However, there can be no assurances that the Company will not incur any financial liabilities in the
future as a result of these obligations.
Concentrations of Credit Risk
Avnet, Inc. (Avnet), one of the Company’s distributors, distributes the Company’s products worldwide. As of March 30, 2013
and March 31, 2012, Avnet accounted for 64% and 67% of the Company’s total net accounts receivable, respectively. Resale of
product through Avnet accounted for 46%, 48% and 51% of the Company’s worldwide net revenues in fiscal 2013, 2012 and
2011, respectively. The percentage of accounts receivable due from Avnet and the percentage of worldwide net revenues from
Avnet are consistent with historical patterns.
Xilinx is subject to concentrations of credit risk primarily in its trade accounts receivable and investments in debt securities to
the extent of the amounts recorded on the consolidated balance sheet. The Company attempts to mitigate the concentration of
credit risk in its trade receivables through its credit evaluation process, collection terms, distributor sales to diverse end
customers and through geographical dispersion of sales. Xilinx generally does not require collateral for receivables from its end
customers or from distributors.
No end customer accounted for more than 10% of the Company’s worldwide net revenues for any of the periods presented.
The Company mitigates concentrations of credit risk in its investments in debt securities by currently investing more than 87%
of its portfolio in AA or higher grade securities as rated by Standard & Poor’s or Moody’s Investors Service. The Company’s
methods to arrive at investment decisions are not solely based on the rating agencies’ credit ratings. Xilinx also performs
additional credit due diligence and conducts regular portfolio credit reviews, including a review of counterparty credit risk
related to the Company’s forward currency exchange contracts. Additionally, Xilinx limits its investments in the debt securities
of a single issuer based upon the issuer’s credit rating and attempts to further mitigate credit risk by diversifying risk across
geographies and type of issuer.
As of March 30, 2013, approximately 36% of the portfolio consisted of mortgage-backed securities. All of the mortgage-
backed securities in the investment portfolio were issued by U.S. government-sponsored enterprises and agencies and are rated
AA+ by Standard & Poor’s and AAA by Moody’s Investors Service.
The global credit and capital markets have continued to experience adverse conditions that have negatively impacted the values
of various types of investment and non-investment grade securities, and have experienced volatility and disruption due to
instability in the global financial system, uncertainty related to global economic conditions and concerns regarding sovereign
financial stability. Therefore, there is a risk that the Company may incur other-than-temporary impairment charges for certain
types of investments should credit market conditions deteriorate or the underlying assets fail to perform as anticipated. See
"Note 4. Financial Instruments" for a table of the Company’s available-for-sale securities.
Dependence on Independent Manufacturers and Subcontractors
The Company does not directly manufacture the finished silicon wafers used to manufacture its products. Xilinx receives a
majority of its finished wafers from independent wafer manufacturers located in Taiwan. The Company is also dependent on a
limited number of subcontractors, primarily located in the Asia Pacific region, to provide semiconductor assembly, test and
shipment services.
Recent Accounting Pronouncements
In the first quarter of fiscal 2013, the Company adopted the authoritative guidance, established by the FASB, to increase the
prominence of items reported in other comprehensive income. Under this guidance, an entity has the option to present the total
of comprehensive income, the components of net income, and the components of other comprehensive income either in a single
continuous statement of comprehensive income or in two separate but consecutive statements. The Company elected to present
its comprehensive income in a separate but consecutive statement. This guidance does not affect the underlying accounting for
components of other comprehensive income.
-51-
In February 2013, the FASB issued the authoritative guidance that sets requirements for presentation for significant items
reclassified out of the accumulated other comprehensive income to net income in their entirety during the period, and for items
not reclassified to net income in their entirety during the period. The guidance will be effective for public companies for fiscal
years and interim periods within those years beginning after December 15, 2012, which for the Company is its first quarter of
fiscal 2014. This guidance does not affect the underlying accounting for components of other comprehensive income.
Note 3. Fair Value Measurements
The guidance for fair value measurements established by the FASB defines fair value as the exchange price that would be
received from selling an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants
at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be
recorded at fair value, the Company considers the principal or most advantageous market in which Xilinx would transact and
also considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer
restrictions and risk of nonperformance.
The Company determines the fair value for marketable debt securities using industry standard pricing services, data providers
and other third-party sources and by internally performing valuation testing and analyses. The Company primarily uses a
consensus price or weighted-average price for its fair value assessment. The Company determines the consensus price using
market prices from a variety of industry standard pricing services, data providers, security master files from large financial
institutions and other third party sources and uses those multiple prices as inputs into a distribution-curve-based algorithm to
determine the daily market value. The pricing services use multiple inputs to determine market prices, including reportable
trades, benchmark yield curves, credit spreads and broker/dealer quotes as well as other industry and economic events. For
certain securities with short maturities, such as discount commercial paper and certificates of deposit, the security is accreted
from purchase price to face value at maturity. If a subsequent transaction on the same security is observed in the marketplace,
the price on the subsequent transaction is used as the current daily market price and the security will be accreted to face value
based on the revised price. For certain other securities, such as student loan auction rate securities, the Company performs its
own valuation analysis using a discounted cash flow pricing model.
The Company validates the consensus prices by taking random samples from each asset type and corroborating those prices
using reported trade activity, benchmark yield curves, binding broker/dealer quotes or other relevant price information. There
have not been any changes to the Company’s fair value methodology during fiscal 2013 and the Company did not adjust or
override any fair value measurements as of March 30, 2013.
Fair Value Hierarchy
The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions
(inputs) used to price the assets or liabilities. The guidance for fair value measurements requires that assets and liabilities
carried at fair value be classified and disclosed in one of the following categories:
Level 1 — Quoted (unadjusted) prices in active markets for identical assets or liabilities.
The Company’s Level 1 assets consist of U.S. government and agency securities and money market funds.
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities
in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are
observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
The Company’s Level 2 assets consist of bank certificates of deposit, commercial paper, corporate bonds, municipal bonds,
U.S. agency securities, foreign government and agency securities, mortgage-backed securities and a debt mutual fund. The
Company’s Level 2 assets and liabilities also include foreign currency forward contracts and commodity swap contracts.
Level 3 — Unobservable inputs to the valuation methodology that are supported by little or no market activity and that are
significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair
value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques,
as well as significant management judgment or estimation.
The Company’s Level 3 assets and liabilities include student loan auction rate securities and the embedded derivative related to
the Company’s debentures.
-52-
Assets and Liabilities Measured at Fair Value on a Recurring Basis
In instances where the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value
measurement has been determined based on the lowest level input that is significant to the fair value measurement in its
entirety. The Company’s assessment of the significance of a particular item to the fair value measurement in its entirety
requires judgment, including the consideration of inputs specific to the asset or liability. The following tables present
information about the Company’s assets and liabilities measured at fair value on a recurring basis as of March 30, 2013 and
March 31, 2012:
March 30, 2013
Quoted
Prices in
Active
Markets for
Identical
Instruments
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total Fair
Value
$
— $
108,311
—
—
95,039
—
—
—
—
—
416,887
—
—
—
—
—
55,142
—
—
675,379
$
— $
—
— $
$
675,379
79,995
208,667
—
54,989
44,992
294,883
40,728
3,706
75,011
214,912
68
235,275
—
21,234
55,143
1,192,612
62,927
2,585,142
1,615
—
1,615
2,583,527
$
$
$
$
— $
—
—
—
—
—
—
—
—
—
—
—
—
28,700
—
—
—
—
28,700
$
— $
1,090
1,090
27,610
$
$
108,311
79,995
208,667
95,039
54,989
44,992
294,883
40,728
3,706
491,898
214,912
68
235,275
28,700
21,234
110,285
1,192,612
62,927
3,289,221
1,615
1,090
2,705
3,286,516
$
(In thousands)
Assets
Cash and cash equivalents:
Money market funds
Bank certificates of deposit
Commercial paper
U.S. government and agency securities
Foreign government and agency securities
Short-term investments:
Bank certificates of deposit
Commercial paper
Corporate bonds
Municipal bonds
U.S. government and agency securities
Foreign government and agency securities
Mortgage-backed securities
Long-term investments:
Corporate bonds
Auction rate securities
Municipal bonds
U.S. government and agency securities
Mortgage-backed securities
Debt mutual fund
Total assets measured at fair value
Liabilities
Derivative financial instruments, net
Convertible debentures — embedded derivative
Total liabilities measured at fair value
Net assets measured at fair value
$
$
$
$
-53-
March 31, 2012
Quoted
Prices in
Active
Markets for
Identical
Instruments
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total Fair
Value
232,017
—
—
75,036
—
—
—
—
322,763
—
—
—
—
—
17,539
—
—
647,355
$
— $
29,994
233,980
84,985
68,993
129,978
360,887
14,257
119,931
180,958
31
— $
—
—
—
—
—
—
—
—
—
—
175,415
—
26,160
48,659
892,745
19,781
2,386,754
$
$
—
28,929
—
—
—
—
28,929
$
— $
—
— $
$
647,355
3,070
$
—
3,070
2,383,684
$
$
— $
931
931
27,998
$
$
232,017
29,994
233,980
160,021
68,993
129,978
360,887
14,257
442,694
180,958
31
175,415
28,929
26,160
66,198
892,745
19,781
3,063,038
3,070
931
4,001
3,059,037
(In thousands)
Assets
Cash and cash equivalents:
Money market funds
Bank certificates of deposit
Commercial paper
U.S. government and agency securities
Foreign government and agency securities
Short-term investments:
Bank certificates of deposit
Commercial paper
Corporate bonds
U.S. government and agency securities
Foreign government and agency securities
Mortgage-backed securities
Long-term investments:
Corporate bonds
Auction rate securities
Municipal bonds
U.S. government and agency securities
Mortgage-backed securities
Debt mutual fund
Total assets measured at fair value
Liabilities
Derivative financial instruments, net
Convertible debentures — embedded derivative
Total liabilities measured at fair value
Net assets measured at fair value
$
$
$
$
$
-54-
Changes in Level 3 Instruments Measured at Fair Value on a Recurring Basis
The following table is a reconciliation of all assets and liabilities measured at fair value on a recurring basis using significant
unobservable inputs (Level 3):
(In thousands)
Balance as of beginning of period
Total realized and unrealized gains (losses):
Included in interest and other expense, net
Included in other comprehensive income (loss)
Sales and settlements, net (1)
Balance as of end of period
Years Ended
March 30,
2013
27,998
$
March 31,
2012
34,005
$
(159)
471
(700)
27,610
$
14
(371)
(5,650)
27,998
$
(1)
During fiscal 2013 and 2012, the Company redeemed $700 thousand and $5.7 million of student loan auction rate
securities, respectively, for cash at par value.
The amount of total gains or (losses) included in net income attributable to the change in unrealized gains or (losses) relating to
assets and liabilities still held as of the end of the period are summarized as follows:
(In thousands)
Included in interest and other expense, net
March 30,
2013
March 31,
2012
April 2,
2011
$
(159) $
14
$
(97)
As of March 30, 2013, marketable securities measured at fair value using Level 3 inputs were comprised of $28.7 million of
student loan auction rate securities. Auction failures during the fourth quarter of fiscal 2008 and the lack of market activity and
liquidity required that the Company’s student loan auction rate securities be measured using observable market data and Level
3 inputs. The fair values of the Company’s student loan auction rate securities were based on the Company’s assessment of the
underlying collateral and the creditworthiness of the issuers of the securities. Substantially all of the underlying assets that
secure the student loan auction rate securities are pools of student loans originated under FFELP, which are substantially
guaranteed by the U.S. Department of Education. The fair values of the Company’s student loan auction rate securities were
determined using a discounted cash flow pricing model that incorporated financial inputs such as projected cash flows, discount
rates, expected interest rates to be paid to investors and an estimated liquidity discount. The most significant assumptions of the
model are the weighted-average life over which cash flows were projected of eight years (given the collateral composition of
the securities) and the discount rates ranging from 2.44% to 3.16% that were applied to the pricing model (based on market
data and information for comparable- or similar-term student loan asset-backed securities). A hypothetical 20% increase or
decrease of the weighted-average life over which cash flows were projected and 100 basis points (one percentage point)
increase or decrease in the discount rates would not have a material effect on the fair values of the Company’s student loan
auction rate securities. The Company does not intend to sell, nor does it believe it is more likely than not that it would be
required to sell, the student loan auction rate securities before anticipated recovery, which could be at final maturity that ranges
from December 2027 to May 2046.
The 3.125% Junior Convertible Debentures due March 15, 2037 (3.125% Debentures) included embedded features that qualify
as an embedded derivative, and was separately accounted for as a discount on the 3.125% Debentures. Its fair value was
established at the inception of the 3.125% Debentures. Each quarter, the change in the fair value of the embedded derivative, if
any, is recorded in the consolidated statements of income. The Company uses a derivative valuation model to derive the value
of the embedded derivative. Key inputs into this valuation model are the Company’s current stock price, risk-free interest rates,
the stock dividend yield, the stock volatility and the 3.125% Debenture’s credit spread over London Interbank Offered Rate.
The first three inputs are based on observable market data and are considered Level 2 inputs while the last two inputs require
management judgment and are Level 3 inputs.
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
The Company’s 2.625% Debentures and 3.125% Debentures are measured at fair value on a quarterly basis for disclosure
purposes. The fair values of the 2.625% and 3.125% Debentures as of March 30, 2013 were approximately $854.0 million and
-55-
$918.9 million, respectively, based on the last trading price of the respective debentures for the period (classified as level 2 in
fair value hierarchy due to relatively low trading volume).
Note 4. Financial Instruments
The following is a summary of cash equivalents and available-for-sale securities as of the end of the periods presented:
(In thousands)
Money market funds
Bank certificates of deposit
Commercial paper
Corporate bonds
Auction rate securities
Municipal bonds
U.S. government and
agency securities
Foreign government and
agency securities
Mortgage-backed securities
Debt mutual fund
March 30, 2013
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
Amortized
Cost
March 31, 2012
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
$
— $
— $
108,311
$
232,017
$
—
—
5,193
—
514
—
—
(135)
(3,200)
(70)
124,987
503,550
276,003
28,700
24,940
159,972
594,867
186,455
32,600
25,454
—
—
1
3,401
—
734
$
— $
232,017
—
(1)
(184)
(3,671)
(28)
159,972
594,867
189,672
28,929
26,160
Amortized
Cost
$ 108,311
124,987
503,550
270,945
31,900
24,496
696,836
431
(45)
697,222
668,702
360
(149)
668,913
269,901
1,180,156
61,350
$ 3,272,432
—
17,601
1,577
—
269,901
(5,077)
1,192,680
—
62,927
249,951
878,842
20,000
$ 25,316
$
(8,527)
$ 3,289,221
$ 3,048,860
—
15,094
—
$ 19,590
—
(1,160)
(219)
249,951
892,776
19,781
$
(5,412)
$ 3,063,038
The following tables show the fair values and gross unrealized losses of the Company’s investments, aggregated by investment
category, for individual securities that have been in a continuous unrealized loss position for the length of time specified, as of
March 30, 2013 and March 31, 2012:
Less Than 12 Months
Gross
Unrealized
Losses
Fair Value
27,114
—
8,927
$
(135)
—
(70)
March 30, 2013
12 Months or Greater
Gross
Unrealized
Losses
Fair Value
$
— $
Fair Value
27,114
$
28,701
8,987
—
(3,200)
—
388,696
367,561
792,298
$
(45)
(4,930)
(5,180)
$
—
(147)
(3,347) $
388,696
378,590
832,088
$
28,701
60
—
11,029
39,790
Total
Gross
Unrealized
Losses
$
$
(135)
(3,200)
(70)
(45)
(5,077)
(8,527)
(In thousands)
Corporate bonds
Auction rate securities
Municipal bonds
U.S. government and
agency securities
Mortgage-backed securities
$
$
-56-
Less Than 12 Months
Gross
Unrealized
Losses
March 31, 2012
12 Months or Greater
Gross
Unrealized
Losses
Fair Value
(In thousands)
Commercial paper
Corporate bonds
Auction rate securities
Municipal bonds
U.S. government and
agency securities
Mortgage-backed securities
Debt mutual fund
$
$
Fair Value
79,994
21,111
—
2,173
460,735
147,726
19,781
731,520
$
$
(1)
(184)
—
(24)
(149)
(1,040)
(219)
(1,617)
$
$
— $
—
28,929
366
—
15,923
—
45,218
$
Total
Gross
Unrealized
Losses
$
$
(1)
(184)
(3,671)
(28)
(149)
(1,160)
(219)
(5,412)
Fair Value
79,994
21,111
28,929
2,539
— $
—
(3,671)
(4)
—
(120)
—
(3,795) $
460,735
163,649
19,781
776,738
The gross unrealized losses that had been outstanding for less than twelve months were primarily related to mortgage-backed
securities, although the percentage of such losses to the total estimated fair value of the mortgage-backed securities was
relatively insignificant. The gross unrealized losses that had been outstanding for more than twelve months were primarily
related to failed auction rate securities, which was due to adverse conditions in the global credit markets during the past four
years.
The Company reviewed the investment portfolio and determined that the gross unrealized losses on these investments as of
March 30, 2013 and March 31, 2012 were temporary in nature as evidenced by the fluctuations in the gross unrealized losses
within the investment categories. Furthermore, the aggregate of individual unrealized losses that had been outstanding for
twelve months or more was not significant as of March 30, 2013 and March 31, 2012. The Company neither intends to sell
these investments nor concludes that it is more-likely-than-not that it will have to sell them until recovery of their carrying
values. The Company also believes that it will be able to collect both principal and interest amounts due to the Company at
maturity, given the high credit quality of these investments and any related underlying collateral.
The amortized cost and estimated fair value of marketable debt securities (bank certificates of deposit, commercial paper,
corporate bonds, auction rate securities, municipal bonds, U.S. and foreign government and agency securities and mortgage-
backed securities), by contractual maturity, are shown below. Actual maturities may differ from contractual maturities because
issuers may have the right to call or prepay obligations without call or prepayment penalties.
(In thousands)
Due in one year or less
Due after one year through five years
Due after five years through ten years
Due after ten years
Certain information related to available-for-sale securities is as follows:
(In thousands)
Gross realized gains on sale of available-for-sale securities
Gross realized losses on sale of available-for-sale securities
Net realized gains on sale of available-for-sale securities
Amortization of premiums on available-for-sale securities
$
$
$
March 30, 2013
Amortized
Cost
$ 1,529,686
360,441
252,596
960,048
$ 3,102,771
Estimated
Fair Value
$ 1,529,877
366,073
257,409
964,624
$ 3,117,983
March 30,
2013
March 31,
2012
April 2,
2011
$
3,488
(673)
2,815
25,123
$
$
2,916
(401)
2,515
13,302
$
$
$
5,169
(1,348)
3,821
7,650
The cost of securities matured or sold is based on the specific identification method.
-57-
Note 5. Derivative Financial Instruments
The Company’s primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk
and interest rate risk. As a result of the use of derivative financial instruments, the Company is exposed to the risk that
counterparties to derivative contracts may fail to meet their contractual obligations. The Company manages counterparty credit
risk in derivative contracts by reviewing counterparty creditworthiness on a regular basis, establishing collateral requirement
and limiting exposure to any single counterparty. The right of set-off that exists with certain transactions enables the Company
to net amounts due to and from the counterparty, reducing the maximum loss from credit risk in the event of counterparty
default.
As of March 30, 2013 and March 31, 2012, the Company had the following outstanding forward currency exchange contracts
(in notional amount), which were derivative financial instruments:
(In thousands and U.S. dollars)
Singapore Dollar
Euro
Indian Rupee
British Pound
Japanese Yen
March 30, 2013
70,197
39,865
16,941
11,602
10,891
149,496
$
$
March 31, 2012
60,925
$
41,467
18,943
14,250
11,076
146,661
$
As part of the Company’s strategy to reduce volatility of operating expenses due to foreign exchange rate fluctuations, the
Company employs a hedging program with a forward outlook of up to two years for major foreign-currency-denominated
operating expenses. The outstanding forward currency exchange contracts expire at various dates between April 2013 and
February 2015. The net unrealized losses, which approximate the fair market value of the outstanding forward currency
exchange contracts, are expected to be realized into net income within the next two years.
As of March 30, 2013, all of the forward foreign currency exchange contracts were designated and qualified as cash flow
hedges and the effective portion of the gain or loss on the forward contracts was reported as a component of other
comprehensive income and reclassified into net income in the same period during which the hedged transaction affects
earnings. The estimated amount of such gains or losses as of March 30, 2013 that is expected to be reclassified into earnings
within the next twelve months was not material. The ineffective portion of the gains or losses on the forward contracts was
included in the net income for all periods presented.
The Company may enter into forward foreign currency exchange contracts to hedge firm commitments such as acquisitions and
capital expenditures. Gains and losses on foreign currency forward contracts that are designated as hedges of anticipated
transactions, for which a firm commitment has been attained and the hedged relationship has been effective, are deferred and
included in income or expenses in the same period that the underlying transaction is settled. Gains and losses on any
instruments not meeting the above criteria are recognized in income or expenses in the consolidated statements of income as
they are incurred.
The 3.125% Debentures include provisions which qualify as an embedded derivative. See "Note 3. Fair Value Measurements"
for more discussion about the embedded derivative. The fair value of the embedded derivative was $1.1 million and $931
thousand as of March 30, 2013 and March 31, 2012, respectively. The changes in the fair value of the embedded derivative
were recorded to interest and other expense, net, on the Company’s consolidated statements of income.
The Company had the following derivative instruments as of March 30, 2013 and March 31, 2012, located on the consolidated
balance sheet, utilized for risk management purposes detailed above:
(In thousands)
March 30, 2013
March 31, 2012
Foreign Exchange Contracts
Asset Derivatives
Liability Derivatives
Balance Sheet
Location
Prepaid expenses and
other current assets
Prepaid expenses and
other current assets
$
$
Fair Value
Balance Sheet
Location
Fair Value
1,179
203
Other accrued
liabilities
Other accrued
liabilities
$
$
2,794
3,273
-58-
The following table summarizes the effect of derivative instruments on the consolidated statements of income for fiscal 2013
and 2012:
(In thousands)
Amount of gains (losses) recognized in other comprehensive income on derivative (effective
portion of cash flow hedging)
Amount of gains (losses) reclassified from accumulated other comprehensive income into
income (effective portion) *
Amount of losses recorded (ineffective portion) *
Foreign Exchange Contracts
2013
2012
1,734
$
(8,324)
(2,793) $
4,659
(5) $
(5)
$
$
$
*
Recorded in Interest and Other Expense location within the consolidated statements of income.
Note 6. Stock-Based Compensation Plans
The Company’s equity incentive plans are broad-based, long-term retention programs that cover employees, consultants and
non-employee directors of the Company. These plans are intended to attract and retain talented employees, consultants and
non-employee directors and to provide such persons with a proprietary interest in the Company.
Stock-Based Compensation
The following table summarizes stock-based compensation expense related to stock awards granted under the Company’s
equity incentive plans and rights to acquire stock granted under the Company’s Employee Stock Purchase Plan (ESPP):
(In thousands)
Stock-based compensation included in:
Cost of revenues
Research and development
Selling, general and administrative
Stock-based compensation effect on income before taxes
Income tax effect
Net stock-based compensation effect on net income
$
$
March 30,
2013
March 31,
2012
April 2,
2011
$
6,356
37,937
33,569
77,862
(22,137)
55,725
$
5,630
32,310
29,478
67,418
(19,214)
48,204
$
$
4,825
28,780
26,653
60,258
(18,561)
41,697
In accordance with the authoritative guidance on accounting for share-based payments, the Company adjusts stock-based
compensation on a quarterly basis for changes to the estimate of expected equity award forfeitures based on actual forfeiture
experience. The effect of adjusting the forfeiture rate for all expense amortization is recognized in the period the forfeiture
estimate is changed. The actual forfeiture adjustment in fiscal 2013, 2012 and 2011 reduced stock-based compensation by $2.6
million, $3.7 million and $5.1 million, respectively.
As of March 30, 2013 and March 31, 2012, the ending inventory balances included $2.0 million and $1.7 million of capitalized
stock-based compensation, respectively. The net stock-based compensation capitalized to, or released from, inventory during
fiscal 2013 and 2012 were immaterial. During fiscal 2013, 2012 and 2011, the tax benefit realized for the tax deduction from
option exercises and other awards, including amounts credited to additional paid-in capital, totaled $32.6 million, $31.2 million
and $25.6 million, respectively.
The fair values of stock options and stock purchase plan rights under the Company’s equity incentive plans and ESPP were
estimated as of the grant date using the Black-Scholes option pricing model. The Company’s expected stock price volatility
assumption for stock options is estimated using implied volatility of the Company’s traded options. The expected life of options
granted is based on the historical exercise activity as well as the expected disposition of all options outstanding. The expected
life of options granted also considers the actual contractual term. The weighted-average fair value per share of stock options
granted during fiscal 2013, 2012, and 2011 were $6.15, $7.63 and $6.80, respectively. The weighted-average fair value per
share of stock purchase rights granted under the Employee Stock Purchase Plan during fiscal 2013, 2012 and 2011 were $8.61,
$9.42 and $8.25, respectively. These fair values per share were estimated at the date of grant using the following weighted-
average assumptions:
-59-
Expected life of options (years)
Expected stock price volatility
Risk-free interest rate
Dividend yield
Stock Options
2012
5.1
31%
1.1%
2.4%
2013
4.9
28%
0.7%
2.6%
2011
5.1
35%
1.8%
2.5%
Employee Stock Purchase Plan
2011
2012
2013
1.3
1.3
1.3
31%
29%
26%
0.3%
0.2%
0.2%
2.3%
2.4%
2.7%
The estimated fair values of restricted stock unit (RSU) awards were calculated based on the market price of Xilinx common
stock on the date of grant, reduced by the present value of dividends expected to be paid on Xilinx common stock prior to
vesting. The per share weighted-average fair value of RSUs granted during fiscal 2013, 2012 and 2011 were $31.58, $33.69
and $25.14, respectively. The weighted average fair value of RSUs granted in fiscal 2013, 2012 and 2011 were calculated
based on estimates at the date of grant using the following weighted-average assumptions:
Risk-free interest rate
Dividend yield
2013
2012
2011
0.4%
2.7%
0.7%
2.2%
1.0%
2.5%
Options outstanding that have vested and are expected to vest in future periods as of March 30, 2013 are as follows:
(Shares and intrinsic value in
thousands)
Vested (i.e., exercisable)
Expected to vest
Total vested and expected to vest
Number of Shares
11,639
1,046
12,685
Weighted-Average
Exercise Price Per
Share
$28.07
$27.46
$28.02
Weighted-Average
Remaining
Contractual Term
(Years)
2.37
4.55
2.55
Total outstanding
12,753
$28.01
2.56
Aggregate Intrinsic
Value (1)
$
$
$
$
122,051
11,228
133,279
134,136
(1) These amounts represent the difference between the exercise price and $38.17, the closing price per share of Xilinx’s stock on March 30, 2013, for all in-
the-money options outstanding.
Options outstanding that are expected to vest are net of estimated future option forfeitures in accordance with the authoritative
guidance of accounting for share-based payment, which are estimated when compensation costs are recognized. Options with a
fair value of $7.7 million completed vesting during fiscal 2013. As of March 30, 2013, total unrecognized stock-based
compensation costs related to stock options and Employee Stock Purchase Plan were $7.6 million and $6.9 million,
respectively. The total unrecognized stock-based compensation cost for stock options and Employee Stock Purchase Plan is
expected to be recognized over a weighted-average period of 1.6 years and 0.5 years, respectively.
Employee Stock Option Plans
Under the Company’s stock option plans (Option Plans), options reserved for future issuance of common shares to employees
and directors of the Company total 28.7 million shares as of March 30, 2013, including 16.0 million shares available for future
grants under the 2007 Equity Incentive Plan (2007 Equity Plan). Options to purchase shares of the Company’s common stock
under the Option Plans are granted at 100% of the fair market value of the stock on the date of grant. The contractual term for
stock awards granted under the 2007 Equity Plan is seven years from the grant date. Prior to April 1, 2007, stock options
granted by the Company generally expire ten years from the grant date. Stock awards granted to existing and newly hired
employees generally vest over a four-year period from the date of grant.
-60-
A summary of shares available for grant under the 2007 Equity Plan is as follows:
(Shares in thousands)
April 3, 2010
Additional shares reserved
Stocks options granted
Stock options cancelled
RSUs granted
RSUs cancelled
April 2, 2011
Additional shares reserved
Stocks options granted
Stock options cancelled
RSUs granted
RSUs cancelled
March 31, 2012
Additional shares reserved
Stocks options granted
Stock options cancelled
RSUs granted
RSUs cancelled
March 30, 2013
Shares Available for Grant
12,322
4,500
(2,345)
365
(2,043)
365
13,164
4,500
(207)
70
(2,977)
358
14,908
3,500
(92)
209
(3,018)
483
15,990
The types of awards allowed under the 2007 Equity Plan include incentive stock options, non-qualified stock options, RSUs,
restricted stock and stock appreciation rights. To date, the Company has issued a mix of non-qualified stock options and RSUs
under the 2007 Equity Plan.
A summary of the Company’s Option Plans activity and related information is as follows:
-61-
(Shares in thousands)
April 3, 2010
Granted
Exercised
Forfeited/cancelled/expired
April 2, 2011
Granted
Exercised
Forfeited/cancelled/expired
March 31, 2012
Granted
Exercised
Forfeited/cancelled/expired
March 30, 2013
Options exercisable at:
March 30, 2013
March 31, 2012
Options Outstanding
Number of
Shares
Weighted-
Average
Exercise Price
Per Share
$
31,026
$
2,345
(5,704) $
(2,698) $
$
24,969
$
207
(3,622) $
(3,766) $
$
17,788
$
92
(3,564) $
(1,563) $
$
12,753
11,639
15,349
$
$
30.51
26.36
25.42
50.69
29.11
34.79
24.70
37.35
28.32
33.83
24.68
39.54
28.01
28.07
28.78
The total pre-tax intrinsic value of options exercised during fiscal 2013 and 2012 was $38.9 million and $35.6 million,
respectively. This intrinsic value represents the difference between the exercise price and the fair market value of the
Company’s common stock on the date of exercise.
Since the Company adopted the policy of retiring all repurchased shares of its common stock, new shares are issued upon
employees’ exercise of their stock options.
The following information relates to options outstanding and exercisable under the Option Plans as of March 30, 2013:
(Shares in thousands)
Range of Exercise Prices
$15.95 - $19.79
$20.14 - $29.93
$30.04 - $38.51
$40.11 - $41.81
Options Outstanding
Weighted-
Average
Remaining
Contractual Term
(Years)
2.93
2.91
2.76
1.01
2.56
Options
Outstanding
169
9,134
1,209
2,241
12,753
Options Exercisable
Weighted-
Average
Exercise
Price Per
Share
Options
Exercisable
167
8,336
895
2,241
11,639
$18.19
$24.29
$34.89
$40.19
$28.01
Weighted-
Average
Exercise
Price Per
Share
$18.18
$24.24
$35.27
$40.19
$28.07
-62-
RSU Awards
A summary of the Company’s RSU activity and related information is as follows:
RSUs Outstanding
(Shares and intrinsic value in thousands)
April 3, 2010
Granted
Vested (2)
Cancelled
April 2, 2011
Granted
Vested (2)
Cancelled
March 31, 2012
Granted
Vested (2)
Cancelled
March 30, 2013
Weighted-
Average
Grant-Date
Fair Value
Number of
Per Share
Shares
21.70
$
3,652
25.14
2,043
$
22.23
(1,192) $
21.99
(288) $
23.19
$
4,215
33.69
2,977
$
23.11
(1,543) $
25.18
(410) $
29.01
$
5,239
31.58
3,018
$
(1,778) $
27.01
29.69
(483) $
30.83
$
5,996
Weighted
Average
Remaining
Contractual
Term
(Years)
Average
Intrinsic
Value (1)
2.53 $ 228,883
Expected to vest as of March 30, 2013
5,475
$
30.92
2.50 $ 208,967
(1) Aggregate intrinsic value for RSUs represents the closing price per share of Xilinx’s stock on March 30, 2013 of $38.17,
multiplied by the number of RSUs outstanding or expected to vest as of March 30, 2013.
(2) The number of RSUs vested includes shares that the Company withheld on behalf of employees to satisfy the statutory tax
withholding requirements.
RSUs with a fair value of $48.0 million were vested during fiscal 2013. As of March 30, 2013, total unrecognized stock-based
compensation costs related to non-vested RSUs was $146.1 million. The total unrecognized stock-based compensation cost for
RSUs is expected to be recognized over a weighted-average period of 2.6 years.
Employee Stock Purchase Plan
Under the Company’s ESPP, qualified employees can obtain a 24-month purchase right to purchase the Company’s common
stock at the end of each six-month exercise period. Participation is limited to 15% of the employee’s annual earnings up to a
maximum of $21 thousand in a calendar year. Approximately 78% of all eligible employees participate in the ESPP. The
purchase price of the stock is 85% of the lower of the fair market value at the beginning of the 24-month offering period or at
the end of each six-month exercise period. Employees purchased 1.3 million shares for $34.5 million in fiscal 2013, 1.2
million shares for $33.1 million in fiscal 2012, and 2.3 million shares for $33.3 million in fiscal 2011. The next scheduled
purchase under the ESPP is in the second quarter of fiscal 2014. As of March 30, 2013, 8.9 million shares were available for
future issuance out of the 48.5 million shares authorized.
-63-
Note 7. Balance Sheet Information
The following tables disclose the current liabilities that individually exceed 5% of the respective consolidated balance sheet
amounts in each fiscal year. Individual balances that are less than 5% of the respective consolidated balance sheet amounts are
aggregated and disclosed as "other."
(In thousands)
Accrued payroll and related liabilities:
Accrued compensation
Deferred compensation plan liability
Other
Other accrued liabilities:
Litigation
Affordable housing credit investments
Unsettled purchase of available-for-sale securities
Sales tax payables
Convertible debts interest payable
Accrued distributor price adjustment
Contingent consideration related to business combinations
Other
Note 8. Restructuring Charges
2013
2012
66,967
50,412
6,816
124,195
$
$
69,640
45,137
6,532
121,309
15,400
14,404
11,214
9,217
5,757
211
—
19,634
75,837
$
$
—
25,730
4,092
8,663
5,757
10,034
5,636
15,940
75,852
$
$
$
$
During the second quarter of fiscal 2012, the Company implemented restructuring measures designed to consolidate its
research and development activities in the U.S. and to reduce its global workforce by 46 net positions, or less than 2%. The
Company completed this restructuring plan and recorded total restructuring charges of $3.4 million in the second quarter of
fiscal 2012, which was predominantly related to severance costs and benefits expenses.
During the third quarter of fiscal 2011, the Company announced restructuring measures designed to realign resources and drive
overall operating efficiencies across the Company. These measures impacted 56 positions of the Company’s global workforce,
in various geographies and functions worldwide. The reorganization plan was completed by the end of the fourth quarter of
fiscal 2011, and the Company recorded total restructuring charges of $10.3 million, primarily related to severance pay
expenses.
All of the restructuring charges above have been shown separately as restructuring charges on the consolidated statements of
income and were paid in full as of March 31, 2012.
-64-
Note 9. Commitments
Xilinx leases some of its facilities and office buildings under non-cancelable operating leases that expire at various dates
through October 2021. Additionally, Xilinx entered into a land lease in conjunction with the Company’s building in Singapore,
which will expire in November 2035 and the lease cost was settled in an up-front payment in June 2006. Some of the operating
leases for facilities and office buildings require payment of operating costs, including property taxes, repairs, maintenance and
insurance. Most of the Company’s leases contain renewal options for varying terms. Approximate future minimum lease
payments under non-cancelable operating leases are as follows:
Fiscal
2014
2015
2016
2017
2018
Thereafter
Total
(In thousands)
6,327
4,114
2,278
1,848
1,440
4,482
20,489
$
$
Aggregate future rental income to be received, which includes rents from both owned and leased property, totaled $3.4 million
as of March 30, 2013. Rent expense, net of rental income, under all operating leases was $3.9 million for fiscal 2013, $3.1
million for fiscal 2012, and $4.9 million for fiscal 2011. Rental income was not material for fiscal 2013, 2012 or 2011.
Other commitments as of March 30, 2013 totaled $96.2 million and consisted of purchases of inventory and other non-
cancelable purchase obligations related to subcontractors that manufacture silicon wafers and provide assembly and some test
services. The Company expects to receive and pay for these materials and services in the next three to six months, as the
products meet delivery and quality specifications. As of March 30, 2013, the Company also had $13.0 million of non-
cancelable license obligations to providers of electronic design automation software and hardware/software maintenance
expiring at various dates through March 2015.
The Company committed up to $5.0 million to acquire, in the future, rights to intellectual property until July 2023. License
payments will be amortized over the useful life of the intellectual property acquired.
Note 10. Net Income Per Common Share
The computation of basic net income per common share for all periods presented is derived from the information on the
consolidated statements of income, and there are no reconciling items in the numerator used to compute diluted net income per
common share.
The total shares used in the denominator of the diluted net income per common share calculation includes 6.8 million, 3.9
million and 346 thousand potentially dilutive common equivalent shares outstanding for fiscal 2013, 2012 and 2011,
respectively, that are not included in basic net income per common share by applying the treasury stock method to the impact
of incremental shares issuable assuming conversion of the debentures. See "Note 13. Convertible Debentures and Revolving
Credit Facility".
Additionally, the total shares used in the denominator of the diluted net income per common share calculation includes 4.1
million, 4.5 million, and 3.6 million potentially dilutive common equivalent shares outstanding for fiscal 2013, 2012 and 2011,
respectively, that are not included in basic net income per common share by applying the treasury stock method to the impact
of our equity incentive plans.
Outstanding stock options, RSUs and warrants (see "Note 13. Convertible Debentures and Revolving Credit Facility" for more
discussion of warrants) to purchase approximately 27.9 million, 30.6 million, and 32.7 million shares, for fiscal 2013, fiscal
2012, and fiscal 2011 respectively, under the Company’s stock award plans were excluded from diluted net income per
common share by applying the treasury stock method, as their inclusion would have been antidilutive. These options, RSUs and
warrants could be dilutive in the future if the Company’s average share price increases and is greater than the combined
exercise prices and the unamortized fair values of these options, RSUs and warrants.
To hedge against potential dilution upon conversion of the 2.625% Debentures, the Company also purchased call options on its
common stock from the hedge counterparties. The call options give the Company the right to purchase up to 20.0 million
shares of its common stock at $29.97 per share. These call options are not considered for purposes of calculating the total
shares outstanding under the basic and diluted net income per share, as their effect would be anti-dilutive. Upon exercise, the
-65-
call options would serve to neutralize the dilutive effect of the 2.625% Debentures and potentially reduce the weighted number
of diluted shares used in per share calculations.
Note 11. Interest and Other Expense, Net
The components of interest and other expense, net are as follows:
(In thousands)
Interest income
Interest expense
Other income (expense), net
$
March 30,
2013
25,574
(55,069)
(4,231)
(33,726) $
March 31,
2012
23,697
(54,576)
157
(30,722)
$
$
April 2,
2011
18,427
(44,715)
1,969
(24,319)
$
$
Note 12. Accumulated Other Comprehensive Income
Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and
circumstances from non-owner sources. The components of accumulated other comprehensive income are as follows:
(In thousands)
Accumulated unrealized gains on available-for-sale securities, net of tax
Accumulated unrealized losses on hedging transactions, net of tax
Accumulated cumulative translation adjustment
Accumulated other comprehensive income
2013
10,519
(1,368)
(491)
8,660
$
$
$
$
2012
8,916
(3,101)
1,449
7,264
The related tax effects of other comprehensive income (loss) were not material for all periods presented.
Note 13. Convertible Debentures and Revolving Credit Facility
2.625% Senior Convertible Debentures
As of March 30, 2013, the Company had $600.0 million principal amount of 2.625% Debentures outstanding. The 2.625%
Debentures are senior in right of payment to the Company’s existing and future unsecured indebtedness that is expressly
subordinated in right of payment to the 2.625% Debentures, including the 3.125% Debentures described below. The 2.625%
Debentures are convertible, subject to certain conditions, into shares of Xilinx common stock at a conversion rate of
33.3681 shares of common stock per $1 thousand principal amount of the 2.625% Debentures, representing an effective
conversion price of approximately $29.97 per share of common stock. The conversion rate is subject to adjustment for certain
events as outlined in the indenture governing the 2.625% Debentures but will not be adjusted for accrued interest.
The carrying values of the liability and equity components of the 2.625% Debentures are reflected in the Company’s
consolidated balance sheets as follows:
(In thousands)
Liability component:
Principal amount of the 2.625% Debentures
Unamortized discount of liability component
Hedge accounting adjustment – sale of interest rate swap
Net carrying value of the 2.625% Debentures
Equity component – net carrying value
2013
2012
$
$
600,000
(64,767)
18,716
553,949
$
105,620
$
$
$
600,000
(80,311)
23,208
542,897
105,620
The remaining unamortized debt discount, net of hedge accounting adjustment from sale of interest rate swap, is being
amortized as additional non-cash interest expense over the expected remaining term of the 2.625% Debentures. As of
March 30, 2013, the remaining term of the 2.625% Debentures is 4.2 years.
-66-
Interest expense related to the 2.625% Debentures was included in interest and other expense, net on the consolidated
statements of income as follows:
(In thousands)
Contractual coupon interest
Amortization of debt issuance costs
Amortization of debt discount, net
Total interest expense related to the 2.625% Debentures
March 30,
2013
15,750
1,448
11,052
28,250
$
$
March 31,
2012
15,750
1,448
11,052
28,250
$
$
April 2,
2011
12,863
1,207
9,739
23,809
$
$
The Company may not redeem the 2.625% Debentures prior to maturity. However, holders of the 2.625% Debentures may
convert their 2.625% Debentures only upon the occurrence of certain events in the future, as outlined in the indenture. The
Company will adjust the conversion rate for holders who elect to convert their 2.625% Debentures in connection with the
occurrence of certain specified corporate events, as defined in the indenture. In addition, holders who convert their 2.625%
Debentures in connection with a fundamental change, as defined in the indenture, may be entitled to a make-whole premium in
the form of an increase in the conversion rate. Furthermore, in the event of a fundamental change, the holders of the 2.625%
Debentures may require Xilinx to purchase all or a portion of their 2.625% Debentures at a purchase price equal to 100% of the
principal amount of the 2.625% Debentures, plus accrued and unpaid interest, if any. As of March 30, 2013, none of the
conditions allowing holders of the 2.625% Debentures to convert had been met.
Upon conversion, the Company would pay the holders of the 2.625% Debentures cash up to the aggregate principal amount of
the 2.625% Debentures. If the conversion value exceeds the principal amount, the Company would deliver shares of its
common stock in respect to the remainder of its conversion obligation in excess of the aggregate principal amount (conversion
spread). Accordingly, there would be no adjustment to the numerator in the net income per common share computation for the
cash settled portion of the 2.625% Debentures, as that portion of the debt liability will always be settled in cash. The
conversion spread will be included in the denominator for the computation of diluted net income per common share, using the
treasury stock method.
To hedge against potential dilution upon conversion of the 2.625% Debentures, the Company also purchased call options on its
common stock from the hedge counterparties. The call options give the Company the right to purchase up to 20.0 million
shares of its common stock at $29.97 per share. The Company paid an aggregate of $112.3 million to purchase these call
options. The call options will terminate upon the earlier of the maturity of the 2.625% Debentures or the last day any of the
2.625% Debentures remain outstanding. To reduce the hedging cost, under separate transactions the Company sold warrants to
the hedge counterparties, which give the hedge counterparties the right to purchase up to 20.0 million shares of the Company’s
common stock at $42.46 per share. These warrants expire on a gradual basis over a specified period starting on September 13,
2017. The Company received an aggregate of $46.9 million from the sale of these warrants.
3.125% Junior Subordinated Convertible Debentures
As of March 30, 2013, the Company had $689.6 million principal amount of 3.125% Debentures outstanding. The 3.125%
Debentures are subordinated in right of payment to the Company’s existing and future senior debt, including the 2.625%
Debentures, and to the other liabilities of the Company’s subsidiaries. The 3.125% Debentures are convertible, subject to
certain conditions, into shares of Xilinx common stock at a conversion rate of 33.9021 shares of common stock per $1 thousand
principal amount of 3.125% Debentures, representing an effective conversion price of approximately $29.50 per share of
common stock. The conversion rate is subject to adjustment for certain events as outlined in the indenture governing the
3.125% Debentures, but will not be adjusted for accrued interest.
-67-
The carrying values of the liability and equity components of the 3.125% Debentures are reflected in the Company’s
consolidated balance sheets as follows:
(In thousands)
Liability component:
Principal amount of the 3.125% Debentures
Unamortized discount of liability component
Unamortized discount of embedded derivative from date of issuance
Carrying value of liability component – 3.125% Debentures
Carrying value of embedded derivative component
Net carrying value of the 3.125% Debentures
Equity component – net carrying value
2013
2012
$
$
$
689,635
(320,620)
(1,388)
367,627
1,090
368,717
229,513
$
$
$
689,635
(325,448)
(1,446)
362,741
931
363,672
229,513
The remaining debt discount is being amortized as additional non-cash interest expense over the expected remaining life of the
debentures using the effective interest rate of 7.20%. As of March 30, 2013, the remaining term of the debentures is 24 years.
Interest expense related to the 3.125% Debentures was included in interest and other expense, net on the consolidated
statements of income, and was recognized as follows:
(In thousands)
Contractual coupon interest
Amortization of debt issuance costs
Amortization of embedded derivative
Amortization of debt discount
Fair value adjustment of embedded derivative
Total interest expense related to the 3.125% Debentures
March 30,
2013
March 31,
2012
April 2,
2011
$
$
21,551
223
58
4,828
159
26,819
$
$
21,551
223
58
4,493
(14)
26,311
$
$
21,551
223
58
4,182
97
26,111
On or after March 15, 2014, the Company may redeem all or part of the remaining 3.125% Debentures outstanding for the
principal amount plus any accrued and unpaid interest, if the closing price of the Company’s common stock has been at least
130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading-day period prior to
the date on which the Company provides notice of redemption. Upon conversion, the Company would pay the holders of the
3.125% Debentures cash value of the applicable number of shares of Xilinx common stock, up to the principal amount of the
3.125% Debentures. If the conversion value exceeds the aggregate principal amount, the Company may also deliver, at its
option, cash or common stock or a combination of cash and common stock for the conversion value in excess of the principal
amount (conversion spread). Accordingly, there would be no adjustment to the numerator in the net income per common share
computation for the cash settled portion of the 3.125% Debentures, as that portion of the debt instrument will deem to be settled
in cash. The conversion spread will be included in the denominator for the computation of diluted net income per common
share, using the treasury stock method.
Holders of the 3.125% Debentures may convert their 3.125% Debentures only upon the occurrence of certain events in the
future, as outlined in the indenture. In addition, holders who convert their 3.125% Debentures in connection with a fundamental
change, as defined in the indenture, may be entitled to a make-whole premium in the form of an increase in the conversion rate.
Furthermore, in the event of a fundamental change, the holders of the 3.125% Debentures may require Xilinx to purchase all or
a portion of their 3.125% Debentures at a purchase price equal to 100% of the principal amount of 3.125% Debentures, plus
accrued and unpaid interest, if any. As of March 30, 2013, none of the conditions allowing holders of the 3.125% Debentures to
convert had been met.
The Company concluded that the embedded features related to the contingent interest payments and the Company making
specific types of distributions (e.g., extraordinary dividends) qualify as derivatives, and should be bundled as a compound
embedded derivative under the authoritative guidance for derivatives instruments and hedging activities issued by the FASB.
The fair value of the derivative was accounted for as a discount on the 3.125% Debentures and will continue to be amortized to
interest expense over the remaining term of the 3.125% Debentures. Any change in fair value of this embedded derivative will
be included in interest and other income (expense), net on the Company’s consolidated statements of income. The Company
also concluded that the 3.125% Debentures are not conventional convertible debt instruments and that the embedded stock
conversion option qualifies as a derivative. In addition, the Company has concluded that the embedded conversion option
-68-
would be classified in stockholders’ equity if it were a freestanding instrument. Accordingly, the embedded conversion option
is not required to be accounted for separately as a derivative.
Revolving Credit Facility
On December 7, 2011, the Company entered into a $250.0 million senior unsecured revolving credit facility with a syndicate of
banks (expiring in December 2016). Borrowings under the credit facility will bear interest at a benchmark rate plus an
applicable margin based upon the Company’s credit rating. In connection with the credit facility, the Company is required to
maintain certain financial and nonfinancial covenants. As of March 30, 2013, the Company had made no borrowings under this
credit facility and was not in violation of any of the covenants.
Note 14. Stockholders’ Equity
Preferred Stock
The Company’s Certificate of Incorporation authorized 2.0 million shares of undesignated preferred stock. The preferred stock
may be issued in one or more series. The Board of Directors is authorized to determine or alter the rights, preferences,
privileges and restrictions granted to, or imposed upon, any wholly unissued series of preferred stock. As of March 30, 2013
and March 31, 2012, no preferred shares were issued or outstanding.
Common Stock and Debentures Repurchase Programs
The Board of Directors has approved stock repurchase programs enabling the Company to repurchase its common stock in the
open market or through negotiated transactions with independent financial institutions. In June 2010, the Board authorized the
repurchase of up to $500.0 million of common stock (2010 Repurchase Program). In August 2012, the Board authorized the
repurchase of an additional $750.0 million of the Company’s common stock and debentures (2012 Repurchase Program). The
shares authorized for purchase under the 2012 Repurchase Program are in addition to the shares that were purchased under the
2010 Repurchase Program. The 2010 and the 2012 Repurchase Programs have no stated expiration date.
Through March 30, 2013, the Company had used all of the $500.0 million authorized under the 2010 Repurchase Program, and
$10.6 million of the $750.0 million authorized under the 2012 Repurchase Program, leaving $739.4 million available for future
repurchases. The Company’s current policy is to retire all repurchased shares, and consequently, no treasury shares were held
as of March 30, 2013 and March 31, 2012.
During fiscal 2013, the Company repurchased 6.2 million shares of common stock in the open market for a total of $197.7
million. During fiscal 2012, the Company repurchased 7.0 million shares of common stock in the open market for a total of
$219.6 million.
-69-
Note 15. Income Taxes
The provision for income taxes consists of the following:
(In thousands)
Federal:
Current
Deferred
State:
Current
Deferred
Foreign:
Current
Deferred
Total
March 30,
2013
March 31,
2012
April 2,
2011
$
$
97,108
(45,465)
51,643
(17,333) $
74,911
57,578
14,172
95,660
109,832
1,007
1,742
2,749
5,455
(377)
5,078
59,470
$
$
(2,999)
6,591
3,592
7,978
(2,176)
5,802
66,972
2,365
13,240
15,605
3,107
661
3,768
129,205
April 2,
2011
161,784
609,296
771,080
$
$
$
The domestic and foreign components of income before income taxes were as follows:
(In thousands)
Domestic
Foreign
Income before income taxes
March 30,
2013
45,617
501,389
547,006
$
$
March 31,
2012
74,959
522,092
597,051
$
$
The tax benefits associated with stock-based compensation recorded in additional paid-in capital were $9.0 million, $9.9
million and $4.9 million, for fiscal 2013, 2012 and 2011, respectively.
As of March 30, 2013, the Company had federal and state net operating loss carryforwards of approximately $20.6 million. If
unused, these carryforwards will expire in 2014 through 2030. All of the federal and state net operating loss carryforwards are
subject to change of ownership limitations provided by the Internal Revenue Code and similar state provisions. The Company
had state research tax credit carryforwards of approximately $128.2 million. The credits have no expiration date. Some of the
state credit carryforwards are subject to change of ownership limitations provided by the Internal Revenue Code and similar
state provisions. The state credit carryforwards include $39.0 million that is not likely to be recovered and has been reduced by
a valuation allowance.
Unremitted foreign earnings that are considered to be permanently invested outside the U.S., and on which no U.S. taxes have
been provided, are approximately $1.99 billion as of March 30, 2013. The residual U.S. tax liability, if such amounts were
remitted, would be approximately $656.7 million.
-70-
The provision for income taxes reconciles to the amount derived by applying the Federal statutory income tax rate to income
before provision for taxes as follows:
(In thousands)
Income before provision for taxes
Federal statutory tax rate
Computed expected tax
State taxes, net of federal benefit
Foreign earnings at lower tax rates
Tax credits
Other
Provision for income taxes
March 30,
2013
$ 547,006
March 31,
2012
$ 597,051
April 2,
2011
$ 771,080
35%
35%
35%
191,452
1,787
(107,730)
(26,305)
266
59,470
$
$
208,968
2,162
(117,013)
(29,633)
2,488
66,972
269,878
10,317
(131,261)
(17,431)
(2,298)
$ 129,205
The Company has manufacturing operations in Singapore where the Company has been granted "Pioneer Status" that is
effective through fiscal 2021. The Pioneer Status reduces the Company’s tax on the majority of Singapore income from 17% to
zero. The benefits of Pioneer Status in Singapore for fiscal 2013, fiscal 2012 and fiscal 2011 were approximately $41.0 million
($0.15 per diluted share), $43.5 million ($0.16 per diluted share), and $54.8 million ($0.21 per diluted share), respectively, on
income considered permanently reinvested outside the U.S. The tax effect of operations in low tax jurisdictions on the
Company’s overall tax rate is reflected in the table above.
The major components of deferred tax assets and liabilities consisted of the following as of March 30, 2013 and March 31,
2012:
(In thousands)
Deferred tax assets:
Stock-based compensation
Deferred income on shipments to distributors
Accrued expenses
Tax loss carryforwards
Tax credit carryforwards
Intangible and fixed assets
Strategic and equity investments
Deferred compensation plan
Other
Subtotal
Valuation allowance
Total deferred tax assets
Deferred tax liabilities:
Unremitted foreign earnings
State income taxes
Convertible debt
Other
Total deferred tax liabilities
Total net deferred tax liabilities
2013
2012
$
$
28,334
10,299
35,601
3,928
96,327
12,409
7,781
19,375
2,827
216,881
(40,065 )
176,816
(244,892 )
(16,793 )
(205,075 )
(8,461 )
(475,221 )
(298,405) $
$
29,451
10,493
39,942
3,856
97,104
4,115
7,313
17,423
4,132
213,829
(28,963)
184,866
(308,017)
(17,343)
(192,397)
(8,605)
(526,362)
(341,496)
Long-term deferred tax assets of $56.4 million and $56.7 million as of March 30, 2013 and March 31, 2012, respectively, were
included in other assets on the consolidated balance sheet.
As of March 30, 2013, gross deferred tax assets were offset by valuation allowances of $40.1 million, which were associated
with state tax credit carryforwards and foreign net operating loss carryforwards.
-71-
The aggregate changes in the balance of gross unrecognized tax benefits for fiscal 2013 and 2012 were as follows:
(In thousands)
Balance as of beginning of fiscal year
Increases in tax positions for prior years
Decreases in tax positions for prior years
Increases in tax positions for current year
Settlements
Lapses in statutes of limitation
Balance as of end of fiscal year
2013
2012
$
$
65,038
2,208
(4,281 )
17,660
(44 )
(10,624 )
69,957
$
$
79,690
56
(653)
3,768
(39)
(17,784)
65,038
If the remaining balance of $70.0 million and $65.0 million of unrecognized tax benefits as of March 30, 2013 and March 31,
2012, respectively, were realized in a future period, it would result in a tax benefit of $32.3 million and $41.7 million,
respectively, thereby reducing the effective tax rate.
The Company’s policy is to include interest and penalties related to income tax liabilities within the provision for income taxes
on the consolidated statements of income. The balances of accrued interest and penalties recorded in the consolidated balance
sheets and the amounts of interest and penalties included in the Company’s provisions for income taxes were not material for
any period presented.
The Company is no longer subject to U.S. federal audits by taxing authorities for years through fiscal 2009. The Company is no
longer subject to U.S. state audits for years through fiscal 2004, except for fiscals 1996 through 2001 which are still open for
audit purposes. The Company is no longer subject to tax audits in Ireland for years through fiscal 2008.
It is reasonably possible that changes to our unrecognized tax benefits could be significant in the next twelve months due to tax
audit settlements and lapses of statutes of limitation. As a result of uncertainties regarding tax audit settlements and their
possible outcomes, an estimate of the range of increase or decrease that could occur in the next twelve months cannot be made.
Note 16. Segment Information
Xilinx designs, develops and markets programmable logic semiconductor devices and the related software design tools. The
Company operates and tracks its results in one operating segment. Xilinx sells its products to OEMs and to electronic
components distributors who resell these products to OEMs or subcontract manufacturers.
Geographic revenue information for fiscal 2013, 2012 and 2011 reflects the geographic location of the distributors or OEMs
who purchased the Company’s products. This may differ from the geographic location of the end customers. Long-lived assets
include property, plant and equipment, which were based on the physical location of the asset as of the end of each fiscal year.
-72-
Net revenues by geographic region were as follows:
(In thousands)
North America:
United States
Other
Total North America
Asia Pacific:
China
Other
Total Asia Pacific
Europe
Japan
Worldwide total
Net long-lived assets by country at fiscal year-ends were as follows:
(In thousands)
United States
Foreign:
Ireland
Singapore
Other
Total foreign
Worldwide total
March 30,
2013
March 31,
2012
April 2,
2011
$
$
558,309
97,251
655,560
596,388
88,037
684,425
$
620,687
89,737
710,424
428,892
324,920
753,812
418,036
326,462
744,498
456,109
387,760
843,869
548,375
210,905
$ 2,168,652
589,802
222,011
$ 2,240,736
615,360
199,792
$ 2,369,445
2013
240,429
$
2012
254,811
50,627
56,481
18,150
125,258
365,687
$
53,255
66,806
20,110
140,171
394,982
$
$
2011
247,187
55,370
69,043
8,970
133,383
380,570
$
$
-73-
Note 17. Litigation Settlements and Contingencies
Patent Litigation
On December 28, 2007, a patent infringement lawsuit was filed by PACT against the Company in the U.S. District Court for
the Eastern District of Texas, Marshall Division (PACT XPP Technologies, AG. v. Xilinx, Inc. and Avnet, Inc. Case No. 2:07-
CV-563). The lawsuit pertained to eleven different patents and PACT sought injunctive relief, damages including enhanced
damages, interest and attorneys’ fees. Nine of the 11 patents were dismissed from the case prior to trial. Trial commenced in
the matter on May 14, 2012 and on May 18, 2012 the jury concluded its deliberations. The jury found five claims of the two
patents held by PACT were valid and were willfully infringed by the Company. The jury awarded PACT the sum of $15.4
million as damages and royalties on past Xilinx sales. The presiding judge will decide the component for willful infringement
at a future date which has not yet been determined, and such enhanced damages, including the willfulness component, could be
as much as treble the $15.4 million jury verdict. In its post trial motions, the plaintiff has moved for attorneys’ fees, an ongoing
royalty for future sales of infringing products, pre- and post-judgment interest, and certain other relief. The Company intends to
appeal the verdict and has filed motions for judgment as a matter of law.
On February 14, 2011, the Company filed a complaint for declaratory judgment of patent non-infringement and invalidity
against Intellectual Ventures in the U.S. District Court for the Northern District of California. On September 30, 2011, the
Company amended its complaint in this case to eliminate certain defendants and patents from the action (Xilinx, Inc. v.
Intellectual Ventures I LLC and Intellectual Ventures II LLC, Case No. CV11-0671). The lawsuit pertains to five patents and
seeks judgments of non-infringement by Xilinx and judgments that the patents are invalid and unenforceable, as well as costs
and attorneys’ fees. Claims related to four of the five patents have been dismissed.
On February 15, 2011, Intellectual Ventures added the Company as a defendant in its complaint for patent infringement
previously filed against Altera, Microsemi and Lattice in the U.S. District Court for the District of Delaware (Intellectual
Ventures I LLC and Intellectual Ventures II LLC v. Altera Corporation, Microsemi Corporation, Lattice Semiconductor
Corporation and Xilinx, Inc., Case No. 10-CV-1065). The lawsuit pertains to five patents, four of which Xilinx is alleged to be
infringing. Intellectual Ventures seeks unspecified damages, interest and attorneys’ fees and the proceedings are in their early
stages. The Company is unable to estimate its range of possible loss in this matter at this time.
On October 17, 2011, Xilinx filed a complaint for patent non-infringement and invalidity and violation of California Business
and Professions Code Section 17200 in the U.S. District Court for the Northern District of California against Intellectual
Ventures and related entities as well as additional defendants (Xilinx, Inc. v. Intellectual Ventures, LLC. Intellectual Ventures
Management, LLC, Detelle Relay KG, LLC, Roldan Block NY LLC, Latrosse Technologies LLC, TR Technologies
Foundation LLC, Taichi Holdings, LLC, Noregin Assets N.V., LLC and Intellectual Venture Funding LLC Case No CV-
04407). By order dated January 25, 2012, the Court granted with leave to amend defendants’ motion to dismiss Xilinx’s claim
for violation of California Business and Professions Code section 17200. The Company has amended its complaint to remove
the claim for violation of California Business and Professions Code section 17200. The remainder of the lawsuit pertains to
seven patents and seeks judgments of non-infringement by Xilinx and judgments that the patents are invalid and unenforceable,
as well as costs and attorneys’ fees. Claims related to five of the seven patents have been dismissed.
On March 23, 2012, a patent infringement lawsuit was filed by APT against the Company in the U.S. District Court for the
Eastern District of Texas, Marshall Division (Advanced Processor Technologies LLC v. Xilinx, Inc., Case No. 2;12-CV-158).
The lawsuit pertains to three patents and APT seeks royalties, injunctive relief and unspecified damages and the proceedings
are in their early stages. The Company is unable to estimate its range of possible loss in this matter at this time.
On May 30, 2012, a patent infringement lawsuit was filed by Semcon against the Company in the U.S. District Court for the
District of Delaware (Semcon Tech, LLC v. Xilinx, Inc., Case No. 1:12-CV-00691). The lawsuit pertains to one patent and
Semcon seeks unspecified damages, costs and expenses and the proceedings are in their early stages. The Company is unable
to estimate its range of possible loss in this matter at this time.
On November 5, 2012, a patent infringement lawsuit was filed by Mosaid against the Company in the U.S. District Court for
the Eastern District of Texas (Mosaid Technologies Inc. v. Xilinx, Inc., Case No. 6:12-CV-00847). The lawsuit pertains to five
patents and Mosaid seeks unspecified damages, costs, fees, royalties and injunctive relief and the proceedings are in their early
stages. The Company is unable to estimate its range of possible loss in this matter at this time.
Other Matters
Except as stated above, there are no pending legal proceedings of a material nature to which the Company is a party or of
which any of its property is the subject.
-74-
From time to time, the Company is involved in various disputes and litigation matters that arise in the ordinary course of its
business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law,
tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, the Company reviews the status
of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is
considered probable and a range of possible losses can be estimated, the Company accrues a liability for the estimated loss.
Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals
are based only on the best information available at the time. As additional information becomes available, the Company
continues to reassess the potential liability related to pending claims and litigation and may revise estimates.
Note 18. Business Combination
During the second quarter of fiscal 2013, the Company purchased substantially all of the assets and assumed certain liabilities
of Modesat Communications, a wireless mobile backhaul solutions company that specializes in the development of microwave
modem solutions for the mobile backhaul market. This acquisition aligns with the Company’s strategy to expand its new
adjacent markets in communication infrastructure by delivering industry leading wireless backhaul solutions to the Company’s
top tier customers.
During the first quarter of fiscal 2012, the Company purchased certain assets and assumed certain liabilities of Modelware,
Inc., a privately-held company that provides Packet Processing solutions in communications equipment, and Sarance
Technologies, Inc., a privately-held company that develops Ethernet and Interlaken IP solutions for the logic IC landscape.
Both acquisitions align with Xilinx’s strategy for accelerating market growth and meet the increasing demand from our wired
communications customers to offer application specific IP.
All of the acquisitions mentioned above were accounted for under the purchase method of accounting. The aggregate financial
impact of these acquisitions was not material to the Company.
-75-
Note 19. Goodwill and Acquisition-Related Intangibles
As of March 30, 2013 and March 31, 2012, the gross and net amounts of goodwill and of acquisition-related intangibles for all
acquisitions were as follows:
(In thousands)
Goodwill
In-process research and development
Core technology, gross
Less accumulated amortization
Core technology, net
Other intangibles, gross
Less accumulated amortization
Other intangibles, net
Total acquisition-related intangibles, gross
Less accumulated amortization
Total acquisition-related intangibles, net
2013
2012
Weighted-Average
Amortization Life
$
$
$
158,990
$
— $
89,360
(54,201)
35,159
46,516
(45,621)
895
135,876
(99,822)
36,054
$
149,538
4,000
76,440
(46,051 )
30,389
46,206
(44,263 )
1,943
126,646
(90,314 )
36,332
5.8 years
2.7 years
Amortization expense for acquisition-related intangibles for fiscal 2013, 2012 and 2011 were $9.5 million, $7.6 million and
$1.0 million, respectively. Based on the carrying value of acquisition-related intangibles recorded as of March 30, 2013, and
assuming no subsequent impairment of the underlying assets, the annual amortization expense for acquisition-related
intangibles is expected to be as follows:
Fiscal
2014
2015
2016
2017
2018
Thereafter
Total
(In thousands)
9,542
8,846
8,244
6,473
2,347
602
36,054
$
$
Note 20. Employee Benefit Plans
Xilinx offers various retirement benefit plans for U.S. and non-U.S. employees. Total contributions to these plans were $9.5
million, $9.8 million and $8.9 million in fiscal 2013, 2012 and 2011, respectively. For employees in the U.S., Xilinx instituted
a Company matching program pursuant to which the Company will match contributions to Xilinx’s 401(k) Plan (the 401(k)
Plan) based on the amount of salary deferral contributions the participant makes to the 401(k) Plan. Xilinx will match up to
50% of the first 8% of an employee’s compensation that the employee contributed to their 401(k) account. The maximum
Company contribution per year is $4,500 per employee. As permitted under Section 401(k) of the Internal Revenue Code, the
401(k) Plan allows tax deferred salary deductions for eligible employees. The Compensation Committee of the Board of
Directors administers the 401(k) Plan. Participants in the 401(k) Plan may make salary deferrals of up to 25% of the eligible
annual salary, limited by the maximum dollar amount allowed by the Internal Revenue Code. Participants who have reached
the age of 50 before the close of the plan year may be eligible to make catch-up salary deferral contributions, up to 25% of
eligible annual salary, limited by the maximum dollar amount allowed by the Internal Revenue Code.
The Company allows its U.S.-based officers, director-level employees and its board members to defer a portion of their
compensation under the Deferred Compensation Plan (the Plan). The Compensation Committee administers the Plan. As of
March 30, 2013, there were more than 142 participants in the Plan who self-direct their contributions into investment options
offered by the Plan. The Plan does not allow Plan participants to invest directly in Xilinx’s stock. In the event Xilinx becomes
insolvent, Plan assets are subject to the claims of the Company’s general creditors. There are no Plan provisions that provide
for any guarantees or minimum return on investments. As of March 30, 2013, Plan assets were $43.3 million and obligations
were $50.4 million. As of March 31, 2012, Plan assets were $38.9 million and obligations were $45.1 million.
-76-
REPORT OF ERNST & YOUNG LLP,
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Xilinx, Inc.
We have audited the accompanying consolidated balance sheets of Xilinx, Inc. as of March 30, 2013 and March 31, 2012, and
the related consolidated statements of income, comprehensive income, stockholders’ equity and cash flows for each of the three
years in the period ended March 30, 2013. Our audits also included the financial statement schedule listed in the Index at
Part IV, Item 15(a)(2). These financial statements and schedule are the responsibility of the Company’s management. Our
responsibility is to express an opinion on these financial statements and schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial
position of Xilinx, Inc. at March 30, 2013 and March 31, 2012, and the consolidated results of its operations and its cash flows
for each of the three years in the period ended March 30, 2013, in conformity with U.S. generally accepted accounting
principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial
statements taken as a whole, presents fairly in all material respects the information set forth therein.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States),
Xilinx, Inc.’s internal control over financial reporting as of March 30, 2013, based on criteria established in Internal Control—
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report
dated May 23, 2013 expressed an unqualified opinion thereon.
/s/ ERNST & YOUNG LLP
San Jose, California
May 23, 2013
-77-
REPORT OF ERNST & YOUNG LLP,
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Xilinx, Inc.
We have audited Xilinx, Inc.’s internal control over financial reporting as of March 30, 2013, based on criteria established in
Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission
(the COSO criteria). Xilinx, Inc.’s management is responsible for maintaining effective internal control over financial
reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying
Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the
company’s internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States).
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal
control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and
operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered
necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures
that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, Xilinx, Inc. maintained, in all material respects, effective internal control over financial reporting as of
March 30, 2013, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States),
the consolidated balance sheets of Xilinx, Inc. as of March 30, 2013 and March 31, 2012, and the related consolidated
statements of income, comprehensive income, stockholders’ equity, and cash flows for each of the three years in the period
ended March 30, 2013 of Xilinx, Inc. and our report dated May 23, 2013 expressed an unqualified opinion thereon.
/s/ ERNST & YOUNG LLP
San Jose, California
May 23, 2013
-78-
XILINX, INC.
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
Beginning
of Year
Additions
Deductions
(a)
End of Year
3,628
$
— $
—
17,841
$
$
$
49
— $
3,579
17,841
(In thousands)
Description
For the year ended April 2, 2011:
Allowance for doubtful accounts
Allowance for deferred tax assets
For the year ended March 31, 2012:
Allowance for doubtful accounts
Allowance for deferred tax assets
For the year ended March 30, 2013:
Allowance for doubtful accounts
Allowance for deferred tax assets
$
$
$
$
$
$
3,579
17,841
3,446
28,963
(a) Represents amounts written off against the allowances or customer returns.
Supplementary Financial Data
Quarterly Data (Unaudited)
(In thousands, except per share amounts)
Year ended March 30, 2013 (1)
Net revenues
Gross margin
Income before income taxes
Net income
Net income per common share: (2)
Basic
Diluted
Shares used in per share calculations:
Basic
Diluted
Cash dividends declared per common share
First
Quarter
582,784
384,373
154,905
129,831
0.49
0.47
263,055
273,820
0.22
$
$
$
$
$
$
$
$
$
$
$
$
180
11,745
$
$
313
623
$
$
3,446
28,963
—
11,102
$
$
22
$
— $
3,424
40,065
Second
Quarter
543,933
356,220
138,083
123,437
$
Third
Quarter
509,767
339,274
115,693
103,648
0.47
0.46
$
$
0.40
0.38
Fourth
Quarter
532,168
351,579
138,325
130,620
0.50
0.47
$
$
$
260,605
270,265
0.22
260,690
271,174
263,035
277,090
$
0.22
$
0.22
(1) Xilinx uses a 52- to 53-week fiscal year ending on the Saturday nearest March 31. Fiscal 2013 was a 52-week year and each quarter was a 13-week
quarter.
(2) Net income per common share is computed independently for each of the quarters presented. Therefore, the sum of the quarterly per common share
information may not equal the annual net income per common share.
-79-
(In thousands, except per share amounts)
Year ended March 31, 2012 (1)
Net revenues
Gross margin
Income before income taxes (2)
Net income
Net income per common share: (3)
Basic
Diluted
Shares used in per share calculations:
Basic
Diluted
Cash dividends declared per common share
First
Quarter
615,463
392,331
180,484
154,374
0.58
0.56
265,313
276,077
0.19
$
$
$
$
Second
Quarter
555,209
354,645
146,241
126,286
Third
Quarter
$ 511,091
336,286
129,938
127,014
0.48
0.47
$
$
0.49
0.47
264,006
267,927
0.19
$
261,257
267,884
0.19
$
$
$
$
Fourth
Quarter
558,973
371,396
140,388
122,405
0.46
0.44
263,261
276,166
0.19
$
$
$
$
(1) Xilinx uses a 52- to 53-week fiscal year ending on the Saturday nearest March 31. Fiscal 2012 was a 52-week year and each quarter was a 13-week
quarter.
(2) Income before income taxes for the second quarter and fourth quarter of fiscal 2012 include restructuring and litigation charges of $3,369 and $15,400,
respectively.
(3) Net income per common share is computed independently for each of the quarters presented. Therefore, the sum of the quarterly per common share
information may not equal the annual net income per common share.
ITEM 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
Not applicable.
ITEM 9A.
CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
An evaluation was carried out, under the supervision of and with the participation of the Company’s management, including
our CEO and CFO, of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon this evaluation, our CEO
and CFO have concluded that, as of the end of the period covered by this Form 10-K, the Company’s disclosure controls and
procedures are effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports
is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and is
accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions
regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the
Exchange Act) during the fiscal quarter ended March 30, 2013 that materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.
Management’s Report on Internal Control Over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in
Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted
accounting principles. This system of internal control is designed to provide reasonable assurance that assets are safeguarded
and transactions are properly recorded and executed in accordance with management’s authorization. The design, monitoring
and revision of the system of internal control over financial reporting involve, among other things, management’s judgments
with respect to the relative cost and expected benefits of specific control measures. The effectiveness of the system of internal
control over financial reporting is supported by the selection, retention and training of qualified personnel and an organizational
-80-
structure that provides an appropriate division of responsibility and formalized procedures. The system of internal control is
periodically reviewed and modified in response to changing conditions.
Because of its inherent limitations, no matter how well designed, a system of internal control over financial reporting can
provide only reasonable assurance and may not prevent or detect all misstatements or all fraud. Further, because of changes in
conditions, the effectiveness of internal control over financial reporting may vary over time. Our system contains self-
monitoring mechanisms, and actions are taken to correct deficiencies as they are identified.
Management has used the criteria established in the Report "Internal Control — Integrated Framework" issued by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO) to evaluate the effectiveness of our internal
control over financial reporting. Based on this evaluation, management has concluded that the Company’s internal control over
financial reporting was effective as of March 30, 2013.
The effectiveness of the Company’s internal control over financial reporting as of March 30, 2013 has been audited by Ernst &
Young LLP, an independent registered public accounting firm, as stated in their report which is included in Part II, Item 8 of
this Form 10-K.
ITEM 9B.
OTHER INFORMATION
None.
-81-
Certain information required by Part III is omitted from this Report in that the Registrant will file a definitive proxy statement
pursuant to Regulation 14A under the Exchange Act (the Proxy Statement) not later than 120 days after the end of the fiscal
year covered by this Report, and certain information included therein is incorporated herein by reference. Only those sections
of the Proxy Statement that specifically address the items set forth herein are incorporated by reference.
PART III
ITEM 10.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required by this item pursuant to Item 401(b), (d), (e) and (f) of Regulation S-K concerning the Company’s
executive officers is incorporated herein by reference to Item 1. "Business — Executive Officers of the Registrant" within this
Form 10-K.
The information required by this item pursuant to Item 401(a), (d), (e), (f) and Items 406 and 407 of Regulation S-K concerning
the Company’s directors, the code of ethics and corporate governance matters is incorporated herein by reference to the
sections entitled "Proposal One-Election of Directors," "Board Matters" and "Corporate Governance Principles" in our Proxy
Statement.
The information required by this item regarding delinquent filers pursuant to Item 405 of Regulation S-K is incorporated herein
by reference to the section entitled "Section 16(a) Beneficial Ownership Reporting Compliance" in our Proxy Statement.
Our codes of conduct and ethics and significant corporate governance principles are available on the investor relations page of
our website at www.investor.xilinx.com. Our code of conduct applies to our directors and employees, including our CEO, CFO
and principal accounting personnel. In addition, our Board of Directors has adopted a code of ethics that pertains specifically to
the Board of Directors. Printed copies of these documents are also available to stockholders without charge upon written
request directed to Corporate Secretary, Xilinx, Inc., 2100 Logic Drive, San Jose CA 95124.
ITEM 11.
EXECUTIVE COMPENSATION
The information required by this item pursuant to Item 402 of Regulation S-K concerning executive compensation is
incorporated herein by reference to the sections entitled "Compensation of Directors" and "Executive Compensation" in our
Proxy Statement.
The information required by this item pursuant to Item 407(e)(4) of Regulation S-K is incorporated herein by reference to the
section entitled "Compensation Committee Interlocks and Insider Participation" in our Proxy Statement.
The information required by this item pursuant to Item 407(e)(5) of Regulation S-K is incorporated herein by reference to the
section entitled "Compensation Committee Report" in our Proxy Statement.
ITEM 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
The information required by this item pursuant to Item 403 of Regulation S-K is incorporated herein by reference to the section
entitled "Security Ownership of Certain Beneficial Owners and Management" in our Proxy Statement. The information
required by Item 201(d) of Regulation S-K is set forth below.
-82-
Equity Compensation Plan Information
The table below sets forth certain information as of fiscal year ended March 30, 2013 about the Company’s common stock that
may be issued upon the exercise of options, RSUs, warrants and rights under all of our existing equity compensation plans
including the ESPP:
(Shares in thousands)
A
B
C
Number of
Securities to be
Issued upon
Exercise of
Outstanding
Options,
Warrants and
Rights
Weighted-average
Exercise Price of
Outstanding
Options, Warrants
and Rights
Equity Compensation Plans Approved by Security Holders
Number of Securities
Remaining
Available for Future
Issuance under
Equity Compensation
Plans (excluding
securities reflected in
Column A)
Plan Category
1997 Stock Plan
2007 Equity Plan
Employee Stock Purchase Plan
Total-Approved Plans
7,118 $
11,656 (2) $
N/A
18,774 $
30.88
24.37
(3)
N/A
28.01
— (1)
15,990 (4)
8,892
24,882
—
24,882
Equity Compensation Plans NOT Approved by Security Holders
Supplemental Stock Option Plan (5)
Total-All Plans
7
$
18,781 $
28.96
28.01
(1) The Company ceased issuing options under the 1997 Stock Plan as of April 1, 2007. The 1997 Stock Plan expired on May 8, 2007 and
all available but unissued shares under this plan were cancelled.
(2) Includes approximately 6.0 million shares issuable upon vesting of RSUs that the Company granted under the 2007 Equity Plan.
(3) The weighted-average exercise price does not take into account shares issuable upon vesting of outstanding RSUs, which have no
exercise price.
(4) On July 26, 2006, the stockholders approved the adoption of the 2007 Equity Plan and authorized 10.0 million shares to be reserved for
issuance thereunder. The 2007 Equity Plan, which became effective on January 1, 2007, replaced both the Company’s 1997 Stock Plan
(which expired on May 8, 2007) and the Supplemental Stock Option Plan. On August 9, 2007, August 14, 2008, August 12, 2009,
August 11, 2010, August 10, 2011, and August 8, 2012 our stockholders authorized the reserve of an additional 5.0 million shares,
4.0 million shares, 5.0 million shares, 4.5 million shares, 4.5 million shares, and 3.5 million shares, respectively. All of the shares
reserved for issuance under the 2007 Equity Plan may be granted as stock options, stock appreciation rights, restricted stock or RSUs.
(5) Under the Supplemental Stock Option Plan, options were granted to employees and consultants of the Company, however neither
officers nor members of our Board were eligible for grants under the Supplemental Stock Option Plan. Only non-qualified stock options
were granted under the Supplemental Stock Option Plan (that is, options that do not entitle the optionee to special U.S. income tax
treatment) and such options generally expire not later than 12 months after the optionee ceases to be an employee or consultant. Upon a
merger of the Company with or into another company, or the sale of substantially all of the Company’s assets, each option granted under
the Supplemental Stock Option Plan may be assumed or substituted with a similar option by the acquiring company, or the outstanding
options will become exercisable in connection with the merger or sale.
ITEM 13.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
The information required by this item concerning related party transactions pursuant to Item 404 of Regulation S-K is
incorporated herein by reference to the section entitled "Related Transactions" in our Proxy Statement.
The information required by this item concerning director independence pursuant to Item 407(a) of Regulation S-K is
incorporated herein by reference to the section entitled "Board Matters" in our Proxy Statement.
ITEM 14.
PRINCIPAL ACCOUNTING FEES AND SERVICES
The information required by this Item is incorporated herein by reference to the sections entitled "Proposal Six - Ratification of
Appointment of External Auditors" and "Fees Paid to Ernst & Young LLP" in our Proxy Statement.
-83-
PART IV
ITEM 15.
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) (1) The financial statements required by Item 15(a) are included in Item 8 of this Annual Report on Form 10-K.
(2) The financial statement schedule required by Item 15(a) (Schedule II, Valuation and Qualifying Accounts) is
included in Item 8 of this Annual Report on Form 10-K.
Schedules not filed have been omitted because they are not applicable, are not required or the information required to
be set forth therein is included in the financial statements or notes thereto.
(3) The exhibits listed below in (b) are filed or incorporated by reference as part of this Annual report on Form 10-K.
(b) Exhibits
Exhibit
No
3.1
3.2
4.1
4.2
EXHIBIT LIST
Exhibit Title
Restated Certificate of Incorporation, as
amended to date
Bylaws of the Company, as amended
and restated as of May 9, 2012
Indenture dated March 5, 2007 between
the Company as Issuer and the Bank of
New York Trust Company, N.A. as
Trustee
Indenture dated June 9, 2010 between
the Company as Issuer and the Bank of
New York Mellon Trust Company,
N.A. as Trustee
1988 Stock Option Plan, as amended
10.1 *
10.2 * Amended and Restated 1990 Employee
10.3 *
Qualified Stock Purchase Plan
1997 Stock Plan and Form of Stock
Option Agreement
10.4 *
Form of Indemnification Agreement
between the Company and its officers
and directors
10.5 *
Supplemental Stock Option Plan
10.6 * Xilinx, Inc. Master Distribution
10.7 *
10.8 *
10.9 *
10.10 *
10.11 *
Agreement with Avnet
Letter Agreement dated June 2, 2005
between the Company and Jon A.
Olson
2007 Equity Incentive Plan
Form of Stock Option Agreement under
2007 Equity Incentive Plan
Form of Restricted Stock Unit
Agreement under 2007 Equity
Incentive Plan
Form of Performance-Based Restricted
Stock Unit Agreement under 2007
Equity Incentive Plan
Incorporated by Reference
Form
10-K
File No.
000-18548
Exhibit
3.1
Filing
Date
Filed
Herewith
5/30/2007
8-K
000-18548
3.2
5/15/2012
10-K
000-18548
4.1
5/30/2007
10-Q
000-18548
4.2
8/9/2010
S-1
DEF
14A
S-8
6/7/1990
333-34568
000-18548 Appendix A 5/29/2012
10.15
333-127318
4.2
8/9/2005
S-1
333-34568
10.17
4/27/1990
10-K
10-Q
10-
Q/A
DEF
14A
10-K
000-18548
000-18548
10.16
10.1
6/17/2002
11/4/2005
000-18548
10.1
8/12/2005
000-18548 Appendix B 5/29/2012
000-18548
10.24
5/30/2007
10-K
000-18548
10.25
5/30/2007
8-K
000-18548
99.1
7/5/2007
-84-
Exhibit
No
10.12 *
Exhibit Title
Letter Agreement dated January 4,
2008 between the Company and Moshe
N. Gavrielov
Incorporated by Reference
Form
8-K
File No.
000-18548
Exhibit
99.2
Filing
Date
1/7/2008
Filed
Herewith
10.13 * Amendment of Employment
8-K
000-18548
99.1
2/20/2008
Agreement dated February 14, 2008
between the Company and Jon A.
Olson
Summary of Fiscal 2013 Executive
Incentive Plan
10.14 *
8-K
000-18548
N/A 5/15/2012
10.15 * Restricted Stock Issuance Agreement
10-Q
000-18548
10.15
8/9/2011
10.16 *
Performance Based Restricted Stock
Issuance Agreement
10-Q
000-18548
10.16
8/9/2011
10.17 * Amendment of Employment
8-K
000-18548
10.17
6/19/2012
Agreement between the Company and
Moshe N. Gavrielov
10.18 * Amendment of Employment
Agreement between the Company and
Jon A. Olson
8-K
000-18548
10.18
6/19/2012
10.19 * Retirement Agreement between the
10-Q
000-18548
10.19
11/2/2012
21.1
23.1
24.1
31.1
31.2
32.1
32.2
Company and Vincent Ratford
Subsidiaries of the Company
Consent of Independent Registered
Public Accounting Firm
Power of Attorney (included in the
signature page)
Certification of Chief Executive Officer
pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
Certification of Chief Financial Officer
pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
Certification of Chief Executive Officer
pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
Certification of Chief Financial Officer
pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
101.INS ** XBRL Instance Document
101.SCH ** XBRL Taxonomy Extension Schema
Document
101.CAL ** XBRL Taxonomy Extension
Calculation Linkbase Document
101.LAB ** XBRL Taxonomy Extension Label
Linkbase Document
101.PRE ** XBRL Taxonomy Extension
Presentation Linkbase Document
X
X
X
X
X
X
X
X
X
X
X
X
*
**
Management contract or compensatory plan or arrangement required to be filed as an exhibit to the Company’s Annual
Report on Form 10-K pursuant to Item 15(b) herein
Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation
relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud
provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission
requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to
comply with the submission requirements. Users of this data are advised that pursuant to Rule 406T, these interactive
data files are deemed not filed and otherwise are not subject to liability.
-85-
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this
Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Jose,
State of California, on the 23rd day of May 2013.
SIGNATURES
XILINX, INC.
By:
/s/ Moshe N. Gavrielov
Moshe N. Gavrielov,
President and Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints
Moshe N. Gavrielov and Jon A. Olson, jointly and severally, his/her attorneys-in-fact, each with the power of substitution, for
him/her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with
exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying
and confirming all that each of said attorneys-in-fact, or his/her substitute or substitutes, may do or cause to be done by virtue
hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934 this Annual Report on Form 10-K has been signed below
by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
Signature
Title
/s/ Moshe N. Gavrielov
(Moshe N. Gavrielov)
/s/ Jon A. Olson
(Jon A. Olson)
/s/ Philip T. Gianos
(Philip T. Gianos)
/s/ John L. Doyle
(John L. Doyle)
/s/ William G. Howard, Jr.
(William G. Howard, Jr.)
/s/ J. Michael Patterson
(J. Michael Patterson)
/s/ Albert A. Pimentel
(Albert A. Pimentel)
/s/ Marshall C. Turner
(Marshall C. Turner)
/s/ Elizabeth W. Vanderslice
(Elizabeth W. Vanderslice)
President and Chief Executive Officer
(Principal Executive Officer) and Director
Senior Vice President, Finance and Chief Financial Officer
(Principal Accounting and Financial Officer)
Chairman of the Board of Directors
Director
Director
Director
Director
Director
Director
Date
May 23, 2013
May 23, 2013
May 23, 2013
May 23, 2013
May 23, 2013
May 23, 2013
May 23, 2013
May 23, 2013
May 23, 2013
-86-
2013
Proxy
This page intentionally left blank.
Dear Xilinx Stockholder:
July 1, 2013
You are cordially invited to attend the 2013 Annual Meeting of Stockholders to be held on Wednesday, August 14, 2013 at
11:00 a.m., Pacific Daylight Time, at the headquarters of Xilinx, Inc. (Xilinx, the Company, we or our) located at 2050 Logic
Drive, San Jose, California 95124. We look forward to your attendance either in person or by proxy. At this meeting, the
agenda includes:
•
•
•
•
•
•
the annual election of directors;
a proposal to approve an amendment to our 1990 Employee Qualified Stock Purchase Plan to increase the
number of shares reserved for issuance thereunder by 2,000,000 shares;
a proposal to approve an amendment to our 2007 Equity Incentive Plan to extend the term by an additional
ten years to December 31, 2023;
a proposal to approve an amendment to our 2007 Equity Incentive Plan to increase the number of shares
reserved for issuance thereunder by 2,000,000 shares;
an advisory vote on executive compensation as described in the attached proxy statement; and
a proposal to ratify the appointment of the Company’s external auditors, Ernst & Young LLP.
The foregoing matters are more fully described in the attached proxy statement. The agenda will also include any other business
that may properly come before the meeting or any adjournment or postponement thereof. The Board of Directors recommends
that you vote FOR the election of each of the director nominees nominated by the Board of Directors, FOR the increase in the
number of shares available for issuance under our 1990 Employee Qualified Stock Purchase Plan, FOR extending the term of
our 2007 Equity Incentive Plan, FOR the increase in the number of shares available for issuance under our 2007 Equity
Incentive Plan, FOR the approval of the compensation of our named executive officers, and FOR the ratification of
appointment of Ernst & Young LLP as external auditors of the Company for the fiscal year ending March 29, 2014. Please refer
to the proxy statement for detailed information on each of the proposals.
You may vote your shares in one of the following ways: (1) via the Internet, by visiting the website shown on the Important
Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on August 14, 2013
(Internet Notice) or proxy card and following the instructions; (2) telephonically by calling the telephone number shown in the
Internet Notice or proxy card; (3) by voting in person at the annual meeting; or (4) by requesting, completing and mailing in a
paper proxy card, as outlined in the Internet Notice.
The Xilinx 2013 Annual Meeting will be held solely to tabulate the votes cast and report the results of voting on the matters
described in the attached proxy statement and any other business that may properly come before the meeting. Certain senior
executives of Xilinx will be in attendance to answer questions following the Annual Meeting; however, no formal presentation
concerning the business of Xilinx will be made at the Annual Meeting.
Whether or not you plan to attend, please take a few minutes now to vote online or via telephone or, alternatively, request a
paper proxy card and mark, sign and date your proxy and return it by mail so that your shares will be represented.
Thank you for your continuing interest in Xilinx.
Very truly yours,
/s/ Moshe N. Gavrielov
Moshe N. Gavrielov
President and Chief Executive Officer
IMPORTANT: WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, YOU ARE REQUESTED TO
VOTE YOUR PROXY ONLINE OR BY TELEPHONE, OR, IN THE ALTERNATIVE, REQUEST, COMPLETE
AND MAIL IN A PAPER PROXY CARD.
This page intentionally left blank.
XILINX, INC.
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
Wednesday, August 14, 2013
TO OUR STOCKHOLDERS:
NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of Xilinx, Inc., a Delaware corporation (Xilinx, the
Company, we or our), will be held on Wednesday, August 14, 2013 at 11:00 a.m., Pacific Daylight Time, at the Company’s
headquarters located at 2050 Logic Drive, San Jose, California 95124 for the following purposes:
1.
2.
3.
4.
5.
6.
to elect the following eight nominees for director to serve on the Board of Directors for the ensuing year or until their
successors are duly elected and qualified: Philip T. Gianos, Moshe N. Gavrielov, John L. Doyle, William G. Howard,
Jr., J. Michael Patterson, Albert A. Pimentel, Marshall C. Turner and Elizabeth W. Vanderslice;
to approve an amendment to our 1990 Employee Qualified Stock Purchase Plan to increase the number of shares
reserved for issuance thereunder by 2,000,000 shares;
to approve an amendment to our 2007 Equity Incentive Plan to extend the term by an additional ten years to December
31, 2023;
to approve an amendment to our 2007 Equity Incentive Plan to increase the number of shares reserved for issuance
thereunder by 2,000,000 shares;
to hold an advisory vote on executive compensation as described in the attached proxy statement;
to ratify the appointment of Ernst & Young LLP, an independent registered public accounting firm, as external
auditors of Xilinx, for the fiscal year ending March 29, 2014; and
7.
to transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
The foregoing items of business are more fully described in the proxy statement accompanying this notice. Only stockholders
of record at the close of business on June 17, 2013 are entitled to notice of and to vote at the meeting.
All stockholders are cordially invited to attend the meeting in person. Certain senior executives of Xilinx will be in attendance
to answer questions following the Annual Meeting; however, there will be no formal presentation concerning the business of
Xilinx.
In order to ensure your representation at the meeting, you are urged to vote as soon as possible.
You may vote your shares in one of the following ways: (1) via the Internet, by visiting the website shown on the Important
Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on August 14, 2013
(Internet Notice) or proxy card and following the instructions; (2) telephonically by calling the telephone number shown in the
Internet Notice or proxy card; (3) by voting in person at the annual meeting; or (4) by requesting, completing and mailing in a
paper proxy card, as outlined in the Internet Notice. If you have Internet access, we encourage you to record your vote on
the Internet.
FOR THE BOARD OF DIRECTORS
/s/ Scott R. Hover-Smoot
Scott R. Hover-Smoot
Secretary
San Jose, California
July 1, 2013
THIS PROXY STATEMENT AND THE ACCOMPANYING PROXY ARE BEING PROVIDED ON OR ABOUT
JULY 1, 2013 IN CONNECTION WITH THE SOLICITATION OF PROXIES ON BEHALF OF THE BOARD OF
DIRECTORS OF XILINX, INC. IMPORTANT: WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING,
YOU ARE REQUESTED TO VOTE YOUR PROXY ONLINE OR BY TELEPHONE, OR, IN THE ALTERNATIVE,
REQUEST, COMPLETE AND MAIL IN A PAPER PROXY CARD.
This page intentionally left blank.
PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS
QUESTIONS AND ANSWERS ABOUT THIS PROXY MATERIAL AND VOTING
XILINX, INC.
Q: Why am I receiving these materials?
A: This proxy statement, the enclosed proxy card and the Annual Report on Form 10-K for the fiscal year ended March 30,
2013 (Form 10-K) are being provided to stockholders of Xilinx, Inc., a Delaware corporation (Xilinx, the Company, we or
our), on or about July 1, 2013 in connection with the solicitation by the Board of Directors (Board) of proxies to be used at
the Annual Meeting of Stockholders of the Company (Annual Meeting) to be held on Wednesday, August 14, 2013 at
11:00 a.m., Pacific Daylight Time, at the Company’s headquarters, located at 2050 Logic Drive, San Jose, California
95124 and any adjournment or postponement thereof.
Q: How much did this proxy solicitation cost and who will pay for the cost?
A: The cost of preparing, assembling and delivery of the notice of Annual Meeting, proxy statement and form of proxy and
the solicitation of proxies will be paid by Xilinx. We have retained the services of Alliance Advisors LLC to assist in
obtaining proxies from brokers and nominees of stockholders for the Annual Meeting. The estimated cost of such services
is approximately $8,000 plus out-of-pocket expenses. Proxies may also be solicited in person, by telephone or
electronically by Xilinx personnel who will not receive any additional compensation for such solicitation. We will pay
brokers or other persons holding stock in their names or the names of their nominees for the expenses of forwarding
soliciting material to their principals.
Q: Why did I receive a one-page notice in the mail regarding Internet availability of proxy materials instead of a full
set of proxy materials?
A: In accordance with the rules of the Securities and Exchange Commission (SEC), instead of mailing a printed copy of our
proxy materials to stockholders, we mailed an Important Notice Regarding the Availability of Proxy Materials for the
Annual Meeting of Stockholders to be held on August 14, 2013 (Internet Notice) to most of our stockholders to instruct
you on how to access and review our proxy materials on the Internet. We believe that it is in the best interests of our
stockholders to take advantage of these rules and reduce the expenses associated with printing and mailing proxy materials
to all of our stockholders. In addition, as a corporate citizen, we want to reduce the use of natural resources and the
environmental impact of printing and mailing the proxy materials. As a result, you will not receive paper copies of the
proxy materials unless you specifically request them.
The Internet Notice provides instructions on how you can: (1) access the proxy materials on the Internet, (2) access your
proxy and (3) vote on the Internet. If you would like to receive paper copies of the proxy materials, please follow the
instructions on the Internet Notice. If you share an address with another stockholder and received only one Internet Notice,
you may write or call us to request a separate copy of the proxy materials at no cost to you. We anticipate that the Internet
Notice will be mailed on or about July 1, 2013 to all stockholders entitled to vote at the meeting.
Q: Who is entitled to vote?
A: Only stockholders of record at the close of business (5:00 p.m., Eastern Daylight Time) on June 17, 2013 (the Record
Date) are entitled to notice of and to vote at the Annual Meeting and at any adjournment or postponement thereof. For
information regarding holders of more than 5% of the outstanding Common Stock, see “SECURITY OWNERSHIP OF
CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.”
Q: What shares may be voted and how may I cast my vote for each proposal?
A: Each stockholder is entitled to one vote for each share of Xilinx common stock (Common Stock) held by such stockholder
as of the Record Date (as defined above) with respect to all matters presented at the Annual Meeting. Stockholders do not
have the right to cumulate their votes in the election of directors.
Q: How many shares are outstanding?
A: As of the close of business on May 10, 2013, there were 263,863,503 shares of Common Stock outstanding. The closing
price of the Company’s Common Stock on May 10, 2013, as reported by the NASDAQ Global Select Market (NASDAQ),
was $38.56 per share.
-1-
Q: How will my shares be voted and what happens if I do not give specific voting instructions?
A: Shares of Common Stock for which proxy cards are properly voted via the Internet or by telephone or are properly
executed and returned, will be voted at the Annual Meeting in accordance with the directions given or, in the absence of
directions, will be voted “FOR” the election of each of the nominees to the Board named herein, “FOR” the approval of
the amendment increasing the number of shares authorized under the Company’s 1990 Employee Qualified Stock
Purchase Plan, “FOR” the approval of the amendment extending the term of the Company’s 2007 Equity Incentive Plan,
“FOR” the approval of the amendment increasing the number of shares authorized under the Company’s 2007 Equity
Incentive Plan, “FOR” the approval of the compensation of our named executive officers, and “FOR” the ratification of the
appointment of Ernst & Young LLP, an independent registered public accounting firm, as the Company’s external auditors
for fiscal 2014. It is not expected that any other matters will be brought before the Annual Meeting. If, however, other
matters are properly presented, the persons named as proxies in the accompanying proxy card will vote in accordance with
their discretion with respect to such matters.
Q: What is the difference between a registered stockholder and a beneficial stockholder?
A: Registered Stockholder or Stockholder of Record: Shares Registered in Your Name
If on the Record Date, your shares were registered directly in your name with the Company’s transfer agent, then you are a
registered stockholder or a stockholder of record. As a stockholder of record, you may vote in person at the Annual
Meeting or vote by proxy. Shares held in a brokerage or bank account are not generally registered directly in your name.
Beneficial Stockholder: Shares Registered in the Name of a Broker or Bank
If on the Record Date, your shares were held in an account at a brokerage firm, bank, dealer, or other similar organization,
then you are the beneficial stockholder of shares held in “street name” and these proxy materials are being forwarded to
you by that organization. The organization holding your account is considered the stockholder of record for purposes of
voting at the Annual Meeting. As a beneficial stockholder, you have the right to direct your broker or other agent on how
to vote the shares in your account. You are also invited to attend the Annual Meeting. However, since you are not the
stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid
proxy from your broker or other agent.
Q: How do I cast my vote?
A: Whether you hold your shares directly as the stockholder of record or beneficially in “street name”, you may vote your
shares by proxy without attending the Annual Meeting. Depending on how you hold your shares, you may vote your shares
in one of the following ways:
Stockholders of Record: If you are a stockholder of record, there are several ways for you to vote your shares.
• By telephone or over the Internet. You may vote your shares by telephone or via the Internet by following the
instructions provided in the Internet Notice. If you vote by telephone or via the Internet, you do not need to return a
proxy card by mail. If you have Internet access, we encourage you to record your vote on the Internet. It is
convenient, reduces the use of natural resources and saves significant postage and processing costs. In addition,
when you vote via the Internet or by phone prior to the meeting date, your vote is recorded immediately and there is
no risk that postal delays will cause your vote to arrive late and therefore not be counted.
• By Mail. If you received printed proxy materials, you may submit your vote by completing, signing and dating each
proxy card received and returning it in the prepaid envelope. Sign your name exactly as it appears on the proxy card.
•
In person at the Annual Meeting. You may vote your shares in person at the Annual Meeting. Even if you plan to
attend the Annual Meeting in person, we recommend that you also submit your proxy card or voting instructions or
vote by telephone or via the Internet by the applicable deadline so that your vote will be counted if you later decide
not to attend the meeting.
Beneficial Stockholders: If you are a beneficial owner of your shares, you should have received an Internet Notice from
the broker or other nominee holding your shares. You should follow the instructions in the Internet Notice or voting
instructions provided by your broker or nominee in order to instruct your broker or other nominee on how to vote your
shares. The availability of telephone and Internet voting will depend on the voting process of the broker or nominee.
Shares held beneficially may be voted in person at the Annual Meeting only if you contact the broker or nominee giving
you the right to vote the shares and obtain a legal proxy from such broker or nominee.
-2-
Q: How many copies of the proxy materials will be delivered to stockholders sharing the same address?
A: In an effort to conserve natural resources and reduce printing costs and postage fees, the Company has adopted a practice
approved by the SEC called “householding.” Under this practice, stockholders who have the same address and last name
and do not participate in electronic delivery of proxy materials will receive only one copy of the Internet Notice unless one
or more of these stockholders notifies the Company that they wish to continue receiving individual copies.
If you share an address with another stockholder and received only one Internet Notice and would like to request a copy of
the proxy materials, please send your request to: Xilinx, Inc., 2100 Logic Drive, San Jose, CA 95124, Attn: Investor
Relations; call Investor Relations at (408) 879-6911; or visit the Company’s website at www.investor.xilinx.com. Xilinx
will deliver a separate copy of these materials promptly upon receipt of your written or verbal request. Similarly, you may
also contact the Company if you received multiple copies of the proxy materials and would prefer to receive a single copy
in the future.
Q: What is the quorum requirement for the Annual Meeting?
A: A quorum of stockholders is necessary to hold a valid meeting. The required quorum for the transaction of business at the
Annual Meeting is a majority of the outstanding shares of Common Stock as of the Record Date. Shares of Common Stock
entitled to vote and represented at the Annual Meeting by proxy or in person will be tabulated by the inspector of elections
appointed for the Annual Meeting and counted towards the quorum. Abstentions and broker non-votes will also be counted
towards the quorum requirement. If there is no quorum, a majority of the votes present at the meeting may adjourn the
meeting to another date.
Q: Who will count my votes?
A: Votes will be counted by the inspector of elections appointed for the meeting, who will separately count “FOR” and
“AGAINST” votes, abstentions and broker non-votes.
Q: What is the effect of a “broker non-vote”?
A: A “broker non-vote” occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal
because the nominee does not have discretionary voting power with respect to that proposal and has not received
instructions with respect to that proposal from the beneficial owner, despite voting on at least one other proposal for which
it does have discretionary authority or for which it has received instructions. Broker non-votes have no effect and will not
be counted towards the vote total for any proposal.
Q: Which ballot measures are considered “routine” or “non-routine”?
A: Brokers who do not receive voting instructions from their clients have the discretion to vote uninstructed shares on
“routine” matters but have no discretion to vote them on “non-routine matters.” Proposal One (election of directors),
Proposal Two (amendment to the 1990 Employee Qualified Stock Purchase Plan), Proposals Three and Four (amendments
to the 2007 Equity Incentive Plan), Proposal Five (advisory vote on executive compensation) are “non-routine” matters. If
you hold your shares in street name and you do not instruct your bank or broker how to vote on “non-routine” matters such
as Proposals One, Two, Three, Four, and Five, no votes will be cast on your behalf. Therefore, if you hold your shares in
street name, it is critical that you cast your vote if you want it to count for “non-routine” matters. Proposal Six (ratification
of external auditors) is a “routine” matter. Brokers or other nominees may generally vote on “routine” matters, and
therefore no broker non-votes are expected to exist in connection with Proposal Six.
Q: How are abstentions treated?
A: Abstentions are counted for purposes of determining whether a quorum is present. For the purpose of determining whether
the stockholders have approved a matter, abstentions are treated as represented and entitled to vote and, therefore, have the
same effect on the outcome of a matter being voted on at the Annual Meeting as a vote “Against” or “Withheld” except in
elections of directors where abstentions have no effect on the outcome.
-3-
Q: How many votes are needed to approve each proposal?
A: The following table sets forth the voting requirement with respect to each of the proposals:
PROPOSAL
Proposal One – Election of eight (8) directors
Proposal Two – Amendment to the 1990
Employee Qualified Stock Purchase Plan to
increase the number of shares reserved for
issuance thereunder by 2,000,000 shares
VOTE REQUIRED
Majority of votes cast, except that in contested
elections, Directors will be elected by the
plurality standard whereby those Directors
with the highest number of votes cast are
elected
Majority of shares entitled to vote and present
in person or represented by proxy
Proposal Three – Approval to extend the term
of the 2007 Equity Incentive Plan by an
additional ten years to December 21, 2023
Majority of shares entitled to vote and present
in person or represented by proxy
BROKER
DISCRETIONARY
VOTE ALLOWED
No
No
No
Proposal Four – Amendment to the 2007
Equity Incentive Plan to increase the number
of shares
issuance
to be reserved for
thereunder by 2,000,000 shares
Majority of shares entitled to vote and present
No
in person or represented by proxy
Proposal Five – Annual advisory vote to
approve the compensation of our named
executive officers
Advisory vote; Majority of shares entitled to
vote and present in person or represented by
proxy
Proposal Six – The ratification of Ernst &
Young LLP as our independent registered
public accounting firm
Majority of shares entitled to vote and present
in person or represented by proxy
No
Yes
In the absence of instructions, shares of Common Stock represented by valid proxies shall be voted in accordance with the
recommendations of the Board as shown on the proxy.
Q: What is the advisory vote to approve the compensation of our Named Executive Officers?
A: At our 2011 Annual Meeting, a majority of our stockholders approved holding an advisory vote on our executive
compensation program (also known as “say-on-pay”) at each annual meeting of stockholders. Therefore, we have included
Proposal Five in this proxy statement to allow our stockholders to provide us a non-binding advisory vote on the
compensation of our named executive officers as disclosed in this proxy statement. Your vote on this item will provide our
Company insight into our stockholders’ view on our compensation practices pertaining to our named executive officers.
Q: How can I change my vote or revoke my proxy?
A: A stockholder giving a proxy may revoke it at any time before it is voted by delivering to the Secretary of the Company, at
2100 Logic Drive, San Jose, California 95124, a written notice of revocation or a duly executed proxy bearing a later date,
or by appearing at the Annual Meeting and voting in person. Attendance at the Annual Meeting will not, by itself, be
sufficient to revoke a proxy. Any stockholder owning Common Stock in street name wishing to revoke his or her voting
instructions must contact the bank, brokerage firm or other custodian who holds his or her shares and obtain a legal proxy
from such bank or brokerage firm to vote such shares in person at the Annual Meeting.
-4-
Q: How and when may I submit proposals for consideration at next year’s Annual Meeting of stockholders?
A: Pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (Exchange Act), to be eligible for
inclusion in the Company’s proxy statement for the Company’s 2014 Annual Meeting of Stockholders, stockholder
proposals must be received by the Secretary of the Company at our principal executive offices at 2100 Logic Drive, San
Jose, California, 95124 no later than March 3, 2014. In order for stockholder proposals made outside of Rule 14a-8 under
the Exchange Act to be considered timely within the meaning of Rule 14a-4(c) under the Exchange Act, such proposals
must be received by the Secretary of the Company at our principal executive offices no later than May 17, 2014. In
addition, the Company’s Prior Notice For Inclusion on Agenda Bylaw provision requires that stockholder proposals made
outside of Rule 14a-8 under the Exchange Act must be submitted in accordance with the requirements of the Company’s
Bylaws, not later than April 16, 2014 and not earlier than March 17, 2014; provided however, that if the Company’s 2014
Annual Meeting of Stockholders is called for a date that is not within 25 days before or after the anniversary of the Annual
Meeting, then to be considered timely, stockholder proposals must be received by the Secretary of the Company at our
principal executive offices not later than the close of business on the tenth day following the day on which notice of the
Company’s 2014 Annual Meeting of Stockholders was mailed or publicly disclosed, whichever occurs first. The full text
of the Company’s Prior Notice for Inclusion on Agenda Bylaw provision described above may be obtained by writing to
the Secretary of the Company.
-5-
PROPOSAL ONE
ELECTION OF DIRECTORS
Nominees
The Board of Directors has nominated the eight (8) individuals named below, each of whom is currently serving as a director
(Director) of the Company, to be elected as a Director at the Annual Meeting. The term of office of each person elected as a
Director will continue until the next annual meeting of stockholders or until his or her successor has been elected and qualified.
Unless otherwise instructed, the proxy holders will vote the proxies received by them for each of the Company’s eight (8)
nominees named below. In the event that any nominee of the Company is unable or declines to serve as a Director at the time
of the Annual Meeting, the proxies will be voted for any nominee who shall be designated by the Board to fill the vacancy. The
Company is not aware of any nominee who will be unable to serve as a Director.
The Company would like to acknowledge the service and leadership of former Board member Jerald G. Fishman, who passed
away suddenly in March 2013. Mr. Fishman served as a Director for 13 years, most recently on the Independent Directors
Committee and the Nominating and Governance Committee. Mr. Fishman was a dedicated and valuable member of our Board,
and will be sorely missed.
Name of Nominee
Philip T. Gianos
Moshe N. Gavrielov
John L. Doyle
William G. Howard, Jr.
J. Michael Patterson
Albert A. Pimentel
Marshall C. Turner
Elizabeth W. Vanderslice
Age
63
59
81
71
67
58
71
49
Director
Since
1985
2008
1994
1996
2005
2010
2007
2000
The Company’s Board of Directors seeks to have members with a variety of backgrounds and experiences. Set forth below is a
brief description of the experience, qualifications, attributes or skills of each of our Director nominees that led the Board to
conclude that the Director should serve on the Board.
Mr. Gianos joined the Company’s Board in December 1985. Mr. Gianos has served as Chairman of the Board since February
2009. Mr. Gianos has been an investor with InterWest Partners, a venture capital firm focused on information technology and
life sciences, since 1982 and a General Partner since 1984. Prior to joining InterWest Partners, Mr. Gianos was with IBM
Corporation, an information technology company, for eight years, six of which were in engineering management.
Mr. Gianos brings to the Board over 30 years of experience as an investor in multiple areas of information technology,
including semiconductors, at a venture capital firm, as well as six years of experience in engineering management. Such
experience has proved valuable to the Board in considering and evaluating strategic investments for the Company, as well as in
overseeing the operational and R&D aspects of the Company’s business.
Mr. Gavrielov joined the Company in January 2008 as President and CEO and was appointed to the Board in February 2008.
Prior to joining the Company, Mr. Gavrielov served at Cadence Design Systems, Inc., an electronic design automation
company, as Executive Vice President and General Manager of the Verification Division from April 2005 through November
2007. Mr. Gavrielov served as CEO of Verisity Ltd., an electronic design automation company, from March 1998 to April
2005 before its acquisition by Cadence Design Systems, Inc. Prior to joining Verisity, Mr. Gavrielov spent nearly 10 years at
LSI Corporation (formerly LSI Logic Corporation), a semiconductor manufacturer, in a variety of executive management
positions, including Executive Vice President of the Products Group, Senior Vice President and General Manager of
International Marketing and Sales and Senior Vice President and General Manager of LSI Logic Europe plc. Additionally,
Mr. Gavrielov held various engineering and engineering management positions at Digital Equipment Corporation and National
Semiconductor Corporation.
With extensive experience in executive management and engineering with semiconductor and software companies,
Mr. Gavrielov understands the Company and its competitors, customers, operations and key business drivers. From this
experience, Mr. Gavrielov has developed a broad array of skills, particularly in the areas of building and developing
semiconductor and software businesses, and providing leadership and a clear vision to the Company’s employees. As the CEO
of the Company, Mr. Gavrielov also brings his strategic vision for the Company to the Board and creates a critical link between
the management and the Board, enabling the Board to perform its oversight function with the benefit of management’s
perspective on the business.
-6-
Mr. Doyle joined the Company’s Board in December 1994. Mr. Doyle held numerous technical and managerial positions at
Hewlett-Packard Company from 1957 to 1991. Mr. Doyle is an independent consultant.
Mr. Doyle has developed a wide breadth of experience since 1991 as an independent technical and business strategy consultant.
Prior to that, Mr. Doyle spent nearly 35 years at Hewlett-Packard Company including time as VP of Personnel, VP of Research
and Development, Director of HP Labs and Executive VP of the Computer Systems, Networks and Peripherals businesses
which included their integrated circuits operations. Mr. Doyle’s executive experience at Hewlett-Packard brings deep
leadership and operational experience to our Board. In addition, Mr. Doyle has extensive knowledge of the Company’s
business, in particular, gained from his service as a Director of the Company since 1994. Mr. Doyle has also served on the
boards of directors of multiple public and private technology companies which provide him with insights into how boards of
other companies have addressed issues similar to those faced by the Company.
Dr. Howard joined the Company’s Board in September 1996. Dr. Howard has worked as an independent consultant for
various semiconductor and microelectronics companies since December 1990. From October 1987 to December 1990,
Dr. Howard was a senior fellow at the National Academy of Engineering conducting studies of technology management.
Dr. Howard held various management positions at Motorola, Inc., a wireless and broadband communications company,
between 1969 and 1987 including Senior Vice President and Director of Research and Development. Dr. Howard also serves as
Chairman of the Board of Ramtron International Corporation, a manufacturer of memory products.
Dr. Howard’s nearly 20 years of experience as an independent consultant for various semiconductor and microelectronics
companies, including SEMATECH, the Semiconductor Industry Association and Dow Corning, provides the Board with
valuable insights into the industry in which the Company competes. Dr. Howard’s 18 years of experience in various
management positions at a leading wireless and broadband communications company, including as its Senior Vice President
and Director of Research and Development, has also proved to be valuable as the Company evaluates its own development
efforts. Through Dr. Howard’s involvement with several scientific and engineering organizations, including as a member of the
National Academy of Engineering and a fellow of the Institute of Electrical Engineers and of the American Association for the
Advancement of Science, he has also gained valuable knowledge of the most recent developments in engineering. Dr. Howard
has also gained a broad range of skills from his service on multiple boards of directors of public and private technology
companies.
Mr. Patterson joined the Company’s Board in October 2005. Mr. Patterson was employed by PricewaterhouseCoopers
(PWC), a public accounting firm, from 1970 until retirement in 2001. The positions he held during his 31-year career at PWC
include chair of the national high tech practice, chair of the semiconductor tax practice, department chair for PWC’s Silicon
Valley tax practice and managing partner of PWC’s Silicon Valley office. Mr. Patterson serves on a few boards of private
companies and advises charitable organizations.
Mr. Patterson’s qualifications to sit on our Board of Directors include his extensive experience with public and financial
accounting matters for complex global organizations. Mr. Patterson’s extensive financial background, including specifically
advising companies in the semiconductor industry, has enabled him to play a meaningful role in the oversight of our financial
reporting and accounting practices and executive compensation practices.
Mr. Pimentel joined the Company’s Board in August 2010. In April 2011, Mr. Pimentel was appointed Executive Vice
President, Chief Sales and Marketing Officer for Seagate Technology LLC, a manufacturer of hard drives and storage
solutions. From May 2008 until August 2010, Mr. Pimentel served as CFO and COO of McAfee, Inc., a security technology
company. Prior to that, Mr. Pimentel served as Executive Vice President and CFO of Glu Mobile, Inc., a publisher of mobile
games, since 2004. Prior to joining Glu Mobile, Mr. Pimentel served as Executive Vice President and CFO of Zone Labs, Inc.,
an end-point security software company, from 2003 until it was acquired in 2004 by Checkpoint Software, Inc. From 2001 to
2003, he served as a partner of Redpoint Ventures. Prior to joining Redpoint, he served as Executive Vice President and CFO
for WebTV Networks, Inc., a provider of set-top Internet access devices and services acquired by Microsoft Corporation, and
LSI Logic Corporation, a semiconductor and storage systems developer. Mr. Pimentel also serves on the board of directors of
Imperva, Inc., a security software company and Lifelock, an identity theft protection company.
Mr. Pimentel’s strong financial background, including his work as the CFO at three different publicly-traded companies,
provides financial expertise to the Board, including an understanding of financial statements, corporate finance and accounting.
As an executive of a publicly-traded company, Mr. Pimentel also brings deep leadership and operational experience to our
Board.
Mr. Turner joined the Company’s Board in March 2007. Mr. Turner served as interim CEO of MEMC Electronic Materials, a
manufacturer of silicon wafers for semiconductor and solar power applications, from November 2008 until March 2009, and
has been a member of their company’s board of directors since 2007. Mr. Turner served as Chairman and CEO of Dupont
Photomasks, Inc., a manufacturer of photomasks for semiconductor chip fabricators, from June 2003 until its sale in April
2005, and then as President and CEO of the company, renamed Toppan Photomasks, Inc., through May 2006. Mr. Turner is
also a member of the board of directors of the AllianceBernstein Funds, a group of 32 mutual funds.
-7-
Mr. Turner has been involved in the semiconductor and software industries for 39 years in a variety of roles including as the
CEO of two global public companies in the semiconductor industry and chairman of two software companies as well as a
venture capital investor. From these experiences, Mr. Turner has developed a broad range of skills that contribute to the
Board’s oversight of the operational, financial and risk management aspects of our business. Mr. Turner has also served on 24
corporate boards of directors and chaired four of them, giving him meaningful perspective regarding the processes and
considerations that our Board may bring to bear on a variety of issues.
Ms. Vanderslice joined the Company’s Board in December 2000. Ms. Vanderslice served as a General Manager of Terra
Lycos, Inc., an Internet access and interactive content provider, from July 1999 until July 2001. Prior to joining Terra Lycos,
Ms. Vanderslice was a Vice President of Wired Digital, Inc., an online services company, beginning in 1995 and served as its
President and CEO from 1996 through June 1999 when she led its acquisition by Terra Lycos. Prior to joining Wired Digital,
Ms. Vanderslice served as a principal in the investment banking firm Sterling Payot Company and in 1994 became a Vice
President at H. W. Jesse & Co., a San Francisco investment banking and business strategy-consulting firm spun off from
Sterling Payot. Ms. Vanderslice holds an MBA from Harvard Business School. Ms. Vanderslice is also on the Board of
Trustees of Boston College.
Ms. Vanderslice brings a broad range of skills to the Board from her experience as a general manager of an internet access and
interactive content provider, CEO of an online services company and as an investment banker at two investment banking firms.
In particular, in addition to her computer science and systems engineer background, Ms. Vanderslice contributes to the Board’s
understanding of the Company’s sales and marketing efforts and engineering management, and her experience in mergers and
acquisitions is valuable to the Board in evaluating strategic transactions.
There are no family relationships among the executive officers of the Company or the Board.
Required Vote
Each nominee receiving more votes “FOR” than “AGAINST” shall be elected as a Director. If you do not wish your shares to
be voted with respect to a nominee, you may “ABSTAIN,” in which case your shares will have no effect on the election of that
nominee.
THE BOARD RECOMMENDS A VOTE “FOR” THE ELECTION OF EACH OF THE DIRECTOR NOMINEES.
-8-
Board Meetings and Committee Composition
BOARD MATTERS
The Company’s Board held a total of six (6) meetings during the fiscal year ended March 30, 2013. All Directors are expected
to attend each meeting of the Board and the Committees on which he or she serves and are also expected to attend the Annual
Meeting. All Directors attended the 2012 annual meeting of stockholders. Each Director attended over 75% of the aggregate of
all meetings of the Board or its Committees on which such Director served during the fiscal year. The Board holds four (4) pre-
scheduled meetings per fiscal year.
The following table reflects the current composition of the Company’s standing Audit Committee, Compensation Committee,
Nominating and Governance Committee, and Committee of Independent Directors.
Non-Employee Directors:
Philip T. Gianos (Chairman)
John L. Doyle
William G. Howard, Jr.
J. Michael Patterson
Albert A. Pimentel
Marshall C. Turner
Elizabeth W. Vanderslice
Employee Director:
Moshe N. Gavrielov
Audit
Committee
Compensation
Committee
Nominating and
Governance
Committee
Committee of
Independent
Directors
Chair
X
X
X
Chair
X
X
X
X
Chair
X
X
X
X
X
X
X
During fiscal 2013, Jerald G. Fishman served on the Nominating and Governance Committee and Independent Directors
Committee before his death in March 2013.
Committees
The Board has a standing Audit Committee, Compensation Committee, Nominating and Governance Committee and
Committee of Independent Directors (the Committees). The Board has determined that each Director currently serving on these
Committees and who served on the Committees in fiscal 2013 is “independent” in accordance with the NASDAQ Marketplace
Rules and Rule 10A-3 of the Exchange Act. The Board and its Committees have authority to engage independent advisors and
consultants and have used such services. Each of the Audit Committee, the Compensation Committee and the Nominating and
Governance Committee, is subject to charters approved by the Board, which are posted on the investor relations page of the
Company’s website at www.investor.xilinx.com under “Corporate Governance.”
Audit Committee
The members of the Audit Committee are John L. Doyle, J. Michael Patterson, Albert A. Pimentel, and Marshall C. Turner.
During fiscal 2013, the Audit Committee held seven (7) meetings. The Audit Committee assists the Board in fulfilling its
oversight responsibilities to the stockholders relating to the Company’s financial statements and the financial reporting process,
the systems of internal accounting and financial controls, and the audit process. The Board has determined that each Audit
Committee member meets the independence and financial knowledge requirements under the SEC rules and the corporate
governance listing standards of NASDAQ. The Audit Committee operates in accordance with a written charter adopted by the
Board, which complies with NASDAQ and SEC listing standards.
The Board has further determined that each member of the Audit Committee qualifies as an “audit committee financial expert”
as defined by SEC rules. Stockholders should understand that this designation is a disclosure requirement of the SEC related to
the Audit Committee members’ individual experience and understanding with respect to certain accounting and auditing
matters. The designation does not impose upon any of the Audit Committee members any duties, obligations or liabilities that
are greater than those generally imposed on each of them as members of the Board nor does it alter the duties, obligations or
liability of any other member of the Board.
Compensation Committee
The members of the Compensation Committee during fiscal 2013 were J. Michael Patterson, Philip T. Gianos, and Elizabeth
W. Vanderslice. The current members of the Compensation Committee are J. Michael Patterson, Marshall C. Turner, and
-9-
Elizabeth W. Vanderslice. The Compensation Committee met sixteen (16) times during fiscal 2013. The Compensation
Committee has responsibility for establishing the compensation policies of the Company. The Compensation Committee
determines the compensation of the Company’s Board and executive officers and has exclusive authority to grant equity-based
awards, including options and restricted stock units (RSUs), to such executive officers under the 2007 Equity Incentive Plan.
The Compensation Committee, together with the Board, evaluates the CEO’s performance and the Compensation Committee
determines CEO compensation, including base salary, incentive pay and equity. The CEO is not present during the
Committee’s or Board’s deliberations or Compensation Committee voting on CEO compensation, but may be present during
voting and deliberations related to compensation of other executive officers. For further information about the processes and
procedures for the consideration and determination of executive compensation, please refer to the section of this proxy
statement entitled “EXECUTIVE COMPENSATION—Compensation Discussion and Analysis.”
The Board has further determined that each member of the Compensation Committee is an “outside director” as that term is
defined in Section 162(m) of the Internal Revenue Code of 1986, as amended (the Tax Code) and a “Disinterested Person” and
a “Non-Employee Director” as those terms are used by the SEC.
Nominating and Governance Committee
The Nominating and Governance Committee, which currently consists of Elizabeth W. Vanderslice, Philip T. Gianos, and
William G. Howard, Jr., met four (4) times during fiscal 2013. Jerald G. Fishman served on the Nominating and Governance
Committee during fiscal 2013, until his death in March 2013. The Nominating and Governance Committee has responsibility
for identifying, evaluating and recommending to the Board individuals to serve as members of the Board, and to establish
policies affecting corporate governance. The Nominating and Governance Committee, among other things, makes suggestions
regarding the size and composition of the Company’s Board, ensures that the Board reviews the Company’s management
organization, including the management succession plans, and the adequacy of the Company’s strategic planning process and
recommends nominees for election as Directors. For further information about the director nomination criteria and process,
please refer to the section of this proxy statement entitled “BOARD MATTERS—Nomination Criteria and Board Diversity.”
Committee of Independent Directors
All independent Directors are members of the Committee of Independent Directors. This Committee met seven (7) times
during fiscal 2013. The Committee’s principal focus is succession planning but it also addresses other topics as deemed
necessary and appropriate. The Committee of Independent Directors typically meets outside the presence of management.
Nomination Criteria and Board Diversity
The Board believes in bringing a diversity of cultural backgrounds and viewpoints to the Board and desires that its Directors
and nominees possess critical skills and experience in the areas of semiconductor design and marketing, manufacturing,
software and finance. These factors, and any other qualifications considered useful by the Board, are reviewed in the context of
an assessment of the perceived needs of the Board at a particular point in time. As a result, the priorities and emphasis of the
Nominating and Governance Committee may change from time to time to take into account changes in business and other
trends, and the portfolio of skills and experience of current and prospective Board members. Therefore, while focused on the
achievement and the ability of potential candidates to make a positive contribution with respect to such factors, the Nominating
and Governance Committee has not established any specific minimum criteria or qualifications that a director or nominee must
possess. The Board remains apprised of qualified individuals who may be considered as Board candidates in the future.
As necessary and as part of its annual evaluation of current Board members, the Nominating and Governance Committee
considers the skills, experience and viewpoints previously mentioned as desirable director qualifications, independence, any job
changes, the amount of time each Director spends on Xilinx matters and to what extent, if any, other commitments the
Directors may have outside of Xilinx impact the Director’s service to Xilinx. In connection with its evaluation of Board
composition, the Nominating and Governance Committee also considers rotating Directors’ positions on the Board
Committees.
Consideration of new Board nominee candidates typically involves a series of internal discussions, review of information
concerning candidates and interviews with selected candidates. In fiscal 2013, the Company did not employ a search firm or
pay fees to other third parties in connection with seeking or evaluating Board nominee candidates. The Nominating and
Governance Committee will consider candidates proposed by stockholders using the same process it uses for a candidate
recommended by a member of the Board, an employee, or a search firm, should one be engaged. A stockholder seeking to
recommend a prospective nominee for the Nominating and Governance Committee’s consideration should submit the
candidate’s name and qualifications by mail addressed to the Corporate Secretary, Xilinx, Inc., 2100 Logic Drive, San Jose, CA
95124, by email to corporate.secretary@xilinx.com, or by fax to the Corporate Secretary at (408) 377-6137.
-10-
Director Independence
The NASDAQ listing standards require that a majority of the members of a listed company’s board of directors must qualify as
“independent” as affirmatively determined by its board of directors. Our Board annually reviews information relating to the
members of our Board to ensure that a majority of our Board is independent under the NASDAQ Marketplace Rules and the
rules of the SEC. After review of all relevant transactions and relationships between each Director nominee, his or her family
members and entities affiliated with each Director nominee and Xilinx, our senior management and our independent registered
public accounting firm, our Board has determined that seven of our eight nominees for Director are independent directors as
defined in the NASDAQ Marketplace Rules and in Rule 10A-3 of the Exchange Act. Mr. Gavrielov, our President and CEO, is
not an independent director within the meaning of the NASDAQ Marketplace Rules or the rules of the SEC because he is a
current employee of Xilinx.
In making a determination of the independence of the nominees for Director, the Board reviewed relationships and transactions
occurring since the beginning of fiscal 2011 between each Director nominee, his or her family members and entities affiliated
with each Director nominee and Xilinx, our senior management and our independent registered public accounting firm. In
making its determination, the Board applied the standards for independence set forth by NASDAQ and the SEC. In each case,
the Board determined that, because of the nature of the relationship or the amount involved in the transaction, the relationship
did not impair the Director nominee’s independence. The transactions listed below were considered by the Board in its
independence determinations.
Mr. Pimentel is employed as an executive officer of a company with which Xilinx does business. Xilinx transactions with Mr.
Pimentel’s company occur in the normal course of business and the amount received by Xilinx in each fiscal year for goods and
services from his company represented less than 1% of Xilinx’s annual revenue. Mr. Pimentel did not have any direct or
indirect material interest in these transactions that requires disclosure under Regulation S-K, Item 404(a).
Each of Messrs. Doyle, Gianos, Pimentel and Dr. Howard is, or was during the previous three fiscal years, a non-management
director of one or more other companies that has done business with Xilinx. All of the transactions with these organizations
occurred in the normal course of business in the purchase or supply of goods or services. In addition, Mr. Gianos serves as a
non-management director of a private company in which Xilinx has made certain investments. Such investments were made by
Xilinx in the ordinary course of its business pursuant to Xilinx investment policies. None of Messrs. Doyle, Gianos, Pimentel,
or Dr. Howard has a direct or indirect material interest in these transactions that requires disclosure under Regulation S-K,
Item 404(a).
Board’s Role in Risk Oversight
Our Board of Directors has overall responsibility for risk oversight at the Company and may delegate particular risk areas to
the appropriate Committees of the Board. The Board’s role in risk oversight builds upon management’s risk management
process. The Company conducts a formal annual risk assessment as well as coordinates on-going risk management activities
throughout the year to identify, analyze, respond to, monitor and report on risks. Risks reviewed by the Company include
operational risks, financial risks, legal and compliance risks, IT risks and strategic risks. The management team then reviews
with the Board any significant risks identified during the process, together with plans to mitigate such risks. In response, the
Board, or the relevant Committee, may request that management conduct additional review of or reporting on select enterprise
risks. The process and risks are reviewed at least annually with the Board and additional review or reporting of significant
enterprise risks will be conducted as needed or as requested by the Board or any of its Committees.
-11-
CORPORATE GOVERNANCE PRINCIPLES
The Company and the Board, through its Nominating and Governance Committee, regularly review and evaluate the
Company’s corporate governance principles and practices. The Significant Corporate Governance Principles, the Company’s
Code of Conduct, the Director's Code of Conduct, and charters for each of the following Board Committees are posted on our
website at www.investor.xilinx.com: Audit Committee, Compensation Committee, and Nominating and Governance
Committee. Printed copies of these documents are also available to stockholders upon written request addressed to the
Corporate Secretary, Xilinx, Inc., 2100 Logic Drive, San Jose, CA 95124 or by email at corporate.secretary@xilinx.com.
Board Leadership Structure and Independence
The Board believes there should be a substantial majority of independent Directors on the Board. The Board also believes that
it is useful and appropriate to have members of management as Directors, including the CEO. Independent Directors are given
an opportunity to meet outside the presence of members of management, and hold such meetings regularly.
It is the written policy of the Board that if the Chairman is not “independent” in accordance with NASDAQ Marketplace Rules
and the Exchange Act, the Board will designate an independent Director to serve as Lead Independent Director. We believe
that having an independent Chairman or a Lead Independent Director, either of whom is responsible for coordinating the
activities of the independent Directors, as well as other duties, including chairing the meetings of the Committee of
Independent Directors, allows the Company’s CEO to better focus on the day-to-day management and leadership of the
Company, while better enabling the Board to advise and oversee the performance of the CEO. The Board’s Nominating and
Governance Committee reviews the position of Lead Independent Director and identifies the Director who serves as Lead
Independent Director in the absence of an independent Chairman. For fiscal 2013, Philip T. Gianos, an independent director,
served as Chairman of the Board, so there was no Lead Independent Director.
Majority Vote Standard
All Directors are elected annually at the annual stockholder meeting. In response to a successful stockholder proposal for
election of directors by majority vote standard, on May 3, 2006, the Board amended the Company’s Bylaws to provide for the
election of Directors in an uncontested election by the majority of votes cast regarding each nominee. In contested elections,
Directors will be elected by the plurality standard whereby those Directors with the highest number of votes cast are elected.
Any existing Director that receives more “AGAINST” votes than “FOR” votes will tender his or her resignation to the Board.
The Board will announce its decision with regard to the resignation within 120 days following the certification of election
results.
Board Evaluation
The Board conducts an annual evaluation of its performance. The process varies from year-to-year, including self-evaluations
and/or one-on-one meetings with each Board member and the chairperson of the Nominating and Governance Committee.
Results of the evaluation are formally presented to the Board. The Board has made changes in Board procedures based on
feedback from the process.
Board Service Limits and Terms
The Board has set a limitation on the number of public boards on which a Director may serve to three (3) for any CEO and four
(4) for all other Directors. This limitation is inclusive of service on the Xilinx Board.
The Board believes that term limits on Directors’ service and a mandatory retirement age do not serve the best interests of the
Company. While such policies could help ensure that fresh ideas and new viewpoints are addressed by the Board, such limits
have the disadvantage of losing the contribution of Directors who over time have developed increased insight and knowledge
into the Company’s operations and who remain active and contributing members of the Board. The Board evaluation process
plays a significant role in determining our Nominating and Governance Committee’s recommendation regarding Board tenure.
Change of Principal Occupation or Association
When a Director’s principal occupation or business association changes substantially during his or her tenure as Director, that
Director shall tender his or her resignation for consideration by the Nominating and Governance Committee. The Nominating
and Governance Committee will recommend to the Board the action, if any, to be taken with respect to the resignation.
-12-
Director Education
The Company offers internal and external course selections for new-Director orientation as well as continuing education. On a
rotating basis, Directors will attend director education programs and report back to the entire Board on key learnings.
Stock Ownership Requirements
Directors
The Board has established minimum stock ownership guidelines for Directors. Under these guidelines, Directors are required to
own Company stock having a value equal to at least five (5) times their annual cash retainer. At the time these ownership
guidelines were adopted, the annual cash retainer for Directors was $60,000, and therefore Directors are required to own
Company stock with a value of at least $300,000. For example, based on $38.56, the closing price of the Company’s Common
Stock on May 10, 2013, $300,000 would purchase 7,780 shares of our Common Stock. Previously, the stock ownership
requirement for Directors was 4,000 shares.
Directors are required to retain half of the shares of Company stock derived from awards of RSUs until this ownership
requirement is met. Half of the RSUs that are vested but are not settled pursuant to a pre-arranged deferral program will count
toward the ownership requirement. Based on $38.56, the closing price of the Company’s Common Stock on May 10, 2013, all
of our Directors have met the stock ownership requirements.
Executive Officers
In August 2011, our Board of Directors approved amendments to the stock ownership guidelines shifting ownership
requirement from a share-based model to a value-based model. Under the revised guidelines, the CEO is required to own
Company stock having a value of at least $2.5 million. Senior vice presidents who are Section 16 officers are required to own
Company stock having a value of at least $750,000 and corporate vice presidents who are Section 16 officers are required to
own Company stock having a value of at least $500,000. In addition, the CEO and all other Section 16 officers must retain half
of the shares of Company stock derived from awards of time-based RSUs until their respective ownership requirements are
met.
Succession Planning
The Board plans for succession to the position of the Chairman of the Board, the position of CEO, and other senior
management positions. To assist the Board, the CEO annually provides the Board with an assessment of senior managers and
of their potential to succeed him. He also provides the Board with an assessment of considered potential successors to certain
senior management positions.
Internal Audit
The Company’s Internal Audit function reports to the Audit Committee of the Board and administratively to the Company’s
CFO.
Codes of Conduct and Ethics
The Board of Directors adopted a Code of Conduct applicable to the Company’s Directors and employees, including the
Company’s CEO, CFO and its principal accounting personnel. The Code of Conduct includes protections for employees who
report violations of the Code of Conduct and other improprieties and includes an anonymous reporting process to provide
employees with an additional channel to report any perceived violations. Independent Directors receive complaints and reports
of violations regarding accounting, internal accounting controls, auditing, legal and other matters reported through the
anonymous reporting process, if any. The Chief Compliance Officer provides a quarterly report to the Audit Committee of
incident reports identified through the anonymous reporting process and otherwise. The Code of Conduct is available on the
investor relations page of our website at www.investor.xilinx.com. Printed copies of these documents are also available to
stockholders upon written request directed to Corporate Secretary, Xilinx, Inc., 2100 Logic Drive, San Jose, CA 95124.
The Board has adopted a separate Code of Ethics pertaining particularly to the Board which covers topics including insider
trading, conflicts of interests, financial reporting and compliance with other laws.
A waiver of any violation of the Code of Conduct by an executive officer or Director and a waiver of any violation of the
Directors’ Code of Ethics may only be made by the Board. The Company will post any such waivers on its website under the
Corporate Governance page at www.investor.xilinx.com. Amendments to the Code of Conduct will also be posted on the
Xilinx website under the Corporate Governance page at www.investor.xilinx.com. No waivers were requested or granted in the
past year. The Code of Conduct was last amended in May 2012.
-13-
Anonymous Reporting and Whistleblower Protection
The Company’s Code of Conduct includes protections for employees who report violations of the Code of Conduct, other
policies, laws, rules and regulations. The Company has implemented an Internet-based anonymous reporting process for
employees to report violations they do not otherwise bring directly to management. The site can be accessed from the
Company’s intranet as well as from any Internet connection around the world.
Stockholder Value
The Board is cognizant of the interests of the stockholders and accordingly:
•
•
•
All employee stock plans will be submitted to the stockholders for approval prior to adoption;
The 2007 Equity Incentive Plan includes a provision that prohibits repricing of options whether by
directly lowering the exercise price, through cancellation of the option or SAR in exchange for a new
option or SAR having a lower exercise price, or by the replacement of the option or SAR with a full
value award (i.e., an award of restricted stock or RSUs); and
The Company is committed to keeping dilution under its stock plans for employees under industry
standards.
Stockholder Communications to the Board
Inc., 2100 Logic Drive, San Jose, CA 95124, by e-mail
Stockholders may initiate any communication with the Company’s Board in writing and send them addressed in care of the
Company’s Corporate Secretary, at Xilinx,
to
corporate.secretary@xilinx.com, or by fax to the Corporate Secretary at (408) 377-6137. The name of any specific intended
recipient, group or committee should be noted in the communication. The Board has instructed the Corporate Secretary to
forward such correspondence only to the intended recipients; however, the Board has also instructed the Corporate Secretary,
prior to forwarding any correspondence, to review such correspondence and, in his discretion, not to forward certain items if
they are deemed of a commercial or frivolous nature or otherwise inappropriate for the Board’s consideration. In such cases,
and as necessary for follow up at the Board’s direction, correspondence may be forwarded elsewhere in the Company for
review and possible response. This centralized process will assist the Board in reviewing and responding to stockholder
communications in an appropriate manner.
-14-
Non-Employee Directors
Cash Compensation
COMPENSATION OF DIRECTORS
In fiscal 2013, the Company paid each of its non-employee Directors serving on its Board a cash retainer of $60,000 per year
for service as a Director, with the exception of the Chairman of the Board. The Chairman of the Board is entitled to an annual
cash retainer equal to twice the amount paid to the other non-employee Directors, or $120,000. The chairperson of the Audit
Committee received an additional $22,500 per year, the chairperson of the Compensation Committee received an additional
$17,500 per year, and the chairperson of the Nominating and Governance Committee received an additional $12,500 per year.
Other than the chairpersons, members of the Audit Committee received an additional $10,000 per year, members of the
Compensation Committee received an additional $7,500 per year and members of the Nominating and Governance Committee
received an additional $5,000 per year. If applicable, the Lead Independent Director is also eligible to receive an additional
$10,000 per year. All payments were made in installments on a quarterly basis. As noted above, for fiscal 2013, Mr. Gianos, an
independent director, served as Chairman of the Board, so there was no Lead Independent Director.
Equity Compensation
Non-employee Directors participate in an equity compensation program under the Company’s 2007 Equity Incentive Plan.
Under this program, eligible non-employee Directors are eligible to receive automatic restricted stock unit awards (RSUs). The
terms of those automatic RSU grants are as follows:
Annual Grant. Each eligible non-employee Director is eligible for an annual RSU award. Each eligible non-employee
Director is automatically granted $165,000 worth of RSUs on the date of each annual meeting of stockholders, and such RSUs
shall vest in full on the day immediately preceding the subsequent annual meeting. Accordingly, on August 8, 2012, on which
date the fair market value of our Common Stock was $33.72, each non-employee Director received a grant of 4,893 RSUs,
which will vest in full on August 13, 2013, the day prior to the 2013 Annual Meeting of Stockholders.
Initial Grant. A non-employee director joining the Board between annual meetings of stockholders will receive a pro-
rated number of RSUs on or about the tenth day of the month following the Director’s initial appointment or election to the
Board. The RSUs vest in full on the day immediately preceding the subsequent annual meeting.
Stock Ownership Guidelines
Under the Company’s stock ownership guidelines, Directors are required to own Company stock having a value equal to at
least $300,000, which is equal to five times their annual retainer in effect at the time the new equity compensation program for
Directors was adopted. Directors are required to retain half of the shares of Company stock derived from awards of RSUs until
their ownership requirements are met. Half of the RSUs that are vested but are not settled pursuant to a pre-arranged deferral
program will count toward the ownership requirement. For more information about stock ownership guidelines for Directors,
please see “CORPORATE GOVERNANCE PRINCIPLES—Stock Ownership Requirements.”
Employee Directors
Directors who are actively employed as executives by the Company receive no additional compensation for their service as
Directors. Mr. Gavrielov is currently the only employee Director of the Company.
Deferred Compensation
We also maintain a nonqualified deferred compensation plan which allows each Director as well as eligible employees to
voluntarily defer receipt of a portion or all of their cash compensation until the date or dates elected by the participant, thereby
allowing the participating Director or employee to defer taxation on such amounts. For a discussion of this plan, see
“EXECUTIVE COMPENSATION— Deferred Compensation Plan.”
-15-
Director Compensation for Fiscal 2013
The following table provides information on Director compensation in fiscal 2013:
Name
Philip T. Gianos
(Chairman)
John L. Doyle
Jerald G. Fishman(5)
William G. Howard, Jr.
J. Michael Patterson
Albert A. Pimentel
Marshall C. Turner
Elizabeth W. Vanderslice
Fees Earned
or Paid
in Cash(1)
($)
Stock
Awards(2)
($)
Option
Awards(3)
($)
Non-Equity
Incentive Plan
Compensation
($)
124,950
79,830
65,236
64,288
83,050
68,220
68,220
77,508
154,325
154,325
154,325
154,325
154,325
154,325
154,325
154,325
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
($)
—(4)
—
—
—(4)
—
—
—
—(4)
All Other
Compensation
($)
Total
($)
—
—
—
—
—
—
—
—
279,275
234,155
219,561
218,613
237,375
222,545
222,545
231,833
Includes amounts deferred at the Director’s election.
(1)
(2) Amounts shown do not reflect compensation actually received by the Director. Instead, the amounts shown reflect the
grant date fair value for stock awards granted in fiscal 2013 as determined pursuant to FASB ASC Topic 718. The
assumptions used to calculate the value of the awards are set forth in Note 6 of the Notes to Consolidated Financial
Statements included in our Annual Report on Form 10-K for fiscal 2013 filed with the SEC on May 23, 2013.
(3) No option awards were granted to Directors during fiscal 2013. The following aggregate number of option awards were
outstanding as of March 30, 2013 for each of the Directors: Mr. Gianos, 66,000; Mr. Doyle, 54,000; Mr. Fishman,
51,500; Dr. Howard, 66,000; Mr. Patterson, 51,000; Mr. Pimentel, 0; Mr. Turner, 36,000; and Ms. Vanderslice, 66,000.
(4) Director participated in the Company’s nonqualified deferred compensation plan in fiscal 2013. For more information
about this plan see the section entitled “EXECUTIVE COMPENSATION—Deferred Compensation Plan.”
(5) Mr. Fishman’s stock awards granted to him in fiscal 2013 became fully vested upon his death in March 2013.
-16-
PROPOSAL TWO
AMENDMENT TO THE 1990 EMPLOYEE QUALIFIED
STOCK PURCHASE PLAN
The Company’s 1990 Employee Qualified Stock Purchase Plan (ESPP) provides eligible employees of the Company and its
participating subsidiaries with the opportunity to purchase shares of Common Stock at a discounted price through payroll
deductions. During the fiscal year ended March 30, 2013, the Company issued 1,272,274 shares of Common Stock under the
ESPP. As of March 30, 2013, a total of 8,891,810 shares remained available for issuance under the ESPP, not including the
2,000,000 additional shares of Common Stock that would be authorized if the amendment described below is approved.
Proposal
At the Annual Meeting, the stockholders will be asked to approve an amendment to the ESPP to increase by 2,000,000 the
maximum number of shares of Common Stock that may be issued under the ESPP.
Unless a sufficient number of shares are authorized and reserved under the ESPP at the beginning of each offering period
(August 1 and February 1) to cover the number of shares purchased throughout its entire 24-month term, the Company may
incur additional compensation expense for financial statement purposes for each period in which the sale of shares is dependent
on obtaining stockholder approval of an additional share authorization. The Board believes an additional 2,000,000 shares will
be necessary to provide for offering periods commencing before the next annual meeting of stockholders.
On May 15, 2013, subject to stockholder approval, the Board adopted an amendment to the ESPP to increase the number of
shares authorized for issuance under the plan by 2,000,000. If the amendment is approved by the stockholders, the total number
of shares available for issuance under the ESPP immediately following such approval will be 10,891,810.
The Board believes that participation by the Company’s employees in the ESPP promotes the success of the Company’s
business through broad-based equity ownership among the employees. The Board further believes that the ESPP is an integral
component of the Company’s benefits program that is intended to provide employees with an incentive to exert maximum
effort for the success of the Company and to participate in that success through acquisition of the Company’s Common Stock.
As long as the ESPP remains in effect, the Company anticipates that it will ask the stockholders each year for the number of
additional shares required to meet the Company’s projected share commitments for offering periods beginning before the next
annual meeting of stockholders.
Subject to the eligibility requirements described below, most of the Company’s 3,329 employees (as of March 30, 2013) are
eligible to participate in the ESPP. As of March 30, 2013, approximately 78% of the Company’s employees were participating
in the ESPP.
Summary of the 1990 Employee Qualified Stock Purchase Plan, as Amended
A summary of the material terms of the ESPP, as amended, is set forth below and is qualified, in its entirety, by the full text of
the plan set forth in Appendix A to our 2013 proxy statement as filed with the SEC and available for viewing without charge at
its website at www.sec.gov. A copy of the ESPP can be obtained from us at no charge upon request.
Purpose
The purpose of the ESPP is to provide employees of the Company and its designated subsidiaries with an opportunity to
purchase Common Stock of the Company through accumulated payroll deductions.
Administration
The ESPP may be administered by the Board or a committee appointed by the Board. All questions of interpretation of the
ESPP are determined by the Board or its committee, whose decisions are final and binding upon all participants. Currently, the
Compensation Committee administers the ESPP.
Authorized Shares
Currently, a maximum of 48,540,000 shares of our Common Stock are authorized for issuance under the ESPP, of which
8,891,810 shares of our Common Stock remained available for future issuance as of March 30, 2013, subject to appropriate
adjustments in the event of any stock dividend, stock split, reverse stock split, recapitalization or similar change in the capital
structure of the Company, or in the event of any merger, sale of assets or other reorganization of the Company. The Board has
amended the ESPP, subject to stockholder approval, to authorize an additional 2,000,000 shares for issuance under the ESPP,
-17-
which would result in a total 50,540,000 shares authorized for issuance, of which 10,891,810 shares of our Common Stock
would be available for future purchases.
Eligibility
Subject to certain limitations imposed by Section 423(b) of the Tax Code, any person who is employed by the Company (or
any designated subsidiary) as of the commencement of an offering period under the ESPP and is customarily employed for at
least 20 hours per week and more than five months in a calendar year is eligible to participate in the offering period. Eligible
employees may become participants in the ESPP by delivering to the Company a subscription agreement authorizing payroll
deductions on or before the first day of the applicable offering period. As of March 30, 2013, most of the Company’s 3,329
employees, including nine current executive officers, were eligible to participate in the ESPP.
Offering Periods
The ESPP is implemented by consecutive and overlapping 24-month offering periods, with a new offering period commencing
on or about the first day of February and August of each year. The Board may generally change the duration of any offering
period without stockholder approval, provided that no offering period may exceed 27 months in duration. In addition, the Board
may establish separate, simultaneous or overlapping offering periods applicable to one or more subsidiaries of the Company
and having different terms and conditions, for example, to comply with the laws of the applicable jurisdiction.
Purchase Price
Each 24-month offering period consists of four exercise periods of six months’ duration. The last day of each exercise period,
which occurs on or about January 31 and July 31 of each year, is an exercise date on which each participant in the offering
period acquires shares. The purchase price of the shares offered under the ESPP in a given exercise period is the lower of 85%
of the fair market value of the Common Stock on the first date of the offering period containing that exercise period or 85% of
the fair market value of the Common Stock on the exercise date. The fair market value of the Common Stock on a given date is
the closing sale price of the Common Stock on such date as reported by NASDAQ. On March 28, 2013, the last trading day of
the 2013 fiscal year, the closing price of our Common Stock as reported on NASDAQ was $38.17 per share.
Payroll Deductions
The purchase price for the shares is accumulated through payroll deductions during each offering period. Payroll deductions
commence on the first payday following the commencement of an offering period and end on the last exercise date of the
offering period, unless sooner terminated as provided in the ESPP. A participant may not authorize deductions of more than
15% or less than 2% of the participant’s eligible compensation, which is defined by the ESPP to include all regular straight
time earnings and any payments for overtime, shift premiums, incentive compensation, bonuses, commissions or other
compensation for a given offering period. The Company may limit a participant’s payroll deductions in any calendar year as
necessary to avoid accumulating an amount in excess of the maximum amount the Tax Code permits to be applied toward the
purchase of shares in any offering under the ESPP. A participant may discontinue participating in the ESPP, or may decrease
the rate of payroll deductions during the offering period. Upon withdrawal from the ESPP, the Company will refund, without
interest, the participant’s accumulated payroll deductions not previously applied to the purchase of shares.
Grant and Exercise of Purchase Right
In general, the maximum number of shares subject to purchase by a participant in an exercise period is that number determined
by dividing the amount of the participant’s total payroll deductions accumulated prior to the relevant exercise date by 85% of
the lower of the fair market value of the Common Stock at the beginning of the offering period or on the exercise date.
However, the maximum number of shares a participant may purchase in any offering period is a number determined by
dividing $50,000 by the fair market value of a share of Common Stock on the first day of the offering period. Unless a
participant withdraws from the ESPP, the participant’s right to purchase shares is exercised automatically on each exercise date
for the maximum number of whole shares that may be purchased at the applicable price.
No employee will be permitted to subscribe for shares under the ESPP if, immediately after the grant of a purchase right, the
employee would own and/or hold purchase rights to acquire 5% or more of the voting securities of the Company. Further, no
employee may be granted a purchase right which would permit the employee to accrue a right to purchase more than $25,000
worth of stock (determined by the fair market value of the shares at the time the purchase right is granted) for each calendar
year in which the purchase right is outstanding at any time.
Automatic Transfer to Low Price Offering Period
In the event that the fair market value of the Company’s Common Stock on any exercise date (other than the last exercise date
of an offering period) is less than on the first day of the offering period, all participants will be withdrawn from the offering
-18-
period after the exercise of their purchase right on such exercise date and enrolled as participants in a new offering period
commencing on or about the day following such exercise date. A participant may elect to remain in the previous offering period
by filing a written statement declaring such election prior to the time of the automatic change to the new offering period.
Withdrawal; Termination of Employment
A participant may withdraw all, but not less than all, payroll deductions credited to his or her account but not yet used to
exercise a purchase right under the ESPP at any time by signing and delivering to the Company a notice of withdrawal from the
ESPP. Any withdrawal by the participant of accumulated payroll deductions for a given offering period automatically
terminates the participant’s interest in that offering period. The failure of a participant to remain in the continuous employment
of the Company for at least 20 hours per week during an offering period will be deemed to be a withdrawal from that offering
period and accumulated payroll deductions will be returned to the participant.
Transferability
No rights or accumulated payroll deductions of a participant under the ESPP may be assigned, transferred, pledged or
otherwise disposed of in any way (other than by will, the laws of descent and distribution or pursuant to the ESPP) and any
attempt to so assign or transfer may be treated by the Company as an election to withdraw from the ESPP.
Adjustments upon Changes in Capitalization
In the event any change is made in the Company’s capitalization pursuant to a stock split or any other increase or decrease in
the number of shares of Common Stock effected without receipt of consideration by the Company, proportionate adjustments
will be made by the Board to the number of shares authorized for issuance under the ESPP and subject to each outstanding
purchase right and in the purchase price per share.
In the event of a sale of all or substantially all of the assets of the Company or a merger of the Company with another
corporation, the acquiring or successor corporation or its parent may assume the purchase rights outstanding under the ESPP or
substitute equivalent purchase rights for the acquiror’s stock, provided that the Board may instead shorten an offering period
and accelerate the exercise date of all offering periods then in progress to a date prior to the transaction.
Amendment or Termination
The Board may at any time and for any reason amend or terminate the ESPP, except that (other than in limited circumstances
set forth in the ESPP) termination will not affect purchase rights previously granted, and no amendment may make any change
in any purchase right previously granted that adversely affects the participant’s rights. Stockholder approval must be obtained
for any amendment to the extent necessary to comply with applicable law. Under its current terms, the ESPP will expire on
January 26, 2030.
Federal Tax Information
The following summary of the effect of United States federal income taxation upon the participant and the Company with
respect to the purchase of shares under the ESPP does not purport to be complete, and reference should be made to the
applicable provisions of the Tax Code. In addition, this summary does not discuss the provisions of the income tax laws of any
municipality, state or foreign country in which the participant may reside.
The ESPP, and the right of participants to make purchases thereunder, is intended to qualify under the provisions of Sections
421 and 423 of the Tax Code. Under these provisions, no income will be taxable to a participant at the time of grant of the
purchase right or purchase of shares. Upon disposition of the shares, the participant will generally be subject to tax, and the
amount of the tax will depend upon the length of time the shares have been held by the participant. If the shares have been held
by the participant for more than two years after the date of grant of the purchase right and more than one (1) year after the date
on which the shares were purchased, then the purchaser will recognize ordinary income equal to the lesser of (a) the excess of
the fair market value of the shares at the time of such disposition over the purchase price of such shares or (b) 15% of the fair
market value of the shares on the first day of the offering period. Any further gain upon such disposition will be treated as long-
term capital gain. If the shares are disposed of before the expiration of these holding periods, the participant will recognize
ordinary income generally equal to the excess of the fair market value of the purchased shares on the date of the purchase over
the purchase price. Any additional gain or loss on the sale will be a capital gain or loss, which will be either long-term or short-
term depending on the actual period for which the shares were held. The Company is entitled to a deduction for amounts taxed
as ordinary income reported by participants upon disposition of shares within two years from date of grant or one year from the
date of acquisition.
-19-
New Plan Benefits
The number of shares that may be purchased under the ESPP will depend on each participant’s voluntary election to participate
and on the fair market value of the Common Stock of the Company on future purchase dates, and therefore the actual number
of shares that may be purchased by any individual is not determinable. No purchase rights have been granted, and no shares of
Common Stock of the Company have been issued with respect to the 2,000,000 additional shares for which stockholder
approval is being sought.
Number of Shares Purchased by Certain Individuals and Groups
The following table sets forth for each of the listed persons and groups (i) the aggregate number of shares of Common Stock of
the Company purchased under the ESPP during fiscal 2013, and (ii) the market value of those shares on the date of such
purchase, minus the purchase price of such shares:
Name and Position
Moshe N. Gavrielov
President and Chief Executive Officer
Jon A. Olson
Senior Vice President, Finance and Chief Financial Officer
Victor Peng
Senior Vice President, Programmable Platforms Group
Vincent L. Tong
Senior Vice President, Worldwide Quality and New Product Introductions
Frank Tornaghi
Senior Vice President, Worldwide Sales
All current executive officers, as a group
All current directors who are not executive officers, as a group (l)
All employees who are not executive officers, as a group
(1) Non-employee Directors are not eligible to participate in the ESPP.
Required Vote
Dollar Value
($)
7,399
7,399
6,546
7,399
7,399
Number of
Shares
785
785
761
785
785
60,618
N/A
9,741,132
6,652
N/A
1,265,622
Affirmative votes constituting a majority of the shares present or represented by proxy and entitled to vote on this proposal will
be required to approve this proposal. Abstentions will have the same effect as a negative vote, while broker non-votes will have
no effect on the outcome of this vote.
THE BOARD RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE AMENDMENT TO THE COMPANY’S
1990 EMPLOYEE QUALIFIED STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF
COMMON STOCK RESERVED FOR ISSUANCE THEREUNDER BY 2,000,000 SHARES.
-20-
APROVAL TO EXTEND THE TERM OF THE 2007 EQUITY INCENTIVE PLAN
PROPOSAL THREE
Proposal
At the Annual Meeting, the stockholders are being requested to approve an amendment to the 2007 Equity Incentive Plan (2007
Equity Plan), to extend its term by an additional ten years to December 31, 2023. This amendment will not increase the
number of shares of our Common Stock authorized for issuance under the 2007 Equity Plan. We are, however, requesting an
increase by 2,000,000 shares in the number of shares of our Common Stock authorized for issuance under the 2007 Equity Plan
in the next proposal. See Proposal Four—Amendment to the 2007 Equity Incentive Plan.
The 2007 Equity Plan was adopted by the Company’s Board on May 3, 2006, approved by stockholders at the Annual
Stockholders Meeting in July 2006, and became effective on January 1, 2007. We make share-based incentive awards under
this plan to newly hired employees and in connection with promotions and our annual performance review process. Without
the proposed amendment, the 2007 Equity Plan would terminate on December 31, 2013, and we would be unable to provide
future equity incentives to our employees. We need the 2007 Equity Plan to attract new employees and retain existing
employees, which helps us to remain competitive in the marketplace.
Key Terms of the 2007 Equity Plan
The following is a summary of the key provisions of the 2007 Equity Plan.
Plan Term:
Currently, January 1, 2007 to December 31, 2013. If the stockholders approve the proposed
amendment, the plan term will continue until December 31, 2023.
Eligible Participants:
Employees, consultants and non-employee directors of Xilinx and its subsidiaries are eligible to
receive awards under the 2007 Equity Plan.
Shares Authorized:
A total of 36,500,000 shares of Common Stock were authorized for issuance under the plan, of
which approximately 15,990,452 shares remained available for future grant as of March 30, 2013,
subject to adjustment to reflect stock splits and similar events. If the stockholders approve Proposal
Four to increase the number of shares of Common Stock authorized for issuance by 2,000,000
shares, a total of 38,500,000 shares will be available for future grants, subject to adjustment to reflect
stock splits and similar events.
Award Types:
Award Limits:
• Non-qualified and incentive stock options
• Restricted stock awards
• Restricted stock units (“RSUs”)
• Stock appreciation rights (“SARs”)
A participant may receive in any calendar year:
Award Terms:
Exercise Price:
Repricing:
• No more than 4,000,000 shares subject to options or SARs, in the aggregate
• No more than 2,000,000 shares subject to awards other than options and SARs
• No more than $6,000,000 subject to awards that may be settled in cash
Stock options and SARs must expire no more than seven years from the date of grant.
The exercise price of stock options or SARs may not be less than 100% of the fair market value of
our Common Stock on the date of grant.
Repricing of out-of-money options or SARs, whether by directly lowering the exercise price, by
canceling an option or SAR in exchange for a new option or SAR having a lower exercise price, or
by substituting a full value award in place of the option or SAR is not permitted without stockholder
approval.
The Board believes that participation in the 2007 Equity Plan by the employees, consultants, and non-employee directors of the
Company and its designated subsidiaries worldwide promotes the success of the Company’s business by providing them with
an incentive to exert their maximum effort toward achieving that success. Therefore, the Board unanimously adopted on May
15, 2013, subject to stockholder approval, an amendment to extend the term of the 2007 Equity Plan by an additional ten years
to December 31, 2023.
-21-
Summary of the 2007 Equity Plan, as Amended
A summary of the material terms of the 2007 Equity Plan, as amended, is set forth below and is qualified, in its entirety, by the
full text of the 2007 Equity Plan set forth in Appendix B to our 2013 proxy statement as filed with the SEC and available for
viewing without charge at its website at www.sec.gov. A copy of the 2007 Equity Plan can be obtained from us at no charge
upon request.
Purpose
The purpose of the 2007 Equity Plan is to attract and retain the services of employees, consultants, and non-employee directors
of the Company and its subsidiaries, and to provide such persons with a proprietary interest in the Company.
Administration
The Compensation Committee of the Board administers the 2007 Equity Plan, unless otherwise determined by the Board. The
Compensation Committee consists of at least two directors of the Company who are both “outside directors” under
Section 162(m) of the Tax Code, and “non-employee directors” under Rule 16b-3 promulgated under the Exchange Act. The
Compensation Committee, in its sole discretion, will interpret the 2007 Equity Plan and prescribe, amend, and rescind any rules
and regulations necessary or appropriate for the administration of the 2007 Equity Plan, including the creation of sub-plans to
take advantage of favorable tax-treatment, comply with local law, or reduce administrative burdens for grants of awards in non-
U.S. jurisdictions.
Eligibility
The Compensation Committee determines the employees, consultants, and non-employee directors of the Company or a
subsidiary who are eligible to receive awards under the 2007 Equity Plan. As of March 30, 2013, there were 3,329 employees,
including nine (9) current executive officers, 109 consultants and seven (7) non-employee directors eligible to participate in the
2007 Equity Plan.
Authorized Shares
Subject to adjustment in the event of certain corporate events (as described below), the maximum number of shares of the
Company’s Common Stock currently authorized under the 2007 Equity Plan is 36,500,000, of which 15,990,452 remained
available for future issuance as of March 30, 2013, all of which may be granted under the terms of the 2007 Equity Plan as
incentive stock options. However, the Board has amended the 2007 Equity Plan, subject to stockholder approval, to authorize
an additional 2,000,000 shares for issuance under the plan, which would result in a total of 38,500,000 authorized shares, of
which 17,990,452 shares would be available for future grants. If any award granted under the 2007 Equity Plan expires or
otherwise terminates in whole or in part for any reason, or if shares issued pursuant to an award are forfeited or otherwise
reacquired by the Company because of the participant’s failure to comply with the conditions of the award or for any other
reason, any such shares subject to a terminated award or reacquired by the Company will again become available for issuance
under the 2007 Equity Plan. Shares will not be treated as having been issued under the 2007 Equity Plan and will therefore not
reduce the number of shares available for issuance to the extent an award is settled in cash. The Compensation Committee is
authorized to adopt such procedures for counting shares against the maximum number of authorized shares as the
Compensation Committee deems appropriate.
Types of Awards
The 2007 Equity Plan allows the Compensation Committee to grant incentive stock options, non-qualified stock options, RSUs,
restricted stock and SARs. Subject to the limits set forth in the 2007 Equity Plan, the Compensation Committee has the
discretionary authority to determine the amount and terms of awards granted under the 2007 Equity Plan.
Automatic Non-employee Director Awards
The 2007 Equity Plan provides for the periodic automatic grant of RSU awards to non-employee directors. Each non-employee
director continuing in office will automatically be granted on the day of each annual meeting of stockholders an award
consisting of a number of RSUs determined by dividing $165,000 by the closing price of the Company's Common Stock on the
grant date. These awards vest in full on the day immediately preceding the subsequent annual meeting. A non-employee
director joining the Board between annual meetings of stockholders will receive a prorated RSU award on or about the tenth
day of the month following the director's initial appointment or election to the Board.
-22-
Limitations on Awards
Awards under the 2007 Equity Plan are subject to the following limitations:
An option’s exercise price cannot be less than 100% of the fair market value of each share underlying the option on the date of
option grant. A SAR’s base level price cannot be less than 100% of the fair market value of each share underlying the SAR on
the date of grant of such SAR.
Section 162(m) of the Tax Code requires, among other things, that the maximum number of shares for which an award may be
granted or the maximum amount of compensation that could be paid to an individual during a specified period must be set forth
in the plan and approved by stockholders in order for the awards to be eligible for treatment as performance-based
compensation that will not be subject to the $1,000,000 limitation on tax deductibility for compensation paid to each “covered
employee.” Covered employees are the Company’s chief executive officer and its three highest compensated executive officers
(excluding the chief executive and chief financial officers) holding office on the last day of the Company’s taxable year.
Accordingly, the 2007 Equity Plan limits awards granted to an individual participant in any calendar year. The aggregate
awards granted under the 2007 Equity Plan to any participant during any calendar year may not exceed (i) 4,000,000 shares of
the Company’s Common Stock subject to stock options or SARs and (ii) 2,000,000 shares of the Company’s Common Stock
subject to awards other than stock options and SARs. In addition, no participant may receive during any calendar year an award
under the 2007 Equity Plan settled in cash exceeding $6,000,000 in the aggregate.
Without stockholder approval, the Company cannot reprice options or SARs, whether by directly lowering the exercise price,
through cancellation of the option or SAR in exchange for a new option or SAR having a lower exercise price, or by the
replacement of the option or SAR with a full value award (i.e., an award of restricted stock or RSUs).
Performance Goals
The Compensation Committee has the sole discretion to condition awards granted to those employees subject to
Section 162(m) of the Tax Code on the attainment of objective performance goals. The Compensation Committee will establish
the performance goals in writing. Such performance goals shall be based on one or more or a combination of the following
criteria in either absolute or relative terms: (i) increased revenue; (ii) net income measures (including, but not limited to,
income after capital costs and income before or after any one or more of the share-based compensation expense, interest, taxes,
appreciation or amortization); (iii) stock price measures (including, but not limited to, growth measures and total stockholder
return); (iv) market segment share; (v) earnings per share (actual or targeted growth); (vi) cash flow measures (including, but
not limited to, net cash flow and net cash flow before financing activities); (vii) return measures (including, but not limited to,
return on equity, return on average assets, return on capital, risk-adjusted return on capital, return on investors’ capital and
return on average equity); (viii) operating measures (including operating income, gross margin, operating margin, funds from
operations, cash from operations, after-tax operating income, sales volumes, production volumes and production efficiency);
(ix) expense measures (including, but not limited to, overhead cost, research and development expense and general and
administrative expense); (x) product technology leadership metrics; and (xi) product quality leadership metrics.
Transferability
Awards granted under the 2007 Equity Plan may not be transferred other than by will or the laws of descent and distribution,
and may be exercised during the lifetime of a participant only by the participant or the participant’s legally authorized
representative. However, the Compensation Committee, in its sole discretion, may allow for the transfer or assignment of a
participant’s award pursuant to a divorce decree or domestic relations order, but only if such participant is a U.S. resident.
Adjustments upon Changes in Capitalization
In the event any change is made in the Company’s capitalization pursuant to a stock split, stock dividend, recapitalization or
any other increase or decrease in the Company’s shares effected without receipt of consideration by the Company, equitable
adjustments will be made to the number of shares of Common Stock available for grant under the 2007 Equity Plan, the
exercise price of options, the SAR base level price, and the number of shares underlying outstanding awards, including
restricted stock and RSU awards.
Merger or Change of Control
In the event of a merger, consolidation, or share exchange pursuant to which the Company is not the surviving or resulting
corporation: (i) the shares or equivalent cash or property of the surviving or resulting corporation shall be substituted for any
unexercised portions of outstanding awards under the 2007 Equity Plan; or (ii) all awards may be canceled by the Company
immediately prior to the effective date of such event and each stockholder may be permitted to purchase all or any portion of
the shares of Common Stock underlying his or her vested and unvested award(s) within 30 days before such effective date. In
the event of a change in control of the Company, among other actions, the Compensation Committee may provide that the
-23-
vesting and exercisability of all or any portion of the outstanding awards will be accelerated and exercisable in full and all
restriction periods, if any, will expire.
Amendment or Termination
The Board may at any time and for any reason amend, alter, revise, suspend or terminate the 2007 Equity Plan, subject to the
written consent of any participant whose rights would be adversely affected. Unless sooner terminated by the Board and subject
to approval by the stockholders of this proposal, the 2007 Equity Plan will terminate on December 31, 2023. Without
stockholder approval, the Board may not amend the 2007 Equity Plan in any manner that would require stockholder approval
under applicable law.
Federal Tax Information
The following summary of the effect of United States federal income taxation upon the participant with respect to the 2007
Equity Plan does not purport to be complete and reference should be made to the applicable provisions of the Tax Code. In
addition, this summary does not discuss the provisions of the income tax laws of any municipality, state or foreign country in
which the participant may reside.
Incentive Stock Options
An individual residing in the U.S. who is granted an incentive stock option is not taxed on the date of grant or vesting of such
option. If the shares underlying the option are held for at least two years from the date of grant, and at least one year from the
date of option exercise (the “holding periods”), then upon the sale of the shares, the individual will generally recognize a long-
term capital gain or loss on the difference between the exercise price of the option and the fair market value of the Common
Stock underlying the option on the date of sale. If either of the holding periods is not satisfied, the individual will generally
recognize as ordinary income on the date of the disposition (a “disqualifying disposition”) of the shares an amount equal to the
difference between the option’s exercise price and the fair market value of the Common Stock underlying the option
determined as of the date of exercise (not to exceed the gain realized upon the disposition if the disposition is a transaction with
respect to which a loss, if sustained, would be recognized). Any further gain or loss upon the disqualifying disposition of the
shares constitutes a capital gain or loss.
In general, the difference between the option exercise price and the fair market value of the shares on the date of exercise of an
incentive stock option is treated as an adjustment in computing the participant’s alternative minimum taxable income and may
be subject to an alternative minimum tax which is paid if such tax exceeds the regular tax for the year. Special rules may apply
with respect to certain subsequent sales of the shares in a disqualifying disposition, certain basis adjustments for purposes of
computing the alternative minimum taxable income on a subsequent sale of the shares and certain tax credits which may arise
with respect to participants subject to the alternative minimum tax.
Non-Qualified Stock Options
An individual who is granted a non-qualified stock option generally is not taxed on the date of grant or vesting of such option.
Rather, the individual will generally recognize as ordinary income on the date of option exercise an amount equal to the
difference between the option’s exercise price and the fair market value of the stock underlying the option on the date of option
exercise. Any further gain or loss upon the subsequent sale or disposition of the shares underlying the option constitutes a
capital gain or loss.
Stock Appreciation Rights
An individual who is granted a SAR will generally recognize ordinary income on the date the SAR is exercised in an amount
equal to the difference between the SAR’s exercise price and the fair market value of the shares underlying the SAR on the date
of exercise.
Restricted Stock
Unless an individual makes a timely election under Section 83(b) of the Tax Code (as described below), an individual will
recognize ordinary income in an amount equal to the excess of the fair market value of the restricted stock on the date of
vesting of the shares over the purchase price, if any, paid for the shares. Any further gain or loss from the subsequent sale of
such restricted stock constitutes capital gain or loss. If the individual makes a timely election under Section 83(b), the
individual is taxed, at ordinary income rates, on the excess of the fair market value of the restricted stock on the date of grant
over the purchase price, if any, paid for the shares, and any further gain or loss on the subsequent sale of the stock constitutes a
capital gain or loss.
-24-
Restricted Stock Units
An individual generally will recognize no income upon the receipt of an award of RSUs. Upon the settlement of RSUs, the
participant generally will recognize ordinary income in the year of receipt in an amount equal to the cash received and/or the
fair market value of any substantially vested shares received in respect of vested RSUs. If the participant receives shares of
restricted stock, the participant generally will be taxed in the same manner as described above under “Restricted Stock.” Any
further gain or loss on a subsequent sale of any shares received will be taxed as capital gain or loss.
In general, the Company is entitled to a deduction in an amount equal to the ordinary income recognized by the individual.
Plan Benefits
The number, amount and type of awards to be granted in the future to eligible persons under the 2007 Equity Plan cannot be
determined at this time. With the exception of the RSUs to be automatically granted to non-employee Directors, awards under
the 2007 Equity Plan will be granted at the discretion of the Compensation Committee or the Board of Directors, and
accordingly cannot be determined at this time. See the above section “Automatic Non-employee Director Awards” for a
discussion of the automatic grant of RSU awards to our non-employee directors under the 2007 Equity Plan.
The table below sets forth the RSUs awards that will be granted under the “Automatic Non-employee Director Awards”
component of the 2007 Equity Plan on the date of the Annual Meeting to certain individuals and groups. This table is furnished
pursuant to the rules of the SEC. Only non-employee directors are eligible to receive automatic non-employee Director awards.
Name and Position
Moshe N. Gavrielov
President and Chief Executive Officer
Jon A. Olson
Senior Vice President, Finance and Chief Financial Officer
Victor Peng
Senior Vice President, Programmable Platforms Group
Vincent L. Tong
Senior Vice President, Worldwide Quality and New Product Introductions
Frank A. Tornaghi
Senior Vice President, Worldwide Sales
All current executive officers, as a group
All current directors who are not executive officers, as a group
All employees who are not executive officers, as a group
Dollar Value
($)
—
Number of
Units
—
—
—
—
—
—
—(1)
—
—
—
—
—
—
—(1)
—
(1) On the date of the 2013 Annual Meeting, each non-employee Director continuing in office following the meeting
automatically will be granted a number of RSUs determined by dividing $165,000 by the closing price of the Company’s
Common Stock on that date.
-25-
Options Granted to Certain Persons
The aggregate number of shares of Common Stock subject to options granted to certain persons under the 2007 Equity Plan
since its inception is reflected in the table below. Since its inception, no option has been granted under the 2007 Equity Plan to
any other nominee for election as a Director, or any associate of any such director, nominee or executive officer, and no other
person has been granted 5% or more of the total amount of options granted under the 2007 Equity Plan.
Name and Position
Moshe N. Gavrielov
President and Chief Executive Officer
Jon A. Olson
Senior Vice President, Finance and Chief Financial Officer
Victor Peng
Senior Vice President, Programmable Platforms Group
Vincent L. Tong
Senior Vice President, Worldwide Quality and New Product Introductions
Frank A. Tornaghi
Senior Vice President, Worldwide Sales
All current executive officers, as a group
All current Directors who are not executive officers, as a group
All employees who are not executive officers, as a group
Required Vote
Amount of
Options
1,450,000
326,250
355,000
246,250
271,000
3,256,550
108,000
6,984,779
Affirmative votes constituting a majority of the shares present or represented by proxy and entitled to vote on this proposal will
be required to approve this proposal. Abstentions will have the same effect as a negative vote, while broker non-votes will have
no effect on the outcome of this vote.
THE BOARD RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE AMENDMENT TO THE COMPANY’S
2007 EQUITY INCENTIVE PLAN TO EXTEND ITS TERM UNTIL DECEMBER 31, 2023.
-26-
PROPOSAL FOUR
AMENDMENT TO THE 2007 EQUITY INCENTIVE PLAN
Our stockholders have previously approved the 2007 Equity Incentive Plan (2007 Equity Plan), under which employees,
officers, directors and consultants may be granted share-based incentive awards. As of March 30, 2013, there were 36,500,000
shares of Common Stock authorized for issuance under the 2007 Equity Plan, of which 15,990,452 shares remained available
for future grants. The stockholders are now being asked to approve an increase to the number of shares of Common Stock
authorized for issuance under the 2007 Equity Plan by 2,000,000 shares, for a total of 38,500,000 authorized shares, of which
17,990,452 shares would be available for future grants.
In a separate proposal, our stockholders are asked to approve an amendment to extend the term of the 2007 Equity Incentive
Plan by ten years to December 31, 2023. See Proposal Three—Approval to Extend the Term of the 2007 Equity Incentive
Plan.
We make stock grants in connection with new hires and promotions and in connection with our annual “Focal Review.” Our
Focal Review is a process in which we evaluate the performance and compensation of each Company employee. Following this
evaluation, we make appropriate adjustments to the compensation of a substantial number of Company employees, including
through equity grants. These compensation adjustments are typically made in July and the majority of our annual stock budget
is used during this period. Our fiscal 2014 Focal Review will occur this July 2013, and our fiscal 2015 Focal Review will occur
next July 2014. This means that we would go through two Focal Review periods, with corresponding equity grants, before
having the opportunity at our next annual meeting to obtain stockholder approval of additional shares under the 2007 Equity
Plan.
Key Equity Metrics
Share Usage. In the past two years, we have used an average of 3,150,000 shares during the course of each year. As of March
30, 2013 there were 15,990,452 shares available for grant. Given the timing of when we issue this proxy statement and when
we hold our annual meetings, we are seeking stockholder approval of a 2,000,000 share increase in the number of shares
authorized and thereby available under the 2007 Equity Plan at the 2013 Annual Meeting, resulting in 17,990,452 shares
available for future grants, in order to ensure that we will have a sufficient number of shares available to meet the requirements
of our equity compensation program over the next two years.
Dilution. We are committed to effectively managing the Company's equity compensation while minimizing stockholder
dilution. For this reason, we carefully manage the Company's use of shares of Common Stock available for equity-based
compensation each year and aim to keep dilution from our stock plans for employees under industry standards. The requested
share increase represents approximately 0.76% of the weighted average outstanding shares of the Company as of March 30,
2013. Because this share reserve increase does not contemplate the amount or timing of specific equity awards in the future, it
is not possible to calculate with certainty the amount of subsequent dilution that may ultimately result from such awards. In
evaluating the share reserve increase, the Company also considered information provided by a leading proxy advisory firm,
Institutional Shareholder Services (ISS) regarding the maximum allowable share increase that ISS would support for the 2007
Equity Plan, based on ISS' proprietary “shareholder value transfer” model.
Grant Practices. Beyond the annual automatic grants to eligible non-employee Directors of the Board described in Proposal
Three, the Company did not review specific projections of stock grants to individuals in connection with its recommendation to
increase the share reserve by 2,000,000 shares.
Equity Utilization Rate. Over the past three fiscal years, the Company has had an ISS average equity utilization rate,
sometimes also referred to as a “burn rate,” of approximately 2.88%. The Company's three-year average ISS adjusted burn rate
was below the 2012 ISS allowable cap for the applicable ISS industry grouping.
-27-
The following table shows key equity metrics:
Key Metrics
Shares subject to awards granted(1)
Gross burn rate(2)
ISS adjusted burn rate(3)
Dilution at Fiscal Year End(4)
Overhang at Fiscal Year End(5)
FY2013
3-Year Average
(FY2011-2013)
3.1 million
1.19%
2.92%
13.28%
7.17%
3.6 million
1.35%
2.88%
14.57%
8.99%
(1) Reflects total number of shares subject to equity awards granted during fiscal 2013 and the average for the prior three
fiscal years, as applicable.
(2) Gross burn rate is calculated by dividing the total number of shares subject to equity awards granted during the
(3)
applicable fiscal period by the total weighted-average number of shares outstanding during the applicable fiscal period.
ISS adjusted burn rate is calculated by dividing the total number of shares subject to equity awards granted during the
applicable fiscal period, adjusted to address the dilutive effect of stock-based awards other than stock options and stock
appreciation rights, by the total weighted-average number of shares outstanding during the applicable fiscal period.
(4) Dilution is calculated by dividing the sum of (x) the number of shares subject to equity awards outstanding at the end of
the applicable fiscal period and (y) the number of shares available for future equity awards under the 2007 Equity Plan
as of the end of the applicable fiscal period, by the weighted-average number of shares outstanding during the applicable
fiscal period.
(5) Overhang is calculated by dividing the number of shares subject to equity awards outstanding at the end of the
applicable fiscal period by the weighted-average number of shares outstanding during the applicable fiscal period.
We believe that the proposed amendment to the 2007 Equity Plan is vital to our continued success. If we do not increase the
shares of Common Stock available for issuance under the 2007 Equity Plan, then based on historical usage rates of shares under
the Plan, we would expect to significantly exhaust the number of shares available for issuance under the Plan by the time of our
next annual meeting, thereby potentially limiting our use of an important compensation tool aligned with stockholder interests
to attract, motivate and retain highly qualified talent.
Summary of the 2007 Equity Plan
For a summary of the material terms of the 2007 Equity Plan, please see Proposal Three—Approval to Extend the Term of the
2007 Equity Incentive Plan. The summary of the 2007 Equity Plan is qualified in its entirety by the specific language of the
2007 Equity Plan, set forth in Appendix B to our 2013 proxy statement as filed with the SEC and available for viewing without
charge at its website at www.sec.gov. A copy of the 2007 Equity Plan can also be obtained from us at no charge upon request.
Federal Income Tax Aspects of the 2007 Equity Plan
For a summary of the U.S. federal income tax consequences of participation in the 2007 Equity Plan, please see Proposal
Three—Approval to Extend the Term of the 2007 Equity Incentive Plan.
Required Vote
Affirmative votes constituting a majority of the shares present or represented by proxy and entitled to vote on this proposal will
be required to approve this proposal. Abstentions will have the same effect as a negative vote, while broker non-votes will have
no effect on the outcome of this vote.
THE BOARD RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE AMENDMENT TO THE COMPANY’S
2007 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK TO BE
RESERVED FOR ISSUANCE THEREUNDER BY 2,000,000 SHARES.
-28-
Equity Compensation Plan Information
The table below sets forth certain information as of fiscal year ended March 30, 2013 about the Company’s common stock that
may be issued upon the exercise of options, RSUs, warrants and rights under all of our existing equity compensation plans
including the ESPP:
A
B
C
Number of Securities
to be Issued upon
Exercise of
Outstanding Options,
Warrants and Rights
Weighted-average
Exercise Price of
Outstanding Options,
Warrants and Rights
Number of Securities
Remaining Available for
Future Issuance under
Equity Compensation
Plans (excluding securities
reflected in Column A)
7,118,065
11,655,986(2)
N/A
18,774,051
7,000
18,781,051
$
$
$
$
$
30.88
24.37(3)
N/A
28.01
— (1)
15,990,452 (4)
8,891,810
24,882,262
28.96
28.01
—
24,882,262
Plan Category
Equity Compensation Plans
Approved by Security
Holders
1997 Stock Plan
2007 Equity Plan
Employee Stock Purchase Plan
Total-Approved Plans
Equity Compensation Plans
NOT Approved by Security
Holders
Supplemental Stock Option
Plan (5)
Total-All Plans
(1)
(2)
(3)
The Company ceased issuing options under the 1997 Stock Plan as of April 1, 2007. The 1997 Stock Plan expired on
May 8, 2007 and all available but unissued shares under this plan were cancelled.
Includes approximately 6,000,000 shares issuable upon vesting of RSUs that the Company granted under the 2007
Equity Plan, and assumes 100% performance achievement for performance-based RSUs granted in fiscal 2013. In May
2013, the Compensation Committee determined the actual number of RSUs earned based on performance achievement
for performance-based RSUs awarded in fiscal 2013. For more information on the number of RSUs at 100%
performance achievement and the actual performance achievement for performance-based RSUs awarded in fiscal 2013,
see the table under “EXECUTIVE COMPENSATION—Compensation Components—Long-Term Equity Incentive
Compensation.”
The weighted-average exercise price does not take into account shares issuable upon vesting of outstanding RSUs,
which have no exercise price.
(4) On July 26, 2006, the stockholders approved the adoption of the 2007 Equity Plan and authorized 10,000,000 shares to
be reserved for issuance thereunder. The 2007 Equity Plan, which became effective on January 1, 2007, replaced both
the Company’s 1997 Stock Plan (which expired on May 8, 2007) and the Supplemental Stock Option Plan. On August 9,
2007, August 14, 2008, August 12, 2009, August 11, 2010, August 10, 2011, and August 8, 2012, our stockholders
authorized the reserve of an additional 5,000,000 shares, 4,000,000 shares, 5,000,000 shares, 4,500,000 shares,
4,500,000 shares and 3,500,000 shares, respectively. All of the shares reserved for issuance under the 2007 Equity Plan
may be granted as stock options, stock appreciation rights, restricted stock or RSUs.
(5) Under the Supplemental Stock Option Plan, options were granted to employees and consultants of the Company,
however neither officers nor members of our Board were eligible for grants under the Supplemental Stock Option Plan.
Only non-qualified stock options were granted under the Supplemental Stock Option Plan (that is, options that do not
entitle the optionee to special U.S. income tax treatment) and such options generally expire not later than 12 months
after the optionee ceases to be an employee or consultant. Upon a merger of the Company with or into another company,
or the sale of substantially all of the Company’s assets, each option granted under the Supplemental Stock Option Plan
may be assumed or substituted with a similar option by the acquiring company, or the outstanding options will become
exercisable in connection with the merger or sale.
-29-
PROPOSAL FIVE
ADVISORY VOTE ON EXECUTIVE COMPENSATION
The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (Dodd-Frank Act) enables our stockholders to vote
to approve, on an advisory (non-binding) basis, the compensation of our named executive officers as disclosed in this proxy
statement in accordance with SEC rules.
Our executive officer compensation program is designed to attract and retain talented and qualified senior executives to manage
and lead our Company and to motivate them to pursue and meet our corporate objectives. Under this program, our named
executive officers are rewarded for individual and collective contributions to our success consistent with our “pay for
performance” orientation. Furthermore, the executive officer total compensation program is aligned with the nature and
dynamics of our business, which focuses management on achieving the Company’s annual and long-term business strategies
and objectives. Additional details about our executive compensation programs are described under the section titled
“EXECUTIVE COMPENSATION—Compensation Discussion and Analysis.”
Our Compensation Committee regularly reviews the executive officer compensation program to ensure that it achieves the
desired goals of emphasizing long-term value creation and aligning the interests of management and stockholders through the
use of equity-based awards.
We are asking our stockholders to indicate their support for our named executive officer compensation as described in this
proxy statement. This proposal, commonly known as a “say-on-pay” proposal, gives our stockholders the opportunity to
express their views on our named executive officers’ compensation. This vote is not intended to address any specific item of
compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices
described in this proxy statement. Accordingly, we ask our stockholders to vote “FOR” the following resolution at the Annual
Meeting:
“RESOLVED, that the Company’s stockholders approve, on an advisory basis, the
compensation of the named executive officers, as disclosed in the Company’s proxy
statement for the 2013 Annual Meeting of Stockholders pursuant to the compensation
disclosure rules of the SEC, including the Compensation Discussion and Analysis, the
Summary Compensation Table and the other related tables and disclosure.”
Required Vote
The “say-on-pay” vote is advisory, and therefore not binding on the Company, the Compensation Committee or our Board of
Directors. Our Board of Directors and our Compensation Committee value the opinions of our stockholders and to the extent
there is any significant vote against the named executive officer compensation as disclosed in this proxy statement, we will
consider our stockholders’ concerns and the Compensation Committee will evaluate whether any actions are necessary to
address those concerns.
THE BOARD RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE COMPENSATION OF OUR NAMED
EXECUTIVE OFFICERS, AS DESCRIBED IN THIS PROXY STATEMENT PURSUANT TO THE
COMPENSATION DISCLOSURE RULES OF THE SEC.
-30-
RATIFICATION OF APPOINTMENT OF EXTERNAL AUDITORS
PROPOSAL SIX
The Audit Committee has selected Ernst & Young LLP, an independent registered public accounting firm, to audit the
consolidated financial statements of Xilinx for the fiscal year ending March 29, 2014 and recommends that stockholders vote
for ratification of such appointment. Although we are not required to submit to a vote of the stockholders the ratification of the
appointment of Ernst & Young LLP, the Company, the Board and the Audit Committee, as a matter of good corporate
governance, have determined to ask the stockholders to ratify the appointment. If the appointment of Ernst & Young LLP is not
ratified, the Audit Committee will take the vote under advisement in evaluating whether to retain Ernst & Young LLP.
Representatives of Ernst & Young LLP attend meetings of the Audit Committee of the Board including executive sessions of
the Audit Committee at which no members of Xilinx management are present. Ernst & Young LLP has audited the Company’s
financial statements for each fiscal year since the fiscal year ended March 31, 1984. Representatives of Ernst & Young LLP are
expected to be present at the Annual Meeting. In addition, they will have an opportunity to make a statement if they desire to
do so, and are expected to be available to respond to appropriate questions from stockholders.
Fees Paid to Ernst & Young LLP
The following table shows the fees billed or to be billed for audit and other services provided by Ernst & Young LLP for fiscal
2013 and 2012.
Audit Fees
Audit-Related Fees
Tax Fees
All Other Fees
Total
Audit Fees
$
$
2013
2,545,000
8,000
170,000
57,000
2,780,000
$
$
2012
2,655,000
8,000
132,000
29,000
2,824,000
This category includes fees for the audit of the Company’s annual financial statements and for the review of the Company’s
interim financial statements on Form 10-Q. This category also includes advice on any audit and accounting matters that arose
during the annual audit, the review of interim financial statements, and statutory audits required by non-U.S. jurisdictions. In
fiscal 2013, audit fees included acquisitions, and in fiscal 2012, audit fees included services related to the Company’s Oracle
R12 implementation and acquisitions.
Audit-Related Fees
This category consists of assurance and related services that are reasonably related to the performance of the annual audit or
interim financial statement review and are not reported under “Audit Fees.” In fiscal 2013 and fiscal 2012, audit-related
services consisted of services performed in connection with the audit of an employee benefit plan.
Tax Fees
This category consists of fees for tax compliance, tax advice and tax planning services, including preparation of tax returns and
assistance and representation in connection with tax audits and appeals.
All Other Fees
In fiscal 2013 and fiscal 2012, all other fees consisted of fees related to advice and consulting services provided in connection
with review of the International Financial Reporting Standards (IFRS).
-31-
Audit Committee’s Pre-approval Policy and Procedures
The Audit Committee has adopted policies and procedures for approval of financial audit (and audit-related), non-financial
audit and tax consulting work performed by Ernst & Young LLP. Pursuant to its charter and those policies, the policy of the
Audit Committee is that any and all services to be provided to the Company by Ernst & Young LLP are subject to pre-approval
by the Audit Committee. The Audit Committee pre-approves annual audit fees, quarterly reviews and tax compliance fees at
the beginning of the fiscal year. In its review of non-financial audit and tax consulting services, the Audit Committee considers
whether the provision of such services are consistent with SEC guidance, and whether the service facilitates the performance of
the financial audit, improves the Company’s financial reporting process, and is otherwise in the Company’s best interests and
compatible with maintaining Ernst & Young LLP’s independence.
The Audit Committee did not waive its pre-approval policies and procedures during the fiscal year ended March 30, 2013.
All of the services described in the fee table above were approved pursuant to the Audit Committee’s pre-approval policy.
Required Vote
Approval of this proposal requires the affirmative vote of a majority of the shares present and entitled to vote either in person
or by proxy. Abstentions and broker non-votes will each be counted as present for purposes of determining the presence of a
quorum. Abstentions will be counted as “AGAINST” votes with respect to the proposal, but broker non-votes will have no
effect on the outcome of the proposal.
THE BOARD RECOMMENDS A VOTE “FOR” THE RATIFICATION OF ERNST & YOUNG LLP AS THE
COMPANY’S EXTERNAL AUDITORS FOR FISCAL 2014.
-32-
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth the beneficial ownership of Common Stock of the Company as of May 10, 2013, including the
right to acquire beneficial ownership within 60 days of May 10, 2013, except as noted below, by: (i) each stockholder known to
the Company to be a beneficial owner of more than 5% of the Company’s Common Stock, (ii) each of the Company’s
Directors and Director nominees, (iii) each of the named executive officers identified in the section entitled “Executive
Compensation” and (iv) all current Directors and executive officers as a group. The Company believes that each of the
beneficial owners of the Common Stock listed below, based on information furnished by such beneficial owners, has sole
voting power and sole investment power with respect to such shares, except as otherwise set forth in the footnotes below and
subject to applicable community property laws.
Beneficial Owners
Greater than 5% Stockholders
Blackrock, Inc.
40 East 52nd Street
New York, NY 10022
T. Rowe Price Associates, Inc.
100 East Pratt Street
Baltimore, MD 21202
The Vanguard Group, Inc.
100 Vanguard Blvd.
Malvern, PA 19355
Directors
Philip T. Gianos
Moshe N. Gavrielov
John L. Doyle
William G. Howard, Jr.
J. Michael Patterson
Albert A. Pimentel
Marshall C. Turner
Elizabeth W. Vanderslice
Named Executive Officers
Jon A. Olson
Victor Peng
Vincent L. Tong
Frank. A. Tornaghi
All current Directors and executive officers as a group (16 persons)
Amount and Nature of
Beneficial Ownership
Percent of
(1)
Class
21,672,027
(2)
16,131,927
(3)
15,888,421
(4)
156,151
1,115,822
71,124
119,052
68,044
9,997
62,102
74,506
619,475
369,883
367,086
258,530
3,723,647
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
8.2
6.1
6.0
*
*
*
*
*
*
*
*
*
*
*
*
1.4
*
(1)
Less than 1%
The beneficial ownership percentage of each stockholder is calculated on the basis of 263,863,503 shares of common
stock outstanding as of May 10, 2013. Any additional shares of common stock that a stockholder has the right to acquire
within 60 days after May 10, 2013 that are not already outstanding at such time are deemed to be outstanding and
beneficially owned for the purpose of calculating that stockholder’s percentage beneficial ownership. They are not,
however, deemed to be outstanding and beneficially owned for the purpose of computing the percentage ownership of
any other person. Unless otherwise indicated, the address of each of the individuals and entities named below is c/o
Xilinx, Inc., 2100 Logic Drive, San Jose, California 95124.
(2) Based on information contained in a Schedule 13G/A, reflecting stock ownership information as of December 31, 2012,
which was filed by this stockholder pursuant to Section 13(d) of the Exchange Act (Section 13(d)), on February 1, 2013
reporting beneficial ownership of 21,672,027 shares of Common Stock consisting of 21,672,027 shares as to which it
has sole voting power and sole dispositive power.
-33-
(3) Based on information contained in a Schedule 13G/A, reflecting stock ownership information as of December 31, 2012,
which was filed by this stockholder pursuant to Section 13(d), on February 11, 2013 reporting beneficial ownership of
16,131,927 shares of Common Stock consisting of 4,847,104 shares as to which it has sole voting power and 16,130,427
shares as to which it has sole dispositive power. According to the stockholder, these securities are owned by various
individual and institutional investors which T. Rowe Price Associates, Inc. (“Price Associates”) serves as investment
adviser with power to direct investments and/or sole power to vote the securities. For purposes of the reporting
requirements of the Exchange Act, Price Associates is deemed to be a beneficial owner of such securities; however,
Price Associates disclaims beneficial ownership of such securities.
(4) Based on information contained in a Schedule 13G/A, reflecting stock ownership information as of December 31, 2012,
which was filed by this stockholder pursuant to Section 13(d), on February 11, 2013 reporting beneficial ownership of
15,888,421 shares of Common Stock consisting of 462,165 shares as to which it has sole voting power, no shares as to
which it has shared voting power, 15,453,239 shares as to which it has sole dispositive power and 435,182 shares as to
which it has shared dispositive power.
(5) Consists of 76,704 shares held directly, 13,427 shares held in a family trust, 20 shares held by Mr. Gianos’ son and
66,000 shares issuable upon exercise of options. Does not include 7,625 shares that are vested but not settled pursuant to
a pre-arranged deferral program.
(6) Consists of 70,378 shares held directly, 995,385 shares issuable upon exercise of options and 50,059 shares issuable
upon settlement of RSUs, which represents 25,660 shares vesting as a result of performance achievement under an RSU
granted in fiscal 2012, and 24,399 shares vesting as a result of performance achievement under an RSU granted in fiscal
2013.
(7) Consists of 17,124 shares held in a family trust and 54,000 shares issuable upon exercise of options.
(8) Consists of 32,000 shares held directly, 21,052 held in a family trust and 66,000 shares issuable upon exercise of
options.
(9) Consists of 8,400 shares held directly, 51,000 shares issuable upon exercise of options, and 8,644 shares issuable upon
settlement of RSUs. Does not include 7,625 shares that are vested but not settled pursuant to a pre-arranged deferral
program.
(10) Consists of 9,997 shares held in a family trust.
(11) Consists of 25,352 shares held directly, 750 shares held by Mr. Turner’s spouse and 36,000 shares issuable upon
exercise of options.
(12) Consists of 5,520 shares held directly, 2,986 shares held in joint tenancy and 66,000 shares issuable upon exercise of
options. Does not include 7,625 shares that are vested but not settled pursuant to a pre-arranged deferral program.
(13) Consists of 40,587 shares held in a family trust, 560,000 shares issuable upon exercise of options and 18,888 shares
issuable upon settlement of RSUs, which represents 9,765 shares vesting as a result of performance achievement under
an RSU granted in fiscal 2012, and 9,123 shares vesting as a result of performance achievement under an RSU granted
in fiscal 2013.
(14) Consists of 19,745 shares held directly, 331,250 shares issuable upon exercise of options and 18,888 shares issuable
upon settlement of RSUs, which represents 9,765 shares vesting as a result of performance achievement under an RSU
granted in fiscal 2012, and 9,123 shares vesting as a result of performance achievement under an RSU granted in fiscal
2013.
(15) Consists of 30,098 shares held directly, 324,250 shares issuable upon exercise of options and 12,738 shares issuable
upon settlement of RSUs, which represents 6,585 shares vesting as a result of performance achievement under an RSU
granted in fiscal 2012, and 6,153 shares vesting as a result of performance achievement under an RSU granted in fiscal
2013.
(16) Consists of 14,792 shares held directly, 231,000 shares issuable upon exercise of options and 12,738 shares issuable
upon settlement of RSUs, which represents 6,585 shares vesting as a result of performance achievement under an RSU
granted in fiscal 2012, and 6,153 shares vesting as a result of performance achievement under an RSU granted in fiscal
2013.
Includes an aggregate of 3,305,430 shares issuable upon exercise of options or settlement of RSUs.
(17)
For certain information concerning our Executive Officers, see “Executive Officers of the Registrant” in Item 1 of Part I of our
Form 10-K.
-34-
EXECUTIVE COMPENSATION
COMPENSATION DISCUSSION AND ANALYSIS
This section of the proxy statement explains our compensation programs in general, and how they operate with respect to our
named executive officers in particular. This year, our “named executive officers” are our CEO, CFO and the three most highly
compensated executive officers serving at the end of fiscal 2013, as follows:
Moshe N. Gavrielov, President and Chief Executive Officer
Jon A. Olson, Senior Vice President, Finance and Chief Financial Officer
Victor Peng, Senior Vice President, Programmable Platforms Group
Vincent L. Tong, Senior Vice President, Worldwide Quality and New Product Introductions
Frank A. Tornaghi, Senior Vice President, Worldwide Sales
•
•
•
•
•
Overview
Financial Performance for Fiscal 2013
Xilinx achieved success in fiscal 2013, despite challenging economic conditions that continued to impact the semiconductor
industry. Although the Company’s overall net revenues were down in fiscal 2013 compared to the prior fiscal year, the
Company achieved a record gross margin percentage in fiscal 2013. In addition, the Company began to see returns on its
investment in research and development with the success of the Company’s 28-nm product portfolio. Following are some
major product and financial highlights in fiscal 2013:
•
•
•
•
•
•
•
•
Overall net revenues were $2.17 billion, compared to $2.24 in the prior fiscal year
Gross margin for the full fiscal year reached a record 66%, compared to 65% in the prior fiscal year
Net revenues from our new products increased 81% in fiscal 2013, compared to the prior fiscal year.
Products in this category are our Virtex®-7, Kintex®-7, Zynq®-7000, Virtex-6, and Spartan®-6 products
Sales from our 28-nm product portfolio, which includes the 7 series FPGAs and the Zynq-7000 family,
surpassed $100 million
We expanded our software leadership with the introduction of the Vivado® Design Suite, a design
environment built from the ground up, providing customers with up to a 4X productivity advantage
We increased our dividend by $0.03 per diluted share, bringing our quarterly dividend to $0.25 per diluted
share, the largest in our history
We returned $198 million to our stockholders through our stock buyback program
Our total stockholder return on an annualized basis over the prior 1-, 3-, and 5-year periods was 7%, 17% and
13%, respectively.
Fiscal 2013 Key Compensation Actions
In keeping with our pay-for-performance philosophy, compensation awarded to the named executive officers for fiscal 2013
reflected our financial results and critical strategic advancements:
•
Pay Mix. We provide our named executive officers with three primary elements of pay: base salary, incentive
cash compensation and long-term equity compensation. The performance-based incentives, consisting of
incentive cash compensation and equity compensation, together constitute the largest portion of potential
compensation for the named executive officers. The following charts show the pay mix for (i) our CEO, and
(ii) all other named executive officers, for fiscal 2013:
-35-
CEO Pay Mix - Fiscal 2013
All Other NEOs Pay Mix - Fiscal 2013
All Other
Compensation
0%
Cash
Incentive
Compensation
15%
Salary
15%
Equity
Compensation
70%
Cash
Incentive
Compensation
15%
All Other
Compensation
2%
Equity
Compensation
58%
Salary
25%
The percentages above were calculated using salary, incentive cash compensation, grant date fair value of equity awards, and
all other compensation as reported in the Summary Compensation Table.
•
Incentive Cash Compensation. We paid bonuses consistent with our financial results and individual performance
goals set for each named executive officer. As discussed below, our 2013 Executive Incentive Plan (2013
Incentive Plan) was designed around the achievement of three components: revenue growth, operating profit
margin, and individual performance. With respect to the operating profit component, the Company exceeded the
target in the first half and performed at target for the second half of fiscal 2013 resulting in 110% and 100%
payouts, respectively. The payouts to the named executive officers (other than our CEO) under the individual
performance component ranged from 105% to 125% of target for the first half of the fiscal year and from 110% to
120% target for the second half of the fiscal year. The payout to Mr. Gavrielov, our CEO, under the individual
performance component was 120% of target, which was measured annually rather than semi-annually. The
Company did not meet its revenue growth component and therefore no bonus was paid for that performance
metric. As a result of the performance outcomes above, annual incentive cash compensation paid to our named
executive officers for fiscal 2013 was below each executive's target annual incentive opportunity.
The following table shows the annual performance achievement as a percentage of target by our named executive officers
under the 2013 Incentive Plan:
Named Executive Officer Actual Incentive Cash Compensation as a Percent of Target
Name
Moshe N. Gavrielov
Jon A. Olson
Victor Peng
Vincent L. Tong
Frank A. Tornaghi
Total Incentive Award
as % of Target
79.47%
77.09%
79.38%
80.47%
75.50%
• Long-Term Equity Incentive Compensation. In fiscal 2013, the Compensation Committee granted restricted stock
units (RSUs) to our named executive officers. The RSUs granted were comprised of a mix of performance-based
RSUs (60%) and time-based RSUs (40%) in fiscal 2013. The Compensation Committee believed that a greater
portion of the RSUs should be specifically tied to performance requirements in line with our business strategy to
align pay with performance. Shares earned under the 2013 performance-based RSU grants were based on three
performance measures that we believe drive long-term shareholder value. These measures are share of revenue,
technology leadership and quality leadership. Performance is measured over one year and any shares earned vest
over an additional two years (for a total of three years of vesting). In fiscal year 2013, the Company exceeded the
thresholds for payout for all three performance measures. As a result, each named executive officer earned
127.3% of the target number of shares granted (one-third of the shares vest in July 2013 and the remainder will
vest one-third in July 2014 and one-third in July 2015).
-36-
Impact of 2012 Shareholder Advisory Vote on Executive Compensation
In August 2012, we conducted a non-binding advisory vote on the compensation of our named executive officers, commonly
referred to as a “say on pay” vote, at our Annual Meeting of Stockholders. Our stockholders overwhelmingly approved the
compensation of the named executive officers, with approximately 91% of stockholder votes cast in favor of our executive
compensation program.
As the Compensation Committee evaluated our executive compensation policies and practices throughout fiscal 2013, it was
mindful of the strong support our stockholders expressed for our compensation philosophy and objectives. Accordingly, and as
a result of the favorable say-on-pay vote, the Company continued its long-term equity incentive philosophy by granting a mix
of time-based and performance-based RSUs and the Compensation Committee decided to retain its general approach to
executive compensation, with an emphasis on granting incentive compensation such as performance-based RSUs that reward
our most senior executives when they deliver value for our stockholders.
Consistent with the recommendation of the Board of Directors and the preference of our stockholders as reflected in the
advisory vote on the frequency of future say-on-pay votes conducted at our 2011 Annual Meeting of Stockholders, the Board of
Directors has adopted a policy providing for an annual advisory vote on the compensation of our named executive officers.
Role of the Compensation Committee
The Compensation Committee, in consultation with the Company’s CEO, is responsible for establishing the Company’s
compensation and benefits philosophy and strategy. The Compensation Committee also oversees the general compensation
policies of the Company and sets specific compensation levels for corporate officers, including the named executive officers.
The Compensation Committee, together with the Board, evaluates the CEO’s performance and, the Compensation Committee
determines CEO compensation. In determining compensation strategy, the Compensation Committee reviews market
competitive data (described below) to ensure that the Company is able to attract, motivate, reward and retain quality
employees, including the named executive officers. The Compensation Committee has the authority to engage its own
independent advisors to assist in carrying out its responsibility and has done so, as described below, but may not delegate its
authority to such advisors.
Compensation Consultant
In fiscal 2013, the Compensation Committee continued to retain the services of Semler Brossy Consulting Group LLC (Semler
Brossy) to act as its independent compensation consultant. Semler Brossy reported directly to the Compensation Committee
and not to management. Semler Brossy provided the Compensation Committee with general advice on compensation matters,
including reviewing the composition of the peer group, providing compensation data related to executives at the selected
companies in the peer group and providing advice on our executive officers’ compensation generally. Based on the above and
its review of the factors set forth under Rule 10C-1 of the Exchange Act, the Compensation Committee assessed the
independence of Semler Brossy and concluded that no conflict of interest exists that would prevent Semler Brossy from
independently representing the Compensation Committee. In fiscal 2013, the Compensation Committee met regularly in
executive session with its independent compensation consultant without management present. Semler Brossy did not provide
any additional services to the Company other than the services for which it was retained by the Compensation Committee, and
the Compensation Committee is not aware of any conflict of interest that exists that would otherwise prevent Semler Brossy
from being independently engaged. The Company pays the cost for Semler Brossy’s services.
Compensation Philosophy and Objectives
The primary objectives of the Compensation Committee with respect to determining executive compensation are to attract,
motivate and retain talented employees and to align executives’ interests with those of stockholders, with the ultimate objective
of improving stockholder value. It is the philosophy of the Compensation Committee that the best way to achieve this is to
align executives’ compensation with their level of performance, thereby compensating executives on a “pay for performance”
basis.
To achieve these objectives, the Compensation Committee has implemented and oversees compensation plans that tie a
significant portion of executives’ overall compensation to our financial performance, including operating profit, revenue
growth, our share of revenue and the trading price of our Common Stock. Overall, the total compensation opportunity is
intended to create an executive compensation program which is competitive with comparable companies. The comparable
companies considered by the Compensation Committee are described more fully below.
For fiscal 2013, the Compensation Committee approved the 2013 Incentive Plan, which is described in greater detail below.
Compensation under the 2013 Incentive Plan varied with our financial performance during the fiscal year. Bonus payments to
executives corresponded with the Company’s performance during the fiscal year, as well as with their individual performance.
This design was intended to accomplish the Company’s goal of aligning executives’ interests with those of stockholders by
-37-
encouraging the executives to work diligently toward the success of the Company, and to reward, as appropriate, achievement
of semi-annual and annual objectives.
In addition to the 2013 Incentive Plan, the Company further seeks to advance its objective of aligning executives’ interests with
the interests of stockholders through its 2007 Equity Incentive Plan (2007 Equity Plan). In May 2013, the Compensation
Committee approved amendments to the 2007 Equity Plan to extend its term by ten years and to increase the number of shares
reserved for issuance by 2,000,000 shares, as further discussed under Proposals Three and Four. The purpose of the 2007
Equity Plan is to promote the success of our business by encouraging equity ownership in the Company. In particular, the 2007
Equity Plan provides officers with incentive to exert maximum effort toward the success of the Company and to participate in
such success through acquisition and retention of our Common Stock.
Procedural Approaches to Accomplish Compensation Objectives
The Compensation Committee believes that the executive compensation provided by the Company to its executives, including
the named executive officers, should include both cash and stock-based compensation that rewards performance as measured
against established goals.
Peer Group Data. To aid in its periodic examination and determination of executive compensation, the Company purchased for
the Compensation Committee data from Radford Surveys + Consulting (Radford), specifically the Radford Global Technology
Survey, to assist in setting executive compensation. In our survey of market data, we focused on companies meeting all or some
of the following criteria: (i) they operate in a similar industry as the Company; (ii) they are of roughly similar size (as measured
by revenues and aggregate market capitalization) as the Company; (iii) they have growth expectations similar to those of the
Company; and (iv) they are companies against whom the Company competes for talent. For fiscal 2013, the Compensation
Committee considered the following peer group companies:
• Advanced Micro Devices, Inc.
• Altera Corporation
• Analog Devices, Inc.
• Applied Materials, Inc.
• Atmel Corporation
• Autodesk, Inc.
• Broadcom Corporation
• Brocade Communications
Systems Inc.
• Cadence Design Systems, Inc.
• Cypress Semiconductor Corporation
• Fairchild Semiconductor
International Inc.
• KLA-Tencor Corporation
• LAM Research Corporation
• Linear Technology Corporation
• LSI Corporation
• Marvell Technology Group Ltd.
• Maxim Integrated Products Inc.
• Microchip Technology Inc.
• Nvidia Corporation
• ON Semiconductor
Corporation
• Sandisk Corporation
• Synopsys, Inc.
The Compensation Committee approved several changes to the peer group in fiscal 2013 to ensure the peer group remained
relevant. First, three companies were added to the list, namely Applied Materials Inc., Autodesk, Inc. and Brocade
Communications Systems, Inc., because they compete for similar end markets and met the criteria enumerated above. Second,
two companies were removed from the list, namely Novellus Systems, Inc. and National Semiconductor Corporation, because
they either had been or were in the process of being acquired. Data on the compensation practices of the above-mentioned peer
group is generally gathered through searches of publicly available information, including publicly available databases. Peer
group data is gathered with respect to base salary, bonus targets and equity awards. The Radford survey reflects more current
information than the information found through publicly available sources. In fiscal 2013 all of the peer group companies
identified above participated in the Radford survey.
As noted above, the Compensation Committee retains the services of Semler Brossy to provide independent compensation
advice and analysis. In addition, the Compensation Committee reviews the Radford survey and publicly available information
of compensation offered by the applicable market comparables. The Committee took the results of the Radford report and
Semler Brossy's analysis into account, along with other relevant considerations as described in this Compensation Discussion
and Analysis, in determining adjustments to executive compensation. The Compensation Committee ensures the Company's
compensation policies for the named executive officers are designed to attract, motivate, and retain talented executive officers
and are aligned with the long-term interests of the Company's shareholders. While the Compensation Committee reviews the
external market data, it does not target any specific pay percentile within those companies for purposes of setting cash and
equity compensation levels nor does the Compensation Committee consider the total shareholder return of the peer group in
making compensation decisions. Rather, the Compensation Committee uses the peer group information merely as a guide to
determine whether we are generally competitive in the market.
-38-
CEO Evaluation and Compensation Determination. The Compensation Committee, together with the Board, annually reviews
the performance of the CEO in light of the goals and objectives of the Company’s executive compensation plans, and approves
CEO compensation. The review of the performance and compensation of the CEO and all other named executive officers is
conducted annually during the period commencing around the middle of May which is called our “Focal Review Period.” The
Compensation Committee uses objective data from peer group companies to assist in determining the compensation of the
CEO, and compares the data to competitive ranges following statistical analysis and review of subjective policies and practices,
including assessment of the CEO’s achievements, and a review of compensation paid to CEOs of the peer group companies. In
determining the long-term incentive component of the CEO’s compensation, the Compensation Committee considers all
relevant factors, including the Company’s performance and relative stockholder return, the value of similar awards to CEOs of
the peer group companies, the awards given to the CEO in prior years, and formal feedback from the independent directors. To
provide further assurance of independence, the Compensation Committee’s independent compensation consultant, Semler
Brossy, provides its recommendation for CEO compensation. The compensation consultant prepares analyses showing
competitive CEO compensation among the peer group for the individual elements of compensation and total direct
compensation. Then, it provides the Compensation Committee with a range of recommendations for any change in the CEO’s
base salary, annual incentive target, equity grant value, and equity mix. The recommendations take into account the peer group
competitive pay analysis, expected future pay trends, and importantly, the position of the CEO in relation to other senior
executives and proposed pay actions for all key employees of the Company. The range allows the Compensation Committee to
exercise its discretion based on the CEO’s individual performance and other factors.
Based on the foregoing and after reviewing comparative compensation data provided by Semler Brossy, the Compensation
Committee approved increases in Mr. Gavrielov’s base salary and target bonus percentages for fiscal 2013. Mr. Gavrielov's
base salary was increased by $50,000 to $750,000 and his target bonus rate was increased by 15 percentage points from 110%
to 125% for fiscal year 2013.
Evaluation of Other Named Executive Officers and Compensation Determination. The CEO works with the Compensation
Committee in establishing the Company’s compensation and benefits philosophy and strategy for its executives and also makes
specific recommendations to the Compensation Committee with respect to the individual compensation for each of the
executive officers, including the named executive officers other than himself. With respect to the named executive officers, the
Compensation Committee annually reviews, with the CEO, the executives’ performance in light of the goals and objectives of
the Company, and approves their compensation. The Compensation Committee also considers all relevant factors in approving
the level of such compensation, including each executive officer’s performance during the year, specifically an officer’s
accomplishments, areas of strength and areas for development, the executive’s scope of responsibility and contributions to the
Company, and the executive’s experience and tenure in the position. During the Focal Review Period, the CEO and members
of the Company’s human resources department evaluate each named executive officer’s performance during the year based on
the CEO’s knowledge of each named executive officer’s performance, individual self-assessment and feedback provided by the
named executive officer’s peers and direct reports. The CEO also reviews compensation data gathered from Radford as well as
from publicly available information such as SEC filings and identifies trends and competitive factors to consider in adjusting
compensation levels of the named executive officers. The CEO then makes a recommendation to the Compensation Committee
as to each element of each named executive officer’s compensation.
-39-
Compensation Components
Our executive compensation is divided into the following components: base salary, incentive cash compensation, and long-term
equity incentive compensation. The following table summarizes these elements of compensation:
Compensation
Element
Base Salary
Objectives
Provides a fixed, baseline level of compensation
for services rendered during the fiscal year.
Performance-
Based
Incentive Cash
Compensation
Rewards participants for achieving or exceeding
corporate and individual performance objectives
and serves to compensate, attract and retain
highly qualified executives.
Long-Term
Equity
Incentive
Compensation
Establishes a corporate culture that supports
strong long-term corporate performance by
encouraging our named executive officers to
take a long-term outlook.
Provides an important retention tool for named
executive officers to the extent that equity
awards are subject to vesting over an extended
period of time.
of
breadth
Key Features
Fixed cash compensation is based on scope of
responsibility,
knowledge,
experience and tenure in the position and
individual performance.
In addition, in determining base salaries for
executive officers, we review the base salaries
being paid to executive officers in comparable
positions in our peer group companies and
conduct an internal review of the executive’s
compensation, both individually and relative
to other executive officers.
The incentive cash bonus is calculated as a
percentage of the named executive officer’s
annual base earnings. Cash incentive awards
are payable based on the achievement of pre-
established corporate objectives, including
and
revenue growth, operating profit,
individual performance goals. The operating
profit component and individual performance
component are paid on a semi-annual basis
for all named executive officers except the
CEO whose operating profit component is
paid on a semi-annual basis but whose
individual performance is paid on an annual
basis. The revenue growth component is paid
on an annual basis for all named executive
officers.
The
number
leadership.
The performance-based RSUs have several
performance-based components,
including
share of revenue, technology leadership and
quality
of
performance-based RSUs earned is dependent
on the level of achievement under these
performance metrics, aligning pay with
performance. Following determination of the
number of performance-based RSUs earned,
the RSUs will be subject to further time-based
vesting. The performance-based RSUs will
vest
installments,
three annual equal
starting one year from the date of grant.
The time-based RSUs vest in one lump sum
on the third anniversary from the date of
grant.
in
Base Salary. In May 2012, as part of the annual Focal Review Period, the Compensation Committee reviewed the base salaries
of our named executive officers focusing on the competitiveness of salaries. Based on comparing current salaries to the base
salary levels at the companies in our peer group, as well as considering the roles and responsibilities and potential performance
of the named executive officers, the Compensation Committee increased the base salaries of Mr. Olson by $10,000, Mr. Peng
by $60,000, Mr. Tong by $20,000 and Mr. Tornaghi by $15,000. The base salary increases were effective July 1, 2012. As
discussed above, Mr. Gavrielov, our CEO, received a $50,000 increase in his base salary in fiscal 2013, also effective on July
1, 2012.
-40-
The following table is a summary of the changes to base salary for our named executive officers in fiscal 2013:
Named Executive Officer Salary Adjustments
Named Executive Officer
Moshe N. Gavrielov
Jon A. Olson
Victor Peng
Vincent L. Tong
Frank A. Tornaghi
Fiscal 2012 Salary(1)
$700,000
470,000
410,000
350,000
370,000
Fiscal 2013 Salary(1)
750,000
480,000
470,000
370,000
385,000
Percent Change
7.1%
2.1%
14.6%
5.7%
4.1%
(1) These amounts reflect the base salaries approved for a particular fiscal year, and not the actual earnings for the
respective named executive officer, which earnings may be different due to certain factors, such as the timing of the
approved salary increase.
Incentive Cash Compensation. In fiscal 2013, the Compensation Committee adopted the 2013 Incentive Plan. The bonus target
for our CEO was increased to 125% of his annual base earnings, up from 110% in fiscal 2012, based on competitive market
data. The bonus target for all other named executive officers was 75% of their annual base earnings, unchanged from fiscal
2012. Under the 2013 Incentive Plan, the cash bonuses for the named executive officers were based on each executive’s
earnings and then determined using three different components, each with a different weighting: (1) the Company’s operating
profit as a percentage of revenue determined in accordance with U.S. Generally Accepted Accounting Principles, or GAAP
(OP Component), but excluding payments under the Company’s non-sales incentive plans and other unusual charges, weighted
at 30%; (2) the Company’s annual revenue growth (Growth Component), weighted at 30%; and (3) the individual performance
component (Individual Performance Component) based on individual performance goals pertaining to such officer’s position
and responsibilities, weighted at 40%. The OP Component and Individual Performance Component are paid on a semi-annual
basis and the Growth Component is paid on an annual basis, except for Mr. Gavrielov, our CEO, whose OP Component is paid
on a semi-annual basis but whose Individual Performance Component and Growth Component are paid on an annual basis.
For fiscal 2013 as compared to fiscal 2012, the weighting of the different components was revised to increase the weighting of
the Growth Component by 10 percentage points and correspondingly reduce the Individual Performance Component by 10
percentage points in order to greater emphasize revenue growth as a factor in determining bonus amounts.
For the first half of fiscal 2013, the Company exceeded the operating profit objective resulting in a 110% payout under the OP
Component. Payouts to the named executive officers (other than our CEO) under the Individual Performance Component for
the first half of the fiscal year ranged from 105% to 125% of target. In the second half of the fiscal year, the Company met its
operating profit objective, resulting in a 100% payout under the OP Component. In the second half of the fiscal year, the
payouts to the named executive officers (other than our CEO) under the Individual Performance Component ranged from 110%
to 120% of target. The payout to Mr. Gavrielov, our CEO, under the Individual Performance Component was 120% of target,
which was measured annually rather than semi-annually. The Company did not meet its revenue growth component and
therefore no bonus was paid for that performance metric. The following table shows the annual performance achievement as a
percentage of target by our named executive officers under the 2013 Incentive Plan:
Named Executive Officer Actual Incentive Cash Compensation as a Percent of Target
Name
Moshe N. Gavrielov
Jon A. Olson
Victor Peng
Vincent L. Tong
Frank A. Tornaghi
Total Incentive Award
as % of Target
79.47%
77.09%
79.38%
80.47%
75.50%
Each component is described in more detail below under the sections entitled “Operating Profit Component,” “Revenue
Growth Component,” and “Individual Performance Component.”
Operating Profit Component. The OP Component is designed to measure and reward improvements in the Company’s
operating profit. The goal in the OP Component is to continually manage and reduce costs and enhance profitability. For
-41-
purposes of the 2013 Incentive Plan, the OP Component is calculated on a semi-annual basis using the financial results for the
fiscal six-month period. The operating profit percentage used in the OP Component, and referred to in the discussion below,
excludes expenses related to bonus payments made under the Company’s non-sales incentive compensation plans and other
non-recurring adjustments or expenses that are not associated with currently planned or on-going business operations such as
litigation expenses and restructuring expenses. In connection with the calculation of the OP Component for the second half of
fiscal 2013, the Compensation Committee exercised its discretion to exclude a restructuring charge, not to exceed $3 million,
incurred by the Company as a result of reductions in force in its offices globally.
The OP Component is subject to a threshold range for any payout and contains a multiplier that increases payout under this
component depending on Company performance. For fiscal 2013, the Compensation Committee instituted a cap of 2 times (2x)
on the multiplier, which means the maximum multiplier for the OP Component is 200%. There was no cap in the OP
Component in fiscal 2012. Except for the cap of 2x on the multiplier, the operating margin percentage targets remained
unchanged from fiscal 2012. The table below outlines the general progression of the multipliers in fiscal 2013:
OP Component Scale (Abbreviated)
Operating Profit Margin
(FY2013)
<13%
13% - 19%
20%
27% - 29%
30%
34%
39%
OP Component
Multiplier
—
20%
30%
100%
110%
150%
200%
Once the Company reached 13% operating profit, then the OP Component multiplier (OP Component Multiplier) would equal
20%. The OP Component Multiplier remained at 20% for each percentage point increase in operating profit until the Company
achieved 20% operating profit. Once the Company’s operating profit reached 20%, then the OP Component Multiplier
increases by 10% for each percentage point increase over 20% operating profit until the Company reaches 27% operating
profit. The Company would then pay 100% of the OP Component of the target bonus for operating profit between 27% and
29%. Thereafter, the OP Component Multiplier increases by 10% for each percentage point increase of operating profit over
29% until a total operating profit of 39%, at which the multiplier is capped at 200%.
The calculations below of the OP Component Multiplier are based on actual fiscal 2013 Company performance, and show the
Company's operating profit exceeded target in the first half of the fiscal year and was at target for the second half of the fiscal
year.
OP Component Multipliers for Fiscal 2013
Period
First Half
Second Half
Actual
Company OP Component
30%
28%
OP Component
Multiplier
1.1
1.0
The OP Component was paid semi-annually and determined by the following formula:
OP Component Weighting (30%) x OP Component Multiplier x Target Bonus % x Semi-Annual Earnings =
Semi-Annual OP Component
Revenue Growth Component. The Growth Component measures increases in the Company’s revenue growth year over year
and rewards increases over a certain minimum threshold. The Growth Component is measured and paid on an annual basis. In
fiscal 2013, the minimum increase in revenue growth for payment was 1%. Once the Company reached 1% revenue growth
year over year, then the Growth Component multiplier (Growth Component Multiplier) would equal 20%. The Growth
Component Multiplier increased by 20% for each percentage point of revenue growth above 1%, and was capped at 200%.
The Growth Component for the year was determined by the following formula:
Growth Component Weighting (30%) x Growth Component Multiplier x Target Bonus % x Annual Earnings = Growth
Component
-42-
In fiscal 2013, the Company did not meet its revenue Growth Component threshold for payout and therefore no bonus was paid
for that performance metric.
Individual Performance Component. Under the Individual Performance Component, for each performance period, each named
executive officer received up to a maximum of ten individual goals, each with a weighting depending on the value of the goal.
The threshold payment for any payout under the Individual Performance Component is 50% overall achievement and the
maximum performance is capped at 150% (Individual Performance Multiplier).
Each individual goal under the Individual Performance Component was (1) directly related to the Company’s business
objectives and (2) corresponded to such executive’s position and responsibilities at the Company. The management goals for
the named executive officers related to the broader corporate goals within the following categories:
•
•
•
•
Product objectives. Goals related to product innovation and development, product quality and product
schedules fell within this category.
Sales and marketing objectives. Goals related to design wins, marketing strategies and product launches fell
within this category.
Operational objectives. Goals related to fiscal discipline, cost reductions, business efficiencies and
profitability fell within this category.
Organizational objectives. Goals related to the implementation of employee performance and compensation
programs, succession planning and compliance fell within this category.
The Individual Performance Component is paid semi-annually for all named executive officers, except the CEO, and
determined by the following formula:
Individual Performance Component Weighting (40%) x Individual Performance Multiplier x Target Bonus % x Semi-Annual
Earnings = Semi-Annual Individual Performance Component
The CEO’s Individual Performance Component was paid annually and determined by the following formula:
Individual Performance Component Weighting (40%) x Individual Performance Multiplier x Target Bonus % x Annual
Earnings = CEO’s Individual Performance Component
For all named executive officers other than the CEO, the CEO, in consultation with each executive, assigned a weight to each
goal which was measured in proportion to how that goal corresponded to the importance of the business objective involved. At
the end of each semi-annual period, the CEO reviewed his determination of the executive's performance along with the
executive's self assessment on a scale of 0% to 150% of the executive's achievement of each goal. Based on the CEO's
determination of the executive's level of goal achievement, the CEO then recommended to the Compensation Committee an
individual performance multiplier, on a scale of 0% to 150%, for each named executive officer.
For the CEO, the Compensation Committee, in consultation with the CEO, set forth each of the CEO’s goals, which were
measured in proportion to the importance of that goal to the business. At the end of the annual period, the CEO self-assessed
his achievement of each goal on the same 0% to 150% scale and submitted the self-assessment to the Compensation
Committee. The performance of these goals was then reviewed and discussed with the Board and the award was approved by
the Compensation Committee.
The table below reflects a hypothetical example of how particular goals would be weighted based on their achievement level,
resulting in the calculation of the Individual Performance Multiplier for an individual executive participating in the plan.
Individual Performance Component Multiplier (Example Only)
Goal
#1
#2
#3
#4
Individual Performance Multiplier
Weighting
20%
30%
30%
20%
Achievement Level
100%
50%
100%
150%
Multiplier
20%
15%
30%
30%
95%
Following the CEO’s assessment and recommendation, the Compensation Committee reviews and approves the multiplier and
semi-annual payout for each named executive officer for each semi-annual period. With respect to the CEO, the Compensation
Committee reviewed the CEO’s self-assessment and made their own assessment of his performance at the end of the annual
period. The Compensation Committee then recommended to the Board of Directors, and the Board of Directors reviewed and
discussed the multiplier and annual payout for the CEO and then the Compensation Committee approved it. In assessing the
-43-
CEO’s achievements and approving his compensation, the Compensation Committee and the Board of Directors considered his
achievements within a broader set of expectations including strategic leadership, organizational quality and effectiveness,
management abilities and responsiveness to economic conditions.
A summary of the goals for each named executive officer under the Individual Performance Component are discussed in the
footnotes to the table below. The target and actual bonus amounts for fiscal 2013 for our named executive officers, based on the
achievement against the financial goals (as discussed above) and achievement against the individual performance goals (as
discussed in the footnotes below) were as follows:
Base Salary
($)
Target
Bonus
($)
First Half
Financial
Metrics
($)
First Half
Individual
Performance
($)
Second Half
Financial
Metrics
($)
Second Half
Individual
Performance
($)
Total
Bonus
Actually
Paid
($)
Annual
Target as
Percentage
of Base
Salary (%)
Bonuses
Actually
Paid as
Percentage
of Base
Salary (%)
Bonus Actually Paid ($)
737,500
477,500
455,000
921,875
358,125
341,250
365,000
273,750
381,250
285,938
149,531
58,781
54,450
44,550
46,716
—
140,625
81,938(2)
82,500(4)
54,000
52,875
442,500(1)
81,360(3)
81,075(5)
67,500(6)
41,625
66,600(7)
59,456(8)
43,313
63,525(9)
732,656
276,079
270,900
220,275
213,010
125
75
75
75
75
99
58
60
60
56
Named
Executive
Officer
Moshe N.
Gavrielov
Jon A. Olson
Victor Peng
Vincent L.
Tong
Frank A.
Tornaghi
(1)
(2)
(3)
(4)
(5)
(6)
(7)
Represents the actual bonus paid to Mr. Gavrielov for fiscal 2013 based achievement against his specific individual
performance goals. For fiscal 2013, Mr. Gavrielov earned 120% of his target bonus attributable to the Individual
Performance Component by successfully: (1) meeting product delivery goals, product development goals, and achieving
sales targets, (2) assessing and presenting to the Board a fabrication strategy and product and portfolio strategy to
increase revenue and market share, and (3) exhibiting strategic leadership through organization cohesiveness, nurturing
a performance-based culture, responding to a changing market and economic environment, developing and retaining a
strong management team, and successfully managing the Company’s relationship with its stockholders.
Represents the actual bonus paid to Mr. Olson for the first half of fiscal 2013 based on achievement against his specific
individual performance goals. For the first half of fiscal 2013, Mr. Olson earned 115% of his target bonus attributable to
the Individual Performance Component by successfully: (1) driving the Company’s efforts on gross margin
improvements, (2) implementing various programs to improve the Company’s profitability and financial decision
making processes, (3) implementing programs to maintain and improve Company controls and processes, and (4)
identifying components for employee development program.
Represents the actual bonus paid to Mr. Olson for the second half of fiscal 2013 based on achievement against his
specific individual performance goals. For the second half of fiscal 2013, Mr. Olson earned 113% of his target bonus
attributable to the Individual Performance Component by successfully: (1) driving the Company’s efforts on gross
margin improvements, (2) driving profitability and completing key strategic initiatives, (3) implementing various
programs to improve the Company’s controls, compliance, and processes, and (4) implementing expanded employee
evaluation and career development programs.
Represents the actual bonus paid to Mr. Peng for the first half of fiscal 2013 based on achievement against his specific
individual performance goals. For the first half of fiscal 2013, Mr. Peng earned 125% of his target bonus attributable to
the Individual Performance Component by successfully: (1) meeting product delivery and production goals,
(2) releasing certain software development tools and next generation products on time, (3) achieving certain business
revenue targets, (4) achieving gross margin goals, and (5) identifying components for employee development program.
Represents the actual bonus paid to Mr. Peng for the second half of fiscal 2013 based on achievement against his
specific individual performance goals. For the second half of fiscal 2013, Mr. Peng earned 115% of his target bonus
attributable to the Individual Performance Component by successfully: (1) releasing next generation software
development tools on time, (2) meeting product delivery and production goals, (3) achieving certain business and
marketing goals, (4) achieving gross margin goals, and (5) designing an action plan to implement career development
program for employees.
Represents the actual bonus paid to Mr. Tong for the first half of fiscal 2013 based on achievement against his specific
individual performance goals. For the first half of fiscal 2013, Mr. Tong earned 125% of his target bonus attributable to
the Individual Performance Component by successfully: (1) achieving the Company’s gross margin goals,
(2) achieving certain quality production goals, (3) attaining certain product deliverables on time, (4) identifying
employee development programs, (5) meeting quality control goals, and (6) identifying components for employee
development.
Represents the actual bonus paid to Mr. Tong for the second half of fiscal 2013 based on achievement against his
specific individual performance goals. For the second half of fiscal 2013, Mr. Tong earned 120% of his target bonus
-44-
(8)
(9)
attributable to the Individual Performance Component by successfully: (1) implementing certain cost control measures,
(2) meeting certain quality production goals, (3) achieving certain quality control and delivery goals on time, (4)
implementing certain employee development and training programs.
Represents the actual bonus paid to Mr. Tornaghi for the first half of fiscal 2013 based on achievement against his
specific individual performance goals. For the first half of fiscal 2013, Mr. Tornaghi earned 105% of his target bonus
attributable to the Individual Performance Component by successfully: (1) achieving gross margin goals, (2) achieving
design win goals for certain product lines, (3) increasing growth in certain customer accounts, and (4) identifying
components for employee development program.
Represents the actual bonus paid to Mr. Tornaghi for the second half of fiscal 2013 based on achievement against his
specific individual performance goals. For the second half of fiscal 2013, Mr. Tornaghi earned 110% of his target bonus
attributable to the Individual Performance Component by successfully: (1) achieving design win goals for certain
in major customer accounts, (3) achieving gross margin goals, and
product
(4) implementing certain employee development and training programs.
lines, (2) increasing growth
Calculation of Payouts for Named Executive Officers. Except for the CEO, to determine the semi-annual payment for the first
half of the fiscal year, the OP Component Multiplier and the Individual Performance Component Multiplier were multiplied by
their respective weights and added together to compile a semi-annual multiplier (Semi-Annual Multiplier). The calculation of
the Semi-Annual Multiplier was as follows:
[OP Component Weighting (30%) x OP Component Multiplier x Target Bonus %] + [Individual Performance Component
Weighting(40%) x Individual Performance Component Multiplier x Target Bonus %] = Semi-Annual Multiplier
The Semi-Annual Multiplier was then applied to the named executive officer’s salary earned during the first half of the fiscal
year, except for the CEO.
The calculation for the CEO’s semi-annual payment for the first half of the fiscal year was as follows:
[OP Component Weighting (30%) x OP Component Multiplier x Target Bonus %] = CEO Semi-Annual Multiplier
The CEO Semi-Annual Multiplier was then applied to the CEO’s salary earned during the first half of the fiscal year. The
calculation does not include the Individual Performance Component Multiplier because that is evaluated and paid on an annual
basis for the CEO.
To determine the payment for all named executive officers for the second half of the fiscal year, except the CEO, the
calculation is a follows:
[OP Component Weighting (30%) x OP Component Multiplier x Target Bonus % x Semi-Annual Earnings] + [Individual
Performance Component Weighting (40%) x Individual Performance Component Multiplier x Target Bonus % x Semi-Annual
Earnings] + [Growth Component Weighting (30%) x Growth Component Multiplier x Target Bonus % x Annual Earnings] =
Non-CEO Second Half Payout
Because the CEO’s Individual Performance and Growth Components are determined on an annual basis, rather than on a semi-
annual basis, the CEO’s payout for the second half of the fiscal year is determined according to the following formula:
[OP Component Weighting (30%) x OP Component Multiplier x Target Bonus % x Semi-Annual Earnings] + [Individual
Performance Component Weighting (40%) x Individual Performance Component Multiplier x Target Bonus % x Annual
Earnings ] + [Growth Component Weighting (30%) x Growth Component Multiplier x Target Bonus % x Annual Earnings] =
CEO Second-Half Payout
Long-Term Equity Incentive Compensation. The Compensation Committee regularly monitors the environment in which the
Company operates and makes changes to our equity program as necessary to help us meet our goals, including achieving long-
term stockholder value and attracting, motivating and retaining talent. In fiscal 2013, the Compensation Committee granted a
mix of performance-based RSUs and time-based RSUs to the named executive officers. The Compensation Committee
believes that RSUs align the executives’ interests with the stockholders’ interests and provide a stronger retention tool for our
executives as compared to stock options that are unpredictable during turbulent economic times. Additionally, the higher value
of RSUs allows us to issue fewer shares of our Common Stock thereby reducing dilution to our stockholders.
For fiscal 2013, the mix of RSUs was as follows: 40% are time-based RSUs and 60% are performance-based RSUs with
additional time-based vesting. The Compensation Committee believed that a portion of the RSUs should be specifically tied to
performance requirements in line with our business strategy to align pay with performance but that a portion should also be
time-based to provide a retention tool for the Company. The basis of determining the number of RSUs granted (viewed in the
aggregate by value) was based on individual performance, peer group data, the pay mix between cash compensation and equity
compensation, the equity mix between options and RSUs, and the Compensation Committee’s assessment of the retention
value of existing and new equity grants. Additionally, further differentiation was made between the named executive officers
-45-
based on competitive peer group data for their respective positions and the Compensation Committee’s assessment of each
executive’s potential future contributions to the Company.
Time-Based RSUs. Time-based RSUs were subject to vesting based on the executive’s continued service with us but not subject
to performance vesting criteria. These time-based RSUs vest in one lump sum on the third anniversary from the date of grant,
thereby promoting retention. The named executive officers, as well as all other Section 16 officers, must retain half of the
shares of Company stock derived from awards of time-based restricted stock units until their respective stock ownership
requirements are met.
Performance-Based RSUs. In fiscal 2013, the Compensation Committee granted our named executive officers performance-
based RSUs based upon its fundamental belief that performance should continue to be a significant factor in our overall equity
compensation program. The amount of the performance-based RSUs that become earned will be based on a one-year
performance cycle as determined subsequent to the end of the Company’s fiscal year. The number of earned performance-
based RSUs may increase with overachievement of the performance goals and may decrease for underachievement of the
performance goals, including no performance-based RSUs being earned. The maximum number of performance-based RSUs
that may be earned is 150% of the target number of performance-based RSUs. Following a determination by the Compensation
Committee of the number of performance-based RSUs earned based on the achievement of the applicable performance goals,
such earned RSUs will be subject to further time-based vesting in equal installments on each of the three anniversaries of the
grant date, which for performance-based RSUs granted in fiscal 2013, will be July 2 of each of 2013, 2014 and 2015.
The performance period for the performance-based RSUs is the Company’s fiscal year. Following the end of the fiscal year, the
performance goals are evaluated and the degree of achievement, between 0-150%, is determined. This data was presented to the
Compensation Committee in May 2013 and after analyzing and reviewing the results, they certified the degree of goal
accomplishment against performance-based components (share of revenue, technology leadership and quality leadership). The
Compensation Committee’s certification also included the total number of RSUs to be issued pursuant to each award based on
the degree of achievement. The first 33.3% of the total number of RSUs subject to an award vests on the one year anniversary
of the date of grant or July 2, 2013. The remaining 66.7% of the unvested shares (as determined based on results from the one-
year performance period) are subject to time-based vesting and shall vest in equal annual installments over the following two
years on the anniversary of the date of grant, or July 2, 2014 and July 2, 2015. The performance components applicable to the
2013 performance-based RSUs consist of the following: share of revenue component (SOR Component), weighted at 20%
which is designed to measure and reward increases in the Company’s share of revenue as compared to specified competitors;
technology leadership component (Technology Component), weighted at 50% which measures the leadership of the
Company’s product portfolio; and quality leadership component (Quality Component), weighted at 30%, which measures the
quality of the Company’s products from both a customer and internal controls perspective.
The following table sets forth the number of targeted and actual performance-based RSUs and actual time-based RSUs awarded
to each of our named executive officers in fiscal 2013, based on the considerations described above:
Named Executive Officer RSU Awards for Fiscal 2013
Name
Moshe N. Gavrielov
Jon A. Olson
Victor Peng
Vincent L. Tong
Frank A. Tornaghi
Performance-
Based RSUs
(Target) (1)
57,500
21,500
21,500
14,500
14,500
Performance-
Based RSUs
(Actual) (2)
73,198
27,370
27,370
18,459
18,459
Time-Based
RSUs
(Actual)
38,500
14,500
14,500
10,000
10,000
(1)
(2)
This column represents the number of performance-based RSUs for fiscal 2013 based on achievement of the
performance goals at 100% of target. Actual RSUs for 2013 may range from 0 to 150% of target depending on the level
of performance.
This column represents the actual number of performance-based RSUs awarded based on performance achievement for
fiscal 2013. The Compensation Committee determined the performance-based RSU multiplier was 1.273 for fiscal
2013.
-46-
Performance Components
The performance-based RSUs are granted subject to the terms and conditions of our 2007 Equity Plan and applicable RSU
agreement. Performance-based RSUs consist of three performance components, as follows:
Share of Revenue Component. The SOR Component was designed to measure and reward increases in the Company’s share of
revenue as compared to certain benchmark programmable logic device (PLD) companies identified by the Compensation
Committee, which for the fiscal 2013 were Altera Corporation and Lattice Semiconductor (collectively, the SOR Comparator
Companies). The SOR Component was selected as a goal because the Company sought to improve its market position relative
to its chief PLD competitors, and the Compensation Committee identified the SOR Comparator Companies as such chief
competitors.
To determine the Company’s share of revenue as compared to the SOR Comparator Companies, the Company measured the
actual revenue result of the Company and the SOR Comparator Companies on an annual basis. The Company’s share of
revenue (the Company SOR) is determined by dividing the Company’s total annual revenue by the annual revenue generated
by the Company and the SOR Comparator Companies during the Company's fiscal year. The SOR Component is subject to a
threshold and a multiplier that increases the target number of shares depending on Company performance above that threshold.
In fiscal 2013, the SOR Component is subject to a threshold of 50.3% and a maximum award of 150% of the target number of
shares. If the performance score is below the 50.3% threshold, no shares will be earned. If the Company reached this threshold,
then the SOR Component payout multiplier (SOR Component Multiplier) was 10%. For each 0.1% increase in the SOR
Component the SOR Component Multiplier increased by 10%. If the Company SOR achieved 51.2%, then the SOR
Component Multiplier increased to 100% and 100% payout would be achieved. The maximum payout was capped at 150% if
the SOR Component reached 51.8% or greater.
Technology Component. The Technology Component was designed to measure and reward significant achievements in the
Company’s technology roadmap. The Technology Component measures a number of factors in assessing the Company’s
competitiveness and status of leadership in the PLD market with respect to its portfolio of products. Such factors include, but
are not limited to, use of power, process node achievements, integration, performance of high speed transceiver technology and
ease of use of software. The Technology Component is subject to a minimum threshold of 20% and a maximum award of
150% of the target number of shares. If the performance score is below the minimum, no shares will be earned.
Quality Component. The Quality Component was designed to measure and reward significant achievements in the quality of
the Company’s products. The Quality Component is measured by both customer experience and internal quality systems
monitoring. The Quality Component is subject to a minimum threshold of 20% and a maximum award of 150% of the target
number of shares. If the performance score is below the minimum, no shares will be earned.
Generally Available Benefit Programs. The Company also maintains generally available benefit programs in which our
executives may participate. The Company maintains the ESPP, under which generally all employees are able to purchase our
Common Stock through payroll deductions at a discounted price. We also maintain a tax-qualified 401(k) Plan for employees
in the U.S., which provides for broad-based employee participation. Under the 401(k) Plan, the Company will match up to 50%
of the first 8% of an employee’s compensation that the employee contributes to their 401(k) account, up to a maximum per
calendar year of $4,500 per employee. We also provide a “true-up” for participants who did not receive their maximum
matching contribution during a 401(k) plan year as a result of meeting their contribution limits early in the year. The Company
makes a matching contribution to help attract and retain employees and to provide an additional incentive for our employees to
save for their retirement in a tax-favored manner.
The Company also offers a number of other benefits to the named executive officers pursuant to benefits programs that provide
for broad-based employee participation which includes medical, dental and vision insurance, disability insurance, various other
insurance programs, health and dependent care flexible spending accounts, educational assistance, employee assistance and
certain other benefits. The terms of these benefits are essentially the same for all eligible employees.
The Company also maintains an unfunded, nonqualified deferred compensation plan which allows eligible participants,
including executive officers and members of the Board, to voluntarily defer receipt of a portion or all of their salary, cash bonus
payment or directorship fees, as the case may be, until the date or dates elected by the participants, thereby allowing the
participating employees and directors to defer taxation on such amounts. Refer to the section below entitled “Deferred
Compensation Plan” for more information about this benefit plan. The Company does not maintain a “SERP” or similar
defined benefit deferred compensation plan for any of its employees.
Consistent with our compensation philosophy, we intend to continue to maintain market-competitive benefits for all employees,
including our named executive officers; provided, however, that the Compensation Committee may revise, amend, or add to the
officer’s executive benefits and perquisites if it deems advisable in order to remain competitive with comparable companies
and/or to retain individuals who are critical to the Company. We believe the benefits and perquisites we offer are currently at
-47-
competitive levels with comparable companies. We do not provide any other perquisites to our named executive officers that
are not made available to other employees.
Fiscal 2014 Compensation Actions
On May 15, 2013, the Compensation Committee approved an executive incentive plan for fiscal 2014 (2014 Incentive Plan).
The 2014 Incentive Plan provides for a cash bonus calculated as a percentage of the executive officer’s base salary. After a
review of market compensation data, the Committee increased the fiscal 2014 bonus target for the CEO from 125% to 140% of
his base salary, and the bonus targets for all other executive officers were increased to a range of 65% to 80% (previously the
range was 60% to 75%) of their respective base salaries, depending on their position. The 2014 Incentive Plan has an operating
profit component, revenue growth component and individual performance component, similar to the 2013 Incentive Plan. The
2014 Incentive Plan components are weighted as follows: the operating profit component, weighted at 30%, the revenue growth
component, weighted at 30%, and the individual performance component, weighted at 40%. For all the named executive
officers except the CEO, the operating profit component and individual performance component are paid on a semi-annual
basis and the revenue growth component is paid on an annual basis. For the CEO, the operating profit component is paid on a
semi-annual basis, but the individual performance component and the revenue growth component are paid on an annual basis.
The 2014 Incentive Plan is effective for fiscal 2014. For fiscal 2014, based on comparing base salary levels at the companies in
our peer group, as well as considering the roles and responsibilities and potential performance of the named executive officers,
the Compensation Committee increased the base salary for Mr. Peng to $480,000, and did not change any of the other named
executive officers. Mr. Peng’s base salary increase will be effective on July 1, 2013.
For fiscal 2014, the Compensation Committee has decided to award equity only in the form of performance-based RSUs to the
Company’s executive officers in order to tie all their equity compensation to Company performance and increase the
executives' focus on key long-term drivers of value.
Employment Agreements with Named Executive Officers
Employment Letter Agreements with Moshe N. Gavrielov and Jon A. Olson. The Company maintains employment letter
agreements with Messrs. Gavrielov and Olson. Mr. Gavrielov’s employment letter agreement, entered into with Mr. Gavrielov
on January 4, 2008, and amended on June 13, 2012, entitles him to certain payments and benefits in the event his employment
is terminated at any time due to disability or other than for cause, or if Mr. Gavrielov voluntarily terminates his employment for
good reason. Mr. Gavrielov’s agreement was entered into with him as part of an arm's length negotiation with the
Compensation Committee when he joined the Company.
The employment letter agreement that we entered into with Mr. Olson on June 2, 2005, and amended on February 14, 2008,
and June 13, 2012, provides Mr. Olson with certain payments and benefits in the event he is terminated without cause within
one year following a change in control of the Company. This arrangement was entered into with Mr. Olson to retain Mr. Olson
and ensure his cooperation with and continued commitment to the success of the Company.
The employment letter agreements with Messers. Gavrielov and Olson were amended on June 13, 2012, to clarify the treatment
of certain equity awards in the event of termination of employment. A description of the terms of Messrs. Gavrielov’s and
Olson’s employment letter agreements, as amended, and a quantification of the potential payments and benefits under these
agreements, are provided below in the section entitled “Potential Payments Upon Termination or Change in Control.”
Equity Grant Procedures and Guidelines
We have conducted an internal review of our equity granting procedures to ensure that our procedures satisfy both our
objectives and all applicable compliance requirements. To this end, the Company has adopted written procedures for the grant
of equity awards. With respect to grants to employees and officers, including named executive officers, the Compensation
Committee reserves the authority to make grants at such time and with such terms as it deems appropriate in its discretion,
subject to the terms of the 2007 Equity Plan. Generally, grants of equity awards are made to officers based on and in
connection with the annual review during the Focal Review Period. The Compensation Committee determines individual grants
to each named executive officer based on a variety of factors that the Compensation Committee determines to be relevant and
appropriate at the time of grant. These factors typically have included the size and value of unvested equity awards held by the
named executive officer, the named executive officer’s job performance, skill set, prior experience, and time in the position, as
well as external market data, internal equity, pressures to attract and retain talent, dilutive effect of grant size and business
conditions. The Compensation Committee also periodically grants equity awards at its scheduled meetings or by unanimous
written consent for new hires and promotions. Grants approved during scheduled meetings become effective and are priced as
of the date of approval or a pre-determined future date. Grants approved by unanimous written consent become effective and
are priced as of the date the last signature is obtained or as of a predetermined future date. The Compensation Committee has
made certain exceptions to these procedures in order to grant an equity award on an executive’s start date, as it did in the case
of the initial option grant to Mr. Gavrielov. The Company has not granted, nor does it intend in the future to grant, equity
awards to executives in anticipation of the release of material nonpublic information that is likely to result in changes to the
-48-
price of the Company’s Common Stock, such as a significant positive or negative earnings announcement. Similarly, the
Compensation Committee has not timed, nor does it intend in the future to time, the release of material nonpublic information
based on equity award grant dates. In any event, because equity compensation awards typically vest over three or four-year
periods, the effect of any immediate increase in the price of the Company’s Common Stock following grant is minimal.
The Board of Directors has delegated to the CEO and CFO limited authority to approve equity award grants to non-officer
employees pursuant to the terms of the 2007 Equity Plan, and subject to the provisions of pre-determined guidelines.
Specifically, with respect to non-officer employees, our annual focal awards will be granted on or about the first business day
of our second fiscal quarter of each year, and other equity awards will generally be granted on the 10th day of the month, or if
on such date the Company’s stock is not traded, the first business day thereafter that the Company’s stock is traded. The
Compensation Committee is responsible for determining and granting all equity awards to executive officers.
Under the 2007 Equity Plan, the exercise price of options and stock appreciation rights may not be less than 100% of the
closing price of the shares underlying such options and stock appreciation rights on the date of grant.
Claw-Back Policy
The Board has adopted a policy for seeking the return (claw-back) from executive officers of compensation to the extent such
amounts were paid due to financial results that later had to be restated, subject to the terms described below. The policy
provides that to the extent the Board, or any Committee thereof, and the Company, in their discretion, determine appropriate,
the Company may require reimbursement of all or a portion of any bonus, incentive payment, commission, equity-based award
or other compensation granted to and received by or for an elected officer beginning in fiscal 2009, where: (1) the
compensation was predicated upon achieving certain financial results that were subsequently the subject of a substantial
restatement of Company financial statements filed with the SEC; (2) the Board (or a Committee thereof), in its sole discretion,
determines the elected officer engaged in intentional misconduct that was directly responsible for the substantial restatement;
and (3) a reduced amount of compensation would have been paid to the elected officer based upon the restated financial results.
Stock Ownership Guidelines
We have adopted stock ownership guidelines for our officers, including the named executive officers, to align more closely the
interests of our officers with those of our stockholders. Under these guidelines, the CEO is required to own Company stock
having a value of at least $2.5 million. Senior vice presidents who are Section 16 officers are required to own Company stock
having a value of at least $750,000 and corporate vice presidents who are Section 16 officers are required to own Company
stock having a value of at least $500,000. In addition, the CEO and all other Section 16 officers must retain half of the shares of
Company stock delivered from awards of time-based restricted stock units until their respective ownership requirements are
met.
Policy Against Short Sales, Other Put-Equivalent Investment and Margin Accounts
All employees, including the named executive officers, are subject to our Insider Trading Policy. Our Insider Trading Policy
prohibits any employee from hedging, engaging in short sales or entering into any transaction, investment or arrangement that
is intended or may be expected to increase in value on the basis of any decrease in value of any of our shares of Common Stock
(such as buying “put” options). In addition, the policy prohibits any employee from holding shares of our Common Stock in a
margin account or pledging shares of our Common Stock. The Company has a corporate policy regarding 10b5-1 trading plans
and pursuant to such policy, key terms of the 10b5-1 trading plans of Directors and executive officers are disclosed on the
Company’s website at www.investor.xilinx.com.
Tax and Accounting Treatment of Compensation
In our review and establishment of compensation programs and payments, we consider, but do not place great emphasis on, the
anticipated accounting and tax treatment of our compensation programs. While we do consider the accounting and tax
treatment, these factors alone are not dispositive. Among other factors that receive greater consideration are the net costs to the
Company and our ability to effectively administer executive compensation arrangements which are in the short and long-term
interests of stockholders. The Compensation Committee seeks to maintain flexibility and judgment in compensating executive
officers in a manner designed to promote varying corporate goals and therefore, has not adopted a policy with respect to the tax
or accounting treatment of compensation.
It is our policy generally to qualify compensation paid to named executive officers for deductibility under Section 162(m) of
the Tax Code. Section 162(m) of the Tax Code places a limit of $1,000,000 on the amount of compensation that the Company
may deduct in any one year with respect to each of its CEO and next three most highly paid executive officers (other than its
CFO, referred to in the Tax Code as “covered persons”). Our stockholder-approved equity plans are qualified so that awards of
stock options and performance based RSUs under these plans may constitute performance-based compensation not subject to
the limit under Section 162(m) of the Tax Code, provided they otherwise satisfied the requirements under Section 162(m) of
-49-
the Tax Code. A portion of the cash payments we make under the 2013 Incentive Plan may not be deductible under
Section 162(m) of the Tax Code. The Compensation Committee intends to continue to evaluate the effects of the Tax Code and
related U.S. Treasury regulations and the advisability of qualifying its executive compensation for deductibility of such
compensation. To maintain flexibility in compensating executive officers in a manner designed to promote varying corporate
goals, however, the Compensation Committee has not adopted a policy that all compensation payable to a covered person must
be deductible on the Company’s federal income tax returns.
We account for equity compensation paid to our employees and non-employee directors in accordance with FASB ASC Topic
718, which requires us to estimate and record expense for each award of equity compensation over the service period of the
award.
Risk Analysis of Compensation Programs
The Compensation Committee considers potential risks when reviewing and approving compensation programs. The
Compensation Committee, in cooperation with management reviewed the Company’s existing compensation programs and
believes that the mix and design of the elements of such programs does not encourage management to assume excessive risks
and accordingly are not reasonably likely to have a material adverse effect on the Company. Our programs have been balanced
to focus on both short-term and long-term financial and operational performance through prudent business judgment and
appropriate, measured risk-taking.
Our incentive cash compensation program is designed to reward financial and management performance in areas considered
critical to short- and long-term success of the Company. The cash incentive plan for our named executive officers is based on a
combination of corporate financial metrics and individualized strategic goals. The financial metric component is based on
multiple financial metrics which counterbalance each other, decreasing the likelihood that executives will pursue any one
metric to the detriment of overall financial performance. The OP Component is designed to reward improvements in the
Company’s operating profit and the Growth Component is designed to measure and reward increases in the Company’s
revenue growth year over year. These metrics limit the ability of an executive to be rewarded for taking excessive risk on
behalf of the Company by, for example, seeking revenue enhancing opportunities at the expenses of profitability. In addition,
there are caps on bonus payments in all the components of the cash incentive plan. The OP Component and Growth Component
are capped at 200% and the Individual Performance Component is capped at 150%. These limitations and caps eliminate the
risk of uncapped cash bonus opportunities and unjustified bonus payments. Finally, the Board has also adopted a clawback
policy (as discussed above) whereby the Company would seek a return (claw-back) from executive officers of compensation to
the extent such amounts were paid due to financial results that later had to be restated. The individual strategic goals for the
CEO are reviewed and discussed with the Board and approved by the Compensation Committee; the individual strategic goals
for each of the named executive officers are reviewed and discussed with the Compensation Committee and approved by the
CEO. Furthermore, payment for the cash incentive bonus for our named executive officers is approved by the Compensation
Committee. This multi-layer approval process in the goal-setting and payment approval process reduces the risk of improper
awards.
Our equity incentive program is designed to promote long-term performance. During fiscal 2013, our equity incentive program
contained a mix of time-based RSUs and performance-based RSUs. Time-based RSUs for employees vest annually over a four-
year vesting schedule and the time-based RSUs for executive officers vest in a lump sum on the third anniversary of the date of
grant. Since restricted stock retains value even in a depressed market, employees are usually incentivized to enhance its value.
Performance-based RSUs are earned upon the attainment of certain performance metrics therefore aligning pay with
performance.
In prior years, our equity incentive program also included awards of stock options that vest monthly over a period of four years.
Some of these stock options remain outstanding. Since options generate value if the stock price appreciates from the date of
grant, these awards also provide incentives to promote behavior that is aligned with stockholder interests over the long term.
As previously discussed, the Company has also adopted stock ownership guidelines which further align executives with
stockholder interests and promote long-term focus on Company growth. Therefore, the Compensation Committee believes that
these equity awards do not encourage unnecessary or excessive risk taking since equity awards are subject to long-term vesting
schedules and the ultimate value of the awards is tied to the appreciation of the Company’s stock price. This helps ensure that
executives have significant value tied to long-term stock price performance.
-50-
The Company has also adopted corporate policies to encourage diligence, prudent decision-making and oversight during the
goal-setting and review process. The processes that are in place to manage and control risk include:
• The Compensation Committee approves the payout scale for the OP Component and the Growth Component.
• The Compensation Committee sets the financial metrics at reasonable levels in light of past performance and market
•
conditions.
Payments under the incentive cash compensation program for executives are subject to the approval of the
Compensation Committee.
• The Compensation Committee retains discretion in administering all awards and in determining performance
achievement.
The Company has implemented a number of effective controls such as the Code of Conduct, a claw-back policy and quarterly
sub-certification process for all executives in order to mitigate the risk of any unethical behavior.
-51-
COMPENSATION COMMITTEE REPORT
The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b)
of Regulation S-K with the management of the Company and, based on such review and discussion, the Compensation
Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this proxy
statement and, through incorporation by reference from this proxy statement, the Company’s Annual Report on Form 10-K for
the fiscal year ended March 30, 2013.
The following non-employee members of the Board participated in the review, discussions and recommendations with respect
to the compensation of the CEO.
The Compensation Committee
—J. Michael Patterson, Chairman
—Marshall C. Turner
—Elizabeth W. Vanderslice
—Philip T. Gianos
—John L. Doyle
—William G. Howard, Jr.
—J. Michael Patterson
—Albert A. Pimentel
—Marshall C. Turner
—Elizabeth W. Vanderslice
The foregoing Report of the Compensation Committee of the Board of Directors is not “soliciting material,” is not deemed
“filed” with the SEC and is not to be incorporated by reference in any filing of Xilinx under the Securities Act of 1933, as
amended (the “Securities Act,”) or under the Exchange Act, whether made before or after the date of this proxy statement and
irrespective of any general incorporation language in any such filing.
-52-
Summary Compensation Table
The following table provides compensation information for the named executive officers.
Salary (1)
($)
Bonus
($)
Name and Position
Moshe N. Gavrielov
President and Chief
Executive Officer
Jon A. Olson(4)
Senior Vice President,
Finance and Chief
Financial Officer
Victor Peng (4)
Senior Vice President,
Programmable
Platforms Group
Year
2013
2012
2011
2013
2012
2011
2013
2012
2011
737,500
700,000
700,000
477,500
467,500
460,000
455,000
407,500
400,000
Vincent L. Tong(5)
2013
365,000
Senior Vice President,
Worldwide Quality
and New Product
Introductions
Frank A. Tornaghi
Senior Vice President,
Worldwide Sales
2013
2012
2011
381,250
367,500
360,000
Stock
Awards (2)
($)
Option
Awards (2)
($)
3,019,200
3,319,785
—
—
—
2,351,650
1,132,200
1,264,680
—
—
739,090
Non-Equity
Incentive Plan
Compensation
($)
732,656
750,750
1,074,150
276,079
337,472
498,525
1,132,200
1,264,680
—
—
—
638,305
270,900
278,972
415,500
770,525
—
220,275
770,525
843,120
—
—
—
537,520
213,010
234,253
368,550
—
—
—
—
—
—
—
—
—
—
—
Change in
Pension Value and
Nonqualified
Deferred
Compensation
Earnings
($)
All Other
Compensation (3)
($)
Total
($)
4,493,793
4,778,535
4,125,800
1,889,562
2,075,002
1,701,348
1,862,825
1,953,940
1,456,055
4,437
8,000
—
3,783
5,350
3,733
4,725
2,788
2,250
139,303
1,495,103
4,625
5,183
3,900
1,369,410
1,450,056
1,269,970
—
—
—
—
—
—
—
—
—
—
—
—
(1) Amounts shown reflect salary earned in fiscal 2013. Effective July 1, 2012, the Compensation Committee increased
annual base salaries to the amounts as follows: Mr. Gavrielov, $750,000; Mr. Olson, $480,000; Mr. Peng, $470,000;
Mr. Tong, $370,000 and Mr. Tornaghi, $385,000.
(2) Amounts shown do not reflect compensation actually received by the named executive officer. Instead, the amounts
shown reflect the grant date fair value for stock awards granted in fiscal 2013 as determined pursuant to FASB ASC
Topic 718. The assumptions used to calculate the value of the awards are set forth in Note 6 of the Notes to Consolidated
Financial Statements included in our Annual Report on Form 10-K for fiscal 2013 filed with the SEC on May 23, 2013.
These compensation costs as they relate to stock awards reflect costs associated with stock awards granted in fiscal
2013. These compensation costs as they relate to option awards reflect option awards granted in 2011. For fiscal 2013,
this includes the following number of performance-based RSUs based on achievement at 100% of target level
performance: Mr. Gavrielov, 57,500 shares; Mr. Olson, 21,500 shares; Mr. Peng, 21,500 shares; Mr. Tong, 14,500
shares; and Mr. Tornaghi, 14,500 shares. The maximum number of performance-based RSUs that could be earned by
our named executive officers based on achievement at 150% of target level performance is as follows: Mr. Gavrielov,
86,250 shares; Mr. Olson, 32,250 shares; Mr. Peng, 32,250 shares; Mr. Tong, 21,750 shares; Mr. Tornaghi, 21,750
shares. In May 2013, the Compensation Committee determined that the following number of performance-based RSUs
were earned based on actual performance achievement: Mr. Gavrielov, 73,198 shares; Mr. Olson, 27,370 shares;
Mr. Peng, 27,370 shares; Mr. Tong, 18,459 shares; and Mr. Tornaghi, 18,459 shares. For fiscal 2013, this also includes
the following number of time-based RSUs: Mr Gavrielov, 38,500 shares; Mr. Olson, 14,500 shares; Mr. Peng, 14,500
shares; Mr. Tong, 10,000; and, Mr. Tornaghi, 10,000 shares.
(3) Unless otherwise indicated, the amounts in this column consist of Company contributions during the applicable fiscal
year under its 401(k) Plan. The Company’s 401(k) Plan includes a program that matches up to $4,500 of employee
contributions calculated on a calendar year basis. In order to provide the relevant contributions for our fiscal year, the
contributions shown in the table overlap two calendar years and may include amounts attributable to catch-up
contributions.
(4) Named executive officer participates in the Company’s non-qualified deferred compensation plan. For more information
about this plan see the section below entitled “Deferred Compensation Plan.”
-53-
(5) Mr. Tong became a named executive officer in fiscal 2013. As a result, information for fiscal 2011 and fiscal 2012 has
been omitted. In addition to Mr. Tong’s role as Senior Vice President, Worldwide Quality and New Product
Introductions, Mr. Tong currently serves as the Company’s executive leader for the Asia Pacific region. In this role, Mr.
Tong’s charter is to expand the Company’s presence and accelerate business development in a region that is
experiencing tremendous growth. In connection with his service in this role, the Company leases an apartment and
automobile for Mr. Tong, and reimburses certain costs incurred by Mr. Tong as a direct result of his work in the Asia
Pacific region. Specifically, in connection with Mr. Tong’s Asia Pacific assignment, in fiscal year 2013 the Company
paid $59,085 for the lease of an apartment and other housing-related expenses; $33,673 for the lease of an automobile
and other transportation-related expenses; $14,370 for a cost of living allowance; $10,966 for home leave expenses, such
as airfare and transportation; and $21,209 for tax services related to his service abroad.
Grants of Plan-Based Awards for Fiscal 2013
The following table provides information on equity and non-equity awards granted to our named executive officers during fiscal 2013.
Estimated Future Payouts
Under Non-Equity Incentive
Plan Awards(1)
Estimated Future Payouts
Under Equity Incentive Plan
Awards(2)
Name
Grant
Date
Approval
Date
Threshold
($)
Target
($)
Maximum
($)
Threshold
(#)
Target
(#)
Maximum
(#)
Type
All Other
Stock
Awards:
Number of
Shares of
Stock or
Units
(#)(3)
All Other
Option
Awards:
Number of
Securities
Underlying
Options
(#)
Exercise
or Base
Price of
Option
Awards
($/Sh)
Moshe N. Gavrielov
RSU 7/2/2012
6/13/2012
PSU 7/2/2012
6/13/2012
EIP
— 5/10/2012
Jon A. Olson
RSU 7/2/2012
6/13/2012
PSU 7/2/2012
6/13/2012
EIP
—
5/9/2012
Victor Peng
RSU 7/2/2012
6/13/2012
PSU 7/2/2012
6/13/2012
EIP
—
5/9/2012
Vincent L. Tong
RSU 7/2/2012
6/13/2012
PSU 7/2/2012
6/13/2012
EIP
—
5/9/2012
Frank A. Tornaghi
RSU 7/2/2012
6/13/2012
PSU 7/2/2012
6/13/2012
EIP
—
5/9/2012
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
921,875
1,659,375
—
—
—
—
358,125
644,625
—
—
—
—
341,250
614,250
—
—
—
—
273,750
492,750
—
—
—
—
—
—
—
38,500
— 57,500
86,250
—
—
—
—
—
—
— 21,500
32,250
—
—
—
—
—
—
— 21,500
32,250
—
—
—
—
—
—
— 14,500
21,750
—
—
—
—
—
—
— 14,500
21,750
—
—
14,500
—
—
14,500
—
—
10,000
—
—
10,000
—
—
285,937
514,688
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Grant Date
Fair Value/
Incremental
Fair Value
of Stock
and Option
Awards
($)(4)
1,210,825
1,808,375
—
456,025
676,175
—
456,025
676,175
—
314,500
456,025
—
314,500
456,025
—
(1) Actual payouts have been made under the fiscal 2013 Incentive Plan, as disclosed in the Summary Compensation Table in the
column entitled “Non-Equity Incentive Plan Compensation.”
(2) Represents performance-based RSU awards granted in fiscal 2013, which become earned based on performance in fiscal 2013.
These columns show the number of performance-based RSU awards that may become earned at threshold, target and maximum
levels of performance. In May 2013, the Compensation Committee determined the actual number of RSUs earned based on
performance for fiscal 2013 were as follows: Mr. Gavrielov, 73,198 shares; Mr. Olson, 27,370 shares, Mr. Peng, 27,370 shares;
Mr. Tong, 18,459 shares; and Mr. Tornaghi, 18,459 shares. These RSUs are subject to further time-based vesting, as described
above under “EXECUTIVE COMPENSATION—Compensation Discussion and Analysis—Long-Term Equity Incentive
Compensation – Performance-Based RSUs.” The awards were granted under our 2007 Equity Plan.
This column represents awards of time-based RSUs granted under our 2007 Equity Plan.
(3)
(4) Amounts in this column represent the grant date fair value of RSUs granted in fiscal 2013 calculated in accordance with FASB
ASC Topic 718. The assumptions used to calculate the value of the awards are set forth in Note 6 of the Notes to Consolidated
Financial Statements included in our Annual Report on Form 10-K for fiscal 2013 filed with the SEC on May 23, 2013.
-54-
Outstanding Equity Awards at Fiscal Year-End 2013
The following table provides information on outstanding stock options and RSUs held by the named executive officers as of
March 30, 2013.
Option Awards
Stock Awards
Name
Moshe N. Gavrielov
Jon A. Olson
Victor Peng
Vincent L. Tong
Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)
Option
Exercise
Price
($)
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
20.46
20.57
25.39
—
—
—
—
25.66
22.80
26.97
24.29
20.57
25.39
—
—
—
—
26.34
20.57
25.39
—
—
—
—
40.11
26.02
22.80
19.79
26.97
26.34
20.57
25.39
—
—
—
—
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
524,965
240,683
175,043
—
29,167
116,667
—
—
—
—
200,000
80,000
37,500
60,000
91,666
73,333
—
—
—
—
170,000
82,500
63,333
—
—
—
—
28,000
25,000
20,000
25,000
26,250
60,000
73,333
53,333
—
—
—
—
—
—
—
—
—
—
—
—
8,334
36,667
—
—
—
—
—
7,500
31,667
—
—
—
—
—
—
—
—
—
—
6,667
26,667
—
—
—
—
Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units
or Other
Rights
That
Have Not
Vested (3)
(#)
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That Have
Not Vested
(2) (#)
—
—
—
—
51,321
—
57,500
—
—
—
—
—
—
—
19,530
—
21,500
—
—
—
—
19,530
—
21,500
—
—
—
—
—
—
—
—
13,171
—
14,500
—
—
—
—
1,958,923
—
2,194,775
—
—
—
—
—
—
—
745,460
—
820,655
—
—
—
—
745,460
—
820,655
—
—
—
—
—
—
—
—
502,737
—
553,465
Number of
Shares or
Units of
Stock That
Have Not
Vested (1)
(#)
Option
Expiration
Date
1/7/2015(4)
7/1/2016(5)
7/6/2017(5)
—
—
—
—
6/27/2015(4)
7/3/2016(5)
7/2/2014(5)
7/1/2015(5)
7/1/2016(5)
7/6/2017(5)
—
—
—
—
5/12/2015(4)
7/1/2016(5)
7/6/2017(5)
—
—
—
—
4/5/2014(5)
12/8/2015(5)
7/3/2016(5)
8/8/2016(5)
7/2/2014(5)
5/12/2015(5)
7/1/2016(5)
7/6/2017(5)
—
—
—
—
—
—
—
38,000
—
38,500
—
—
—
—
—
—
—
14,500
—
14,500
—
—
—
—
14,500
—
14,500
—
—
—
—
—
—
—
—
—
9,500
—
10,000
—
Market
Value
of Shares
or
Units of
Stock
That Have
Not
Vested (2)
($)
—
—
—
1,450,460
—
1,469,545
—
—
—
—
—
—
—
553,465
—
553,465
—
—
—
—
553,465
—
553,465
—
—
—
—
—
—
—
—
362,615
—
381,700
—
Grant
Date
1/7/2008
7/1/2009
7/6/2010
7/5/2011
7/5/2011
7/2/2012
7/2/2012
6/27/2005
7/3/2006
7/2/2007
7/1/2008
7/1/2009
7/6/2010
7/5/2011
7/5/2011
7/2/2012
7/2/2012
5/12/2008
7/1/2009
7/6/2010
7/5/2011
7/5/2011
7/2/2012
7/2/2012
4/5/2004
12/8/2005
7/3/2006
8/8/2006
7/2/2007
5/12/2008
7/1/2009
7/6/2010
7/5/2011
7/5/2011
7/2/2012
7/2/2012
-55-
Frank A. Tornaghi
61,000
30,000
73,333
53,333
—
—
—
—
—
—
6,667
26,667
—
—
—
—
—
—
—
—
—
—
—
—
21.98
24.29
20.57
25.39
—
—
—
—
2/11/2008
7/1/2008
7/1/2009
7/6/2010
7/5/2011
7/5/2011
7/2/2012
7/2/2012
2/11/2015(4)
7/1/2015(5)
7/1/2016(5)
7/6/2017(5)
—
—
—
—
—
—
—
—
9,500
—
10,000
—
—
—
—
—
362,615
—
381,700
—
—
—
—
—
—
13,171
—
14,500
—
—
—
—
—
502,737
—
553,465
(3)
(1)
Time-based RSUs vest 100% on the third anniversary of the date of grant, subject to continued employment with the Company.
(2) Market value is computed by multiplying the closing price of the Company’s stock on the last trading day of the fiscal year by
the number of shares reported in the adjacent column. The closing price of the Company’s stock on March 28, 2013 was
$38.17.
Performance-based RSUs vest 33.3% on the anniversary of the date of grant, and then 33.3% on each anniversary date
thereafter, subject to continued employment with the Company. The number of shares subject to RSUs in this column are
based on the number of performance-based RSUs that were earned based on actual performance achievement, except for those
awarded in fiscal 2013. For the performance-based RSUs awarded in fiscal 2013, this column represents the number of RSU
shares assuming achievement at 100% of target level performance. In May 2013, the Compensation Committee determined
that the following number of performance-based RSUs were earned based on actual performance achievement: Mr. Gavrielov,
73,198 shares; Mr. Olson, 27,370 shares; Mr. Peng, 27,370 shares; Mr. Tong, 18,459 shares; Mr. Tornaghi, 18,459 shares.
The stock option vests and becomes exercisable over a period of four years, with 25% of the shares vesting on the first
anniversary of the date of grant, and the remainder of the shares vesting in equal monthly installments for the following three
years, subject to continued employment with the Company.
The stock option vests and becomes exercisable over a period of four years in equal monthly installments beginning on the first
monthly anniversary of the date of grant, subject to continued employment with the Company.
(5)
(4)
-56-
Option Exercises and Stock Vested for Fiscal 2013
The following table provides information on stock option exercises and the value realized upon exercise, and all stock awards
vested and the value realized upon vesting, by the named executive officers during fiscal 2013.
Name
Moshe N. Gavrielov
Jon A. Olson
Victor Peng
Vincent L. Tong
Frank A. Tornaghi
Option Awards
Stock Awards
Number of
Shares Acquired
on Exercise
(#)
43,680
18,750
—
28,000
20,000
Value Realized on
Exercise (1)
($)
526,571
188,845
—
310,270
326,384
Number of Shares
Acquired on
Vesting
(#)
Value Realized on
Vesting (2)
($)
25,660
9,764
14,764
6,585
6,585
858,327
326,606
492,806
220,268
220,268
(1)
(2)
The value realized upon exercise is the product realized by multiplying the number of shares of stock by the difference
between the market value of the underlying shares on the exercise date and the exercise price applicable to the stock
options.
The value realized upon vesting is the product realized by multiplying the number of shares of stock by the market value
of the underlying shares on the vesting date.
Deferred Compensation Plan
The Company maintains an unfunded, nonqualified deferred compensation plan which allows our employees in director-level
and above positions, including our named executive officers, as well as our Directors, to voluntarily defer receipt of a portion
or all of their salary, cash bonus payment and/or sales incentive payment or directorship fees, as the case may be, until the
earliest “distribution event” (e.g., specific date, termination of employment, death or change of control) elected by the
participants or provided for by the plan, thereby allowing the participating employees and Directors to defer taxation on such
amounts. Distributions may be made in a lump sum payment or in installments (not to exceed 15 years). This deferred
compensation plan is offered in order to allow participants to defer more compensation than they would otherwise be permitted
to defer under a tax-qualified retirement plan, such as our 401(k) Plan. Further, the Company offers the deferred compensation
plan as a competitive practice to enable it to attract and retain top talent by providing employees with an opportunity to save in
a tax efficient manner.
Amounts credited to the deferred compensation plan consist only of cash compensation that has been earned and payment of
which has been timely and properly deferred by the participant. Under the deferred compensation plan, the Company is
obligated to deliver on a future date the deferred compensation credited to the relevant participant’s account, adjusted for any
positive or negative notional investment results from hypothetical investment alternatives selected by the participant under the
deferred compensation plan (Obligations). The Obligations are unsecured general obligations of the Company and rank in
parity with other unsecured and subordinated indebtedness of the Company.
In addition, the Company, acting through the Board, may make discretionary contributions to the accounts of one or more
deferred compensation plan participants. In fiscal 2013, there were no discretionary contributions made by the Company to the
deferred compensation plan accounts, and we do not guarantee minimum returns to any participant in the deferred
compensation plan. We incur only limited administration expenses to maintain the deferred compensation plan. The deferred
compensation plan is evaluated for competitiveness in the marketplace from time to time, but the level of benefits provided is
not typically taken into account in determining an executive’s overall compensation package for a particular year.
-57-
Nonqualified Deferred Compensation for Fiscal 2013
The following table provides information on non-qualified deferred compensation for the named executive officers during
fiscal 2013.
Name
Moshe N. Gavrielov
Jon A. Olson
Victor Peng
Vincent Tong
Frank A. Tornaghi
Executive
Contributions in
Last FY(1)
($)
Registrant
Contributions in
Last FY
($)
Aggregate
Earnings in
Last FY
($)
Aggregate
Withdrawals/
Distributions
($)
—
89,375
265,494
—
—
—
—
—
—
—
—
263,912
91,623
—
—
—
—
—
—
—
Aggregate
Balance at
Last FYE
($)
—
2,685,669
732,210
—
—
(1) Mr. Olson's contributions consist of salary earned by him during fiscal 2013, which is also reported in the Summary
Compensation Table. Mr. Peng's contributions are for bonus earned by him during fiscal 2012.
Potential Payments upon Termination or Change in Control
The 2007 Equity Plan does not provide for automatic acceleration of vesting upon termination or a change in control. However,
as described above in the section entitled “EXECUTIVE COMPENSATION—Compensation Discussion and Analysis—
Employment Agreements with Named Executive Officers,” the Company maintains employment letter agreements with certain
of our named executive officers that provide for acceleration under certain conditions, such as certain employment terminations
or a change in control. The narrative and tables that follow describe potential payments and benefits to such executives under
their existing employment letter agreements, including payments and benefits that would be due to them in connection with the
occurrence of a change in control, assuming their employment terminated on March 30, 2013, the last day of the Company’s
fiscal year.
Employment Letter Agreement with Moshe N. Gavrielov. Under an employment letter agreement that we entered into with
Mr. Gavrielov on January 4, 2008, and amended on June 13, 2012, if the Company terminates Mr. Gavrielov’s employment at
any time due to disability or other than for Cause or if Mr. Gavrielov voluntarily terminates his employment for Good Reason
(in each case, as defined in his agreement and described below in the section entitled “Definitions of Good Reason, Cause and
Change in Control”) then, subject to Mr. Gavrielov’s execution of a release of claims in favor of the Company, he will be
eligible for: (i) one year of his base salary, (ii) one year of his target bonus, (iii) one year of COBRA premiums for medical and
dental insurance, (iv) a pro rata portion of his bonus for the fiscal year during which his employment was terminated, and
(v) 24 months accelerated vesting of all equity grants received from the Company prior to his termination of employment; for
determining the 24 months of accelerated vesting of (a) performance-based RSUs, the number of accelerated shares will be the
actual number of RSUs earned for actual performance achievement as determined by the Compensation Committee that would
have vested in the 24 months following termination of employment, had the original vesting schedule been based on a monthly
rather than an annual basis, unless his employment is terminated within one year of a Change in Control, in which case the 24
months of accelerated vesting of the performance-based RSUs will be based on the target number of RSUs determined at the
time of grant, had the original vesting schedule had been based on a monthly rather than an annual basis, and (b) time-based
RSUs, the number of shares that will accelerate will be the number of RSUs that otherwise would have vested in the 24 months
following termination of employment, had the original vesting schedule been based on a monthly rather than an annual basis.
Mr. Gavrielov’s employment agreement was amended on June 13, 2012 to clarify this treatment relating to the accelerated
vesting of RSUs and the intent to comply, to the extent applicable, with Section 409A of the Tax Code.
Potential Payments upon Termination of Mr. Gavrielov’s Employment. Under his employment agreement, Mr. Gavrielov will
receive certain compensation in the event we terminate his employment, as set forth above. Assuming Mr. Gavrielov's
employment was terminated without Cause or Good Reason on March 30, 2013, Mr. Gavrielov would have received the
following severance benefits under his employment agreement: (i) a lump sum payment of $750,000, consisting of his annual
base salary for fiscal 2012; (ii) a lump sum payment of $937,500, consisting of his target bonus for fiscal 2012; (iii) Company
paid COBRA coverage for 12 months valued at $26,902; (iv) a lump sum payment of $509,375, consisting of a pro rata portion
of his bonus for fiscal 2013; (v) accelerated vesting of stock options to purchase an aggregate of 131,250 shares of our
Common Stock; and (vi) accelerated vesting of 188,608 shares of Common Stock subject to RSUs, which includes 72,222
shares under time-based RSUs, and 116,386 shares under performance-based RSUs. Based on the difference between the
weighted average exercise price of the options and $38.17, the closing price of our Common Stock on March 28, 2013 (the last
-58-
trading day of the fiscal year), the net value of the accelerated options would be $1,782,813 and the value of his RSUs would
be $7,199,168. The table below calculates all payments to be made to Mr. Gavrielov in connection with such termination:
Annual Base Salary
750,000
$
Annual Target
Bonus
$
937,500
$
Pro Rata
Portion of
Target Bonus
509,375
Medical and
Dental
Insurance
$
26,902
$
Value of
Options
1,782,813
$
Value of
RSUs(1)
7,199,168
Total
11,205,758
$
(1)
Includes 24-months’ acceleration of time-based RSUs and performance-based RSUs (based on actual performance of the
applicable performance metrics), and assuming monthly vesting from the date of grant. In May 2013, the Compensation
Committee determined Mr. Gavrielov earned 73,198 shares under his fiscal 2013 performance-based RSUs based on
actual performance achievement, of which 65,065 shares would have accelerated upon his termination of employment.
If Mr. Gavrielov's employment had been terminated within one year of a Change in Control, then the number of shares
that would have accelerated under his fiscal 2013 performance-based RSUs would have been based on the target
number, which was 57,500 shares, of which 51,111 shares would have accelerated, reducing the total in the chart above
by approximately $532,624.
Employment Letter Agreement with Jon A. Olson. Under an employment letter agreement that we entered into with Mr. Olson
on June 2, 2005, and amended on February 14, 2008, and June 13, 2012, in the event Mr. Olson is terminated without Cause (in
each case, as defined in his agreement and described below in the section entitled “Definitions of Good Reason, Cause and
Change in Control”) within one year of such Change in Control, and subject to Mr. Olson’s execution of a release of claims in
favor of the Company, he will be eligible for: (i) one year of his base salary, (ii) one year of his target bonus, (iii) one year of
COBRA premium for medical and dental insurance and (iv) 12 months accelerated vesting of all equity grants received from
the Company prior to such termination of employment; for determining the 12 months of accelerated vesting of (a)
performance-based RSUs, the number of accelerated shares will be based on the target number of RSUs determined at the time
of grant that would have vested in the 12 months following his termination of employment, had the original vesting schedule
been based on a monthly rather than an annual basis, and (b) time-based RSUs, the number of shares that accelerate will be the
number of RSUs that otherwise would have vested in the 12 months following termination of employment, had the original
vesting schedule been based on a monthly rather than an annual basis. Mr. Olson’s employment agreement was amended on
June 13, 2012 to clarify this treatment relating to the accelerated vesting of RSUs and the intent to comply, to the extent
applicable, with Section 409A of the Tax Code.
Potential Payments upon Change in Control and Termination of Mr. Olson’s Employment. Under his employment
agreement, Mr. Olson will receive certain compensation as set forth above. Assuming Mr. Olson's employment had been
terminated without Cause within one year of a Change in Control on March 30, 2012, Mr. Olson would have received the
following severance benefits under his employment agreement: (i) a lump sum payment of $480,000, consisting of his annual
base salary for fiscal 2013; (ii) a lump sum payment of approximately $360,000, consisting of his target bonus for fiscal 2013;
(iii) Company paid COBRA coverage for 12 months valued at $26,902; (iv) accelerated vesting of stock options to purchase an
aggregate of 33,750 shares of Common Stock that were in-the-money as of March 28, 2013; and (v) accelerated vesting of
49,163 shares of Common Stock subject to RSUs, which includes 20,945 shares under time-based RSUs, and 28,218 shares
under performance-based RSUs. Based on the difference between the weighted average exercise price of the options and
$38.17, the closing price of our Common Stock on March 28, 2013 (the last trading day of the fiscal year), the net value of the
accelerated stock options would be $461,450 and the value of the accelerated performance-based RSUs would be $1,876,552.
The table below calculates all payments to be made to Mr. Olson in connection with such termination:
Annual Base Salary
$
480,000
Annual Target
Bonus
Medical and
Dental
Insurance
Value of
Options
$
360,000
$
26,902
$
461,450
$
Value of
RSUs(1)
1,876,552
$
Total
3,204,904
(1)
Includes 12-months’ acceleration of time-based RSUs and performance-based RSUs based on the target number of
RSUs determined at the time of grant.
Definitions of Good Reason, Cause and Change in Control. Under Mr. Gavrielov’s employment letter agreement, the
following events would constitute “Good Reason”: (i) a reduction of 10% or more in his base compensation, target bonus
opportunity or guaranteed bonus; (ii) a material reduction in his authority, duties or responsibilities; (iii) his no longer being
CEO; or (iv) a relocation of the Company’s headquarters outside of the San Francisco Bay Area; provided that Mr. Gavrielov
has given the Company notice of, and the Company has failed to cure, the event giving rise to Good Reason and
Mr. Gavrielov’s employment terminates within six months of the occurrence of such event.
“Cause” under Mr. Gavrielov’s employment letter agreement includes: (i) continued neglect of, or willful failure or misconduct
in the performance of, his duties; (ii) a material breach of the Company’s Proprietary Information and Inventions Agreement,
-59-
Code of Conduct or other policies; (iii) fraud, embezzlement or material misappropriation; (iv) conviction of, or entry of a plea
of no contest or nolo contendere, to a felony; or (v) any continued willful and wrongful act or omission that materially injures
the financial condition or business reputation of the Company and its subsidiaries; subject in certain of the above cases to
applicable notice and cure periods.
The Company will have “Cause” to terminate Mr. Olson’s employment if he: (i) engages in financial fraud or embezzles
property of the Company or any of its subsidiaries; (ii) fails to pay an obligation owed to the Company; (iii) breaches a
fiduciary duty or deliberately disregards Company policies, which results in loss to the Company; (iv) engages in any activity
for any competitor of the Company or any of its subsidiaries; (v) discloses any confidential information or trade secret, or
engages in the theft of any trade secret, of the Company or any of its subsidiaries; or (vi) violates securities, antitrust, unfair
competition or other laws or otherwise engages in conduct that puts the Company or any of its subsidiaries at substantial risk of
violating such laws.
A “Change in Control” will generally be deemed to have occurred under Messrs. Gavrielov's and Olson’s agreements in the
event: (i) any person or group acquires more than 50% of the fair market value or voting power of the Company’s shares
(however, if any one person or more than one person acting as a group, is considered to own more than 50% of the total fair
market value or total voting power of the shares of Common Stock of the Company, then the acquisition of additional shares by
that person or persons will not be considered to cause a “Change in Control”); (ii) a change in the majority of the members of
the board of directors during any 12-month period unless such change is endorsed by a majority of the board members serving
prior to the change; or (iii) any person or group acquires all or substantially all of the assets of the Company.
Other than those described above, none of the other named executive officers have severance or change in control agreements
with the Company. The Company has not provided any named executive officer with a gross-up or other reimbursement for tax
amounts the named executive officer might be required to pay pursuant to Section 280G, or any related section, of the Tax
Code.
-60-
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
The Audit Committee oversees the Company’s financial reporting process on behalf of the Board. It assists the Board in
fulfilling its oversight responsibilities to the stockholders relating to the Company’s financial statements and the financial
reporting process, the systems of internal accounting and financial controls, and the audit process. While the Audit Committee
sets the overall corporate tone for quality financial reporting, management has the primary responsibility for the preparation,
presentation and integrity of the Company’s financial statements and implementation of the reporting process including the
systems of internal controls and procedures designed to reasonably assure compliance with accounting standards, applicable
laws and regulations. In accordance with the law, the Audit Committee has ultimate authority and responsibility to select,
compensate, evaluate and, when appropriate, replace the Company’s independent auditors. The Charter of the Audit Committee
can be found at www.investor.xilinx.com under “Corporate Governance.”
The Company’s external auditors, Ernst & Young LLP, are responsible for performing an independent audit of the Company’s
consolidated financial statements in accordance with generally accepted auditing standards and expressing opinions on the
conformity of the Company’s audited financial statements to generally accepted accounting principles in the United States and
the effectiveness of the Company’s internal control over financial reporting. In carrying out its responsibilities, the Audit
Committee has the power to retain outside counsel or other experts and is empowered to investigate any matter with full access
to all books, records, facilities and personnel of the Company. The Audit Committee members are not professional accountants
or auditors, and their functions are not intended to duplicate or certify the activities of management and the independent
auditors.
In fulfilling its oversight responsibilities, the Audit Committee reviewed the audited consolidated financial statements for the
fiscal year ended March 30, 2013 with management and Ernst & Young LLP, including a discussion of the quality, not just the
acceptability, of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the
financial statements. The Audit Committee also discussed with Ernst & Young LLP, matters required to be discussed under
standards published by the Public Company Accounting Oversight Board (PCAOB), including, among other things, matters
related to the conduct of the audit of the Company’s consolidated financial statements and other required communications with
audit committees. In addition, the Audit Committee has received and reviewed the written disclosures and the letter from
Ernst & Young LLP required by applicable requirements of the PCAOB regarding the independent accountant’s
communications with the audit committee concerning independence, and has discussed with them their independence from the
Company and its management.
The Audit Committee reviewed and discussed with management its assessment and report on the effectiveness of the
Company’s internal control over financial reporting as of March 30, 2013. The Audit Committee has also reviewed and
discussed with Ernst & Young LLP its audit of and report on the Company’s internal control over financial reporting. The
Company published these reports in its Annual Report on Form 10-K for the fiscal year ended March 30, 2013.
Based on the reviews and discussions referred to above, the Audit Committee recommended to the Board that the audited
financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 30, 2013 for
filing with the SEC.
The Audit Committee of the Board of Directors
—John L. Doyle, Chairman
—J. Michael Patterson
—Albert A. Pimentel
—Marshall C. Turner
The foregoing Report of the Audit Committee of the Board of Directors is not “soliciting material,” is not deemed “filed” with
the SEC and is not to be incorporated by reference in any filing of Xilinx under the Securities Act or under the Exchange Act,
whether made before or after the date of this proxy statement and irrespective of any general incorporation language in any
such filing.
-61-
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
The members of the Compensation Committee are J. Michael Patterson, Marshall C. Turner and Elizabeth W. Vanderslice.
During fiscal 2013, Philip T. Gianos also served on the Compensation Committee. No member of the Compensation
Committee is, or was during fiscal 2013, an officer or employee of the Company or any of its subsidiaries or was formerly an
officer of the Company or any of its subsidiaries. No member of the Compensation Committee is, or was during fiscal 2013, an
executive officer of another company whose board of directors has a comparable committee on which one of the Company’s
executive officers serves. For further discussion regarding transactions with related parties, see the section above entitled
“BOARD MATTERS-Director Independence.”
SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires the Company’s officers and Directors, and persons who own more than 10% of a
registered class of the Company’s equity securities, to file reports of ownership and changes in ownership of such securities
with the SEC. Officers, Directors and greater than 10% beneficial owners are required by applicable regulations to furnish the
Company with copies of all Section 16(a) forms they file. To the Company’s knowledge, based solely upon a review of the
copies of such reports furnished to the Company, and written representations from certain reporting persons that no other
reports were required, the Company believes that its officers, Directors and greater-than-10% stockholders complied with all
Section 16(a) filing requirements during the 2013 fiscal year.
RELATED TRANSACTIONS
Our Audit Committee is responsible for reviewing and approving all related party transactions. Related parties include any of
our Directors or executive officers, certain of our stockholders and their immediate family members. This obligation is set forth
in writing in the Audit Committee charter. The Audit Committee reviews related party transactions due to the potential for a
conflict of interest. A conflict of interest arises when an individual’s personal interest interferes with the Company’s interests.
All transactions identified through our disclosure controls and procedures as potential related party transactions, or transactions
that may create a conflict of interest or the appearance of a conflict of interest, are brought to the attention of the Audit
Committee for its review. In reviewing related party transactions, the Audit Committee applies the standards set forth in the
Company’s Code of Conduct and the Directors’ Code of Ethics which provide that Directors, officers and employees are to
avoid any activity, investment or association that would cause or even appear to cause a conflict of interest. Copies of the Audit
Committee Charter, the Code of Conduct and the Directors’ Code of Ethics are available on our website at
http://www.investor.xilinx.com under “Corporate Governance.” For further discussion regarding transactions with related
parties, see the section above entitled “BOARD MATTERS—Director Independence.”
In fiscal 2011, our Audit Committee pre-approved our engagement of BlackRock, Inc. (“BlackRock”) as an investment
manager. At the time we entered into this engagement, BlackRock was the beneficial owner of more than five percent of our
outstanding common stock and is currently a beneficial owner of more than five percent of our outstanding common stock.
Xilinx paid BlackRock $234,185 in management fees during fiscal 2013.
The Company knows of no other matters to be submitted to the meeting. If any other matters properly come before the meeting,
it is the intention of the persons named in the enclosed proxy card to vote the shares they represent as the Board may
recommend.
OTHER MATTERS
THE BOARD OF DIRECTORS
Dated: July 1, 2013
-62-
BOARD OF DIRECTORS
CORPORATE OFFICERS
CORPORATE INFORMATION
Philip T. Gianos
Chairman of the Board
Moshe N. Gavrielov
Common Stock
President and Chief Executive Officer
Xilinx’s common stock trades on the NASDAQ Global Select Market
under the symbol XLNX.
Moshe N. Gavrielov
Ivo Bolsens
President and Chief Executive Officer
John L. Doyle
William G. Howard, Jr.
J. Michael Patterson
Albert A. Pimentel
Marshall C. Turner
Elizabeth W. Vanderslice
Senior Vice President and
Chief Technology Officer
Kevin J. Cooney
Corporate Vice President and
Chief Information Officer
Steven L. Glaser
Senior Vice President,
Corporate Strategy & Marketing Group
Scott R. Hover-Smoot
Corporate Vice President,
General Counsel and Secretary
Marilyn Stiborek Meyer
Corporate Vice President,
Worldwide Human Resources
Jon A. Olson
Senior Vice President, Finance and
Chief Financial Officer
Victor Peng
Senior Vice President,
Programmable Platforms Group
Raja G. Petrakian
Senior Vice President,
Worldwide Operations
Krishna Rangasayee
Senior Vice President and
General Manager
Communications Business Unit
Vincent L. Tong
Senior Vice President,
Worldwide Quality and
New Product Introductions
Executive Leader, Asia Pacific
Frank A. Tornaghi
Senior Vice President,
Worldwide Sales
As of May 3, 2013, there are approximately 600 stockholders of
record. Since many holders’ shares are listed under their brokerage
firms’ names, the actual number of stockholders is estimated to be
over 110,000.
Dividend Information
Xilinx currently pays a quarterly common stock dividend. Please
refer to the Dividend FAQ page on www.investor.xilinx.com for more
information regarding our stock dividend program. Xilinx does not
currently offer a Dividend Reinvestment or Direct Purchase Program.
Twelve Month Closing Stock Price Range:
April 2012 to March 2013: $30.63 - $39.14
Transfer Agent and Registrar
Please send change of address and other correspondence to:
Computershare Trust Company, N.A.
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940-3078
www.computershare.com
Phone: +1-781-575-2879
Inquiries Concerning the Company
If you have questions regarding Xilinx’s operations, recent results or
historical performance, please contact:
Xilinx, Inc.
Investor Relations
2100 Logic Drive
San Jose, CA 95124
www.investor.xilinx.com
Email: ir@xilinx.com
Copies of the Xilinx Annual Report, Form 10-K and Proxy are available
to all stockholders without charge.
Independent Auditors
Ernst & Young LLP
San Jose, CA
Annual Meeting
The 2013 Xilinx Annual Meeting of stock holders will be held on
August 14, 2013 at 11 a.m. Pacific Daylight Time at Xilinx, Inc.,
2050 Logic Drive, San Jose, CA 95124.
Corporate Headquarters
Europe
Japan
Asia Pacific
Xilinx, Inc.
2100 Logic Drive
San Jose, CA 95124
USA
Tel: +1-408-559-7778
www.xilinx.com
Xilinx Europe
2020 Bianconi Avenue
Citywest Business Campus
Saggart, County Dublin
Ireland
Tel: +353-1-464-0311
www.xilinx.com
Xilinx K.K.
Art Village Osaki Central Tower 4F
1-2-2, Osaki
Shinagawa-ku, Tokyo, 141-0032
Japan
Tel: +81-3-6744-7777
japan.xilinx.com
Xilinx Asia Pacific Pte. Ltd.
5 Changi Business Park Vista
Singapore 486040
Tel: +65-6407-3000
www.xilinx.com
© Copyright 2013 Xilinx, Inc. XILINX, the Xilinx logo, Artix, ISE, Kintex, Spartan, Virtex, Vivado, Zynq, and other designated brands included herein are trademarks of Xilinx
in the United States and other countries. All other trademarks are the property of their respective owners
3
1
/
6
0
0
9
3
1
S
C
.
A
S
U
n
i
d
e
t
n
i
r
P
.
d
e
v
r
e
s
e
r
s
t
h
g
i
r
l
l
A
.
c
n
I
x
n
i
l
i
X
3
1
0
2
©